data_2kq8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kq8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.848 -0.427 . . . . 74.12 109.848 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 87.2 mt -71.05 90.67 0.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.571 -0.529 . . . . 71.32 109.571 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 72.5 m-20 -97.96 -29.94 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 75.13 112.131 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 55' ' ' ILE . 63.6 t -64.86 -51.39 67.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.718 -0.475 . . . . 72.32 109.718 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.885 ' HG3' HD13 ' A' ' 25' ' ' ILE . 6.5 mtp180 -155.31 -177.01 6.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.151 -0.931 . . . . 70.03 108.528 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 22.9 t 75.16 3.96 4.14 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.977 0.798 . . . . 71.21 110.246 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.57 16.91 31.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.002 -0.618 . . . . 63.35 111.968 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CG ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -99.69 -46.71 5.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.002 -0.74 . . . . 75.41 109.002 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.52 4.87 49.29 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.72 -1.127 . . . . 72.32 110.57 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -101.34 -51.39 3.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.275 -0.462 . . . . 74.53 110.717 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.5 88.6 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.379 -0.6 . . . . 74.21 109.379 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.882 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 19.6 p90 -95.82 4.7 52.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 -169.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -106.37 -0.06 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.252 -0.579 . . . . 71.31 111.513 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.767 HG21 HG13 ' A' ' 25' ' ' ILE . 54.2 mt -77.41 -55.82 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.338 -0.392 . . . . 61.1 111.854 -174.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.885 HD13 ' HG3' ' A' ' 15' ' ' ARG . 2.0 mt -140.54 178.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.554 -0.535 . . . . 72.51 109.554 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.701 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -125.83 -118.1 2.22 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.954 -0.641 . . . . 71.05 112.534 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -139.81 105.68 5.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.022 0.439 . . . . 62.14 111.933 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -152.32 57.68 2.26 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.842 -0.617 . . . . 64.45 111.054 173.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 28' ' ' LEU . 19.7 Cg_endo -95.66 166.29 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.19 2.594 . . . . 64.22 112.172 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 63.44 104.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.4 0.619 . . . . 73.24 111.373 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.94 -32.58 7.36 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.394 -0.682 . . . . 72.43 111.394 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.33 -172.71 2.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 64.52 110.021 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 38.7 ttpt -85.98 157.66 20.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.299 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 94.2 t 76.23 126.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.695 0.759 . . . . 72.44 112.056 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.83 175.45 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 73.21 109.839 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.632 ' HA ' HG21 ' A' ' 46' ' ' ILE . 17.3 m -76.06 125.67 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.961 -0.385 . . . . 73.5 109.961 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -81.63 -55.97 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.46 -0.337 . . . . 51.21 110.515 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -171.07 150.82 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 38.6 110.9 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -80.02 131.43 35.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.577 -0.738 . . . . 73.05 110.193 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -134.96 114.49 12.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.615 0.245 . . . . 74.34 110.956 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t 71.84 5.52 5.38 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.453 -0.794 . . . . 75.03 111.779 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.4 -48.76 0.95 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 64.22 111.854 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -84.67 160.53 20.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 73.52 110.315 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 68.5 m -96.28 140.25 31.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.766 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -82.86 118.69 23.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.07 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.632 HG21 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -133.81 144.55 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 64.22 110.232 173.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -122.03 113.55 19.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.975 -1.12 . . . . 64.43 107.975 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 69.3 t80 -105.56 86.1 2.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.138 -0.483 . . . . 74.45 110.908 -170.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 62.32 46.33 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.229 0.538 . . . . 74.41 110.826 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.46 -17.57 58.75 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 73.32 113.512 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.3 pt20 -103.48 128.1 50.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.38 0.609 . . . . 74.1 110.225 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 151.82 21.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 53.21 111.067 -172.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.96 173.7 38.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.403 -0.903 . . . . 61.35 113.353 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 72.1 m-85 -132.97 144.74 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 74.21 109.269 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.522 ' CG2' ' HA ' ' A' ' 15' ' ' ARG . 2.8 pp -136.03 161.69 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.618 0.247 . . . . 74.44 110.946 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.36 123.31 6.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.601 -0.809 . . . . 44.24 111.814 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -64.76 -7.07 9.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.009 0.433 . . . . 75.03 111.7 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -65.76 -37.57 86.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.454 -0.339 . . . . 75.51 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -124.32 120.64 32.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.523 0.678 . . . . 75.4 111.744 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 66.6 mt -155.89 175.64 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.112 -1.44 . . . . 73.33 107.112 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 29' ' ' PRO . 6.1 p -111.47 118.14 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.607 -0.837 . . . . 55.45 111.456 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.029 -0.987 . . . . 71.35 109.206 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.285 0 CA-C-O 121.054 0.454 . . . . 70.44 110.389 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.814 ' H ' HD21 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -79.95 69.6 6.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.82 0.819 . . . . 73.01 109.499 174.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -117.61 -44.73 2.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.787 -1.097 . . . . 71.51 110.578 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' NE ' ' A' ' 15' ' ' ARG . 18.9 t -124.68 -67.11 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.32 -0.4 . . . . 71.11 111.04 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.556 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -130.59 142.47 50.46 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.553 -0.294 . . . . 74.12 110.894 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 53.9 p 45.92 74.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 124.087 0.867 . . . . 71.53 112.654 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . -127.49 -14.69 2.58 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.421 -0.895 . . . . 43.53 111.992 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -163.5 115.62 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.076 -0.713 . . . . 60.13 109.076 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.51 -152.95 24.96 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.5 -0.857 . . . . 73.45 112.402 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -68.91 -31.92 71.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 75.03 111.571 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -133.04 123.57 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 14.6 p90 -130.12 8.59 5.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.731 0.641 . . . . 75.34 112.731 -171.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -116.79 -11.16 10.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.329 0.862 . . . . 72.51 113.329 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.505 ' HB ' HD12 ' A' ' 25' ' ' ILE . 5.0 pt -67.15 -56.45 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 114.365 1.246 . . . . 74.03 114.365 -167.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 15' ' ' ARG . 3.3 mp -111.73 -63.58 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.428 1.013 . . . . 54.23 111.664 -176.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.8 -151.61 16.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.212 -0.994 . . . . 62.14 112.944 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.3 97.71 6.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 62.43 111.28 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.2 tp -160.75 87.68 1.75 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.95 -0.568 . . . . 71.53 110.086 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -82.56 81.67 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.874 2.383 . . . . 63.42 111.549 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -104.3 -48.36 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 74.13 110.39 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.12 104.66 0.39 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 72.31 112.031 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.91 98.65 11.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.46 . . . . 62.01 110.246 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -149.43 42.7 0.92 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.964 -0.754 . . . . 55.34 108.964 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 48' ' ' TYR . 6.2 p -123.14 -46.78 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.743 -0.662 . . . . 75.42 111.677 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -83.54 76.71 9.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.497 0.665 . . . . 64.33 110.629 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.66 3.32 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.771 -1.104 . . . . 64.41 109.15 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -77.06 -57.76 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.81 -0.632 . . . . 72.02 110.631 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 p -178.62 149.98 0.51 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.475 0.655 . . . . 53.32 111.661 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.67 127.23 56.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.987 -1.006 . . . . 71.53 108.55 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.94 171.43 7.52 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.541 -0.464 . . . . 75.25 110.776 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.3 t -64.57 -22.27 66.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 53.21 110.826 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.87 -73.78 0.99 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.971 -0.633 . . . . 41.44 111.972 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -117.23 161.91 18.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.151 0.501 . . . . 73.02 110.877 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.564 ' HB2' HG23 ' A' ' 57' ' ' THR . 35.4 t -87.97 126.72 35.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.012 -0.736 . . . . 64.24 109.012 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.9 ttmt -83.97 123.05 29.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.133 0.492 . . . . 64.21 111.326 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.462 HG22 ' HB3' ' A' ' 35' ' ' GLN . 20.0 pt -139.91 156.8 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 74.34 110.648 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -126.3 113.75 17.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 73.3 109.074 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' CE1' ' HD3' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -101.26 84.11 2.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.619 -0.432 . . . . 74.33 110.832 -178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.29 56.15 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 74.13 112.098 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.74 56.57 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.09 -0.576 . . . . 42.22 114.16 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.22 128.72 54.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.653 0.726 . . . . 72.34 110.501 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -73.18 133.55 44.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.169 -0.923 . . . . 74.44 110.577 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.8 159.02 23.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.812 -0.708 . . . . 60.13 111.671 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -138.48 139.8 38.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.61 -0.515 . . . . 74.53 109.61 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.551 HD12 HD23 ' A' ' 60' ' ' LEU . 2.6 pp -137.52 149.12 25.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.517 -0.311 . . . . 71.23 110.453 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 123.1 8.21 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.638 -0.791 . . . . 74.2 111.943 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -62.3 -18.15 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 74.12 112.058 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.51 -32.98 74.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.026 -0.533 . . . . 75.24 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.87 114.37 26.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.615 0.245 . . . . 73.22 110.354 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 55' ' ' ILE . 32.3 mt -159.22 151.51 21.22 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.884 -0.598 . . . . 73.41 111.206 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -97.25 118.82 34.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 164.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.797 0.332 . . . . 65.02 111.108 -173.352 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 111.999 0.37 . . . . 71.23 111.999 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 6.4 mp -80.69 44.94 0.76 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.75 0.31 . . . . 71.04 111.459 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 22.4 m120 -74.98 -31.01 61.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 64.03 111.569 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -95.11 30.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 74.4 111.603 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.813 HH11 ' HA2' ' A' ' 26' ' ' GLY . 17.8 tpt180 -80.48 47.88 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.709 0.29 . . . . 74.1 111.463 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 t 64.51 4.87 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.494 0.717 . . . . 62.2 112.616 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.32 80.73 0.7 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.393 -0.908 . . . . 63.41 111.484 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HG2' ' H ' ' A' ' 19' ' ' GLY . 35.6 tt0 70.93 175.9 0.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.946 0.498 . . . . 62.22 109.74 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -79.01 59.1 4.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.818 -0.706 . . . . 63.44 112.879 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -93.79 -33.33 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.104 0.478 . . . . 75.12 110.148 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' A' ' 24' ' ' ILE . 22.2 t-20 -153.3 145.2 23.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.257 -1.016 . . . . 75.13 108.257 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 7.11 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.959 -0.697 . . . . 74.44 111.755 -173.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -116.68 -32.78 5.06 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.832 -0.747 . . . . 74.43 112.738 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 25' ' ' ILE . 70.4 mt -61.4 -55.96 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 72.54 111.19 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.587 HG22 ' CZ ' ' A' ' 48' ' ' TYR . 12.9 mt -129.7 158.75 42.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.813 ' HA2' HH11 ' A' ' 15' ' ' ARG . . . -131.42 -105.02 1.01 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.968 -1.111 . . . . 62.32 113.924 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -147.22 93.58 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.617 -0.512 . . . . 73.4 109.617 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -154.09 80.54 4.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.488 -0.56 . . . . 63.52 109.488 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.715 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 10.3 Cg_exo -75.23 89.09 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.107 2.538 . . . . 73.1 112.115 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.8 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tt0 -117.51 -49.33 2.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.675 -0.693 . . . . 73.24 109.391 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.85 17.08 79.21 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.781 -0.645 . . . . 63.31 114.291 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.8 ' HG3' ' HG2' ' A' ' 30' ' ' GLN . 31.5 mt-30 -80.94 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.618 0.709 . . . . 71.13 110.152 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 4.3 mptp? -101.14 0.1 37.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.381 0.61 . . . . 54.33 109.935 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 41.3 t -93.26 92.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 72.14 109.093 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -112.69 141.22 46.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.853 -0.612 . . . . 74.52 110.965 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 ' HA ' HG22 ' A' ' 46' ' ' ILE . 16.9 m -84.53 126.24 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.801 -0.636 . . . . 72.33 109.824 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.12 -49.63 12.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.125 0.488 . . . . 65.34 110.181 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -163.52 168.39 20.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.533 -0.758 . . . . 71.41 108.97 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 pp20? -139.91 152.36 46.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.831 0.348 . . . . 74.53 110.815 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -156.15 129.33 8.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 75.24 109.649 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.7 t 71.8 -0.55 3.15 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.09 -0.505 . . . . 71.05 112.004 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.98 -21.62 10.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.809 -0.71 . . . . 74.44 111.838 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -95.74 150.5 20.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.666 -0.494 . . . . 74.11 109.666 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.4 t -117.34 140.17 49.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.157 0.503 . . . . 74.03 110.99 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.98 108.74 16.51 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.228 -0.896 . . . . 74.02 108.77 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.609 HD12 HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -130.06 163.21 36.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.028 0.442 . . . . 75.33 111.351 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 9.1 t30 -101.57 113.13 25.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.375 -0.829 . . . . 74.24 108.859 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.587 ' CZ ' HG22 ' A' ' 25' ' ' ILE . 90.0 t80 -105.6 98.2 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.504 -0.317 . . . . 73.3 110.241 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t30 56.21 34.68 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.206 0.526 . . . . 74.52 111.007 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.49 62.42 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.77 -0.729 . . . . 44.2 113.908 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.1 pt20 -124.2 155.73 38.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.453 0.627 . . . . 55.32 110.24 174.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -90.5 142.12 28.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.442 -0.345 . . . . 73.14 110.649 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.99 25.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.635 -0.793 . . . . 74.12 112.218 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.8 146.76 51.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.764 -0.458 . . . . 74.3 109.764 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.609 HG13 HD12 ' A' ' 46' ' ' ILE . 2.7 pp -144.38 171.76 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.146 0.279 . . . . 73.43 110.365 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.64 109.92 3.53 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.718 -0.753 . . . . 62.11 111.839 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 1.4 m -63.78 -24.0 67.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.993 0.368 . . . . 74.35 111.993 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -67.79 -43.84 78.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.297 -0.41 . . . . 74.13 111.885 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -122.79 117.66 26.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.985 0.421 . . . . 63.13 110.656 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 85.7 mt -155.05 153.82 31.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.09 -0.959 . . . . 71.12 110.124 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.715 ' HB2' ' HB3' ' A' ' 29' ' ' PRO . 34.8 m -109.24 120.8 43.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.482 -0.933 . . . . 70.24 108.482 171.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 75.03 111.428 -169.296 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 74.22 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt 61.05 21.21 11.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.551 -0.75 . . . . 71.0 111.945 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 16.7 m120 -53.54 -43.6 68.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.071 -0.513 . . . . 72.14 112.064 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.492 HG23 ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.89 48.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.172 0.511 . . . . 74.02 110.822 177.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -80.19 27.38 0.33 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.035 -0.529 . . . . 74.42 111.074 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.473 ' HA ' HG21 ' A' ' 55' ' ' ILE . 11.8 t 56.86 32.61 21.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 74.2 111.292 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 110.16 -124.25 7.03 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.487 -0.863 . . . . 53.51 112.057 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.607 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 21.6 mm-40 -86.29 11.68 11.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 73.33 110.449 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.89 16.58 61.09 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.374 -1.091 . . . . 64.4 110.374 -170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.1 m -62.57 -54.26 42.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.028 -0.586 . . . . 72.13 110.711 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -102.4 100.47 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.139 -0.689 . . . . 73.33 109.139 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -93.48 5.32 51.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.732 -0.667 . . . . 74.34 111.45 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -100.98 -38.41 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.466 0.543 . . . . 73.51 112.466 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.544 HG22 HG13 ' A' ' 25' ' ' ILE . 12.7 tt -82.86 -55.33 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.943 0.72 . . . . 64.34 112.943 -169.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.563 HG12 ' CD2' ' A' ' 48' ' ' TYR . 16.6 mt -126.82 148.76 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.976 -0.379 . . . . 74.02 109.976 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -150.25 159.0 27.93 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.007 -0.837 . . . . 62.14 111.007 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -75.98 96.97 3.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.492 . . . . 73.25 111.78 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -149.84 72.11 9.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.651 -0.704 . . . . 72.41 109.768 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.5 90.48 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.727 2.284 . . . . 72.04 112.055 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -97.33 59.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.51 -0.768 . . . . 74.25 110.141 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.39 -78.05 1.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.493 -1.043 . . . . 63.13 110.493 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -73.16 137.03 44.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.032 -0.729 . . . . 61.04 109.032 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 46.6 mttp -116.05 -75.94 0.58 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.022 0.439 . . . . 74.21 110.108 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.449 HG21 ' HD1' ' A' ' 48' ' ' TYR . 8.3 p 174.3 -29.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.179 -0.919 . . . . 75.21 108.619 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 72.58 127.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.414 -1.266 . . . . 72.35 111.491 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 44' ' ' SER . 58.1 t -82.96 108.26 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.652 -0.704 . . . . 75.22 110.179 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 46' ' ' ILE . 4.7 mt -75.28 -49.53 27.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.836 -0.62 . . . . 75.11 111.346 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 m -153.24 150.95 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.054 0.454 . . . . 72.03 110.937 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.63 123.88 47.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.464 -0.789 . . . . 64.44 109.245 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.34 140.73 26.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.516 -0.179 . . . . 73.34 110.516 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t 75.24 -54.33 0.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.857 0.723 . . . . 74.31 111.662 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.11 -51.84 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.514 -0.634 . . . . 62.42 111.514 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.607 ' HZ2' ' HG2' ' A' ' 18' ' ' GLU . 25.5 m0 -87.61 160.14 18.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.089 0.471 . . . . 74.45 110.691 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.54 ' HB3' HG12 ' A' ' 36' ' ' VAL . 44.4 m -91.34 140.79 29.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.63 -0.714 . . . . 74.23 109.352 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -105.45 129.88 53.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 120.935 0.398 . . . . 73.32 109.939 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.875 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -142.91 170.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.704 . . . . 74.33 110.315 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -108.79 115.11 29.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.253 -0.647 . . . . 74.41 109.253 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.563 ' CD2' HG12 ' A' ' 25' ' ' ILE . 5.8 t80 -113.47 101.23 9.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 73.11 110.156 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t30 63.02 41.79 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 73.04 110.35 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.21 56.86 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.555 -0.748 . . . . 53.31 113.65 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.79 145.86 38.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.388 0.594 . . . . 74.35 111.689 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 m -72.52 123.21 22.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 74.22 111.002 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.5 168.58 18.6 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.779 -0.724 . . . . 72.33 111.75 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.39 144.4 51.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.817 0.341 . . . . 73.33 110.434 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.602 HG12 HD11 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.92 156.26 31.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.74 -0.664 . . . . 64.13 109.668 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -72.36 129.1 14.13 Favored Glycine 0 C--O 1.219 -0.815 0 C-N-CA 120.631 -0.795 . . . . 73.43 112.137 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -77.24 -13.57 59.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.322 0.582 . . . . 71.21 110.428 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.557 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 17.3 ptt85 -85.65 -16.84 37.86 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.382 -0.372 . . . . 75.43 111.271 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.557 ' HD1' ' HG3' ' A' ' 58' ' ' ARG . 30.9 m-85 -127.12 116.33 20.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.204 -0.665 . . . . 74.0 109.204 171.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.1 mt -140.96 173.83 11.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.279 0.561 . . . . 75.02 110.876 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . 10.1 t -109.26 127.44 54.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.696 -0.684 . . . . 73.34 109.174 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.718 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.234 -0.654 . . . . 73.41 109.234 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 15' ' ' ARG . 4.3 mm? 67.19 28.69 8.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.471 0.482 . . . . 73.22 110.079 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 88.0 m-20 -63.19 -50.08 71.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.439 -0.801 . . . . 72.13 111.727 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.02 6.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.482 -0.562 . . . . 72.24 109.482 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.487 ' HG3' ' HA ' ' A' ' 12' ' ' LEU . 37.6 mtp180 -69.41 176.89 3.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.793 -0.64 . . . . 65.13 110.911 -172.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.948 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 3.9 m 69.97 44.63 0.79 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.683 -0.689 . . . . 64.42 111.044 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.87 ' HA3' HD12 ' A' ' 25' ' ' ILE . . . -56.49 -35.84 68.05 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 114.246 0.458 . . . . 71.4 114.246 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 21' ' ' ASN . 42.2 mt-10 -90.3 9.93 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.213 0.507 . . . . 71.24 110.532 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA3' ' CH2' ' A' ' 43' ' ' TRP . . . 76.73 -65.69 2.83 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 116.097 -0.501 . . . . 63.51 112.229 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.9 p -82.41 -28.31 31.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.854 0.359 . . . . 75.31 110.763 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 27.5 t30 -100.17 118.11 35.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.948 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 24.2 m-85 -93.8 -36.88 12.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.869 -0.605 . . . . 75.21 111.807 -170.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -73.88 -6.61 48.23 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.068 0.766 . . . . 74.04 113.068 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.44 -35.88 64.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 73.02 111.935 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.87 HD12 ' HA3' ' A' ' 17' ' ' GLY . 33.2 mt -124.13 156.32 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.3 -0.259 . . . . 74.21 110.3 -173.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.45 -135.91 6.1 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.191 -0.528 . . . . 74.31 112.2 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 13' ' ' ASN . . . -148.88 99.18 2.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.066 0.433 . . . . 75.45 112.098 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.9 tp -157.1 69.5 4.44 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.976 0.417 . . . . 75.35 110.776 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -97.94 63.73 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.106 2.537 . . . . 36.9 112.506 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.7 -77.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 73.22 110.024 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.9 3.49 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.508 -0.637 . . . . 73.33 111.508 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.79 153.26 14.47 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.904 -1.147 . . . . 75.23 107.904 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -80.07 15.09 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.111 0.481 . . . . 72.43 111.213 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 89.0 t -76.61 97.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.034 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -138.98 169.7 17.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.837 -0.619 . . . . 74.01 110.69 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.63 125.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.685 -0.689 . . . . 74.44 109.547 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -78.29 -55.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.511 0.672 . . . . 72.52 109.618 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 t -147.06 155.74 42.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.925 -1.034 . . . . 62.12 109.18 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.74 159.21 35.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.255 0.55 . . . . 74.45 111.412 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -132.53 174.24 10.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.574 -0.739 . . . . 72.51 109.337 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 t -74.66 78.89 2.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.708 0.766 . . . . 64.02 110.538 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.03 -70.99 0.31 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.12 -0.946 . . . . 73.41 111.465 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.3 m0 -115.42 146.07 41.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.996 0.427 . . . . 72.44 110.425 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.1 m -115.32 135.8 53.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 73.44 110.094 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.7 ttmt -82.57 125.29 30.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.356 0.598 . . . . 73.24 111.355 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 pt -128.08 171.04 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.484 -0.78 . . . . 74.42 110.858 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 t-20 -126.58 113.92 17.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.036 -0.727 . . . . 71.4 109.036 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.75 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 31.2 t80 -103.72 77.79 1.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 75.01 109.885 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 58.47 48.02 12.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.14 111.863 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.76 -17.21 59.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.584 -0.817 . . . . 71.42 113.66 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.8 pt20 -100.37 148.39 24.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.659 0.73 . . . . 71.44 110.344 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.3 m -86.74 140.7 29.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.595 -0.729 . . . . 75.2 111.306 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.17 161.39 31.99 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.915 -0.659 . . . . 62.24 112.133 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.39 139.03 47.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 2.9 pp -121.53 167.52 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.019 -0.273 . . . . 75.41 111.713 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.33 118.86 5.02 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.87 -0.681 . . . . 64.02 111.773 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -58.56 -17.39 21.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.648 0.61 . . . . 64.44 112.648 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -72.06 -25.85 61.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.914 0.338 . . . . 72.54 111.914 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -121.04 119.31 32.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.049 0.452 . . . . 75.12 110.767 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.6 mt -156.87 160.87 39.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.48 -0.782 . . . . 74.01 110.192 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -100.29 120.26 39.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 53.11 110.549 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 174.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.591 ' HA ' ' OG ' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.11 0.781 . . . . 73.25 113.11 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 54.4 mt -84.17 22.91 1.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.008 0.373 . . . . 74.54 112.008 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -117.94 6.78 12.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.913 0.338 . . . . 72.52 111.913 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 25' ' ' ILE . 6.0 t -82.87 49.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 121.885 -0.509 . . . . 65.31 110.395 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.833 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 9.1 ptt180 -120.2 83.16 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.347 0.594 . . . . 72.31 111.965 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.4 m 59.29 25.78 14.48 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.189 -0.914 . . . . 72.13 111.621 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' H ' ' A' ' 56' ' ' GLY . . . 113.85 -143.06 17.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.836 -0.697 . . . . 72.14 111.46 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.22 -27.29 68.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 53.33 110.887 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.92 63.62 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.348 -0.701 . . . . 72.14 111.348 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 m -87.69 -61.55 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 64.22 111.033 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 21' ' ' ASN . 6.6 m120 -123.93 127.23 47.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.168 -0.679 . . . . 53.35 109.168 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -97.56 6.6 47.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.265 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -107.72 -54.66 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.338 -0.392 . . . . 71.51 111.643 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 25' ' ' ILE . 8.1 tt -59.94 -41.88 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 74.43 111.627 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.662 HG21 ' CE1' ' A' ' 48' ' ' TYR . 28.3 mt -136.53 165.07 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.32 -0.992 . . . . 73.13 108.32 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 179.9 -166.33 35.37 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.362 -0.923 . . . . 72.33 112.176 -171.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -81.07 91.78 6.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.05 0.452 . . . . 72.24 111.851 -174.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.544 HD12 ' HE2' ' A' ' 33' ' ' LYS . 1.8 pt? -173.71 77.42 0.38 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.4 -0.818 . . . . 65.04 109.613 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -88.09 85.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.161 2.574 . . . . 75.15 112.401 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -165.35 155.22 12.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 75.1 109.823 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.8 174.75 50.48 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.934 -0.65 . . . . 72.33 113.317 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -92.45 7.32 43.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 74.25 110.802 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HE2' HD12 ' A' ' 28' ' ' LEU . 22.9 pttp -66.96 -15.71 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 73.32 110.995 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 4.4 p -146.63 123.2 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.336 0.589 . . . . 72.11 110.532 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -130.69 132.19 45.26 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.424 -0.584 . . . . 65.21 109.424 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.792 ' HA ' HG23 ' A' ' 46' ' ' ILE . 5.6 p -75.95 126.66 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.099 0.476 . . . . 62.21 110.553 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.43 -56.61 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.664 -0.495 . . . . 74.41 109.664 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -179.17 159.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.629 -0.714 . . . . 64.45 109.7 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.779 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -85.24 144.96 27.8 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.573 -0.739 . . . . 74.42 109.813 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -146.65 113.36 6.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.9 0.381 . . . . 72.31 110.698 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 t 57.9 62.92 1.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 74.23 111.314 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 -59.3 3.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.961 -0.638 . . . . 73.14 112.921 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 14.4 m0 -91.09 159.61 16.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.786 0.326 . . . . 74.41 110.629 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 9.6 t -105.22 142.42 35.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.277 -0.42 . . . . 64.31 110.035 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' A' ' 54' ' ' TYR . 2.9 mtpt -87.88 127.34 35.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 116.178 -0.465 . . . . 63.45 110.829 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 36' ' ' VAL . 46.0 pt -143.23 164.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.723 -0.672 . . . . 64.22 110.954 -177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 26.6 t-20 -112.97 117.34 31.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.454 -0.943 . . . . 74.43 108.454 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CE1' HG21 ' A' ' 25' ' ' ILE . 5.8 t80 -110.23 105.04 13.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.703 0.287 . . . . 74.04 110.515 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.9 t30 62.21 35.29 15.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.675 -0.693 . . . . 73.34 110.919 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.97 -17.48 59.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.887 -0.673 . . . . 54.31 113.234 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -107.92 133.78 51.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.35 0.575 . . . . 71.34 110.601 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -73.93 130.83 40.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.896 -0.593 . . . . 74.32 110.808 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.02 -172.19 12.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.833 -0.699 . . . . 74.43 112.405 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.498 ' CE2' ' HG2' ' A' ' 45' ' ' LYS . 97.0 m-85 -136.06 144.93 45.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.224 -0.287 . . . . 72.31 110.224 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 2.6 pp -135.29 162.43 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.348 -0.387 . . . . 72.23 110.239 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' H ' ' HA2' ' A' ' 17' ' ' GLY . . . -79.71 143.55 25.71 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 71.24 112.055 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.785 ' HA ' HD11 ' A' ' 60' ' ' LEU . 8.7 m -85.07 -5.4 59.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.757 0.789 . . . . 74.21 109.332 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -34.37 57.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.361 -0.836 . . . . 74.34 110.809 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -135.87 118.62 16.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.038 0.447 . . . . 75.11 111.457 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.785 HD11 ' HA ' ' A' ' 57' ' ' THR . 5.2 mp -140.38 173.86 11.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.856 . . . . 72.41 109.062 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 45.9 m -142.39 124.33 15.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.658 -0.497 . . . . 74.31 109.658 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tttt . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 75.4 109.737 -177.665 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 121.015 0.436 . . . . 73.32 110.782 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.687 HD12 ' HE1' ' A' ' 22' ' ' TYR . 59.2 mt -88.48 133.25 34.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.165 -0.47 . . . . 64.32 110.422 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.94 -60.35 1.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.978 0.362 . . . . 61.33 111.978 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 55' ' ' ILE . 4.7 t -74.55 -65.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 73.51 111.385 -172.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 58.33 17.96 5.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.934 0.716 . . . . 71.12 112.934 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 21' ' ' ASN . 37.9 t 62.33 25.21 15.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.212 0.53 . . . . 73.04 110.189 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.36 -108.48 0.67 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.112 -0.795 . . . . 74.52 111.112 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -118.14 14.59 14.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 71.23 110.201 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.17 48.69 0.18 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.588 -0.733 . . . . 73.2 111.467 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.4 m -94.2 -34.97 12.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 74.03 109.913 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 16' ' ' SER . 18.5 m-80 -140.24 142.06 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.195 -0.912 . . . . 73.24 109.591 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.687 ' HE1' HD12 ' A' ' 12' ' ' LEU . 55.7 m-85 -129.53 -13.95 4.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.543 0.687 . . . . 75.14 110.274 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -71.73 -49.9 35.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.913 -1.039 . . . . 73.21 111.109 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 HG21 ' H ' ' A' ' 25' ' ' ILE . 2.7 tt -97.09 -55.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 72.41 111.526 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 48' ' ' TYR . 60.6 mt -101.23 127.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.715 -0.476 . . . . 60.43 109.715 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.47 -108.54 1.01 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.552 -0.832 . . . . 38.03 111.762 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -132.63 92.25 3.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.443 . . . . 71.44 110.164 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.5 pt? -173.39 86.43 0.39 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.352 -0.84 . . . . 72.12 109.834 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.82 71.37 4.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.699 2.266 . . . . 62.11 110.835 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.75 140.97 29.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.163 -0.926 . . . . 64.24 111.088 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.83 177.35 28.17 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.678 -0.773 . . . . 75.44 112.129 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -90.92 51.01 1.88 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 72.12 110.045 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HG3' HG23 ' A' ' 34' ' ' VAL . 47.1 pttt -175.36 -156.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.263 -0.881 . . . . 65.34 109.341 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 33' ' ' LYS . 82.2 t 75.89 -28.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.24 0.616 . . . . 75.12 112.091 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -59.67 -66.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 75.4 110.9 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -174.38 125.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 72.5 110.65 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.2 mt -113.77 -54.06 4.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.227 0.537 . . . . 73.55 110.061 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.9 t -143.06 171.81 13.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.125 -0.694 . . . . 73.35 109.125 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.693 ' HG2' ' HG ' ' A' ' 44' ' ' SER . 39.9 mt-10 -137.95 149.71 46.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.052 -0.351 . . . . 71.42 110.052 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -162.86 117.58 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 65.43 111.628 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 t 63.43 33.05 14.03 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.585 -0.734 . . . . 75.43 112.457 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.55 -32.85 6.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.666 -0.778 . . . . 73.23 112.956 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -102.17 155.13 18.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.992 0.425 . . . . 74.43 110.302 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.693 ' HG ' ' HG2' ' A' ' 39' ' ' GLU . 25.0 m -106.02 143.46 34.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.135 -0.484 . . . . 64.45 110.689 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -82.8 117.53 22.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.508 -0.769 . . . . 73.01 110.363 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.701 ' HA ' HD13 ' A' ' 37' ' ' ILE . 31.4 pt -137.65 171.65 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.966 0.413 . . . . 73.34 110.94 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -115.04 114.68 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.068 -0.716 . . . . 72.34 109.068 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.642 ' CE2' HG23 ' A' ' 25' ' ' ILE . 6.0 t80 -111.05 113.1 25.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.456 -0.338 . . . . 74.25 110.351 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.85 35.06 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.264 0.554 . . . . 74.3 111.109 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.23 64.52 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 63.43 114.033 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -131.12 167.6 18.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.572 0.686 . . . . 61.12 110.782 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.8 m -70.17 119.98 15.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 64.13 110.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.63 169.27 15.79 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.814 -0.707 . . . . 70.52 111.689 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -139.02 150.62 46.02 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.637 -0.505 . . . . 73.35 109.637 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.752 HG23 HG12 ' A' ' 14' ' ' VAL . 2.5 pp -130.33 154.01 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 123.088 0.243 . . . . 75.24 110.681 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.34 108.76 3.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.705 -0.958 . . . . 74.12 110.705 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -59.56 -15.04 15.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.661 0.615 . . . . 73.12 112.661 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -73.4 -16.49 61.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.691 0.282 . . . . 75.42 111.499 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 118.62 15.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.321 -0.251 . . . . 75.14 110.321 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.695 HD23 HD12 ' A' ' 55' ' ' ILE . 36.4 mt -153.37 156.1 37.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.568 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 t -155.27 121.84 5.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.3 mttp . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 116.078 -0.51 . . . . 72.12 109.935 178.215 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.307 0 CA-C-O 120.371 0.129 . . . . 54.11 110.764 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt 56.42 42.18 27.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.093 0.473 . . . . 65.24 111.312 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -68.21 -52.88 29.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.761 -0.654 . . . . 61.45 111.362 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' SER . 4.8 t -87.85 48.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 74.43 110.589 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.819 ' HD2' ' HB2' ' A' ' 22' ' ' TYR . 3.0 mmt180 -74.79 37.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.647 0.61 . . . . 72.23 112.647 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.497 ' HA ' HG21 ' A' ' 55' ' ' ILE . 4.5 m 49.64 73.82 0.23 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.484 0.659 . . . . 73.35 112.525 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.64 ' H ' ' HA ' ' A' ' 55' ' ' ILE . . . 101.97 -139.34 14.37 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.572 -0.74 . . . . 65.02 111.472 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -110.59 39.37 2.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.605 -0.887 . . . . 64.24 108.605 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.01 21.25 33.71 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -1.0 . . . . 74.51 111.055 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -87.08 -61.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 62.24 111.508 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -108.95 34.92 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 64.55 109.582 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.819 ' HB2' ' HD2' ' A' ' 15' ' ' ARG . 28.7 p90 -50.71 -21.99 1.87 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.926 -1.034 . . . . 74.2 113.646 -168.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -58.5 -35.46 72.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.321 0.489 . . . . 75.22 112.321 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.72 -56.94 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 62.43 111.895 -170.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.585 HG12 ' CD2' ' A' ' 48' ' ' TYR . 1.7 mt -128.27 157.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.338 -0.616 . . . . 73.03 109.338 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -144.79 -77.94 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.703 -1.237 . . . . 74.03 114.34 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.739 ' O ' ' HD3' ' A' ' 29' ' ' PRO . . . -81.35 -153.32 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.677 0.621 . . . . 71.21 112.677 -168.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 61' ' ' SER . 56.9 tp -91.16 90.03 0.33 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.355 -0.839 . . . . 75.45 110.762 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.739 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 68.2 Cg_endo -85.59 -7.16 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.574 2.182 . . . . 72.31 112.56 -173.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 67.43 166.0 0.23 Allowed 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.638 0.586 . . . . 71.31 110.633 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.2 67.53 2.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.074 -0.584 . . . . 72.32 112.637 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.63 -67.69 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.358 0.599 . . . . 70.15 110.022 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -139.97 -36.7 0.49 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.848 -1.069 . . . . 72.02 108.785 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -78.46 115.88 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.336 -0.847 . . . . 75.2 110.521 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.446 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 3.9 pm0 -122.79 13.83 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.371 -0.377 . . . . 55.01 110.57 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.887 ' HA ' HG22 ' A' ' 46' ' ' ILE . 95.2 t 73.67 118.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.651 -0.704 . . . . 73.23 109.891 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.25 -51.07 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.129 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -168.65 150.72 4.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.606 -0.724 . . . . 71.53 110.394 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.72 125.84 35.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.499 -0.773 . . . . 72.54 110.195 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -97.62 177.72 5.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.884 -0.598 . . . . 73.54 109.857 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 p -62.36 76.54 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.011 -0.995 . . . . 74.1 111.411 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.08 -68.41 0.55 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.363 -0.835 . . . . 74.12 112.001 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 42.0 m0 -112.61 160.21 18.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 74.35 110.731 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 13.2 m -103.55 129.32 50.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.891 -0.595 . . . . 75.3 109.7 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 38.0 ttmt -83.08 132.28 35.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.168 0.509 . . . . 74.34 111.738 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.887 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -140.02 153.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.592 -0.731 . . . . 75.14 109.954 176.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -111.98 113.77 26.27 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.428 -0.953 . . . . 74.1 108.428 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.672 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 11.8 t80 -115.53 110.96 20.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.253 -0.431 . . . . 62.41 110.137 -172.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.25 33.75 16.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 72.23 110.711 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 -10.2 75.26 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 75.51 113.808 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 14.0 pt20 -106.86 147.01 30.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.751 0.775 . . . . 74.14 110.982 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -84.88 131.29 34.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 62.44 111.418 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.84 174.17 26.77 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.786 -0.721 . . . . 62.5 111.849 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 66.6 m-85 -134.02 147.45 50.96 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.27 -0.641 . . . . 75.32 109.27 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.64 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 2.8 pp -126.86 154.65 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.529 0.204 . . . . 73.1 110.709 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 130.57 11.37 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.556 -0.831 . . . . 72.11 111.817 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 m -69.16 -9.12 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.14 0.495 . . . . 55.2 111.331 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.02 -47.22 86.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.109 0.481 . . . . 71.41 110.189 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.2 118.99 22.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.765 -0.652 . . . . 74.53 110.489 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 36' ' ' VAL . 5.0 tt -138.07 134.98 35.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.314 -0.857 . . . . 75.3 108.817 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.508 ' HB3' HD13 ' A' ' 28' ' ' LEU . 71.1 m -83.86 119.59 25.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 75.41 111.237 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 C--N 1.319 -0.728 0 N-CA-C 107.952 -1.129 . . . . 72.2 107.952 174.441 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.305 0.574 . . . . 72.24 110.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.608 ' HA ' ' HD3' ' A' ' 15' ' ' ARG . 85.9 mt -89.63 69.58 7.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 72.45 110.631 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -119.18 -59.14 1.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.064 0.459 . . . . 75.54 111.455 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.35 49.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 72.25 110.352 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.608 ' HD3' ' HA ' ' A' ' 12' ' ' LEU . 22.0 mmm180 -81.23 42.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.13 112.363 -171.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.8 p 54.22 22.62 3.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.748 0.819 . . . . 75.54 112.777 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 109.3 -116.05 4.46 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 72.21 111.721 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.658 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 2.4 mm-40 -79.03 -72.41 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.633 -0.877 . . . . 73.22 108.633 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 18' ' ' GLU . . . -160.32 30.39 0.37 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.324 -1.51 . . . . 64.03 109.324 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -50.49 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.162 -1.019 . . . . 72.5 111.994 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.642 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.4 t30 -166.86 60.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.032 -0.729 . . . . 72.31 109.032 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -74.63 7.18 3.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.89 -0.595 . . . . 75.0 111.762 -173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.56 -24.1 56.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.582 . . . . 74.4 110.127 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.715 HG13 HG13 ' A' ' 25' ' ' ILE . 29.5 pt -79.19 -45.26 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.402 -0.363 . . . . 74.02 111.698 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.715 HG13 HG13 ' A' ' 24' ' ' ILE . 10.2 mt -132.66 138.05 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.908 -0.405 . . . . 74.43 109.908 -176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.46 -75.42 0.69 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.008 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.09 101.31 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.794 0.331 . . . . 62.52 110.722 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -140.05 75.75 28.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.458 -0.571 . . . . 50.3 109.458 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 6.1 Cg_exo -79.85 117.68 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.238 2.625 . . . . 63.35 111.305 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER 75.37 113.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 124.2 0.938 . . . . 74.15 109.953 -174.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.11 -51.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.509 -0.769 . . . . 63.14 111.32 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' A' ' 33' ' ' LYS . 42.2 mt-30 -134.83 -86.03 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.745 -0.465 . . . . 70.13 109.745 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.916 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 64.1 mttm -127.43 10.53 6.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.609 0.719 . . . . 74.5 109.529 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.74 82.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 122.072 0.939 . . . . 75.51 110.373 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -161.85 44.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.864 -1.062 . . . . 65.43 109.465 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m 43.82 86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.1 0.96 . . . . 70.3 113.164 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -74.74 -55.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.925 -0.58 . . . . 70.23 110.389 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -141.61 172.2 13.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 73.5 109.169 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.14 137.57 47.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.593 0.235 . . . . 70.42 110.485 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -155.56 132.99 11.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.707 -0.479 . . . . 64.43 109.707 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t 71.87 8.42 6.03 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.557 0.536 . . . . 70.22 111.297 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.98 -32.42 6.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.897 -0.668 . . . . 44.25 112.368 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.753 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 18.1 m0 -92.58 158.29 16.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.98 0.419 . . . . 74.04 110.723 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 54' ' ' TYR . 15.2 m -99.56 143.31 29.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.93 -0.577 . . . . 71.35 111.14 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -82.46 121.75 27.15 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.559 -0.746 . . . . 74.33 110.968 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.0 pt -139.57 156.53 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 61.35 110.157 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.916 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 22.8 t-20 -123.41 118.24 27.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.852 -0.425 . . . . 62.32 109.852 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.693 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 40.3 t80 -121.89 112.07 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.785 -0.643 . . . . 72.43 109.806 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.66 32.53 21.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.386 0.612 . . . . 73.42 111.153 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.16 56.96 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.827 -0.624 . . . . 38.21 113.637 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.693 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 5.1 pt20 -92.77 140.1 29.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.714 0.757 . . . . 72.13 110.902 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.2 m -78.79 123.71 27.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.997 -1.001 . . . . 52.53 110.12 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.81 22.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.72 -0.752 . . . . 54.52 112.331 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.753 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 95.9 m-85 -130.96 147.25 52.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.564 -0.532 . . . . 72.44 109.564 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 2.6 pp -134.84 160.96 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.407 -0.22 . . . . 74.43 110.407 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -83.78 132.48 11.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.669 -0.777 . . . . 74.41 112.153 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -63.39 -17.05 62.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 74.13 112.025 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.463 HH11 ' HD2' ' A' ' 58' ' ' ARG . 58.4 mtt85 -59.12 -48.82 80.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.413 -0.358 . . . . 74.24 111.616 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.524 ' O ' HD22 ' A' ' 60' ' ' LEU . 7.4 m-85 -117.11 116.77 27.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.312 0.577 . . . . 74.21 111.513 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD22 ' O ' ' A' ' 59' ' ' TYR . 1.2 mm? -142.12 175.28 9.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 73.05 108.187 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -83.1 119.53 24.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.626 -0.509 . . . . 74.25 109.626 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 108.701 -0.851 . . . . 74.52 108.701 178.023 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.971 0.415 . . . . 74.3 110.786 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.502 HD21 ' H ' ' A' ' 12' ' ' LEU . 2.2 mm? -73.06 10.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.59 -0.732 . . . . 73.23 112.473 -170.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -95.01 1.2 55.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.277 0.473 . . . . 75.25 112.277 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 5.7 t -91.5 32.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.045 0.926 . . . . 64.23 108.706 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 22' ' ' TYR . 13.2 tpt180 -78.12 3.67 14.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.856 -1.065 . . . . 63.53 110.829 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.701 ' HB2' HD13 ' A' ' 25' ' ' ILE . 22.4 t 71.59 16.44 5.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.659 -0.701 . . . . 72.21 111.449 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.74 -122.23 1.4 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.424 -0.893 . . . . 62.0 112.719 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -160.99 -69.38 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.5 -0.555 . . . . 62.52 109.5 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.18 -32.77 0.48 Allowed Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.142 -0.783 . . . . 45.53 111.142 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.71 HG23 ' CZ2' ' A' ' 43' ' ' TRP . 4.7 t -55.76 -31.75 62.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.204 0.526 . . . . 74.45 111.09 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -171.83 114.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.088 -0.708 . . . . 73.31 109.088 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 15' ' ' ARG . 42.5 p90 -132.15 7.74 4.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.054 0.454 . . . . 75.55 110.804 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 23' ' ' ARG . 12.5 ptt180 -88.16 -24.57 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.015 0.746 . . . . 73.31 113.015 -169.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mm -69.92 -55.69 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.734 -0.387 . . . . 73.14 111.872 -171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.866 HG21 ' H ' ' A' ' 26' ' ' GLY . 1.1 mp -132.26 -169.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.651 -0.5 . . . . 74.44 109.651 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.866 ' H ' HG21 ' A' ' 25' ' ' ILE . . . -145.99 -65.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 72.32 112.516 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.75 94.14 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.729 -0.277 . . . . 71.22 111.01 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 28' ' ' LEU . 1.2 tm? -166.32 86.29 0.9 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.26 -0.644 . . . . 64.42 109.26 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.86 76.73 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.065 2.51 . . . . 74.11 113.314 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.879 ' HG2' ' H ' ' A' ' 31' ' ' GLY . 49.4 tt0 59.64 -154.43 0.37 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 75.01 110.587 173.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.879 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 90.59 -83.05 1.32 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.26 -0.495 . . . . 75.21 112.292 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.74 -47.35 75.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.155 0.502 . . . . 72.32 111.216 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 26.5 tptp -154.17 168.71 25.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.006 -1.109 . . . . 73.11 108.006 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG22 ' CD1' ' A' ' 48' ' ' TYR . 72.7 t 75.8 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.305 0.574 . . . . 73.35 111.462 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -136.32 148.06 47.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.993 -0.549 . . . . 75.13 110.468 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.433 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.3 p -92.04 143.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.065 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -93.84 -56.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.791 0.329 . . . . 72.53 110.369 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 p -173.6 151.18 1.86 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.021 -0.536 . . . . 72.34 110.007 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -110.59 137.85 47.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.603 -0.726 . . . . 71.11 111.623 -176.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -95.73 174.14 7.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.092 -1.077 . . . . 64.11 108.092 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -70.66 -11.25 60.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.011 0.434 . . . . 64.15 110.536 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.94 -74.68 0.97 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.983 -0.627 . . . . 65.25 111.567 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.71 ' CZ2' HG23 ' A' ' 20' ' ' THR . 52.0 m0 -117.61 159.48 22.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 74.41 110.745 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.0 t -109.9 142.91 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.29 -0.414 . . . . 60.05 110.053 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HG2' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -89.49 116.26 27.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.904 0.383 . . . . 65.51 111.697 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 36' ' ' VAL . 40.8 pt -131.61 156.72 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 71.11 110.106 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.545 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.4 p30 -115.15 113.83 24.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.3 109.594 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 34' ' ' VAL . 16.0 t80 -98.91 84.72 3.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.785 -0.45 . . . . 74.24 109.785 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.95 55.11 8.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.097 -0.956 . . . . 75.23 111.663 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.17 59.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.847 -0.692 . . . . 63.33 113.139 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.31 152.27 21.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.951 0.405 . . . . 60.31 110.407 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.1 m -93.57 114.44 26.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.563 -0.744 . . . . 75.34 109.389 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.37 148.35 18.49 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.278 -0.963 . . . . 75.51 112.983 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' SER . 95.8 m-85 -128.79 144.96 51.3 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.234 -1.024 . . . . 71.25 108.234 172.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.737 HD12 HD22 ' A' ' 60' ' ' LEU . 2.7 pp -133.19 158.73 43.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 110.024 -0.362 . . . . 65.3 110.024 175.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 127.19 8.19 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.511 -0.852 . . . . 52.41 112.317 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -75.29 -6.73 51.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.622 0.725 . . . . 74.51 110.496 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -74.02 -49.69 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.589 -0.732 . . . . 62.35 110.546 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.12 120.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.984 -0.553 . . . . 75.44 110.305 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.737 HD22 HD12 ' A' ' 55' ' ' ILE . 6.1 mt -134.59 174.15 10.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.872 -0.603 . . . . 74.44 111.067 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -148.98 145.83 27.52 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.58 -0.896 . . . . 75.14 108.58 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tptt . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.842 -0.429 . . . . 74.05 109.842 -177.138 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 N-CA-C 111.971 0.36 . . . . 74.43 111.971 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 15' ' ' ARG . 3.7 pp -112.3 139.82 47.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 61.12 111.021 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -117.63 -59.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.764 -0.653 . . . . 65.25 110.652 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 55' ' ' ILE . 7.1 t -119.5 13.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.107 -1.072 . . . . 75.3 108.107 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.664 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 3.2 tmt_? -63.66 110.83 2.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.772 -1.104 . . . . 65.34 109.55 -175.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.757 ' CB ' ' HA ' ' A' ' 23' ' ' ARG . 45.9 p 55.71 15.27 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.17 -0.923 . . . . 74.32 112.548 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 53.92 -109.36 1.09 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.468 -0.653 . . . . 73.42 111.468 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -117.77 161.16 20.16 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.729 -0.841 . . . . 73.31 108.729 169.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 58.93 2.26 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.178 -0.534 . . . . 60.4 114.2 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 21' ' ' ASN . 6.3 t -103.1 -60.03 1.62 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.086 0.443 . . . . 75.13 110.839 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.515 ' H ' HG22 ' A' ' 20' ' ' THR . 7.9 t30 -161.27 -4.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.673 0.749 . . . . 74.51 110.487 177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.5 m-85 -83.47 15.33 3.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.621 -0.718 . . . . 73.31 112.524 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.757 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 98.7 mtt180 -44.64 -23.54 0.13 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.659 0.985 . . . . 74.33 113.659 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 pt -77.4 -5.41 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.732 0.641 . . . . 62.45 112.732 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.575 HG22 ' CE1' ' A' ' 48' ' ' TYR . 53.7 mt -90.09 167.63 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.425 -0.583 . . . . 74.41 109.425 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 15' ' ' ARG . . . -150.83 176.62 29.3 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 73.14 111.439 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.32 93.39 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.92 0.36 . . . . 74.23 110.941 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -171.3 62.61 0.36 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 70.25 110.874 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.02 -40.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.799 1.666 . . . . 70.25 111.631 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.602 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 4.4 pt20 44.71 25.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.866 1.266 . . . . 75.41 113.21 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.46 19.57 57.9 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.371 -0.442 . . . . 73.14 112.624 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -82.41 -57.64 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.206 -0.294 . . . . 72.13 110.206 -175.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 24.0 ttmm -143.63 -70.57 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.621 -0.432 . . . . 74.54 111.769 -177.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.49 100.89 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.708 0.766 . . . . 62.41 111.582 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -140.01 -179.45 5.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 72.31 109.629 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 60' ' ' LEU . 31.8 m -76.11 138.83 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.21 0.529 . . . . 74.15 111.872 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.52 -55.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.67 -0.695 . . . . 64.05 109.955 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.5 t -160.05 155.19 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 74.31 109.98 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.601 ' HG3' ' HG ' ' A' ' 44' ' ' SER . 2.5 mp0 -106.9 153.15 22.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.946 -0.57 . . . . 74.14 110.918 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -170.19 131.05 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.52 110.364 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.0 t 69.35 17.35 8.2 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.033 -0.53 . . . . 71.14 111.415 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.98 -18.66 55.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.676 -0.773 . . . . 74.22 112.049 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.452 ' HD1' ' HA2' ' A' ' 56' ' ' GLY . 22.1 m0 -105.65 157.48 17.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.86 0.362 . . . . 74.35 110.499 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.601 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 20.1 t -121.81 146.55 46.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.947 -0.57 . . . . 72.32 110.092 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CD ' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -80.61 123.12 27.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.88 -176.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 pt -134.1 156.73 41.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.724 -0.671 . . . . 75.1 110.115 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -115.0 114.68 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.59 -0.522 . . . . 72.43 109.59 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.575 ' CE1' HG22 ' A' ' 25' ' ' ILE . 59.8 t80 -112.46 106.18 14.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.425 -0.352 . . . . 72.23 110.192 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 60.32 34.68 20.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.985 -0.552 . . . . 73.41 111.502 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.31 84.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.649 -0.786 . . . . 54.02 112.918 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -106.48 156.52 18.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.924 0.392 . . . . 55.31 110.586 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -76.8 128.4 34.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.674 -0.694 . . . . 64.11 109.886 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 22' ' ' TYR . . . -131.14 156.75 21.94 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.31 -0.948 . . . . 54.21 112.436 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' HE1' ' CD ' ' A' ' 45' ' ' LYS . 73.9 m-85 -128.26 140.55 51.83 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.038 -0.356 . . . . 72.44 110.038 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.565 HG22 ' HA2' ' A' ' 17' ' ' GLY . 2.7 pp -135.52 151.99 30.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.032 -0.531 . . . . 63.22 109.621 173.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HD1' ' A' ' 43' ' ' TRP . . . -76.5 140.0 24.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.27 -0.967 . . . . 65.34 111.743 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 m -65.74 -10.8 40.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.32 0.581 . . . . 75.34 110.55 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -81.17 -11.67 59.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.607 -0.724 . . . . 73.11 111.222 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.16 118.44 16.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.222 0.534 . . . . 72.42 112.031 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 36' ' ' VAL . 18.7 mt -157.51 173.27 17.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 73.12 108.969 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.4 m -82.99 119.09 24.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.402 -0.592 . . . . 71.02 109.402 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 62' ' ' LYS . 12.4 tmtt? . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.646 -0.706 . . . . 75.01 110.441 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.069 0.461 . . . . 73.43 110.781 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.811 HD22 ' H ' ' A' ' 12' ' ' LEU . 1.4 pt? -75.02 39.88 0.14 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.871 0.367 . . . . 72.23 111.654 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' ALA . 2.3 m-20 -68.41 -54.68 15.52 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.349 0.5 . . . . 73.02 112.349 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.08 21.31 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.641 0.734 . . . . 64.35 109.203 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.712 ' CG ' ' HA ' ' A' ' 12' ' ' LEU . 19.0 mmt180 -54.62 -38.52 66.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 73.1 112.797 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 25' ' ' ILE . 23.2 m 65.23 28.61 12.0 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.531 0.519 . . . . 64.43 111.677 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.87 133.77 27.22 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.667 -0.778 . . . . 51.34 111.914 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.14 -31.34 69.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.125 0.488 . . . . 71.13 110.281 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.06 -109.44 1.27 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.722 -0.951 . . . . 50.14 110.722 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.8 p -99.7 -4.81 29.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.353 0.597 . . . . 74.34 109.5 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -77.68 86.64 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.322 -0.854 . . . . 74.25 110.496 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.57 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 38.3 m-85 -93.9 5.78 50.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 73.52 111.548 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -90.26 -0.54 57.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.51 109.551 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -52.4 -42.38 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.179 -0.919 . . . . 72.44 110.208 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' A' ' 48' ' ' TYR . 68.1 mt -132.58 -79.66 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 110.441 -0.207 . . . . 72.4 110.441 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . 140.08 169.76 11.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.21 -0.995 . . . . 70.14 112.643 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -92.91 94.46 8.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.102 -0.333 . . . . 72.02 110.102 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HG ' HE22 ' A' ' 30' ' ' GLN . 19.4 tp -122.51 85.18 48.24 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.315 -0.624 . . . . 74.44 109.315 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.77 93.81 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.292 2.661 . . . . 72.32 113.378 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.6 HE22 ' HG ' ' A' ' 28' ' ' LEU . 2.5 mp0 -85.79 160.05 19.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 74.5 109.777 171.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.03 83.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.362 -0.446 . . . . 74.2 112.47 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 74.41 109.713 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.654 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? 71.94 143.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 71.03 111.895 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -77.13 -19.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.918 -0.583 . . . . 75.32 111.388 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.724 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 23.3 tt0 70.79 174.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.668 -0.696 . . . . 73.24 110.946 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.724 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 7.5 p -102.58 143.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.142 -0.481 . . . . 42.5 110.547 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 47' ' ' ASN . 5.3 mt -76.65 -56.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.828 -0.434 . . . . 73.25 109.828 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -172.18 161.67 5.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.585 -0.734 . . . . 73.21 109.599 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -117.15 139.8 50.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.74 -0.664 . . . . 61.14 110.289 -177.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -173.62 156.85 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.185 -0.461 . . . . 65.13 109.922 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.115 -0.493 . . . . 73.21 111.691 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.78 27.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.96 -0.638 . . . . 71.23 113.181 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -125.49 162.33 25.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.446 0.641 . . . . 74.41 111.479 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 36.6 m -101.17 122.57 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.254 -0.884 . . . . 74.14 109.609 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.0 ttmt -82.53 124.19 29.89 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.095 -0.502 . . . . 61.43 110.716 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG21 ' HA ' ' A' ' 36' ' ' VAL . 9.7 pt -126.19 148.55 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.571 -0.74 . . . . 73.31 110.922 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.689 ' HB2' HD12 ' A' ' 37' ' ' ILE . 26.2 t-20 -109.54 113.39 26.14 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.294 -0.632 . . . . 70.41 109.294 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.596 ' CD2' HD11 ' A' ' 25' ' ' ILE . 32.7 t80 -104.03 85.69 2.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.124 0.488 . . . . 74.43 109.705 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.88 50.03 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 73.2 111.107 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.67 -17.66 58.87 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.059 -0.591 . . . . 64.53 114.213 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -103.41 147.39 27.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.075 0.937 . . . . 75.44 110.753 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -93.65 129.46 39.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 71.24 111.45 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.17 170.69 22.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.585 -0.606 . . . . 53.43 111.585 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.79 151.38 51.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 73.04 110.538 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 2.5 pp -143.69 153.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.801 -0.636 . . . . 73.52 109.919 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' H ' HD11 ' A' ' 12' ' ' LEU . . . -74.62 128.4 10.32 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.502 -0.856 . . . . 70.12 111.392 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 m -64.23 -4.5 3.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.406 0.521 . . . . 74.4 112.406 -174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -68.65 -34.37 75.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.169 -0.308 . . . . 64.31 110.169 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.05 119.43 23.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.011 0.434 . . . . 75.44 110.378 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -155.53 129.81 8.89 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.715 -0.846 . . . . 73.13 108.715 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -87.51 120.67 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.461 -0.57 . . . . 53.02 109.461 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.938 -0.574 . . . . 64.3 110.534 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 N-CA-C 109.644 -0.502 . . . . 75.12 109.644 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.767 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 mm? -82.33 75.26 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.338 -0.986 . . . . 65.32 108.338 172.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 -38.24 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.599 0.592 . . . . 72.04 112.599 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.602 HG13 ' H ' ' A' ' 16' ' ' SER . 47.8 t -77.26 -66.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.454 -0.498 . . . . 74.23 111.463 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 53.86 20.86 2.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.599 0.592 . . . . 62.3 112.599 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.602 ' H ' HG13 ' A' ' 14' ' ' VAL . 14.9 m 61.47 25.94 15.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.853 0.461 . . . . 72.13 111.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.38 -113.31 3.5 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.645 -0.788 . . . . 73.4 112.573 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 15.3 mm-40 -73.69 -5.83 43.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.641 0.258 . . . . 72.33 111.192 -175.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.58 29.11 9.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.052 -0.594 . . . . 62.44 112.2 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 p -75.42 -62.01 1.71 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 72.55 110.955 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.423 ' HB3' HG23 ' A' ' 24' ' ' ILE . 39.1 m-80 -103.58 93.34 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.841 -0.618 . . . . 70.24 110.354 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -93.03 -1.13 56.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.055 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -82.89 -24.08 33.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 70.34 111.267 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.654 HG12 HG13 ' A' ' 25' ' ' ILE . 4.8 tt -93.16 -55.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.233 . . . . 75.41 111.317 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.654 HG13 HG12 ' A' ' 24' ' ' ILE . 7.2 mt -129.54 138.65 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.313 -0.625 . . . . 64.31 109.313 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.21 -71.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.103 -1.046 . . . . 40.0 113.622 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . . . -74.69 -162.03 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.386 0.513 . . . . 74.33 112.386 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.91 90.16 0.37 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 75.52 109.352 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 52.3 Cg_endo -82.26 6.74 5.53 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.906 2.404 . . . . 73.02 113.105 -169.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 33.2 mm-40 70.59 -67.1 0.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.481 0.712 . . . . 73.11 111.251 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.77 77.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.724 -0.751 . . . . 63.54 112.713 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.76 -50.94 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 72.24 110.664 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -139.98 19.19 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.414 -0.958 . . . . 74.14 108.414 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 47' ' ' ASN . 15.2 t -129.97 116.39 37.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.785 -1.098 . . . . 70.43 111.217 -169.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.933 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 4.3 pm0 -145.22 -86.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.774 -0.37 . . . . 72.42 110.519 169.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.933 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 75.4 t -144.43 114.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.827 -0.434 . . . . 71.1 109.827 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 46' ' ' ILE . 5.4 mt -99.85 -56.69 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.857 -0.337 . . . . 74.25 110.39 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -167.56 153.27 7.44 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.905 0.383 . . . . 71.31 110.213 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 5.5 pt-20 -117.38 149.47 40.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.384 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -160.24 130.59 5.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.524 . . . . 70.24 109.798 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t 71.84 24.55 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.348 0.594 . . . . 74.23 111.106 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.89 44.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 64.12 112.853 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' HE1' ' HG2' ' A' ' 18' ' ' GLU . 9.6 m0 -119.09 152.7 36.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.921 0.391 . . . . 74.13 110.912 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.814 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.2 m -97.05 137.1 36.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.896 -0.593 . . . . 72.24 109.547 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.79 131.0 45.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.881 -0.414 . . . . 74.34 109.881 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.657 ' HA ' HD11 ' A' ' 37' ' ' ILE . 25.2 pt -145.0 171.24 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 65.12 110.949 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 34' ' ' VAL . 23.7 t-20 -113.01 113.65 25.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 172.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.625 ' CD2' HG12 ' A' ' 25' ' ' ILE . 50.7 t80 -110.1 106.9 16.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.597 -0.274 . . . . 71.31 110.336 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.05 34.43 13.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.68 0.753 . . . . 75.12 110.654 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.92 73.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.936 -0.649 . . . . 74.21 113.571 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -120.45 157.57 29.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.382 0.591 . . . . 75.24 110.882 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 m -73.02 125.26 27.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 74.44 110.752 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.7 166.03 24.37 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.575 -0.821 . . . . 74.11 112.313 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -132.81 148.19 52.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.805 -0.443 . . . . 74.34 109.805 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -137.18 168.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.205 -0.452 . . . . 75.44 110.098 177.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.38 155.03 19.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.347 -0.93 . . . . 73.43 111.981 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -85.87 -21.76 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 75.11 109.682 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.0 -41.93 13.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.69 -0.687 . . . . 64.25 110.448 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -95.14 113.07 24.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.4 -0.963 . . . . 75.23 108.4 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -158.68 174.1 15.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.152 -0.476 . . . . 75.5 110.648 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -121.17 117.64 27.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.454 -0.943 . . . . 65.33 108.454 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 tptt . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 107.733 -1.21 . . . . 71.41 107.733 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.837 0.351 . . . . 75.15 111.515 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 53.7 mt -97.54 128.06 43.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.249 -0.649 . . . . 75.1 109.249 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.69 -42.23 5.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.922 0.392 . . . . 55.13 111.072 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.65 49.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 71.44 109.813 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 21' ' ' ASN . 5.7 mmm180 -43.99 -72.62 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.731 -1.122 . . . . 63.13 112.938 -173.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.967 ' HB2' HD12 ' A' ' 25' ' ' ILE . 2.2 m 57.64 37.66 27.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.239 0.543 . . . . 73.41 110.257 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' HG23 ' A' ' 24' ' ' ILE . . . -83.91 168.87 45.76 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.801 -0.714 . . . . 71.34 113.429 -172.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -70.88 -42.36 70.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.489 0.661 . . . . 75.22 109.512 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.4 -65.25 0.16 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.186 -0.916 . . . . 73.34 111.583 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 4.5 p -123.82 -6.53 7.94 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.638 -0.331 . . . . 72.21 111.811 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 15' ' ' ARG . 10.8 t-20 75.13 122.82 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.992 0.808 . . . . 73.21 111.807 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.62 -60.81 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.556 -0.747 . . . . 74.31 111.008 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -119.06 -13.51 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.317 0.858 . . . . 75.01 113.317 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.733 HG12 HG13 ' A' ' 25' ' ' ILE . 11.6 tt -61.79 -55.89 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.72 -0.392 . . . . 70.01 112.022 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.967 HD12 ' HB2' ' A' ' 16' ' ' SER . 59.4 mt -138.44 155.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.079 -0.712 . . . . 71.2 109.079 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.9 -113.05 2.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.492 -0.861 . . . . 73.41 112.37 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.81 94.55 4.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.197 0.522 . . . . 51.44 110.975 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 tp -147.43 84.98 6.93 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.67 -0.696 . . . . 74.51 109.41 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -92.6 -10.85 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.005 2.47 . . . . 73.23 113.398 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -94.67 97.37 10.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.629 0.728 . . . . 72.45 110.694 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.0 150.06 21.26 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.413 -0.812 . . . . 64.3 111.435 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -68.91 -24.14 64.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.12 0.486 . . . . 73.13 110.381 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -122.13 22.14 10.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.363 0.601 . . . . 73.31 109.521 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.72 108.0 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.677 . . . . 63.01 110.793 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -166.23 156.81 12.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.15 109.888 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.989 ' HA ' HG21 ' A' ' 46' ' ' ILE . 61.9 t -73.8 125.14 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.031 -0.359 . . . . 71.3 110.031 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.63 -56.34 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.774 0.321 . . . . 75.53 110.586 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -144.45 159.31 42.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.406 -0.361 . . . . 72.23 110.179 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 9.7 pt-20 -129.01 142.61 50.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.161 -0.472 . . . . 71.04 110.799 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -112.03 173.36 6.4 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.499 -0.926 . . . . 75.02 108.499 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -74.51 69.18 1.67 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 63.25 109.749 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.77 -75.65 0.21 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.243 -0.743 . . . . 62.54 111.243 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -118.46 144.88 45.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.087 0.47 . . . . 73.54 110.782 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 27.4 m -101.39 139.38 37.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.724 -0.671 . . . . 74.32 110.678 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HD2' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -82.03 114.69 20.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.401 0.68 . . . . 72.34 110.16 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.989 HG21 ' HA ' ' A' ' 36' ' ' VAL . 20.1 pt -132.19 167.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.184 0.516 . . . . 73.54 111.551 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.84 114.63 14.92 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.574 -0.899 . . . . 74.31 108.574 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.665 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 43.3 t80 -99.7 88.37 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.864 0.364 . . . . 75.43 110.247 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 58.6 47.1 13.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.537 0.684 . . . . 52.22 110.88 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.35 -6.07 74.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.678 -0.772 . . . . 71.14 113.856 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -113.24 162.41 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.678 0.739 . . . . 73.31 111.237 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -73.82 143.32 45.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.484 -0.78 . . . . 73.33 111.887 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.92 155.58 26.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.541 -0.838 . . . . 51.32 112.508 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.473 ' HE1' ' HD2' ' A' ' 45' ' ' LYS . 78.8 m-85 -141.71 145.28 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.301 -0.629 . . . . 72.42 109.301 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 15' ' ' ARG . 2.5 pp -131.12 145.35 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 121.243 -0.183 . . . . 75.23 110.589 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.28 126.55 22.8 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.408 -0.901 . . . . 74.32 111.148 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -57.07 -22.06 36.38 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.507 0.323 . . . . 54.24 111.823 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -55.91 -34.63 65.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.463 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.68 119.15 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.011 0.434 . . . . 72.42 111.216 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.633 HD21 ' H ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -144.6 156.16 43.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.82 -0.807 . . . . 73.34 108.82 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.633 ' H ' HD21 ' A' ' 60' ' ' LEU . 34.5 t -98.84 141.78 31.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.931 0.395 . . . . 61.44 110.26 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 115.363 -0.835 . . . . 74.12 110.404 176.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.591 ' H ' ' HB3' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 112.691 0.626 . . . . 73.21 112.691 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.7 mt 56.42 30.41 16.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.372 -0.831 . . . . 73.25 112.763 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.547 ' OD1' ' HB ' ' A' ' 55' ' ' ILE . 38.3 t30 -110.58 -59.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.162 0.506 . . . . 55.31 111.478 -176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.713 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 4.3 t -86.04 48.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 73.33 110.823 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.758 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 14.6 mmt180 -77.92 -1.11 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.08 -0.509 . . . . 74.11 112.235 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t 66.47 28.18 9.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.615 -1.254 . . . . 72.14 107.615 -167.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . 160.14 -170.36 36.21 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.421 -1.872 . . . . 71.22 108.421 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -110.56 -73.93 0.66 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.359 1.08 . . . . 75.24 109.619 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.79 -7.61 17.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 44.45 111.233 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.34 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.445 . . . . 72.01 111.271 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -141.78 130.96 23.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.909 -0.774 . . . . 72.44 108.909 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 49.8 p90 -130.02 8.2 5.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.085 -0.507 . . . . 74.23 110.675 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -79.18 -48.84 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.239 0.829 . . . . 71.32 113.239 -166.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.592 ' H ' HD11 ' A' ' 24' ' ' ILE . 3.4 mp -77.47 -56.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.56 -0.456 . . . . 63.13 112.224 -167.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.713 ' HB ' ' O ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -130.3 163.71 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.79 -0.448 . . . . 72.34 109.79 -176.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.758 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -121.17 -67.13 0.26 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.059 -0.591 . . . . 37.85 112.019 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 11' ' ' ALA . . . -151.17 94.15 2.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.777 0.322 . . . . 73.44 110.401 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -157.59 86.04 2.68 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 72.13 109.926 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.697 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 51.3 Cg_endo -106.26 -164.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.81 3.006 . . . . 74.12 113.194 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 75.39 109.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.311 -0.859 . . . . 75.42 112.567 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.89 -102.63 2.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.352 -0.84 . . . . 63.31 113.649 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.59 -13.17 60.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.269 0.557 . . . . 74.21 110.643 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HD2' ' HE2' ' A' ' 48' ' ' TYR . 45.7 mmtm -126.46 136.57 52.8 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.502 -0.772 . . . . 73.51 109.405 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.67 148.46 5.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.974 0.416 . . . . 61.04 110.59 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.774 ' HG3' HG11 ' A' ' 36' ' ' VAL . 12.5 pt20 -124.2 -34.17 2.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 72.13 111.643 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.774 HG11 ' HG3' ' A' ' 35' ' ' GLN . 5.5 p -165.76 125.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.35 . . . . 75.21 111.079 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.6 mt -113.68 -56.24 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.45 -0.341 . . . . 73.24 110.601 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.3 t -155.22 149.25 25.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.033 0.444 . . . . 62.03 110.311 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -104.95 146.35 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.603 -0.726 . . . . 73.44 110.399 -173.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.49 119.51 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.461 -0.336 . . . . 74.31 110.784 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t 65.99 24.86 11.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.672 -0.695 . . . . 75.44 111.756 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.29 -46.63 1.13 Allowed Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.664 -0.779 . . . . 73.3 112.676 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.52 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 47.9 m0 -90.08 161.4 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 75.33 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 22.8 t -111.22 134.24 52.96 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.239 -1.022 . . . . 70.32 108.239 171.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 32.4 ttmt -82.09 130.93 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.983 -0.553 . . . . 74.54 111.889 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.72 ' HA ' HD13 ' A' ' 37' ' ' ILE . 23.2 pt -134.99 171.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.494 -0.776 . . . . 73.32 109.121 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.91 117.79 16.22 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.662 -0.415 . . . . 74.32 110.507 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.634 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 7.0 m-85 -122.48 114.18 20.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.003 0.43 . . . . 75.5 111.067 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.29 34.37 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.871 -1.059 . . . . 74.35 110.955 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.4 -17.76 46.24 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.833 -0.621 . . . . 51.22 113.693 173.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 20.8 pt20 -93.53 153.53 18.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.303 0.552 . . . . 71.42 110.197 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -75.0 118.06 17.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.172 -0.467 . . . . 72.25 110.856 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.92 168.57 13.07 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.748 -0.739 . . . . 73.43 111.883 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 84.7 m-85 -144.0 166.47 24.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.56 -0.533 . . . . 71.51 109.56 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.547 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 2.7 pp -123.79 143.42 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 108.702 -0.851 . . . . 72.24 108.702 166.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 43' ' ' TRP . . . -96.55 100.31 2.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.15 -1.024 . . . . 71.43 111.251 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -50.52 -20.84 1.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.283 0.846 . . . . 63.45 113.283 -172.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 58' ' ' ARG . 13.9 mtm180 -53.11 -37.19 61.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.766 0.317 . . . . 74.32 110.593 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.78 147.95 45.92 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.072 0.463 . . . . 72.44 109.846 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.0 mt -152.59 135.79 15.75 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.479 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 11' ' ' ALA . 3.4 p -129.08 135.87 49.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.759 -0.655 . . . . 73.52 109.686 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 109.892 -0.41 . . . . 75.24 109.892 -178.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 70.33 111.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 129.39 34.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.24 111.639 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.13 6.93 20.53 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.657 0.741 . . . . 65.34 110.175 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.61 -3.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.775 1.028 . . . . 74.53 113.775 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.616 ' HA ' HG21 ' A' ' 25' ' ' ILE . 17.9 mtm180 -121.41 -46.04 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.039 0.381 . . . . 74.12 111.113 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.539 ' HB2' HG23 ' A' ' 24' ' ' ILE . 66.4 m 64.91 4.25 2.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.481 0.919 . . . . 65.15 113.481 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.84 -109.58 1.71 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.964 -0.636 . . . . 74.11 112.272 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -157.63 154.61 28.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.94 -135.83 2.02 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.622 -0.799 . . . . 75.54 112.308 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -72.68 -8.11 53.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.919 0.39 . . . . 75.42 111.515 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -136.11 138.93 42.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.943 -0.762 . . . . 72.01 108.943 172.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.2 -16.39 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.776 0.798 . . . . 74.4 110.086 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.16 6.54 39.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.732 -1.122 . . . . 74.53 109.871 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 10.4 tp -55.83 -9.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 114.903 -1.044 . . . . 73.14 113.679 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 15' ' ' ARG . 1.3 pp -59.74 135.1 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 63.11 112.123 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.25 148.8 5.31 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.585 -0.816 . . . . 40.52 113.904 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.685 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -146.98 -178.51 6.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.655 -0.498 . . . . 62.45 109.655 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 36' ' ' VAL . 41.2 mt -128.67 65.84 73.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 111.861 0.319 . . . . 71.54 111.861 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 27' ' ' ALA . 3.6 Cg_endo -86.0 -55.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.29 1.993 . . . . 75.43 111.044 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 179.37 131.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.281 -0.872 . . . . 74.23 109.486 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.14 168.73 11.35 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.192 -1.004 . . . . 74.51 113.225 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.38 15.0 11.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.139 0.495 . . . . 73.2 110.532 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.585 ' HZ1' ' HB3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -70.86 -25.44 62.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.77 -0.65 . . . . 75.31 110.264 177.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.862 HG12 ' H ' ' A' ' 35' ' ' GLN . 2.4 p -135.85 -80.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.029 -0.532 . . . . 74.0 110.092 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.862 ' H ' HG12 ' A' ' 34' ' ' VAL . 26.5 tt0 65.89 152.93 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.711 0.767 . . . . 73.23 112.123 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 28' ' ' LEU . 71.2 t -91.12 137.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.668 -0.697 . . . . 61.02 110.462 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.78 -55.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.245 -0.65 . . . . 74.43 109.245 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.9 m -159.45 155.32 26.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.243 -0.89 . . . . 75.12 109.097 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.475 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 7.7 pt-20 -124.91 141.97 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.962 0.41 . . . . 60.42 111.01 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.27 159.52 7.29 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.791 -0.641 . . . . 72.23 109.859 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 27.51 16.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.013 0.745 . . . . 72.04 113.013 158.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.83 -50.6 0.83 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.518 -0.849 . . . . 72.21 113.271 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -123.0 162.33 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.466 0.65 . . . . 72.42 111.251 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' HD11 ' A' ' 55' ' ' ILE . 20.8 t -103.45 120.47 40.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.194 -0.912 . . . . 71.42 108.687 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 54' ' ' TYR . 31.2 ttpt -82.45 137.01 34.8 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.529 0.566 . . . . 70.24 112.529 -171.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.7 170.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.192 -0.913 . . . . 63.53 110.547 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 24.4 t-20 -127.8 113.89 16.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.336 -0.616 . . . . 73.54 109.336 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.673 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 34.1 t80 -125.87 112.85 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.478 -0.328 . . . . 75.32 110.554 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.98 37.31 18.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.702 0.763 . . . . 73.31 110.509 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -17.45 58.52 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.634 -0.712 . . . . 73.03 114.022 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 29.7 pt20 -98.9 155.71 17.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.416 0.608 . . . . 74.12 110.789 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.8 m -97.57 114.06 25.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.759 -0.655 . . . . 71.54 109.773 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.06 -176.69 15.93 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.82 -0.705 . . . . 72.13 112.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 73.3 m-85 -136.89 139.31 41.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.18 -0.674 . . . . 72.34 109.18 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.687 HD12 HD22 ' A' ' 60' ' ' LEU . 2.8 pp -120.18 155.58 23.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.881 -0.414 . . . . 60.05 109.881 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.66 116.37 4.35 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.03 -1.081 . . . . 38.39 111.553 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -12.36 25.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.692 0.397 . . . . 74.21 111.869 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -69.57 -34.77 74.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.387 -0.369 . . . . 74.12 111.508 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.76 120.01 26.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.086 0.47 . . . . 75.52 111.918 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD22 HD12 ' A' ' 55' ' ' ILE . 56.4 mt -155.66 152.1 28.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.21 108.907 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -92.92 120.3 33.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.211 -0.663 . . . . 73.03 109.211 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 116.357 -0.383 . . . . 74.31 110.56 -179.87 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 110.323 -0.251 . . . . 53.33 110.323 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HB2' ' HA3' ' A' ' 17' ' ' GLY . 27.1 tp 58.93 27.72 16.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.209 0.528 . . . . 72.13 110.71 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.621 HD22 ' HB3' ' A' ' 61' ' ' SER . 27.1 t-20 -58.41 -42.27 86.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.719 -0.673 . . . . 54.52 110.87 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.18 -65.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 107.697 -1.223 . . . . 72.14 107.697 170.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.664 ' HG2' HG23 ' A' ' 55' ' ' ILE . 4.3 mmp_? -138.57 -164.42 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.847 -1.069 . . . . 74.44 108.482 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 34.5 t 65.63 74.65 0.37 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.419 0.628 . . . . 64.21 110.699 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.589 ' HA3' ' HB2' ' A' ' 12' ' ' LEU . . . -176.2 -173.71 42.09 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.49 -0.777 . . . . 72.13 111.2 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.13 84.14 1.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.391 0.615 . . . . 71.3 110.807 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.15 -86.8 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.345 -0.843 . . . . 43.45 111.311 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -123.52 -65.23 1.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.915 0.388 . . . . 73.2 110.661 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -130.86 133.06 45.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.602 -0.888 . . . . 71.41 108.602 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.7 p90 -108.91 8.4 26.44 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.124 0.416 . . . . 73.15 112.124 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 38.0 ttt180 -115.25 -2.44 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.787 -0.365 . . . . 74.35 111.633 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -58.41 -56.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.093 0.405 . . . . 75.33 112.093 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.502 HD11 ' HG3' ' A' ' 15' ' ' ARG . 2.7 mp -129.13 -78.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 63.32 110.23 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 16' ' ' SER . . . 148.69 -171.23 29.06 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.217 -0.753 . . . . 72.23 111.217 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.28 94.41 4.33 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 71.32 110.543 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 28' ' ' LEU . 1.5 pt? -120.52 85.37 37.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.375 0.607 . . . . 75.02 110.122 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.56 5.14 6.56 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.557 2.838 . . . . 64.52 113.029 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.36 59.52 4.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.719 . . . . 75.14 111.615 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.43 -33.88 5.04 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.808 -0.633 . . . . 72.13 113.432 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.47 -164.91 0.95 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.045 0.422 . . . . 74.54 110.35 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.748 ' HG3' ' H ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -175.55 -85.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.52 0.512 . . . . 75.21 110.373 175.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.748 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 36.9 t -142.12 -85.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 34' ' ' VAL . 12.4 mm100 -157.89 -39.31 0.07 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 72.24 110.111 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.598 ' HA ' HG21 ' A' ' 46' ' ' ILE . 7.4 p 44.35 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.417 1.087 . . . . 70.34 112.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.57 -57.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 74.45 111.278 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 t -167.29 169.16 12.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.43 109.762 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.0 pt-20 -123.52 161.89 24.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.194 0.521 . . . . 75.54 111.418 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.21 115.3 4.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.25 -0.886 . . . . 65.03 109.528 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 t 68.67 26.3 6.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 71.41 111.419 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.28 -22.1 25.45 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.283 -0.961 . . . . 73.25 113.564 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -109.73 145.16 37.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.874 0.337 . . . . 73.23 110.942 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.6 m -109.59 132.11 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 74.12 109.742 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -84.45 132.5 34.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.849 0.356 . . . . 75.23 111.17 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.598 HG21 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -139.26 144.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.126 -0.488 . . . . 72.52 109.921 173.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.85 114.12 26.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.587 . . . . 71.12 109.414 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 60.5 t80 -110.79 107.71 17.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.574 -0.528 . . . . 74.21 109.574 -177.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m120 61.87 34.71 16.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.557 -0.747 . . . . 72.34 110.66 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 -17.89 58.24 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.67 -0.696 . . . . 61.34 113.995 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.5 pt20 -95.99 154.96 16.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.026 0.913 . . . . 74.4 110.788 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -87.42 123.92 32.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.916 -0.584 . . . . 74.45 110.791 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.97 169.66 21.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.65 -0.58 . . . . 63.12 111.65 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 99.3 m-85 -136.39 143.11 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.897 0.348 . . . . 75.24 110.818 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.832 HD12 HD22 ' A' ' 60' ' ' LEU . 2.8 pp -119.52 166.36 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 72.05 109.581 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 132.97 11.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.374 -0.917 . . . . 70.52 112.458 -176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 m -67.61 -17.64 64.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.788 0.328 . . . . 65.31 111.151 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 58' ' ' ARG . 5.3 mmt85 -53.98 -50.23 67.03 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.238 -0.437 . . . . 65.12 111.196 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -121.38 118.86 30.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.975 -0.379 . . . . 75.22 109.975 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.832 HD22 HD12 ' A' ' 55' ' ' ILE . 26.3 mt -155.66 148.29 24.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.843 0.354 . . . . 73.33 110.663 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.621 ' HB3' HD22 ' A' ' 13' ' ' ASN . 31.7 p -108.25 121.74 45.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.215 -0.448 . . . . 70.13 110.675 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 109.012 -0.736 . . . . 74.32 109.012 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.08 0.4 . . . . 63.23 112.08 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD21 HD21 ' A' ' 28' ' ' LEU . 87.2 mt 65.13 1.23 1.47 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.264 0.839 . . . . 74.53 113.264 173.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -118.94 9.81 12.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.337 0.495 . . . . 73.35 112.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 17' ' ' GLY . 46.8 t -65.92 -59.96 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.937 0.347 . . . . 62.41 111.937 -170.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.508 ' HA ' ' H ' ' A' ' 26' ' ' GLY . 20.0 ttm105 65.84 74.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.11 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 24' ' ' ILE . 37.8 p 49.38 31.65 4.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.417 -0.811 . . . . 72.34 113.176 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -80.51 -7.03 88.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.742 . . . . 70.22 112.104 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.76 107.49 3.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 61.32 109.78 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.72 -173.27 43.91 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.538 -0.625 . . . . 73.32 111.538 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -83.56 -24.17 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.093 0.473 . . . . 74.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -124.99 133.32 53.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.69 -0.856 . . . . 71.22 108.69 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.96 8.03 43.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.997 0.427 . . . . 74.32 110.973 -173.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -115.96 -0.79 12.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 71.42 111.18 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.442 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 2.3 pp -88.54 0.12 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.682 0.623 . . . . 72.2 112.682 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 26' ' ' GLY . 1.6 mt 68.54 172.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.109 0.48 . . . . 73.02 111.345 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 25' ' ' ILE . . . 177.46 49.36 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.037 -1.225 . . . . 72.54 110.037 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.53 9.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.883 0.373 . . . . 75.24 111.443 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -128.58 69.12 79.08 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.586 -0.894 . . . . 60.11 108.586 172.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.66 67.39 6.42 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.342 2.695 . . . . 64.33 112.503 -168.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 69.18 119.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.937 -1.028 . . . . 60.32 112.002 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.1 -6.95 37.32 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.091 -0.804 . . . . 64.15 111.091 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.655 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -147.77 134.72 20.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.756 . . . . 72.31 108.96 179.102 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -128.03 92.77 3.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 71.41 111.118 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 28' ' ' LEU . 27.5 m -100.72 176.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.196 -0.668 . . . . 75.01 109.196 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -137.76 146.26 43.41 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.681 -0.408 . . . . 74.03 110.547 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.2 113.04 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.341 -0.39 . . . . 74.23 110.138 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.465 HD11 ' H ' ' A' ' 37' ' ' ILE . 4.0 mp -71.42 -56.74 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 64.51 110.481 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -170.36 165.76 8.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.585 -0.734 . . . . 61.31 110.693 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -118.02 169.32 9.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.111 -0.949 . . . . 63.14 110.094 178.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -173.48 123.38 0.37 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.106 0.254 . . . . 71.24 110.789 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t 70.65 32.44 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 54.22 110.874 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.37 -36.29 4.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.749 -0.739 . . . . 45.03 112.617 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -100.32 155.7 17.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.913 0.387 . . . . 73.41 110.779 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 25.6 t -110.11 139.94 44.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.939 -0.573 . . . . 72.02 109.904 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.681 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 14.6 ttmt -89.67 129.21 36.13 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.096 -0.502 . . . . 73.24 111.207 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.85 143.2 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.598 -0.728 . . . . 73.33 110.598 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -109.73 114.59 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.623 -0.88 . . . . 75.21 108.623 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 1.8 t80 -122.84 110.22 15.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.304 -0.407 . . . . 73.44 110.457 -174.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.71 34.28 22.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.561 0.696 . . . . 73.33 110.676 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.87 73.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 72.21 113.671 174.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 2.8 pt20 -118.8 156.08 30.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.437 0.619 . . . . 73.14 110.257 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m -98.6 128.11 44.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 72.12 111.302 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' HA2' ' HB ' ' A' ' 24' ' ' ILE . . . -116.12 162.47 12.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.091 -0.576 . . . . 36.87 111.803 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.681 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 91.1 m-85 -138.3 139.09 38.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.848 -0.427 . . . . 72.42 109.848 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.566 HD11 HD23 ' A' ' 60' ' ' LEU . 2.4 pp -137.75 154.95 29.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 74.14 110.907 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 110.45 3.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.362 -0.695 . . . . 60.53 111.362 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -4.39 53.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.575 0.226 . . . . 74.43 111.479 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -61.72 -53.57 54.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.17 0.509 . . . . 64.14 109.989 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.51 118.97 21.9 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.038 -0.528 . . . . 74.43 110.291 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 55' ' ' ILE . 95.8 mt -114.36 127.49 55.87 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.578 -0.737 . . . . 71.4 109.052 176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.4 t -148.61 159.82 43.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.034 -0.53 . . . . 62.12 110.091 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.2 tttt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.763 -0.199 . . . . 72.21 110.819 177.7 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.613 0.244 . . . . 65.23 111.656 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 5.3 mp -76.35 92.9 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 74.44 110.792 -174.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 61' ' ' SER . 29.6 m-80 -117.56 -58.31 2.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.931 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 48' ' ' TYR . 2.6 t -121.14 37.31 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.441 0.639 . . . . 73.44 110.314 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -75.41 32.73 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.874 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 33.0 t 60.69 37.42 19.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.675 0.75 . . . . 74.01 109.822 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 90.34 -57.89 3.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.179 -0.919 . . . . 71.41 111.372 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 20' ' ' THR . 0.3 OUTLIER -161.64 168.76 22.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.47 -0.937 . . . . 74.34 108.47 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.44 36.91 0.82 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.371 -0.442 . . . . 75.22 113.437 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 18' ' ' GLU . 25.1 m -90.34 -34.08 15.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.338 -0.615 . . . . 74.43 109.338 174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.452 HD21 HG12 ' A' ' 24' ' ' ILE . 4.2 t30 -142.74 52.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.541 -0.911 . . . . 72.22 108.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -62.5 -6.36 3.33 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.477 -1.238 . . . . 73.1 113.422 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -11.99 60.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.198 0.444 . . . . 74.44 112.198 -174.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.872 HG22 HG13 ' A' ' 25' ' ' ILE . 47.5 mm -70.62 -55.79 13.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.301 0.482 . . . . 72.15 112.301 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.872 HG13 HG22 ' A' ' 24' ' ' ILE . 18.7 mt -135.98 -83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 121.035 -0.266 . . . . 75.54 111.239 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.96 -169.24 16.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.578 -0.82 . . . . 62.41 112.465 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.51 92.67 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.456 -0.438 . . . . 39.47 110.693 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.76 87.8 2.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.649 -0.705 . . . . 73.22 109.743 176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.67 72.81 3.66 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.991 2.46 . . . . 73.0 112.459 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -168.5 98.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.563 . . . . 74.35 110.453 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.37 167.44 12.37 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 111.103 -0.799 . . . . 60.41 111.103 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.59 80.77 5.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.269 0.557 . . . . 74.52 110.953 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 33' ' ' LYS . 3.7 mptp? 58.75 62.44 1.92 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.017 -0.992 . . . . 63.21 111.264 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.09 125.62 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.336 -0.847 . . . . 71.43 110.56 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -133.31 -68.46 0.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 71.31 109.989 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -141.02 126.62 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 72.24 109.899 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.8 mt -114.44 -56.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 64.11 111.494 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.0 t -141.06 155.43 46.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 74.31 110.383 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 14.3 mp0 -114.8 135.94 53.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.697 -0.683 . . . . 74.33 110.526 -175.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -107.59 174.86 5.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.129 -0.693 . . . . 70.13 109.129 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.0 m -71.12 75.16 0.68 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.745 -0.661 . . . . 71.53 110.563 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.79 -61.25 0.48 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.728 -0.669 . . . . 75.41 111.621 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -126.69 162.67 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.092 0.472 . . . . 75.04 110.276 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 37.9 t -96.77 129.23 44.23 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.968 -0.753 . . . . 70.25 108.968 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -90.73 130.69 36.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.558 -0.292 . . . . 65.32 111.115 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.639 HD13 HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.98 148.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 64.3 110.175 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.01 112.55 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.851 -0.796 . . . . 74.52 108.851 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CE2' HG11 ' A' ' 14' ' ' VAL . 11.9 t80 -109.8 98.99 8.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.465 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.41 40.52 24.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.36 0.6 . . . . 71.33 110.861 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 -17.57 59.06 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.858 -0.61 . . . . 60.43 114.405 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.84 154.88 24.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.077 0.939 . . . . 73.43 110.994 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.4 m -76.52 119.03 19.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 74.45 110.793 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.686 ' HA2' HG23 ' A' ' 24' ' ' ILE . . . -122.31 175.45 16.39 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.032 -0.604 . . . . 62.34 111.914 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' SER . 81.3 m-85 -135.68 151.44 50.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.107 0.48 . . . . 74.44 111.198 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.639 HG12 HD13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.59 146.41 27.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.458 -0.792 . . . . 71.1 109.988 175.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.518 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -85.15 159.84 34.37 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.428 -0.892 . . . . 71.12 112.054 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -42.2 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.116 0.484 . . . . 74.43 110.227 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -76.86 -51.84 10.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.651 -0.704 . . . . 73.1 110.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CD2' ' HB2' ' A' ' 12' ' ' LEU . 63.1 m-85 -107.84 119.26 38.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.745 . . . . 75.21 108.99 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.676 HD21 ' N ' ' A' ' 61' ' ' SER . 4.8 tt -154.11 157.52 39.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.797 -1.092 . . . . 72.13 108.154 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.676 ' N ' HD21 ' A' ' 60' ' ' LEU . 14.0 p -81.83 117.54 22.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.372 0.606 . . . . 71.01 110.667 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 74.33 109.761 176.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.861 0.362 . . . . 63.21 110.598 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.729 ' H ' HD21 ' A' ' 12' ' ' LEU . 2.0 pt? -113.98 118.87 35.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.38 0.61 . . . . 73.33 110.944 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.583 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.2 t-20 -83.82 -15.89 46.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.784 -0.643 . . . . 64.13 110.326 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 12.3 p -68.91 -12.68 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.376 -0.829 . . . . 71.11 113.144 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -101.79 67.25 1.09 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.801 -0.76 . . . . 74.05 110.193 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p 47.49 47.31 17.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.997 -1.001 . . . . 70.11 111.53 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.31 -91.35 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.018 -0.61 . . . . 44.01 112.833 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.24 111.7 1.71 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.108 0.48 . . . . 73.41 110.847 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.45 26.11 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.564 -1.015 . . . . 63.14 110.564 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 54' ' ' TYR . 5.2 m -70.11 -44.93 67.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.243 0.522 . . . . 73.04 109.873 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.77 90.18 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.13 -0.693 . . . . 70.55 109.13 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -108.96 10.33 26.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.481 -0.781 . . . . 75.52 110.99 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -44.56 -59.05 2.64 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.629 0.581 . . . . 72.42 112.516 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.532 HD11 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -121.89 -20.86 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 72.41 110.972 -179.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.0 pp -138.16 -164.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.51 -0.314 . . . . 72.53 111.708 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 177.35 -79.28 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 72.5 113.041 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . . . -74.55 172.08 12.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 72.22 111.719 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.9 89.09 8.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.695 -0.684 . . . . 71.3 109.515 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 43.3 Cg_endo -69.53 -55.76 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.495 2.13 . . . . 52.55 112.667 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -118.88 -39.44 2.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.77 2.63 58.44 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.567 -0.742 . . . . 71.33 112.037 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -78.27 66.95 3.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.954 0.407 . . . . 70.23 110.793 -175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 179.2 -49.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.522 -0.763 . . . . 74.11 109.601 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.724 ' HB ' ' HD1' ' A' ' 48' ' ' TYR . 10.9 p -97.84 -39.51 8.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.625 -0.716 . . . . 75.32 110.733 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 64.45 174.32 0.19 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.174 0.59 . . . . 74.44 111.74 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -86.7 121.58 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.332 0.587 . . . . 73.23 111.223 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.7 mt -107.47 -53.23 6.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 72.35 110.701 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -164.56 149.85 10.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 72.44 110.894 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.93 143.65 46.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.54 -0.755 . . . . 74.15 110.626 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.64 173.46 8.97 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.379 0.609 . . . . 75.34 109.52 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.2 m -84.43 80.36 9.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.024 -0.989 . . . . 55.14 110.059 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.64 -53.62 0.68 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 63.32 112.112 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -120.85 152.87 37.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 75.24 110.662 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.06 119.97 40.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.768 -0.827 . . . . 61.45 108.768 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.9 ttmt -82.89 121.04 26.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.588 -0.733 . . . . 60.2 111.377 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.611 ' HB ' HG23 ' A' ' 34' ' ' VAL . 32.7 pt -142.3 153.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.598 -0.728 . . . . 75.22 111.54 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -116.95 114.06 23.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.501 -0.926 . . . . 73.34 108.501 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.724 ' HD1' ' HB ' ' A' ' 34' ' ' VAL . 28.8 t80 -119.34 114.28 22.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.47 -0.332 . . . . 63.34 110.823 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 t30 58.4 34.53 24.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.476 0.655 . . . . 63.15 110.994 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.24 69.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.603 -0.808 . . . . 71.22 113.69 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.1 pt20 -103.94 148.06 26.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.618 0.709 . . . . 73.2 110.984 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -85.7 117.16 24.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.769 . . . . 63.24 109.777 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.39 150.03 18.02 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.185 -1.007 . . . . 75.33 112.496 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' HB ' ' A' ' 20' ' ' THR . 49.5 m-85 -127.67 140.07 52.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.079 -0.712 . . . . 72.14 109.079 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.497 HG22 ' HA2' ' A' ' 26' ' ' GLY . 2.7 pp -135.61 160.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.94 -0.393 . . . . 55.42 109.94 177.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.12 124.35 6.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.299 -0.953 . . . . 62.25 112.145 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 m -61.43 -18.75 60.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.505 0.669 . . . . 75.54 110.202 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -69.3 -9.12 51.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.392 -0.822 . . . . 72.34 111.447 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -131.58 115.06 15.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.803 0.335 . . . . 72.32 110.122 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -157.74 174.15 15.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.803 -0.635 . . . . 72.0 109.742 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 15.4 t -108.28 118.93 38.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.52 -0.918 . . . . 65.41 108.52 172.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.47 -0.567 . . . . 52.44 109.47 -177.223 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.635 ' HG2' HG13 ' A' ' 2' ' ' ILE . 52.1 ttm . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.798 -0.445 . . . . 75.13 109.798 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.5 mt 67.6 16.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.078 0.942 . . . . 71.51 109.606 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 5.91 58.02 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.476 -0.784 . . . . 55.15 111.19 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.73 99.46 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.115 0.483 . . . . 73.24 109.937 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -131.09 30.1 4.6 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 61.0 108.691 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -68.72 149.92 48.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 74.45 110.455 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.71 -46.79 95.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.244 -0.65 . . . . 73.52 109.244 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 62' ' ' LYS . 12.3 t-20 67.47 -74.64 0.07 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.152 -0.931 . . . . 70.11 110.977 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.94 -153.88 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.209 0.528 . . . . 73.15 111.772 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.6 m -143.19 98.2 3.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.069 -0.514 . . . . 73.01 109.964 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.06 -155.44 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.53 . . . . 74.12 109.848 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 87.2 mt -71.05 90.67 0.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.571 -0.529 . . . . 71.32 109.571 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 72.5 m-20 -97.96 -29.94 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 75.13 112.131 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 55' ' ' ILE . 63.6 t -64.86 -51.39 67.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.718 -0.475 . . . . 72.32 109.718 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.885 ' HG3' HD13 ' A' ' 25' ' ' ILE . 6.5 mtp180 -155.31 -177.01 6.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.151 -0.931 . . . . 70.03 108.528 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 22.9 t 75.16 3.96 4.14 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.977 0.798 . . . . 71.21 110.246 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.57 16.91 31.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.002 -0.618 . . . . 63.35 111.968 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CG ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -99.69 -46.71 5.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.002 -0.74 . . . . 75.41 109.002 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.52 4.87 49.29 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.72 -1.127 . . . . 72.32 110.57 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -101.34 -51.39 3.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.275 -0.462 . . . . 74.53 110.717 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.5 88.6 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.379 -0.6 . . . . 74.21 109.379 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.882 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 19.6 p90 -95.82 4.7 52.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 -169.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -106.37 -0.06 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.252 -0.579 . . . . 71.31 111.513 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.767 HG21 HG13 ' A' ' 25' ' ' ILE . 54.2 mt -77.41 -55.82 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.338 -0.392 . . . . 61.1 111.854 -174.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.885 HD13 ' HG3' ' A' ' 15' ' ' ARG . 2.0 mt -140.54 178.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.554 -0.535 . . . . 72.51 109.554 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.701 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -125.83 -118.1 2.22 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.954 -0.641 . . . . 71.05 112.534 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -139.81 105.68 5.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.022 0.439 . . . . 62.14 111.933 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -152.32 57.68 2.26 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.842 -0.617 . . . . 64.45 111.054 173.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 28' ' ' LEU . 19.7 Cg_endo -95.66 166.29 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.19 2.594 . . . . 64.22 112.172 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 63.44 104.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.4 0.619 . . . . 73.24 111.373 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.94 -32.58 7.36 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.394 -0.682 . . . . 72.43 111.394 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.33 -172.71 2.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 64.52 110.021 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 38.7 ttpt -85.98 157.66 20.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.299 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 94.2 t 76.23 126.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.695 0.759 . . . . 72.44 112.056 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.83 175.45 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 73.21 109.839 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.632 ' HA ' HG21 ' A' ' 46' ' ' ILE . 17.3 m -76.06 125.67 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.961 -0.385 . . . . 73.5 109.961 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -81.63 -55.97 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.46 -0.337 . . . . 51.21 110.515 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -171.07 150.82 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 38.6 110.9 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -80.02 131.43 35.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.577 -0.738 . . . . 73.05 110.193 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -134.96 114.49 12.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.615 0.245 . . . . 74.34 110.956 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t 71.84 5.52 5.38 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.453 -0.794 . . . . 75.03 111.779 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.4 -48.76 0.95 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 64.22 111.854 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -84.67 160.53 20.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 73.52 110.315 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 68.5 m -96.28 140.25 31.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.766 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -82.86 118.69 23.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.07 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.632 HG21 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -133.81 144.55 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 64.22 110.232 173.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -122.03 113.55 19.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.975 -1.12 . . . . 64.43 107.975 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 69.3 t80 -105.56 86.1 2.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.138 -0.483 . . . . 74.45 110.908 -170.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 62.32 46.33 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.229 0.538 . . . . 74.41 110.826 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.46 -17.57 58.75 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 73.32 113.512 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.3 pt20 -103.48 128.1 50.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.38 0.609 . . . . 74.1 110.225 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 151.82 21.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 53.21 111.067 -172.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.96 173.7 38.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.403 -0.903 . . . . 61.35 113.353 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 72.1 m-85 -132.97 144.74 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 74.21 109.269 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.522 ' CG2' ' HA ' ' A' ' 15' ' ' ARG . 2.8 pp -136.03 161.69 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.618 0.247 . . . . 74.44 110.946 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.36 123.31 6.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.601 -0.809 . . . . 44.24 111.814 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -64.76 -7.07 9.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.009 0.433 . . . . 75.03 111.7 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -65.76 -37.57 86.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.454 -0.339 . . . . 75.51 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -124.32 120.64 32.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.523 0.678 . . . . 75.4 111.744 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 66.6 mt -155.89 175.64 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.112 -1.44 . . . . 73.33 107.112 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 29' ' ' PRO . 6.1 p -111.47 118.14 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.607 -0.837 . . . . 55.45 111.456 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -166.88 -22.12 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.029 -0.987 . . . . 71.35 109.206 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 39.5 tp -83.81 34.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.503 -0.771 . . . . 75.42 109.565 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 66' ' ' HIS . 6.7 pt-20 -71.31 177.92 3.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.746 -0.661 . . . . 71.03 109.8 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER 69.93 23.77 5.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.282 0.563 . . . . 75.53 109.734 -168.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.492 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 26.7 p80 -91.15 134.42 34.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.345 -0.843 . . . . 70.4 110.175 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -86.2 146.13 26.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 75.05 110.962 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -95.25 36.95 1.19 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.803 -0.635 . . . . 75.43 109.545 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 66.53 87.87 0.12 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.854 -0.795 . . . . 71.11 108.854 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 C--O 1.25 1.087 0 CA-C-N 114.875 -1.057 . . . . 72.32 110.494 -175.054 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HB2' ' OD1' ' A' ' 4' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.781 -0.451 . . . . 75.52 109.781 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.625 HG13 ' H ' ' A' ' 3' ' ' GLY . 19.3 pt -98.8 -56.28 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.97 0.414 . . . . 73.43 110.373 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 2' ' ' ILE . . . -161.6 24.61 0.24 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.739 -0.944 . . . . 37.9 110.739 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 2.3 m-20 -60.25 109.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.534 -0.833 . . . . 64.34 110.492 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -100.83 95.2 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.022 -0.536 . . . . 71.1 111.027 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -120.24 -58.2 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.692 -0.685 . . . . 70.21 109.407 174.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt 56.72 82.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.655 -1.157 . . . . 70.5 110.465 -173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 67.05 -179.45 0.21 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.187 -0.915 . . . . 73.51 110.8 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.88 33.19 10.22 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.133 0.492 . . . . 45.21 111.096 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 14.2 t -154.75 -176.57 5.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.208 -0.664 . . . . 73.11 109.208 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.38 97.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.054 0.454 . . . . 70.44 110.389 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.814 HD21 ' H ' ' A' ' 12' ' ' LEU . 0.8 OUTLIER -79.95 69.6 6.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.82 0.819 . . . . 73.01 109.499 174.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.7 t30 -117.61 -44.73 2.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.787 -1.097 . . . . 71.51 110.578 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' NE ' ' A' ' 15' ' ' ARG . 18.9 t -124.68 -67.11 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.32 -0.4 . . . . 71.11 111.04 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.556 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -130.59 142.47 50.46 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.553 -0.294 . . . . 74.12 110.894 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 53.9 p 45.92 74.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 124.087 0.867 . . . . 71.53 112.654 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . -127.49 -14.69 2.58 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.421 -0.895 . . . . 43.53 111.992 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -163.5 115.62 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.076 -0.713 . . . . 60.13 109.076 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.51 -152.95 24.96 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.5 -0.857 . . . . 73.45 112.402 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -68.91 -31.92 71.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 75.03 111.571 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -133.04 123.57 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 14.6 p90 -130.12 8.59 5.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.731 0.641 . . . . 75.34 112.731 -171.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -116.79 -11.16 10.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.329 0.862 . . . . 72.51 113.329 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.505 ' HB ' HD12 ' A' ' 25' ' ' ILE . 5.0 pt -67.15 -56.45 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 114.365 1.246 . . . . 74.03 114.365 -167.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 15' ' ' ARG . 3.3 mp -111.73 -63.58 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.428 1.013 . . . . 54.23 111.664 -176.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.8 -151.61 16.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.212 -0.994 . . . . 62.14 112.944 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.3 97.71 6.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 62.43 111.28 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.2 tp -160.75 87.68 1.75 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.95 -0.568 . . . . 71.53 110.086 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -82.56 81.67 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.874 2.383 . . . . 63.42 111.549 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -104.3 -48.36 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 74.13 110.39 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.12 104.66 0.39 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 72.31 112.031 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.91 98.65 11.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.46 . . . . 62.01 110.246 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -149.43 42.7 0.92 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.964 -0.754 . . . . 55.34 108.964 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 48' ' ' TYR . 6.2 p -123.14 -46.78 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.743 -0.662 . . . . 75.42 111.677 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -83.54 76.71 9.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.497 0.665 . . . . 64.33 110.629 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.66 3.32 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.771 -1.104 . . . . 64.41 109.15 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -77.06 -57.76 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.81 -0.632 . . . . 72.02 110.631 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 p -178.62 149.98 0.51 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.475 0.655 . . . . 53.32 111.661 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.67 127.23 56.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.987 -1.006 . . . . 71.53 108.55 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.94 171.43 7.52 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.541 -0.464 . . . . 75.25 110.776 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.3 t -64.57 -22.27 66.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 53.21 110.826 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.87 -73.78 0.99 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.971 -0.633 . . . . 41.44 111.972 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -117.23 161.91 18.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.151 0.501 . . . . 73.02 110.877 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.564 ' HB2' HG23 ' A' ' 57' ' ' THR . 35.4 t -87.97 126.72 35.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.012 -0.736 . . . . 64.24 109.012 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.9 ttmt -83.97 123.05 29.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.133 0.492 . . . . 64.21 111.326 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.462 HG22 ' HB3' ' A' ' 35' ' ' GLN . 20.0 pt -139.91 156.8 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 74.34 110.648 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -126.3 113.75 17.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 73.3 109.074 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' CE1' ' HD3' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -101.26 84.11 2.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.619 -0.432 . . . . 74.33 110.832 -178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.29 56.15 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 74.13 112.098 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.74 56.57 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.09 -0.576 . . . . 42.22 114.16 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.22 128.72 54.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.653 0.726 . . . . 72.34 110.501 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -73.18 133.55 44.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.169 -0.923 . . . . 74.44 110.577 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.8 159.02 23.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.812 -0.708 . . . . 60.13 111.671 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -138.48 139.8 38.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.61 -0.515 . . . . 74.53 109.61 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.551 HD12 HD23 ' A' ' 60' ' ' LEU . 2.6 pp -137.52 149.12 25.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.517 -0.311 . . . . 71.23 110.453 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 123.1 8.21 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.638 -0.791 . . . . 74.2 111.943 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -62.3 -18.15 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 74.12 112.058 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.51 -32.98 74.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.026 -0.533 . . . . 75.24 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.87 114.37 26.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.615 0.245 . . . . 73.22 110.354 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 55' ' ' ILE . 32.3 mt -159.22 151.51 21.22 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.884 -0.598 . . . . 73.41 111.206 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -97.25 118.82 34.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 164.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -98.52 163.3 12.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.797 0.332 . . . . 65.02 111.108 -173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.9 tp -88.62 17.2 5.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 75.32 110.462 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.19 66.78 9.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.527 0.679 . . . . 75.43 110.656 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -128.39 70.44 1.37 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.232 -1.025 . . . . 55.44 108.232 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.05 -20.56 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.516 -1.22 . . . . 74.45 109.41 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.86 83.34 0.15 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.028 -0.987 . . . . 71.43 110.28 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -60.0 124.23 19.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 73.21 110.301 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -76.92 118.11 19.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.092 -0.504 . . . . 73.12 109.917 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.441 -0.79 . . . . 65.43 109.679 -177.243 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HG2' HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.189 -0.3 . . . . 41.34 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG12 ' HG2' ' A' ' 1' ' ' MET . 35.5 mm 69.07 52.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 122.374 1.083 . . . . 64.15 109.376 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.74 37.82 0.32 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 108.82 -1.712 . . . . 61.51 108.82 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.33 50.26 0.81 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.095 -1.053 . . . . 73.21 111.182 -167.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -74.42 109.24 7.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.511 0.672 . . . . 73.0 109.496 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.42 ' HB3' ' HB1' ' A' ' 9' ' ' ALA . 33.5 m-85 -106.44 93.36 4.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.209 0.528 . . . . 75.32 111.319 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 11.6 tt -75.02 -19.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.894 0.854 . . . . 73.33 109.186 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -89.93 24.26 2.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.781 -1.1 . . . . 71.35 110.477 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 6' ' ' TYR . . . -107.6 -162.04 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.744 -0.662 . . . . 71.42 110.06 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -109.76 27.19 9.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.295 . . . . 75.34 111.011 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -67.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.999 0.37 . . . . 71.23 111.999 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' ILE . 6.4 mp -80.69 44.94 0.76 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.75 0.31 . . . . 71.04 111.459 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 22.4 m120 -74.98 -31.01 61.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 64.03 111.569 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -95.11 30.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 74.4 111.603 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.813 HH11 ' HA2' ' A' ' 26' ' ' GLY . 17.8 tpt180 -80.48 47.88 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.709 0.29 . . . . 74.1 111.463 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 t 64.51 4.87 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.494 0.717 . . . . 62.2 112.616 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.32 80.73 0.7 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.393 -0.908 . . . . 63.41 111.484 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' HG2' ' H ' ' A' ' 19' ' ' GLY . 35.6 tt0 70.93 175.9 0.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.946 0.498 . . . . 62.22 109.74 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -79.01 59.1 4.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.818 -0.706 . . . . 63.44 112.879 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -93.79 -33.33 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.104 0.478 . . . . 75.12 110.148 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' A' ' 24' ' ' ILE . 22.2 t-20 -153.3 145.2 23.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.257 -1.016 . . . . 75.13 108.257 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 7.11 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.959 -0.697 . . . . 74.44 111.755 -173.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -116.68 -32.78 5.06 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.832 -0.747 . . . . 74.43 112.738 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 25' ' ' ILE . 70.4 mt -61.4 -55.96 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 72.54 111.19 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.587 HG22 ' CZ ' ' A' ' 48' ' ' TYR . 12.9 mt -129.7 158.75 42.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.813 ' HA2' HH11 ' A' ' 15' ' ' ARG . . . -131.42 -105.02 1.01 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.968 -1.111 . . . . 62.32 113.924 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -147.22 93.58 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.617 -0.512 . . . . 73.4 109.617 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -154.09 80.54 4.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.488 -0.56 . . . . 63.52 109.488 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.715 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 10.3 Cg_exo -75.23 89.09 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.107 2.538 . . . . 73.1 112.115 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.8 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tt0 -117.51 -49.33 2.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.675 -0.693 . . . . 73.24 109.391 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.85 17.08 79.21 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.781 -0.645 . . . . 63.31 114.291 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.8 ' HG3' ' HG2' ' A' ' 30' ' ' GLN . 31.5 mt-30 -80.94 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.618 0.709 . . . . 71.13 110.152 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 4.3 mptp? -101.14 0.1 37.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.381 0.61 . . . . 54.33 109.935 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 41.3 t -93.26 92.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 72.14 109.093 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -112.69 141.22 46.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.853 -0.612 . . . . 74.52 110.965 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 ' HA ' HG22 ' A' ' 46' ' ' ILE . 16.9 m -84.53 126.24 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.801 -0.636 . . . . 72.33 109.824 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.12 -49.63 12.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.125 0.488 . . . . 65.34 110.181 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -163.52 168.39 20.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.533 -0.758 . . . . 71.41 108.97 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 pp20? -139.91 152.36 46.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.831 0.348 . . . . 74.53 110.815 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -156.15 129.33 8.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 75.24 109.649 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.7 t 71.8 -0.55 3.15 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.09 -0.505 . . . . 71.05 112.004 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.98 -21.62 10.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.809 -0.71 . . . . 74.44 111.838 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -95.74 150.5 20.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.666 -0.494 . . . . 74.11 109.666 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.4 t -117.34 140.17 49.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.157 0.503 . . . . 74.03 110.99 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.98 108.74 16.51 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.228 -0.896 . . . . 74.02 108.77 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.609 HD12 HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -130.06 163.21 36.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.028 0.442 . . . . 75.33 111.351 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 9.1 t30 -101.57 113.13 25.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.375 -0.829 . . . . 74.24 108.859 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.587 ' CZ ' HG22 ' A' ' 25' ' ' ILE . 90.0 t80 -105.6 98.2 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.504 -0.317 . . . . 73.3 110.241 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t30 56.21 34.68 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.206 0.526 . . . . 74.52 111.007 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.49 62.42 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.77 -0.729 . . . . 44.2 113.908 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.1 pt20 -124.2 155.73 38.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.453 0.627 . . . . 55.32 110.24 174.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -90.5 142.12 28.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.442 -0.345 . . . . 73.14 110.649 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.99 25.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.635 -0.793 . . . . 74.12 112.218 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.8 146.76 51.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.764 -0.458 . . . . 74.3 109.764 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.609 HG13 HD12 ' A' ' 46' ' ' ILE . 2.7 pp -144.38 171.76 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.146 0.279 . . . . 73.43 110.365 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.64 109.92 3.53 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.718 -0.753 . . . . 62.11 111.839 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 1.4 m -63.78 -24.0 67.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.993 0.368 . . . . 74.35 111.993 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -67.79 -43.84 78.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.297 -0.41 . . . . 74.13 111.885 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -122.79 117.66 26.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.985 0.421 . . . . 63.13 110.656 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 85.7 mt -155.05 153.82 31.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.09 -0.959 . . . . 71.12 110.124 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.715 ' HB2' ' HB3' ' A' ' 29' ' ' PRO . 34.8 m -109.24 120.8 43.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.482 -0.933 . . . . 70.24 108.482 171.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.718 ' HG2' HD22 ' A' ' 63' ' ' LEU . 28.8 ttpt -100.45 179.82 4.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 75.03 111.428 -169.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD22 ' HG2' ' A' ' 62' ' ' LYS . 2.5 pt? -90.63 14.72 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.463 . . . . 74.51 111.754 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -82.09 -5.79 58.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.129 0.49 . . . . 74.14 110.521 178.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -114.28 163.18 15.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.619 -0.719 . . . . 71.43 109.749 172.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -61.12 136.21 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.089 0.471 . . . . 73.42 110.658 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.18 98.19 6.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.508 -0.769 . . . . 73.13 111.112 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -80.28 102.96 9.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.922 -0.581 . . . . 73.4 110.58 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -92.25 154.21 18.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.563 -0.532 . . . . 63.33 109.563 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.768 -0.634 . . . . 75.25 110.237 -177.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.765 0.317 . . . . 53.1 110.335 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 pt -65.19 139.43 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 73.41 111.37 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.1 -19.41 51.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.996 -0.621 . . . . 73.23 111.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 66.08 176.97 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.178 0.591 . . . . 75.1 111.483 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.67 -32.78 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.919 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -109.72 103.03 11.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 75.12 111.417 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.595 HD11 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -120.54 -170.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.964 -1.016 . . . . 74.15 109.218 174.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.506 ' OD1' ' HB2' ' A' ' 60' ' ' LEU . 37.2 t-20 60.08 49.23 7.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.741 0.781 . . . . 73.03 109.615 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.35 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.067 -0.969 . . . . 41.22 110.158 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.1 t -114.24 122.44 46.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 70.2 110.56 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.9 146.58 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.1 0.875 . . . . 74.22 112.684 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt 61.05 21.21 11.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.551 -0.75 . . . . 71.0 111.945 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 16.7 m120 -53.54 -43.6 68.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.071 -0.513 . . . . 72.14 112.064 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG23 ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.89 48.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.172 0.511 . . . . 74.02 110.822 177.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -80.19 27.38 0.33 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.035 -0.529 . . . . 74.42 111.074 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.473 ' HA ' HG21 ' A' ' 55' ' ' ILE . 11.8 t 56.86 32.61 21.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 74.2 111.292 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 110.16 -124.25 7.03 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.487 -0.863 . . . . 53.51 112.057 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.607 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 21.6 mm-40 -86.29 11.68 11.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 73.33 110.449 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.89 16.58 61.09 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.374 -1.091 . . . . 64.4 110.374 -170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.1 m -62.57 -54.26 42.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.028 -0.586 . . . . 72.13 110.711 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -102.4 100.47 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.139 -0.689 . . . . 73.33 109.139 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -93.48 5.32 51.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.732 -0.667 . . . . 74.34 111.45 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -100.98 -38.41 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.466 0.543 . . . . 73.51 112.466 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.544 HG22 HG13 ' A' ' 25' ' ' ILE . 12.7 tt -82.86 -55.33 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.943 0.72 . . . . 64.34 112.943 -169.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.563 HG12 ' CD2' ' A' ' 48' ' ' TYR . 16.6 mt -126.82 148.76 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.976 -0.379 . . . . 74.02 109.976 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -150.25 159.0 27.93 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.007 -0.837 . . . . 62.14 111.007 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -75.98 96.97 3.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.492 . . . . 73.25 111.78 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -149.84 72.11 9.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.651 -0.704 . . . . 72.41 109.768 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.5 90.48 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.727 2.284 . . . . 72.04 112.055 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -97.33 59.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.51 -0.768 . . . . 74.25 110.141 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.39 -78.05 1.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.493 -1.043 . . . . 63.13 110.493 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -73.16 137.03 44.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.032 -0.729 . . . . 61.04 109.032 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 46.6 mttp -116.05 -75.94 0.58 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.022 0.439 . . . . 74.21 110.108 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.449 HG21 ' HD1' ' A' ' 48' ' ' TYR . 8.3 p 174.3 -29.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.179 -0.919 . . . . 75.21 108.619 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 72.58 127.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.414 -1.266 . . . . 72.35 111.491 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 44' ' ' SER . 58.1 t -82.96 108.26 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.652 -0.704 . . . . 75.22 110.179 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.875 HD12 ' HA ' ' A' ' 46' ' ' ILE . 4.7 mt -75.28 -49.53 27.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.836 -0.62 . . . . 75.11 111.346 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 m -153.24 150.95 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.054 0.454 . . . . 72.03 110.937 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.63 123.88 47.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.464 -0.789 . . . . 64.44 109.245 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.34 140.73 26.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.516 -0.179 . . . . 73.34 110.516 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t 75.24 -54.33 0.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.857 0.723 . . . . 74.31 111.662 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.11 -51.84 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.514 -0.634 . . . . 62.42 111.514 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.607 ' HZ2' ' HG2' ' A' ' 18' ' ' GLU . 25.5 m0 -87.61 160.14 18.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.089 0.471 . . . . 74.45 110.691 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.54 ' HB3' HG12 ' A' ' 36' ' ' VAL . 44.4 m -91.34 140.79 29.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.63 -0.714 . . . . 74.23 109.352 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -105.45 129.88 53.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 120.935 0.398 . . . . 73.32 109.939 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.875 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -142.91 170.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.704 . . . . 74.33 110.315 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -108.79 115.11 29.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.253 -0.647 . . . . 74.41 109.253 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.563 ' CD2' HG12 ' A' ' 25' ' ' ILE . 5.8 t80 -113.47 101.23 9.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 73.11 110.156 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t30 63.02 41.79 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 73.04 110.35 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.21 56.86 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.555 -0.748 . . . . 53.31 113.65 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.79 145.86 38.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.388 0.594 . . . . 74.35 111.689 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 m -72.52 123.21 22.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 74.22 111.002 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.5 168.58 18.6 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.779 -0.724 . . . . 72.33 111.75 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.39 144.4 51.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.817 0.341 . . . . 73.33 110.434 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.602 HG12 HD11 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.92 156.26 31.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.74 -0.664 . . . . 64.13 109.668 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -72.36 129.1 14.13 Favored Glycine 0 C--O 1.219 -0.815 0 C-N-CA 120.631 -0.795 . . . . 73.43 112.137 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -77.24 -13.57 59.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.322 0.582 . . . . 71.21 110.428 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.557 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 17.3 ptt85 -85.65 -16.84 37.86 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.382 -0.372 . . . . 75.43 111.271 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.557 ' HD1' ' HG3' ' A' ' 58' ' ' ARG . 30.9 m-85 -127.12 116.33 20.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.204 -0.665 . . . . 74.0 109.204 171.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 97.1 mt -140.96 173.83 11.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.279 0.561 . . . . 75.02 110.876 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . 10.1 t -109.26 127.44 54.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.696 -0.684 . . . . 73.34 109.174 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 8' ' ' ASN . 75.3 mmtt -79.89 158.22 26.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.718 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.824 HD11 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.6 -5.83 41.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.669 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 74.34 142.23 0.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.368 -0.833 . . . . 70.32 111.273 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -109.83 -3.49 16.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.128 0.418 . . . . 70.22 112.128 -171.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -71.94 148.03 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.991 -0.683 . . . . 74.34 110.54 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -136.01 152.5 50.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.282 -0.636 . . . . 73.04 109.282 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -93.96 110.13 21.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.205 0.526 . . . . 75.14 112.173 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -82.61 -28.25 30.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.114 -1.069 . . . . 72.11 108.114 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 p80 . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.732 -1.122 . . . . 75.14 109.527 173.91 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.882 -0.414 . . . . 55.21 109.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.8 pt 47.94 -169.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.443 1.097 . . . . 62.25 112.625 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.31 87.38 0.11 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.525 -0.845 . . . . 61.2 112.473 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -165.3 -35.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 74.54 110.706 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -114.92 131.39 56.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.324 . . . . 71.41 111.637 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 62.48 19.22 11.04 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.402 -0.817 . . . . 74.21 112.657 171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 16.5 tt -146.07 147.18 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.019 -0.734 . . . . 75.03 109.019 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 18.7 m120 73.02 -59.45 0.57 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.701 0.626 . . . . 74.42 110.44 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.47 -158.72 0.32 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.691 0.619 . . . . 53.42 111.321 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.1 m -132.12 27.49 4.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 73.44 109.864 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -139.66 145.31 38.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.206 -0.906 . . . . 73.41 109.234 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 15' ' ' ARG . 4.3 mm? 67.19 28.69 8.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.471 0.482 . . . . 73.22 110.079 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 88.0 m-20 -63.19 -50.08 71.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.439 -0.801 . . . . 72.13 111.727 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.02 6.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.482 -0.562 . . . . 72.24 109.482 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.487 ' HG3' ' HA ' ' A' ' 12' ' ' LEU . 37.6 mtp180 -69.41 176.89 3.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.793 -0.64 . . . . 65.13 110.911 -172.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.948 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 3.9 m 69.97 44.63 0.79 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.683 -0.689 . . . . 64.42 111.044 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.87 ' HA3' HD12 ' A' ' 25' ' ' ILE . . . -56.49 -35.84 68.05 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 114.246 0.458 . . . . 71.4 114.246 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 21' ' ' ASN . 42.2 mt-10 -90.3 9.93 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.213 0.507 . . . . 71.24 110.532 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA3' ' CH2' ' A' ' 43' ' ' TRP . . . 76.73 -65.69 2.83 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 116.097 -0.501 . . . . 63.51 112.229 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.9 p -82.41 -28.31 31.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.854 0.359 . . . . 75.31 110.763 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 27.5 t30 -100.17 118.11 35.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.948 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 24.2 m-85 -93.8 -36.88 12.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.869 -0.605 . . . . 75.21 111.807 -170.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -73.88 -6.61 48.23 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.068 0.766 . . . . 74.04 113.068 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.44 -35.88 64.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 73.02 111.935 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.87 HD12 ' HA3' ' A' ' 17' ' ' GLY . 33.2 mt -124.13 156.32 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.3 -0.259 . . . . 74.21 110.3 -173.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.45 -135.91 6.1 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.191 -0.528 . . . . 74.31 112.2 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 13' ' ' ASN . . . -148.88 99.18 2.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.066 0.433 . . . . 75.45 112.098 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.9 tp -157.1 69.5 4.44 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.976 0.417 . . . . 75.35 110.776 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -97.94 63.73 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.106 2.537 . . . . 36.9 112.506 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.7 -77.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 73.22 110.024 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.9 3.49 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.508 -0.637 . . . . 73.33 111.508 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.79 153.26 14.47 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.904 -1.147 . . . . 75.23 107.904 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -80.07 15.09 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.111 0.481 . . . . 72.43 111.213 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 89.0 t -76.61 97.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.034 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -138.98 169.7 17.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.837 -0.619 . . . . 74.01 110.69 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.63 125.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.685 -0.689 . . . . 74.44 109.547 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -78.29 -55.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.511 0.672 . . . . 72.52 109.618 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 t -147.06 155.74 42.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.925 -1.034 . . . . 62.12 109.18 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.74 159.21 35.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.255 0.55 . . . . 74.45 111.412 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -132.53 174.24 10.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.574 -0.739 . . . . 72.51 109.337 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 t -74.66 78.89 2.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.708 0.766 . . . . 64.02 110.538 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.03 -70.99 0.31 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.12 -0.946 . . . . 73.41 111.465 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.3 m0 -115.42 146.07 41.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.996 0.427 . . . . 72.44 110.425 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.1 m -115.32 135.8 53.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 73.44 110.094 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.7 ttmt -82.57 125.29 30.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.356 0.598 . . . . 73.24 111.355 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 pt -128.08 171.04 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.484 -0.78 . . . . 74.42 110.858 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 t-20 -126.58 113.92 17.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.036 -0.727 . . . . 71.4 109.036 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.75 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 31.2 t80 -103.72 77.79 1.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 75.01 109.885 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 58.47 48.02 12.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.14 111.863 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.76 -17.21 59.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.584 -0.817 . . . . 71.42 113.66 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.8 pt20 -100.37 148.39 24.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.659 0.73 . . . . 71.44 110.344 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.3 m -86.74 140.7 29.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.595 -0.729 . . . . 75.2 111.306 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.17 161.39 31.99 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.915 -0.659 . . . . 62.24 112.133 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.39 139.03 47.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 2.9 pp -121.53 167.52 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.019 -0.273 . . . . 75.41 111.713 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.33 118.86 5.02 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.87 -0.681 . . . . 64.02 111.773 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -58.56 -17.39 21.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.648 0.61 . . . . 64.44 112.648 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -72.06 -25.85 61.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.914 0.338 . . . . 72.54 111.914 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -121.04 119.31 32.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.049 0.452 . . . . 75.12 110.767 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.6 mt -156.87 160.87 39.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.48 -0.782 . . . . 74.01 110.192 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -100.29 120.26 39.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 53.11 110.549 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -112.24 142.91 44.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.35 -48.72 66.67 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.126 0.266 . . . . 75.32 111.056 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HG2' ' N ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER 43.59 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.065 1.346 . . . . 70.23 111.331 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.586 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 7.1 p80 -136.35 67.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.843 0.83 . . . . 73.44 110.554 170.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' A' ' 67' ' ' HIS . 64.4 m-70 -129.85 -39.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.905 -1.043 . . . . 74.02 110.245 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 25.4 m-70 67.23 96.87 0.06 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.562 -0.745 . . . . 72.13 109.192 -169.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -46.58 134.16 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.993 -1.003 . . . . 64.31 112.064 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 95.2 m-70 -60.69 -40.09 90.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.721 -1.127 . . . . 75.51 112.677 -167.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 84.2 t60 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.154 -0.926 . . . . 74.44 109.856 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.863 0.363 . . . . 65.55 110.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.75 158.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.984 -0.553 . . . . 65.54 110.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.72 -15.64 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.024 -0.608 . . . . 74.15 112.083 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.41 ' HB3' ' HD1' ' A' ' 6' ' ' TYR . 4.2 m-20 -90.81 89.78 7.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.818 0.342 . . . . 73.5 110.506 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -94.4 60.65 2.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.201 0.524 . . . . 75.01 110.028 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.43 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 46.0 p90 -82.45 36.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.594 -0.73 . . . . 75.03 111.473 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 6' ' ' TYR . 47.1 mm 74.53 147.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 123.497 0.498 . . . . 73.34 110.196 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 75.24 -38.28 0.36 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.72 0.808 . . . . 54.24 111.663 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 7' ' ' ILE . . . -69.62 1.72 3.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.732 0.642 . . . . 74.42 112.732 -175.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -72.81 -31.87 65.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.488 -0.19 . . . . 54.35 110.488 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.591 ' HA ' ' OG ' ' A' ' 61' ' ' SER . . . 70.4 -39.05 0.43 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.738 0.815 . . . . 73.25 113.11 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 54.4 mt -84.17 22.91 1.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.008 0.373 . . . . 74.54 112.008 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -117.94 6.78 12.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.913 0.338 . . . . 72.52 111.913 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 25' ' ' ILE . 6.0 t -82.87 49.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 121.885 -0.509 . . . . 65.31 110.395 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.833 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 9.1 ptt180 -120.2 83.16 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.347 0.594 . . . . 72.31 111.965 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.4 m 59.29 25.78 14.48 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.189 -0.914 . . . . 72.13 111.621 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' H ' ' A' ' 56' ' ' GLY . . . 113.85 -143.06 17.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.836 -0.697 . . . . 72.14 111.46 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.22 -27.29 68.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 53.33 110.887 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.92 63.62 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.348 -0.701 . . . . 72.14 111.348 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 m -87.69 -61.55 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 64.22 111.033 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 21' ' ' ASN . 6.6 m120 -123.93 127.23 47.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.168 -0.679 . . . . 53.35 109.168 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -97.56 6.6 47.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.265 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -107.72 -54.66 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.338 -0.392 . . . . 71.51 111.643 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 25' ' ' ILE . 8.1 tt -59.94 -41.88 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 74.43 111.627 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.662 HG21 ' CE1' ' A' ' 48' ' ' TYR . 28.3 mt -136.53 165.07 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.32 -0.992 . . . . 73.13 108.32 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 179.9 -166.33 35.37 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.362 -0.923 . . . . 72.33 112.176 -171.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -81.07 91.78 6.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.05 0.452 . . . . 72.24 111.851 -174.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.544 HD12 ' HE2' ' A' ' 33' ' ' LYS . 1.8 pt? -173.71 77.42 0.38 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.4 -0.818 . . . . 65.04 109.613 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -88.09 85.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.161 2.574 . . . . 75.15 112.401 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -165.35 155.22 12.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 75.1 109.823 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.8 174.75 50.48 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.934 -0.65 . . . . 72.33 113.317 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -92.45 7.32 43.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 74.25 110.802 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HE2' HD12 ' A' ' 28' ' ' LEU . 22.9 pttp -66.96 -15.71 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 73.32 110.995 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 4.4 p -146.63 123.2 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.336 0.589 . . . . 72.11 110.532 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -130.69 132.19 45.26 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.424 -0.584 . . . . 65.21 109.424 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.792 ' HA ' HG23 ' A' ' 46' ' ' ILE . 5.6 p -75.95 126.66 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.099 0.476 . . . . 62.21 110.553 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.43 -56.61 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.664 -0.495 . . . . 74.41 109.664 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -179.17 159.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.629 -0.714 . . . . 64.45 109.7 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.779 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -85.24 144.96 27.8 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.573 -0.739 . . . . 74.42 109.813 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -146.65 113.36 6.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.9 0.381 . . . . 72.31 110.698 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 t 57.9 62.92 1.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 74.23 111.314 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 -59.3 3.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.961 -0.638 . . . . 73.14 112.921 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 14.4 m0 -91.09 159.61 16.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.786 0.326 . . . . 74.41 110.629 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 9.6 t -105.22 142.42 35.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.277 -0.42 . . . . 64.31 110.035 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' A' ' 54' ' ' TYR . 2.9 mtpt -87.88 127.34 35.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 116.178 -0.465 . . . . 63.45 110.829 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.792 HG23 ' HA ' ' A' ' 36' ' ' VAL . 46.0 pt -143.23 164.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.723 -0.672 . . . . 64.22 110.954 -177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 26.6 t-20 -112.97 117.34 31.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.454 -0.943 . . . . 74.43 108.454 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.662 ' CE1' HG21 ' A' ' 25' ' ' ILE . 5.8 t80 -110.23 105.04 13.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.703 0.287 . . . . 74.04 110.515 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.9 t30 62.21 35.29 15.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.675 -0.693 . . . . 73.34 110.919 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.97 -17.48 59.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.887 -0.673 . . . . 54.31 113.234 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -107.92 133.78 51.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.35 0.575 . . . . 71.34 110.601 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -73.93 130.83 40.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.896 -0.593 . . . . 74.32 110.808 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.02 -172.19 12.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.833 -0.699 . . . . 74.43 112.405 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.498 ' CE2' ' HG2' ' A' ' 45' ' ' LYS . 97.0 m-85 -136.06 144.93 45.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.224 -0.287 . . . . 72.31 110.224 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 2.6 pp -135.29 162.43 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.348 -0.387 . . . . 72.23 110.239 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' H ' ' HA2' ' A' ' 17' ' ' GLY . . . -79.71 143.55 25.71 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 71.24 112.055 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.785 ' HA ' HD11 ' A' ' 60' ' ' LEU . 8.7 m -85.07 -5.4 59.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.757 0.789 . . . . 74.21 109.332 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -34.37 57.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.361 -0.836 . . . . 74.34 110.809 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -135.87 118.62 16.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.038 0.447 . . . . 75.11 111.457 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.785 HD11 ' HA ' ' A' ' 57' ' ' THR . 5.2 mp -140.38 173.86 11.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.856 . . . . 72.41 109.062 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 45.9 m -142.39 124.33 15.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.658 -0.497 . . . . 74.31 109.658 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -72.96 137.1 45.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 75.4 109.737 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.29 -11.28 49.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.19 0.441 . . . . 64.4 112.19 -174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.91 98.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.083 0.772 . . . . 62.15 113.083 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -90.5 73.43 6.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.627 -0.879 . . . . 73.03 108.627 171.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.12 141.28 50.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 74.3 111.185 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -90.09 79.83 6.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.584 -0.734 . . . . 71.1 111.097 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 58.45 88.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.431 -0.804 . . . . 74.32 110.813 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -155.91 146.38 21.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.983 -0.747 . . . . 74.31 108.983 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.158 -0.925 . . . . 73.42 110.426 177.206 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' HG2' HG21 ' A' ' 2' ' ' ILE . 52.6 ttm . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.537 -0.171 . . . . 65.34 110.537 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.587 HG21 ' HG2' ' A' ' 1' ' ' MET . 8.4 tp 43.27 86.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.22 1.008 . . . . 74.41 112.455 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.58 41.11 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.484 -0.78 . . . . 71.24 111.646 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -116.18 121.61 42.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.196 0.522 . . . . 72.12 110.77 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -148.92 10.54 0.81 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.527 -0.761 . . . . 74.33 109.235 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.514 -0.767 . . . . 65.11 110.019 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt 177.32 137.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.922 -1.035 . . . . 61.54 109.189 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 m120 62.14 -85.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.964 0.412 . . . . 73.5 111.928 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.35 84.7 3.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.219 0.533 . . . . 64.52 111.007 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.1 m -125.21 -54.43 1.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.714 -0.676 . . . . 73.12 110.162 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.6 -85.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.015 0.436 . . . . 73.32 110.782 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.687 HD12 ' HE1' ' A' ' 22' ' ' TYR . 59.2 mt -88.48 133.25 34.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.165 -0.47 . . . . 64.32 110.422 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.94 -60.35 1.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.978 0.362 . . . . 61.33 111.978 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 55' ' ' ILE . 4.7 t -74.55 -65.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 73.51 111.385 -172.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 58.33 17.96 5.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.934 0.716 . . . . 71.12 112.934 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 21' ' ' ASN . 37.9 t 62.33 25.21 15.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.212 0.53 . . . . 73.04 110.189 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.36 -108.48 0.67 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.112 -0.795 . . . . 74.52 111.112 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -118.14 14.59 14.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 71.23 110.201 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.17 48.69 0.18 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.588 -0.733 . . . . 73.2 111.467 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.4 m -94.2 -34.97 12.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 74.03 109.913 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.412 ' HB2' ' CB ' ' A' ' 16' ' ' SER . 18.5 m-80 -140.24 142.06 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.195 -0.912 . . . . 73.24 109.591 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.687 ' HE1' HD12 ' A' ' 12' ' ' LEU . 55.7 m-85 -129.53 -13.95 4.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.543 0.687 . . . . 75.14 110.274 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -71.73 -49.9 35.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.913 -1.039 . . . . 73.21 111.109 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 HG21 ' H ' ' A' ' 25' ' ' ILE . 2.7 tt -97.09 -55.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 72.41 111.526 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 48' ' ' TYR . 60.6 mt -101.23 127.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.715 -0.476 . . . . 60.43 109.715 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.47 -108.54 1.01 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.552 -0.832 . . . . 38.03 111.762 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -132.63 92.25 3.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.443 . . . . 71.44 110.164 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.5 pt? -173.39 86.43 0.39 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.352 -0.84 . . . . 72.12 109.834 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.82 71.37 4.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.699 2.266 . . . . 62.11 110.835 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.75 140.97 29.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.163 -0.926 . . . . 64.24 111.088 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.83 177.35 28.17 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.678 -0.773 . . . . 75.44 112.129 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -90.92 51.01 1.88 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 72.12 110.045 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HG3' HG23 ' A' ' 34' ' ' VAL . 47.1 pttt -175.36 -156.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.263 -0.881 . . . . 65.34 109.341 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 33' ' ' LYS . 82.2 t 75.89 -28.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.24 0.616 . . . . 75.12 112.091 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -59.67 -66.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 75.4 110.9 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -174.38 125.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 72.5 110.65 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.2 mt -113.77 -54.06 4.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.227 0.537 . . . . 73.55 110.061 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.9 t -143.06 171.81 13.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.125 -0.694 . . . . 73.35 109.125 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.693 ' HG2' ' HG ' ' A' ' 44' ' ' SER . 39.9 mt-10 -137.95 149.71 46.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.052 -0.351 . . . . 71.42 110.052 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -162.86 117.58 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 65.43 111.628 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 t 63.43 33.05 14.03 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.585 -0.734 . . . . 75.43 112.457 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.55 -32.85 6.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.666 -0.778 . . . . 73.23 112.956 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -102.17 155.13 18.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.992 0.425 . . . . 74.43 110.302 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.693 ' HG ' ' HG2' ' A' ' 39' ' ' GLU . 25.0 m -106.02 143.46 34.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.135 -0.484 . . . . 64.45 110.689 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -82.8 117.53 22.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.508 -0.769 . . . . 73.01 110.363 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.701 ' HA ' HD13 ' A' ' 37' ' ' ILE . 31.4 pt -137.65 171.65 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.966 0.413 . . . . 73.34 110.94 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -115.04 114.68 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.068 -0.716 . . . . 72.34 109.068 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.642 ' CE2' HG23 ' A' ' 25' ' ' ILE . 6.0 t80 -111.05 113.1 25.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.456 -0.338 . . . . 74.25 110.351 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.85 35.06 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.264 0.554 . . . . 74.3 111.109 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.23 64.52 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 63.43 114.033 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -131.12 167.6 18.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.572 0.686 . . . . 61.12 110.782 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.8 m -70.17 119.98 15.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 64.13 110.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.63 169.27 15.79 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.814 -0.707 . . . . 70.52 111.689 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -139.02 150.62 46.02 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.637 -0.505 . . . . 73.35 109.637 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.752 HG23 HG12 ' A' ' 14' ' ' VAL . 2.5 pp -130.33 154.01 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 123.088 0.243 . . . . 75.24 110.681 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.34 108.76 3.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.705 -0.958 . . . . 74.12 110.705 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -59.56 -15.04 15.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.661 0.615 . . . . 73.12 112.661 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -73.4 -16.49 61.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.691 0.282 . . . . 75.42 111.499 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 118.62 15.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.321 -0.251 . . . . 75.14 110.321 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.695 HD23 HD12 ' A' ' 55' ' ' ILE . 36.4 mt -153.37 156.1 37.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.568 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 t -155.27 121.84 5.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.626 ' HB2' ' HG3' ' A' ' 64' ' ' GLU . 49.3 mttp -89.07 -163.05 0.93 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.078 -0.51 . . . . 72.12 109.935 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 mp -85.13 32.06 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.225 0.536 . . . . 73.35 109.914 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 39.3 mt-10 -80.89 158.33 25.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.485 -0.78 . . . . 74.43 109.42 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 61.4 24.46 14.56 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.052 0.93 . . . . 73.12 108.76 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -151.05 131.82 14.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 72.22 108.725 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -67.23 139.95 57.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.587 -0.445 . . . . 75.04 109.942 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -92.75 150.78 20.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.77 -0.455 . . . . 75.43 109.77 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -96.57 94.03 7.11 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.895 -1.15 . . . . 74.12 107.895 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 . . . . . 0 C--O 1.249 1.068 0 O-C-N 123.959 0.787 . . . . 73.42 109.549 -168.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.913 -0.403 . . . . 62.41 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt -121.99 109.6 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 74.13 111.2 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 13.16 7.48 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.404 -1.078 . . . . 44.22 110.404 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.94 111.13 23.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.918 -0.641 . . . . 64.21 110.193 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -131.09 82.41 2.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.775 -0.454 . . . . 73.42 109.775 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HD2' HG13 ' A' ' 7' ' ' ILE . 17.7 t80 -157.18 152.87 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 75.24 109.777 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.56 HG13 ' HD2' ' A' ' 6' ' ' TYR . 57.3 mt 68.19 -78.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.095 0.558 . . . . 61.2 111.032 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 3.3 m-20 -85.97 -41.99 14.41 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.422 -0.214 . . . . 62.44 110.422 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.42 -159.88 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.911 -0.586 . . . . 61.53 110.582 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.5 t -74.77 -12.92 60.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.901 0.334 . . . . 72.04 111.901 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.98 160.53 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.295 -0.162 . . . . 54.11 110.764 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt 56.42 42.18 27.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.093 0.473 . . . . 65.24 111.312 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -68.21 -52.88 29.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.761 -0.654 . . . . 61.45 111.362 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' SER . 4.8 t -87.85 48.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 74.43 110.589 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.819 ' HD2' ' HB2' ' A' ' 22' ' ' TYR . 3.0 mmt180 -74.79 37.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.647 0.61 . . . . 72.23 112.647 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.497 ' HA ' HG21 ' A' ' 55' ' ' ILE . 4.5 m 49.64 73.82 0.23 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.484 0.659 . . . . 73.35 112.525 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.64 ' H ' ' HA ' ' A' ' 55' ' ' ILE . . . 101.97 -139.34 14.37 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.572 -0.74 . . . . 65.02 111.472 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -110.59 39.37 2.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.605 -0.887 . . . . 64.24 108.605 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.01 21.25 33.71 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -1.0 . . . . 74.51 111.055 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -87.08 -61.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 62.24 111.508 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -108.95 34.92 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 64.55 109.582 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.819 ' HB2' ' HD2' ' A' ' 15' ' ' ARG . 28.7 p90 -50.71 -21.99 1.87 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.926 -1.034 . . . . 74.2 113.646 -168.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -58.5 -35.46 72.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.321 0.489 . . . . 75.22 112.321 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.72 -56.94 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 62.43 111.895 -170.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.585 HG12 ' CD2' ' A' ' 48' ' ' TYR . 1.7 mt -128.27 157.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.338 -0.616 . . . . 73.03 109.338 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -144.79 -77.94 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.703 -1.237 . . . . 74.03 114.34 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.739 ' O ' ' HD3' ' A' ' 29' ' ' PRO . . . -81.35 -153.32 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.677 0.621 . . . . 71.21 112.677 -168.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 61' ' ' SER . 56.9 tp -91.16 90.03 0.33 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.355 -0.839 . . . . 75.45 110.762 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.739 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 68.2 Cg_endo -85.59 -7.16 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.574 2.182 . . . . 72.31 112.56 -173.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 67.43 166.0 0.23 Allowed 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.638 0.586 . . . . 71.31 110.633 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.2 67.53 2.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.074 -0.584 . . . . 72.32 112.637 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.63 -67.69 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.358 0.599 . . . . 70.15 110.022 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -139.97 -36.7 0.49 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.848 -1.069 . . . . 72.02 108.785 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -78.46 115.88 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.336 -0.847 . . . . 75.2 110.521 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.446 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 3.9 pm0 -122.79 13.83 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.371 -0.377 . . . . 55.01 110.57 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.887 ' HA ' HG22 ' A' ' 46' ' ' ILE . 95.2 t 73.67 118.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.651 -0.704 . . . . 73.23 109.891 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.25 -51.07 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.129 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -168.65 150.72 4.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.606 -0.724 . . . . 71.53 110.394 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.72 125.84 35.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.499 -0.773 . . . . 72.54 110.195 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -97.62 177.72 5.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.884 -0.598 . . . . 73.54 109.857 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 p -62.36 76.54 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.011 -0.995 . . . . 74.1 111.411 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.08 -68.41 0.55 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.363 -0.835 . . . . 74.12 112.001 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 42.0 m0 -112.61 160.21 18.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 74.35 110.731 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . 13.2 m -103.55 129.32 50.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.891 -0.595 . . . . 75.3 109.7 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 38.0 ttmt -83.08 132.28 35.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.168 0.509 . . . . 74.34 111.738 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.887 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -140.02 153.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.592 -0.731 . . . . 75.14 109.954 176.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -111.98 113.77 26.27 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.428 -0.953 . . . . 74.1 108.428 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.672 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 11.8 t80 -115.53 110.96 20.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.253 -0.431 . . . . 62.41 110.137 -172.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.25 33.75 16.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 72.23 110.711 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 -10.2 75.26 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 75.51 113.808 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 14.0 pt20 -106.86 147.01 30.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.751 0.775 . . . . 74.14 110.982 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -84.88 131.29 34.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 62.44 111.418 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.84 174.17 26.77 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.786 -0.721 . . . . 62.5 111.849 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 66.6 m-85 -134.02 147.45 50.96 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.27 -0.641 . . . . 75.32 109.27 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.64 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 2.8 pp -126.86 154.65 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.529 0.204 . . . . 73.1 110.709 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 130.57 11.37 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.556 -0.831 . . . . 72.11 111.817 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 m -69.16 -9.12 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.14 0.495 . . . . 55.2 111.331 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.02 -47.22 86.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.109 0.481 . . . . 71.41 110.189 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CG ' ' HB2' ' A' ' 8' ' ' ASN . 7.7 m-85 -130.2 118.99 22.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.765 -0.652 . . . . 74.53 110.489 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 36' ' ' VAL . 5.0 tt -138.07 134.98 35.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.314 -0.857 . . . . 75.3 108.817 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.508 ' HB3' HD13 ' A' ' 28' ' ' LEU . 71.1 m -83.86 119.59 25.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 75.41 111.237 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HG3' ' H ' ' A' ' 63' ' ' LEU . 15.0 tppt? -110.8 175.34 5.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.952 -1.129 . . . . 72.2 107.952 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' A' ' 62' ' ' LYS . 4.4 mm? -67.42 -65.12 0.73 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.149 -0.22 . . . . 73.04 111.441 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 65' ' ' HIS . 0.1 OUTLIER 61.83 -178.08 0.12 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.184 -0.673 . . . . 72.03 109.184 -176.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.442 ' H ' ' CD ' ' A' ' 64' ' ' GLU . 1.5 t-80 -120.48 77.29 1.26 Allowed 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.901 -0.499 . . . . 71.42 110.298 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -100.79 96.81 7.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.716 -0.675 . . . . 74.34 110.401 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -77.54 133.62 38.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.601 -0.889 . . . . 73.52 108.601 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 43.9 t-80 70.88 12.66 7.11 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.861 0.362 . . . . 70.23 110.666 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 51.1 m-70 70.06 -65.93 0.3 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.251 0.62 . . . . 74.1 110.27 -173.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.0 p80 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.924 -1.036 . . . . 71.04 109.791 176.197 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.365 0.603 . . . . 72.21 110.622 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -132.63 120.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 73.43 111.215 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.45 -75.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.121 -1.192 . . . . 70.41 110.121 170.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 44.07 60.13 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.745 0.818 . . . . 72.31 113.177 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 p90 49.84 15.87 0.19 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.262 1.208 . . . . 72.32 114.262 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -105.33 -42.53 5.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 73.33 109.734 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.6 mm -71.5 128.74 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.468 -0.787 . . . . 73.55 110.025 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 8.4 t30 71.42 104.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.939 0.775 . . . . 65.54 111.043 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.64 -80.2 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.215 -0.448 . . . . 74.23 110.172 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -141.5 -70.19 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 74.12 110.427 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.47 11.29 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.305 0.574 . . . . 72.24 110.551 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.608 ' HA ' ' HD3' ' A' ' 15' ' ' ARG . 85.9 mt -89.63 69.58 7.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 72.45 110.631 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -119.18 -59.14 1.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.064 0.459 . . . . 75.54 111.455 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.35 49.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 72.25 110.352 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.608 ' HD3' ' HA ' ' A' ' 12' ' ' LEU . 22.0 mmm180 -81.23 42.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.13 112.363 -171.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.8 p 54.22 22.62 3.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.748 0.819 . . . . 75.54 112.777 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 109.3 -116.05 4.46 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 72.21 111.721 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.658 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 2.4 mm-40 -79.03 -72.41 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.633 -0.877 . . . . 73.22 108.633 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 18' ' ' GLU . . . -160.32 30.39 0.37 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.324 -1.51 . . . . 64.03 109.324 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -50.49 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.162 -1.019 . . . . 72.5 111.994 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.642 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.4 t30 -166.86 60.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.032 -0.729 . . . . 72.31 109.032 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -74.63 7.18 3.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.89 -0.595 . . . . 75.0 111.762 -173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.56 -24.1 56.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.582 . . . . 74.4 110.127 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.715 HG13 HG13 ' A' ' 25' ' ' ILE . 29.5 pt -79.19 -45.26 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.402 -0.363 . . . . 74.02 111.698 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.715 HG13 HG13 ' A' ' 24' ' ' ILE . 10.2 mt -132.66 138.05 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.908 -0.405 . . . . 74.43 109.908 -176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.46 -75.42 0.69 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.008 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.09 101.31 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.794 0.331 . . . . 62.52 110.722 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -140.05 75.75 28.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.458 -0.571 . . . . 50.3 109.458 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 6.1 Cg_exo -79.85 117.68 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.238 2.625 . . . . 63.35 111.305 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER 75.37 113.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 124.2 0.938 . . . . 74.15 109.953 -174.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.11 -51.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.509 -0.769 . . . . 63.14 111.32 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' A' ' 33' ' ' LYS . 42.2 mt-30 -134.83 -86.03 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.745 -0.465 . . . . 70.13 109.745 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.916 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 64.1 mttm -127.43 10.53 6.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.609 0.719 . . . . 74.5 109.529 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.74 82.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 122.072 0.939 . . . . 75.51 110.373 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -161.85 44.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.864 -1.062 . . . . 65.43 109.465 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m 43.82 86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.1 0.96 . . . . 70.3 113.164 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -74.74 -55.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.925 -0.58 . . . . 70.23 110.389 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -141.61 172.2 13.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 73.5 109.169 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.14 137.57 47.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.593 0.235 . . . . 70.42 110.485 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -155.56 132.99 11.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.707 -0.479 . . . . 64.43 109.707 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t 71.87 8.42 6.03 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.557 0.536 . . . . 70.22 111.297 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.98 -32.42 6.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.897 -0.668 . . . . 44.25 112.368 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.753 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 18.1 m0 -92.58 158.29 16.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.98 0.419 . . . . 74.04 110.723 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 54' ' ' TYR . 15.2 m -99.56 143.31 29.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.93 -0.577 . . . . 71.35 111.14 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -82.46 121.75 27.15 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.559 -0.746 . . . . 74.33 110.968 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.0 pt -139.57 156.53 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 61.35 110.157 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.916 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 22.8 t-20 -123.41 118.24 27.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.852 -0.425 . . . . 62.32 109.852 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.693 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 40.3 t80 -121.89 112.07 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.785 -0.643 . . . . 72.43 109.806 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.66 32.53 21.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.386 0.612 . . . . 73.42 111.153 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.16 56.96 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.827 -0.624 . . . . 38.21 113.637 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.693 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 5.1 pt20 -92.77 140.1 29.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.714 0.757 . . . . 72.13 110.902 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.2 m -78.79 123.71 27.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.997 -1.001 . . . . 52.53 110.12 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.81 22.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.72 -0.752 . . . . 54.52 112.331 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.753 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 95.9 m-85 -130.96 147.25 52.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.564 -0.532 . . . . 72.44 109.564 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 2.6 pp -134.84 160.96 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.407 -0.22 . . . . 74.43 110.407 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -83.78 132.48 11.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.669 -0.777 . . . . 74.41 112.153 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -63.39 -17.05 62.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 74.13 112.025 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.463 HH11 ' HD2' ' A' ' 58' ' ' ARG . 58.4 mtt85 -59.12 -48.82 80.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.413 -0.358 . . . . 74.24 111.616 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' O ' HD22 ' A' ' 60' ' ' LEU . 7.4 m-85 -117.11 116.77 27.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.312 0.577 . . . . 74.21 111.513 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD22 ' O ' ' A' ' 59' ' ' TYR . 1.2 mm? -142.12 175.28 9.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 73.05 108.187 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -83.1 119.53 24.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.626 -0.509 . . . . 74.25 109.626 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -97.98 141.08 31.38 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.701 -0.851 . . . . 74.52 108.701 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.59 -21.3 64.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.007 -0.277 . . . . 65.13 111.243 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.49 92.57 3.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.052 0.453 . . . . 63.43 110.056 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -111.2 -72.91 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.465 . . . . 73.31 110.603 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.8 172.23 0.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.382 -0.826 . . . . 74.42 111.15 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -117.74 92.91 3.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.764 0.792 . . . . 74.22 109.01 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -92.45 2.75 56.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 74.41 109.215 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 56.47 131.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.383 1.473 . . . . 74.3 112.587 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.492 -0.766 . . . . 73.02 109.864 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.066 -0.346 . . . . 64.13 110.066 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.663 ' H ' HD12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -117.45 179.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 71.22 111.961 -172.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.95 61.27 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.336 -1.106 . . . . 75.2 110.336 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 6' ' ' TYR . 3.5 m-20 66.77 116.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.335 0.654 . . . . 71.35 110.79 -172.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.44 72.08 4.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.524 0.678 . . . . 71.13 111.6 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.439 ' HD2' ' HB3' ' A' ' 4' ' ' ASP . 89.5 m-85 -140.56 -179.9 6.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.028 -1.101 . . . . 74.15 108.028 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.26 89.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.829 -1.175 . . . . 54.34 107.829 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -139.38 136.12 34.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.805 . . . . 74.13 110.613 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.97 93.8 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.767 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 10.5 t -165.18 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 72.13 109.486 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -179.47 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.647 -0.706 . . . . 74.3 110.786 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD21 ' H ' ' A' ' 12' ' ' LEU . 2.2 mm? -73.06 10.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.59 -0.732 . . . . 73.23 112.473 -170.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -95.01 1.2 55.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.277 0.473 . . . . 75.25 112.277 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 5.7 t -91.5 32.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.045 0.926 . . . . 64.23 108.706 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 22' ' ' TYR . 13.2 tpt180 -78.12 3.67 14.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.856 -1.065 . . . . 63.53 110.829 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.701 ' HB2' HD13 ' A' ' 25' ' ' ILE . 22.4 t 71.59 16.44 5.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.659 -0.701 . . . . 72.21 111.449 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.74 -122.23 1.4 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.424 -0.893 . . . . 62.0 112.719 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -160.99 -69.38 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.5 -0.555 . . . . 62.52 109.5 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.18 -32.77 0.48 Allowed Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.142 -0.783 . . . . 45.53 111.142 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.71 HG23 ' CZ2' ' A' ' 43' ' ' TRP . 4.7 t -55.76 -31.75 62.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.204 0.526 . . . . 74.45 111.09 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -171.83 114.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.088 -0.708 . . . . 73.31 109.088 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 15' ' ' ARG . 42.5 p90 -132.15 7.74 4.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.054 0.454 . . . . 75.55 110.804 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 23' ' ' ARG . 12.5 ptt180 -88.16 -24.57 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.015 0.746 . . . . 73.31 113.015 -169.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mm -69.92 -55.69 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.734 -0.387 . . . . 73.14 111.872 -171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.866 HG21 ' H ' ' A' ' 26' ' ' GLY . 1.1 mp -132.26 -169.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.651 -0.5 . . . . 74.44 109.651 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.866 ' H ' HG21 ' A' ' 25' ' ' ILE . . . -145.99 -65.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 72.32 112.516 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.75 94.14 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.729 -0.277 . . . . 71.22 111.01 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 28' ' ' LEU . 1.2 tm? -166.32 86.29 0.9 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.26 -0.644 . . . . 64.42 109.26 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.86 76.73 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.065 2.51 . . . . 74.11 113.314 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.879 ' HG2' ' H ' ' A' ' 31' ' ' GLY . 49.4 tt0 59.64 -154.43 0.37 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 75.01 110.587 173.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.879 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 90.59 -83.05 1.32 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.26 -0.495 . . . . 75.21 112.292 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.74 -47.35 75.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.155 0.502 . . . . 72.32 111.216 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 26.5 tptp -154.17 168.71 25.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.006 -1.109 . . . . 73.11 108.006 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG22 ' CD1' ' A' ' 48' ' ' TYR . 72.7 t 75.8 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.305 0.574 . . . . 73.35 111.462 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -136.32 148.06 47.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.993 -0.549 . . . . 75.13 110.468 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.433 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.3 p -92.04 143.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.065 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -93.84 -56.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.791 0.329 . . . . 72.53 110.369 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 p -173.6 151.18 1.86 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.021 -0.536 . . . . 72.34 110.007 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -110.59 137.85 47.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.603 -0.726 . . . . 71.11 111.623 -176.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -95.73 174.14 7.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.092 -1.077 . . . . 64.11 108.092 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -70.66 -11.25 60.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.011 0.434 . . . . 64.15 110.536 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.94 -74.68 0.97 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.983 -0.627 . . . . 65.25 111.567 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.71 ' CZ2' HG23 ' A' ' 20' ' ' THR . 52.0 m0 -117.61 159.48 22.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 74.41 110.745 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.0 t -109.9 142.91 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.29 -0.414 . . . . 60.05 110.053 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HG2' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -89.49 116.26 27.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.904 0.383 . . . . 65.51 111.697 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 36' ' ' VAL . 40.8 pt -131.61 156.72 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 71.11 110.106 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.545 ' O ' HG12 ' A' ' 34' ' ' VAL . 5.4 p30 -115.15 113.83 24.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.3 109.594 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.642 ' CD1' HG22 ' A' ' 34' ' ' VAL . 16.0 t80 -98.91 84.72 3.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.785 -0.45 . . . . 74.24 109.785 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.95 55.11 8.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.097 -0.956 . . . . 75.23 111.663 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.17 59.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.847 -0.692 . . . . 63.33 113.139 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.31 152.27 21.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.951 0.405 . . . . 60.31 110.407 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.1 m -93.57 114.44 26.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.563 -0.744 . . . . 75.34 109.389 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.37 148.35 18.49 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.278 -0.963 . . . . 75.51 112.983 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' SER . 95.8 m-85 -128.79 144.96 51.3 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.234 -1.024 . . . . 71.25 108.234 172.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.737 HD12 HD22 ' A' ' 60' ' ' LEU . 2.7 pp -133.19 158.73 43.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 110.024 -0.362 . . . . 65.3 110.024 175.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 127.19 8.19 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.511 -0.852 . . . . 52.41 112.317 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -75.29 -6.73 51.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.622 0.725 . . . . 74.51 110.496 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -74.02 -49.69 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.589 -0.732 . . . . 62.35 110.546 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.12 120.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.984 -0.553 . . . . 75.44 110.305 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.737 HD22 HD12 ' A' ' 55' ' ' ILE . 6.1 mt -134.59 174.15 10.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.872 -0.603 . . . . 74.44 111.067 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -148.98 145.83 27.52 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.58 -0.896 . . . . 75.14 108.58 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -117.19 -67.76 0.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.842 -0.429 . . . . 74.05 109.842 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -137.03 -58.11 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.352 -0.61 . . . . 75.21 109.352 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER 60.97 -179.64 0.11 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.344 -0.844 . . . . 74.51 112.542 174.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 59.09 35.88 23.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.455 -0.793 . . . . 75.12 110.829 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -95.31 130.04 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.173 -0.921 . . . . 75.24 110.043 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 61.08 93.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.632 0.583 . . . . 74.23 111.356 -176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.82 -27.47 60.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.68 -0.859 . . . . 73.42 108.68 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -178.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.092 -1.413 . . . . 72.41 107.782 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 C--O 1.242 0.685 0 CA-C-N 114.725 -1.125 . . . . 64.03 108.68 172.917 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.606 0.241 . . . . 73.31 110.368 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.556 HG21 ' H ' ' A' ' 4' ' ' ASP . 43.5 mm -122.91 -63.9 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 75.33 109.957 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.5 61.16 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 62.3 112.604 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.556 ' H ' HG21 ' A' ' 2' ' ' ILE . 5.4 m-20 -81.14 0.68 35.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.06 0.457 . . . . 54.23 111.312 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -110.37 23.39 14.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.133 0.492 . . . . 74.11 110.96 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 81.9 m-85 -111.02 110.71 21.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.679 -0.691 . . . . 74.21 109.747 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.628 HD11 ' H ' ' A' ' 7' ' ' ILE . 4.2 mp -72.38 -52.97 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.673 -0.694 . . . . 75.52 110.714 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m120 61.97 36.3 15.72 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.487 -0.778 . . . . 70.12 111.241 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.55 164.64 22.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 72.23 110.518 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 m 66.85 13.99 9.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.959 -0.564 . . . . 74.31 111.007 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.36 25.42 14.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.636 -0.711 . . . . 74.43 111.971 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 15' ' ' ARG . 3.7 pp -112.3 139.82 47.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 61.12 111.021 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -117.63 -59.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.764 -0.653 . . . . 65.25 110.652 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 55' ' ' ILE . 7.1 t -119.5 13.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.107 -1.072 . . . . 75.3 108.107 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.664 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 3.2 tmt_? -63.66 110.83 2.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.772 -1.104 . . . . 65.34 109.55 -175.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.757 ' CB ' ' HA ' ' A' ' 23' ' ' ARG . 45.9 p 55.71 15.27 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.17 -0.923 . . . . 74.32 112.548 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 53.92 -109.36 1.09 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.468 -0.653 . . . . 73.42 111.468 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -117.77 161.16 20.16 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.729 -0.841 . . . . 73.31 108.729 169.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 58.93 2.26 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.178 -0.534 . . . . 60.4 114.2 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 21' ' ' ASN . 6.3 t -103.1 -60.03 1.62 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.086 0.443 . . . . 75.13 110.839 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.515 ' H ' HG22 ' A' ' 20' ' ' THR . 7.9 t30 -161.27 -4.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.673 0.749 . . . . 74.51 110.487 177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.5 m-85 -83.47 15.33 3.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.621 -0.718 . . . . 73.31 112.524 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.757 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 98.7 mtt180 -44.64 -23.54 0.13 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.659 0.985 . . . . 74.33 113.659 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 pt -77.4 -5.41 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.732 0.641 . . . . 62.45 112.732 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.575 HG22 ' CE1' ' A' ' 48' ' ' TYR . 53.7 mt -90.09 167.63 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.425 -0.583 . . . . 74.41 109.425 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 15' ' ' ARG . . . -150.83 176.62 29.3 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 73.14 111.439 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.32 93.39 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.92 0.36 . . . . 74.23 110.941 -176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -171.3 62.61 0.36 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 70.25 110.874 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' OE2' ' A' ' 64' ' ' GLU . 69.3 Cg_endo -83.02 -40.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.799 1.666 . . . . 70.25 111.631 172.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.602 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 4.4 pt20 44.71 25.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.866 1.266 . . . . 75.41 113.21 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.46 19.57 57.9 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.371 -0.442 . . . . 73.14 112.624 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -82.41 -57.64 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.206 -0.294 . . . . 72.13 110.206 -175.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 24.0 ttmm -143.63 -70.57 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.621 -0.432 . . . . 74.54 111.769 -177.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.49 100.89 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.708 0.766 . . . . 62.41 111.582 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -140.01 -179.45 5.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 72.31 109.629 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 60' ' ' LEU . 31.8 m -76.11 138.83 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.21 0.529 . . . . 74.15 111.872 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.52 -55.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.67 -0.695 . . . . 64.05 109.955 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.5 t -160.05 155.19 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 74.31 109.98 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.601 ' HG3' ' HG ' ' A' ' 44' ' ' SER . 2.5 mp0 -106.9 153.15 22.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.946 -0.57 . . . . 74.14 110.918 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -170.19 131.05 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.52 110.364 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.0 t 69.35 17.35 8.2 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.033 -0.53 . . . . 71.14 111.415 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.98 -18.66 55.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.676 -0.773 . . . . 74.22 112.049 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.452 ' HD1' ' HA2' ' A' ' 56' ' ' GLY . 22.1 m0 -105.65 157.48 17.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.86 0.362 . . . . 74.35 110.499 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.601 ' HG ' ' HG3' ' A' ' 39' ' ' GLU . 20.1 t -121.81 146.55 46.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.947 -0.57 . . . . 72.32 110.092 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CD ' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -80.61 123.12 27.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.88 -176.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 pt -134.1 156.73 41.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.724 -0.671 . . . . 75.1 110.115 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -115.0 114.68 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.59 -0.522 . . . . 72.43 109.59 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.575 ' CE1' HG22 ' A' ' 25' ' ' ILE . 59.8 t80 -112.46 106.18 14.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.425 -0.352 . . . . 72.23 110.192 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 60.32 34.68 20.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.985 -0.552 . . . . 73.41 111.502 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.31 84.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.649 -0.786 . . . . 54.02 112.918 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -106.48 156.52 18.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.924 0.392 . . . . 55.31 110.586 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -76.8 128.4 34.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.674 -0.694 . . . . 64.11 109.886 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 22' ' ' TYR . . . -131.14 156.75 21.94 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.31 -0.948 . . . . 54.21 112.436 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' HE1' ' CD ' ' A' ' 45' ' ' LYS . 73.9 m-85 -128.26 140.55 51.83 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.038 -0.356 . . . . 72.44 110.038 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.565 HG22 ' HA2' ' A' ' 17' ' ' GLY . 2.7 pp -135.52 151.99 30.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.032 -0.531 . . . . 63.22 109.621 173.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' HA2' ' HD1' ' A' ' 43' ' ' TRP . . . -76.5 140.0 24.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.27 -0.967 . . . . 65.34 111.743 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 m -65.74 -10.8 40.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.32 0.581 . . . . 75.34 110.55 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -81.17 -11.67 59.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.607 -0.724 . . . . 73.11 111.222 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.16 118.44 16.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.222 0.534 . . . . 72.42 112.031 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 6' ' ' TYR . 18.7 mt -157.51 173.27 17.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 73.12 108.969 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.4 m -82.99 119.09 24.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.402 -0.592 . . . . 71.02 109.402 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 62' ' ' LYS . 12.4 tmtt? -97.26 -51.54 4.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.646 -0.706 . . . . 75.01 110.441 -173.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 63' ' ' LEU . 2.5 tm? -79.17 -22.65 44.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 73.33 110.294 -176.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 11.8 tt0 -79.75 54.58 1.85 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.717 -0.674 . . . . 72.0 111.756 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -149.82 -171.69 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.826 -0.805 . . . . 74.25 108.826 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.9 t60 69.8 163.45 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.422 0.451 . . . . 73.44 111.291 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 74.39 6.84 4.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.614 . . . . 74.44 111.71 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.22 142.68 43.11 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.072 -0.392 . . . . 74.14 110.126 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -119.84 152.82 36.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.269 -0.423 . . . . 65.25 111.079 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.9 m170 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.532 -0.747 . . . . 73.34 109.238 172.374 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.41 -0.589 . . . . 75.45 109.41 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt 63.19 102.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.5 0.667 . . . . 75.21 111.387 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.97 -9.9 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 65.14 112.189 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.43 124.12 31.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.236 0.541 . . . . 65.3 110.178 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 81.0 m-85 -130.85 35.48 3.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.618 -0.719 . . . . 75.15 109.571 -176.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 75.8 t80 75.43 143.58 0.08 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.26 0.975 . . . . 74.14 109.854 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.0 123.3 39.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 71.11 111.003 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.3 t30 70.38 175.77 0.29 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.174 -0.921 . . . . 72.54 110.163 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.8 75.67 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.748 0.419 . . . . 65.43 110.673 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 m 63.43 49.3 3.21 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.331 -0.849 . . . . 54.52 110.634 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -77.58 -152.17 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.207 -0.906 . . . . 73.43 110.781 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.811 HD22 ' H ' ' A' ' 12' ' ' LEU . 1.4 pt? -75.02 39.88 0.14 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.871 0.367 . . . . 72.23 111.654 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' ALA . 2.3 m-20 -68.41 -54.68 15.52 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.349 0.5 . . . . 73.02 112.349 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.08 21.31 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.641 0.734 . . . . 64.35 109.203 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.712 ' CG ' ' HA ' ' A' ' 12' ' ' LEU . 19.0 mmt180 -54.62 -38.52 66.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 73.1 112.797 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 25' ' ' ILE . 23.2 m 65.23 28.61 12.0 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.531 0.519 . . . . 64.43 111.677 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.87 133.77 27.22 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.667 -0.778 . . . . 51.34 111.914 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.14 -31.34 69.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.125 0.488 . . . . 71.13 110.281 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.06 -109.44 1.27 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.722 -0.951 . . . . 50.14 110.722 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.8 p -99.7 -4.81 29.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.353 0.597 . . . . 74.34 109.5 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -77.68 86.64 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.322 -0.854 . . . . 74.25 110.496 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.578 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 38.3 m-85 -93.9 5.78 50.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 73.52 111.548 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -90.26 -0.54 57.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.51 109.551 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -52.4 -42.38 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.179 -0.919 . . . . 72.44 110.208 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' A' ' 48' ' ' TYR . 68.1 mt -132.58 -79.66 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 110.441 -0.207 . . . . 72.4 110.441 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . 140.08 169.76 11.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.21 -0.995 . . . . 70.14 112.643 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -92.91 94.46 8.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.102 -0.333 . . . . 72.02 110.102 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HG ' HE22 ' A' ' 30' ' ' GLN . 19.4 tp -122.51 85.18 48.24 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.315 -0.624 . . . . 74.44 109.315 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.77 93.81 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.292 2.661 . . . . 72.32 113.378 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.6 HE22 ' HG ' ' A' ' 28' ' ' LEU . 2.5 mp0 -85.79 160.05 19.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 74.5 109.777 171.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.03 83.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.362 -0.446 . . . . 74.2 112.47 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 74.41 109.713 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.654 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? 71.94 143.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 71.03 111.895 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -77.13 -19.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.918 -0.583 . . . . 75.32 111.388 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.724 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 23.3 tt0 70.79 174.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.668 -0.696 . . . . 73.24 110.946 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.724 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 7.5 p -102.58 143.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.142 -0.481 . . . . 42.5 110.547 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 47' ' ' ASN . 5.3 mt -76.65 -56.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.828 -0.434 . . . . 73.25 109.828 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -172.18 161.67 5.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.585 -0.734 . . . . 73.21 109.599 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -117.15 139.8 50.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.74 -0.664 . . . . 61.14 110.289 -177.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -173.62 156.85 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.185 -0.461 . . . . 65.13 109.922 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.115 -0.493 . . . . 73.21 111.691 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.78 27.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.96 -0.638 . . . . 71.23 113.181 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -125.49 162.33 25.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.446 0.641 . . . . 74.41 111.479 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 36.6 m -101.17 122.57 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.254 -0.884 . . . . 74.14 109.609 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.0 ttmt -82.53 124.19 29.89 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.095 -0.502 . . . . 61.43 110.716 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG21 ' HA ' ' A' ' 36' ' ' VAL . 9.7 pt -126.19 148.55 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.571 -0.74 . . . . 73.31 110.922 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.689 ' HB2' HD12 ' A' ' 37' ' ' ILE . 26.2 t-20 -109.54 113.39 26.14 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.294 -0.632 . . . . 70.41 109.294 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.596 ' CD2' HD11 ' A' ' 25' ' ' ILE . 32.7 t80 -104.03 85.69 2.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.124 0.488 . . . . 74.43 109.705 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.88 50.03 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 73.2 111.107 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.67 -17.66 58.87 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.059 -0.591 . . . . 64.53 114.213 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -103.41 147.39 27.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.075 0.937 . . . . 75.44 110.753 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -93.65 129.46 39.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 71.24 111.45 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.17 170.69 22.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.585 -0.606 . . . . 53.43 111.585 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.79 151.38 51.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 73.04 110.538 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 2.5 pp -143.69 153.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.801 -0.636 . . . . 73.52 109.919 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' H ' HD11 ' A' ' 12' ' ' LEU . . . -74.62 128.4 10.32 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.502 -0.856 . . . . 70.12 111.392 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 m -64.23 -4.5 3.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.406 0.521 . . . . 74.4 112.406 -174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -68.65 -34.37 75.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.169 -0.308 . . . . 64.31 110.169 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.05 119.43 23.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.011 0.434 . . . . 75.44 110.378 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -155.53 129.81 8.89 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.715 -0.846 . . . . 73.13 108.715 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 t -87.51 120.67 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.461 -0.57 . . . . 53.02 109.461 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' A' ' 63' ' ' LEU . 12.5 ttmm -75.96 -163.65 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.938 -0.574 . . . . 64.3 110.534 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 2.8 pp -67.47 -31.48 71.66 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.335 -0.228 . . . . 71.14 110.752 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' N ' HD11 ' A' ' 63' ' ' LEU . 13.7 mm-40 46.78 65.5 1.21 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.7 1.0 . . . . 71.33 113.7 171.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 52.86 92.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.439 -0.8 . . . . 70.42 112.579 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' HD1' ' HB2' ' A' ' 63' ' ' LEU . 13.5 p-80 -116.59 164.78 14.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 73.42 110.109 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.99 135.59 37.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.083 0.468 . . . . 72.44 110.318 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -97.05 106.32 18.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.034 -0.53 . . . . 72.42 109.756 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -85.9 113.9 22.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.961 0.41 . . . . 73.24 110.54 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.681 -0.676 . . . . 73.23 109.598 178.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.343 -0.243 . . . . 74.42 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.07 84.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.49 -0.93 . . . . 71.34 108.49 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . -109.96 0.77 30.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.207 -0.997 . . . . 60.21 113.357 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 m-20 71.89 -51.05 0.7 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.934 0.494 . . . . 65.21 112.036 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -79.1 -37.04 39.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 75.33 110.544 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.33 74.6 3.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.62 . . . . 73.42 110.687 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 tt -174.53 154.5 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.299 -0.864 . . . . 74.4 108.997 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.567 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 60.7 t30 -93.49 91.0 6.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.595 0.236 . . . . 72.45 110.539 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.28 98.74 5.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 72.34 111.128 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 m -151.69 -71.78 0.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.109 -0.496 . . . . 72.22 110.123 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.64 -57.49 0.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.789 -0.641 . . . . 75.12 109.644 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.767 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 mm? -82.33 75.26 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.338 -0.986 . . . . 65.32 108.338 172.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 -38.24 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.599 0.592 . . . . 72.04 112.599 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.602 HG13 ' H ' ' A' ' 16' ' ' SER . 47.8 t -77.26 -66.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.454 -0.498 . . . . 74.23 111.463 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 53.86 20.86 2.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.599 0.592 . . . . 62.3 112.599 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.602 ' H ' HG13 ' A' ' 14' ' ' VAL . 14.9 m 61.47 25.94 15.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.853 0.461 . . . . 72.13 111.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.38 -113.31 3.5 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.645 -0.788 . . . . 73.4 112.573 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 15.3 mm-40 -73.69 -5.83 43.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.641 0.258 . . . . 72.33 111.192 -175.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.58 29.11 9.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.052 -0.594 . . . . 62.44 112.2 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 p -75.42 -62.01 1.71 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 72.55 110.955 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.423 ' HB3' HG23 ' A' ' 24' ' ' ILE . 39.1 m-80 -103.58 93.34 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.841 -0.618 . . . . 70.24 110.354 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -93.03 -1.13 56.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.055 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -82.89 -24.08 33.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 70.34 111.267 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.654 HG12 HG13 ' A' ' 25' ' ' ILE . 4.8 tt -93.16 -55.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.233 . . . . 75.41 111.317 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.654 HG13 HG12 ' A' ' 24' ' ' ILE . 7.2 mt -129.54 138.65 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.313 -0.625 . . . . 64.31 109.313 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.21 -71.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.103 -1.046 . . . . 40.0 113.622 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . . . -74.69 -162.03 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.386 0.513 . . . . 74.33 112.386 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.91 90.16 0.37 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 75.52 109.352 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 52.3 Cg_endo -82.26 6.74 5.53 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.906 2.404 . . . . 73.02 113.105 -169.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 33.2 mm-40 70.59 -67.1 0.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.481 0.712 . . . . 73.11 111.251 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.77 77.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.724 -0.751 . . . . 63.54 112.713 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.76 -50.94 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 72.24 110.664 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -139.98 19.19 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.414 -0.958 . . . . 74.14 108.414 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 47' ' ' ASN . 15.2 t -129.97 116.39 37.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.785 -1.098 . . . . 70.43 111.217 -169.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.933 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 4.3 pm0 -145.22 -86.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.774 -0.37 . . . . 72.42 110.519 169.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.933 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 75.4 t -144.43 114.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.827 -0.434 . . . . 71.1 109.827 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 46' ' ' ILE . 5.4 mt -99.85 -56.69 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.857 -0.337 . . . . 74.25 110.39 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -167.56 153.27 7.44 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.905 0.383 . . . . 71.31 110.213 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 5.5 pt-20 -117.38 149.47 40.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.384 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -160.24 130.59 5.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.524 . . . . 70.24 109.798 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t 71.84 24.55 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.348 0.594 . . . . 74.23 111.106 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.89 44.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 64.12 112.853 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' HE1' ' HG2' ' A' ' 18' ' ' GLU . 9.6 m0 -119.09 152.7 36.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.921 0.391 . . . . 74.13 110.912 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.814 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.2 m -97.05 137.1 36.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.896 -0.593 . . . . 72.24 109.547 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.79 131.0 45.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.881 -0.414 . . . . 74.34 109.881 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.657 ' HA ' HD11 ' A' ' 37' ' ' ILE . 25.2 pt -145.0 171.24 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 65.12 110.949 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 34' ' ' VAL . 23.7 t-20 -113.01 113.65 25.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 172.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.625 ' CD2' HG12 ' A' ' 25' ' ' ILE . 50.7 t80 -110.1 106.9 16.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.597 -0.274 . . . . 71.31 110.336 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.05 34.43 13.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.68 0.753 . . . . 75.12 110.654 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.92 73.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.936 -0.649 . . . . 74.21 113.571 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -120.45 157.57 29.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.382 0.591 . . . . 75.24 110.882 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 m -73.02 125.26 27.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 74.44 110.752 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.7 166.03 24.37 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.575 -0.821 . . . . 74.11 112.313 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -132.81 148.19 52.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.805 -0.443 . . . . 74.34 109.805 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -137.18 168.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.205 -0.452 . . . . 75.44 110.098 177.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.38 155.03 19.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.347 -0.93 . . . . 73.43 111.981 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -85.87 -21.76 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 75.11 109.682 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.0 -41.93 13.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.69 -0.687 . . . . 64.25 110.448 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 8' ' ' ASN . 20.5 m-85 -95.14 113.07 24.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.4 -0.963 . . . . 75.23 108.4 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -158.68 174.1 15.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.152 -0.476 . . . . 75.5 110.648 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -121.17 117.64 27.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.454 -0.943 . . . . 65.33 108.454 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.771 ' HG3' ' H ' ' A' ' 63' ' ' LEU . 41.6 tptt -114.12 -154.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.733 -1.21 . . . . 71.41 107.733 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.771 ' H ' ' HG3' ' A' ' 62' ' ' LYS . 57.0 tp -77.41 -62.97 1.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.566 -0.531 . . . . 73.3 109.566 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 62' ' ' LYS . 2.3 mp0 56.15 -175.08 0.05 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.554 -0.748 . . . . 72.54 111.864 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -129.75 93.22 3.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.75 -0.833 . . . . 73.33 108.75 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.27 128.56 22.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 75.33 110.73 -173.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -89.46 123.16 33.34 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.493 -0.776 . . . . 74.34 111.117 -175.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -62.47 134.78 56.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.486 -0.325 . . . . 75.24 110.422 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -88.78 142.45 27.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.055 -0.35 . . . . 74.32 110.055 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--O 1.248 0.993 0 O-C-N 123.969 0.793 . . . . 72.42 110.278 -176.277 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.715 0.293 . . . . 74.11 110.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.702 HD11 ' HA3' ' A' ' 19' ' ' GLY . 1.7 pp -143.6 14.91 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.43 . . . . 72.42 111.434 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.59 6.05 66.7 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.999 -0.619 . . . . 51.31 112.723 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.44 -4.73 57.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.533 . . . . 72.14 111.085 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -87.27 -39.15 15.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.36 . . . . 72.35 111.234 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 59.23 27.16 16.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.15 0.426 . . . . 72.42 112.15 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.49 114.91 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.273 0.559 . . . . 54.42 112.219 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.688 ' HB3' ' HB2' ' A' ' 59' ' ' TYR . 4.9 m-20 -93.73 92.01 7.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.591 -0.731 . . . . 74.24 109.593 171.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.33 84.1 0.78 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.0 0.429 . . . . 64.31 110.893 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 12' ' ' LEU . 15.2 m -157.01 24.71 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.785 -0.643 . . . . 64.14 109.78 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.98 -6.36 1.1 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.666 -0.697 . . . . 75.15 111.515 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 10' ' ' SER . 53.7 mt -97.54 128.06 43.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.249 -0.649 . . . . 75.1 109.249 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.69 -42.23 5.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.922 0.392 . . . . 55.13 111.072 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.65 49.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 71.44 109.813 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 21' ' ' ASN . 5.7 mmm180 -43.99 -72.62 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.731 -1.122 . . . . 63.13 112.938 -173.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.967 ' HB2' HD12 ' A' ' 25' ' ' ILE . 2.2 m 57.64 37.66 27.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.239 0.543 . . . . 73.41 110.257 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' HG23 ' A' ' 24' ' ' ILE . . . -83.91 168.87 45.76 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.801 -0.714 . . . . 71.34 113.429 -172.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -70.88 -42.36 70.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.489 0.661 . . . . 75.22 109.512 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.702 ' HA3' HD11 ' A' ' 2' ' ' ILE . . . -126.4 -65.25 0.16 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.186 -0.916 . . . . 73.34 111.583 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 4.5 p -123.82 -6.53 7.94 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.638 -0.331 . . . . 72.21 111.811 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 15' ' ' ARG . 10.8 t-20 75.13 122.82 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.992 0.808 . . . . 73.21 111.807 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -129.62 -60.81 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.556 -0.747 . . . . 74.31 111.008 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -119.06 -13.51 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.317 0.858 . . . . 75.01 113.317 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.733 HG12 HG13 ' A' ' 25' ' ' ILE . 11.6 tt -61.79 -55.89 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.72 -0.392 . . . . 70.01 112.022 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.967 HD12 ' HB2' ' A' ' 16' ' ' SER . 59.4 mt -138.44 155.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.079 -0.712 . . . . 71.2 109.079 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.9 -113.05 2.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.492 -0.861 . . . . 73.41 112.37 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.81 94.55 4.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.197 0.522 . . . . 51.44 110.975 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 tp -147.43 84.98 6.93 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.67 -0.696 . . . . 74.51 109.41 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -92.6 -10.85 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.005 2.47 . . . . 73.23 113.398 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -94.67 97.37 10.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.629 0.728 . . . . 72.45 110.694 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.0 150.06 21.26 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.413 -0.812 . . . . 64.3 111.435 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -68.91 -24.14 64.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.12 0.486 . . . . 73.13 110.381 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -122.13 22.14 10.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.363 0.601 . . . . 73.31 109.521 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.72 108.0 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.677 . . . . 63.01 110.793 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -166.23 156.81 12.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.15 109.888 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.989 ' HA ' HG21 ' A' ' 46' ' ' ILE . 61.9 t -73.8 125.14 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.031 -0.359 . . . . 71.3 110.031 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.63 -56.34 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.774 0.321 . . . . 75.53 110.586 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -144.45 159.31 42.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.406 -0.361 . . . . 72.23 110.179 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 9.7 pt-20 -129.01 142.61 50.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.161 -0.472 . . . . 71.04 110.799 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -112.03 173.36 6.4 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.499 -0.926 . . . . 75.02 108.499 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -74.51 69.18 1.67 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 63.25 109.749 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.77 -75.65 0.21 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.243 -0.743 . . . . 62.54 111.243 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -118.46 144.88 45.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.087 0.47 . . . . 73.54 110.782 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 27.4 m -101.39 139.38 37.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.724 -0.671 . . . . 74.32 110.678 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HD2' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -82.03 114.69 20.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.401 0.68 . . . . 72.34 110.16 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.989 HG21 ' HA ' ' A' ' 36' ' ' VAL . 20.1 pt -132.19 167.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.184 0.516 . . . . 73.54 111.551 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.84 114.63 14.92 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.574 -0.899 . . . . 74.31 108.574 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.665 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 43.3 t80 -99.7 88.37 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.864 0.364 . . . . 75.43 110.247 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 58.6 47.1 13.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.537 0.684 . . . . 52.22 110.88 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.35 -6.07 74.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.678 -0.772 . . . . 71.14 113.856 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -113.24 162.41 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.678 0.739 . . . . 73.31 111.237 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -73.82 143.32 45.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.484 -0.78 . . . . 73.33 111.887 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.92 155.58 26.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.541 -0.838 . . . . 51.32 112.508 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.473 ' HE1' ' HD2' ' A' ' 45' ' ' LYS . 78.8 m-85 -141.71 145.28 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.301 -0.629 . . . . 72.42 109.301 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 15' ' ' ARG . 2.5 pp -131.12 145.35 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 121.243 -0.183 . . . . 75.23 110.589 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.28 126.55 22.8 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.408 -0.901 . . . . 74.32 111.148 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -57.07 -22.06 36.38 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.507 0.323 . . . . 54.24 111.823 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -55.91 -34.63 65.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.463 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -127.68 119.15 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.011 0.434 . . . . 72.42 111.216 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.633 HD21 ' H ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -144.6 156.16 43.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.82 -0.807 . . . . 73.34 108.82 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.633 ' H ' HD21 ' A' ' 60' ' ' LEU . 34.5 t -98.84 141.78 31.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.931 0.395 . . . . 61.44 110.26 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -68.53 138.4 55.14 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.363 -0.835 . . . . 74.12 110.404 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.0 mt -102.8 -49.18 3.87 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.964 -0.754 . . . . 74.34 108.964 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 44.84 83.16 0.03 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.382 1.051 . . . . 74.55 111.989 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -63.56 126.61 28.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.406 -0.59 . . . . 70.24 109.406 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.9 146.73 37.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 72.5 110.444 -171.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -107.73 127.72 53.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 70.32 110.556 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -108.14 136.14 48.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.189 -0.671 . . . . 72.21 109.189 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -66.31 153.74 41.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 74.04 110.855 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.742 -0.647 . . . . 73.31 110.007 176.366 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.889 0.376 . . . . 74.42 110.183 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tt -147.3 112.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.561 0.696 . . . . 74.12 110.787 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.63 18.33 6.37 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.786 -0.926 . . . . 72.14 110.786 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 41.22 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.997 -0.602 . . . . 75.42 111.011 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -82.12 -52.67 6.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.27 -0.423 . . . . 74.44 111.376 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 60.85 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.692 0.758 . . . . 75.32 110.314 -172.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.694 HD11 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -106.49 -166.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.235 -0.893 . . . . 73.4 112.004 -169.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.619 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 9.0 p30 59.41 131.13 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.262 1.425 . . . . 75.21 113.27 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.59 -85.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.88 -1.055 . . . . 62.33 109.275 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 t -174.96 160.31 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 75.12 109.185 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.591 ' H ' ' HB3' ' A' ' 61' ' ' SER . . . 65.0 168.6 0.19 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.909 0.756 . . . . 73.21 112.691 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.7 mt 56.42 30.41 16.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.372 -0.831 . . . . 73.25 112.763 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.547 ' OD1' ' HB ' ' A' ' 55' ' ' ILE . 38.3 t30 -110.58 -59.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.162 0.506 . . . . 55.31 111.478 -176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.713 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 4.3 t -86.04 48.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 73.33 110.823 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.758 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 14.6 mmt180 -77.92 -1.11 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.08 -0.509 . . . . 74.11 112.235 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t 66.47 28.18 9.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.615 -1.254 . . . . 72.14 107.615 -167.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . 160.14 -170.36 36.21 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.421 -1.872 . . . . 71.22 108.421 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -110.56 -73.93 0.66 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.359 1.08 . . . . 75.24 109.619 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.79 -7.61 17.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 44.45 111.233 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.34 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.445 . . . . 72.01 111.271 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -141.78 130.96 23.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.909 -0.774 . . . . 72.44 108.909 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 49.8 p90 -130.02 8.2 5.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.085 -0.507 . . . . 74.23 110.675 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -79.18 -48.84 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.239 0.829 . . . . 71.32 113.239 -166.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.592 ' H ' HD11 ' A' ' 24' ' ' ILE . 3.4 mp -77.47 -56.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.56 -0.456 . . . . 63.13 112.224 -167.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.713 ' HB ' ' O ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -130.3 163.71 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.79 -0.448 . . . . 72.34 109.79 -176.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.758 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -121.17 -67.13 0.26 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.059 -0.591 . . . . 37.85 112.019 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 11' ' ' ALA . . . -151.17 94.15 2.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.777 0.322 . . . . 73.44 110.401 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -157.59 86.04 2.68 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 72.13 109.926 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.697 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 51.3 Cg_endo -106.26 -164.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.81 3.006 . . . . 74.12 113.194 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.729 ' HG3' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER 75.39 109.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.311 -0.859 . . . . 75.42 112.567 170.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.89 -102.63 2.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.352 -0.84 . . . . 63.31 113.649 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.59 -13.17 60.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.269 0.557 . . . . 74.21 110.643 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HD2' ' HE2' ' A' ' 48' ' ' TYR . 45.7 mmtm -126.46 136.57 52.8 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.502 -0.772 . . . . 73.51 109.405 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.67 148.46 5.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.974 0.416 . . . . 61.04 110.59 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.774 ' HG3' HG11 ' A' ' 36' ' ' VAL . 12.5 pt20 -124.2 -34.17 2.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 72.13 111.643 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.774 HG11 ' HG3' ' A' ' 35' ' ' GLN . 5.5 p -165.76 125.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.35 . . . . 75.21 111.079 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.6 mt -113.68 -56.24 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.45 -0.341 . . . . 73.24 110.601 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.3 t -155.22 149.25 25.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.033 0.444 . . . . 62.03 110.311 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -104.95 146.35 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.603 -0.726 . . . . 73.44 110.399 -173.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.49 119.51 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.461 -0.336 . . . . 74.31 110.784 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t 65.99 24.86 11.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.672 -0.695 . . . . 75.44 111.756 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.29 -46.63 1.13 Allowed Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.664 -0.779 . . . . 73.3 112.676 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.52 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 47.9 m0 -90.08 161.4 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 75.33 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 22.8 t -111.22 134.24 52.96 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.239 -1.022 . . . . 70.32 108.239 171.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 32.4 ttmt -82.09 130.93 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.983 -0.553 . . . . 74.54 111.889 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.72 ' HA ' HD13 ' A' ' 37' ' ' ILE . 23.2 pt -134.99 171.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.494 -0.776 . . . . 73.32 109.121 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.91 117.79 16.22 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.662 -0.415 . . . . 74.32 110.507 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.634 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 7.0 m-85 -122.48 114.18 20.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.003 0.43 . . . . 75.5 111.067 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.29 34.37 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.871 -1.059 . . . . 74.35 110.955 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.4 -17.76 46.24 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.833 -0.621 . . . . 51.22 113.693 173.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 20.8 pt20 -93.53 153.53 18.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.303 0.552 . . . . 71.42 110.197 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -75.0 118.06 17.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.172 -0.467 . . . . 72.25 110.856 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.92 168.57 13.07 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.748 -0.739 . . . . 73.43 111.883 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 84.7 m-85 -144.0 166.47 24.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.56 -0.533 . . . . 71.51 109.56 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.547 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 2.7 pp -123.79 143.42 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 108.702 -0.851 . . . . 72.24 108.702 166.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 43' ' ' TRP . . . -96.55 100.31 2.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.15 -1.024 . . . . 71.43 111.251 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -50.52 -20.84 1.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.283 0.846 . . . . 63.45 113.283 -172.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.461 ' HA ' HG22 ' A' ' 7' ' ' ILE . 13.9 mtm180 -53.11 -37.19 61.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.766 0.317 . . . . 74.32 110.593 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.78 147.95 45.92 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.072 0.463 . . . . 72.44 109.846 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HB2' ' HA ' ' A' ' 8' ' ' ASN . 73.0 mt -152.59 135.79 15.75 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.479 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 11' ' ' ALA . 3.4 p -129.08 135.87 49.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.759 -0.655 . . . . 73.52 109.686 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -140.28 114.83 9.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.892 -0.41 . . . . 75.24 109.892 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.39 -42.86 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.509 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.729 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 11.6 pt-20 46.5 -163.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.108 0.88 . . . . 74.22 111.777 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -70.08 145.5 51.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.884 -0.413 . . . . 71.31 109.884 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -76.38 126.89 31.8 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.775 -0.454 . . . . 74.15 109.775 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.56 145.69 38.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.711 -0.396 . . . . 73.15 110.757 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 134.83 38.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 72.13 110.355 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -96.84 -34.66 11.2 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.418 -0.586 . . . . 71.44 109.418 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.202 -0.904 . . . . 75.41 109.674 174.101 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.575 0.226 . . . . 73.03 110.768 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.402 HD11 ' N ' ' A' ' 2' ' ' ILE . 4.3 mp 50.12 87.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.515 -0.766 . . . . 62.15 111.942 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -20.01 75.29 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.361 -0.923 . . . . 61.13 111.415 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.6 t0 63.63 41.39 7.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.764 0.792 . . . . 74.32 110.204 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -80.98 95.58 6.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 74.44 110.657 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -68.47 124.29 23.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.827 -0.624 . . . . 73.31 109.962 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.598 HG21 ' HA ' ' A' ' 16' ' ' SER . 4.0 mp -77.64 -72.41 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.842 -0.429 . . . . 72.43 109.842 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.1 t30 69.69 -60.56 0.47 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.673 -0.694 . . . . 70.41 111.232 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' ALA . . . 50.82 42.43 27.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.665 0.603 . . . . 72.22 111.301 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 t 72.4 -40.38 0.47 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.328 -0.851 . . . . 61.22 111.504 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ALA . . . -167.68 -61.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 70.33 111.18 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 129.39 34.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.24 111.639 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.13 6.93 20.53 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.657 0.741 . . . . 65.34 110.175 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.61 -3.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.775 1.028 . . . . 74.53 113.775 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.616 ' HA ' HG21 ' A' ' 25' ' ' ILE . 17.9 mtm180 -121.41 -46.04 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.039 0.381 . . . . 74.12 111.113 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 7' ' ' ILE . 66.4 m 64.91 4.25 2.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.481 0.919 . . . . 65.15 113.481 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.84 -109.58 1.71 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.964 -0.636 . . . . 74.11 112.272 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -157.63 154.61 28.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.474 -0.565 . . . . 74.1 109.474 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.94 -135.83 2.02 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.622 -0.799 . . . . 75.54 112.308 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -72.68 -8.11 53.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.919 0.39 . . . . 75.42 111.515 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -136.11 138.93 42.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.943 -0.762 . . . . 72.01 108.943 172.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.2 -16.39 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.776 0.798 . . . . 74.4 110.086 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -89.16 6.54 39.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.732 -1.122 . . . . 74.53 109.871 172.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 10.4 tp -55.83 -9.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 114.903 -1.044 . . . . 73.14 113.679 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 15' ' ' ARG . 1.3 pp -59.74 135.1 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 63.11 112.123 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.25 148.8 5.31 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.585 -0.816 . . . . 40.52 113.904 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.685 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -146.98 -178.51 6.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.655 -0.498 . . . . 62.45 109.655 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 36' ' ' VAL . 41.2 mt -128.67 65.84 73.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 111.861 0.319 . . . . 71.54 111.861 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 27' ' ' ALA . 3.6 Cg_endo -86.0 -55.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.29 1.993 . . . . 75.43 111.044 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 179.37 131.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.281 -0.872 . . . . 74.23 109.486 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.14 168.73 11.35 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.192 -1.004 . . . . 74.51 113.225 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.38 15.0 11.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.139 0.495 . . . . 73.2 110.532 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.585 ' HZ1' ' HB3' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -70.86 -25.44 62.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.77 -0.65 . . . . 75.31 110.264 177.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.862 HG12 ' H ' ' A' ' 35' ' ' GLN . 2.4 p -135.85 -80.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.029 -0.532 . . . . 74.0 110.092 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.862 ' H ' HG12 ' A' ' 34' ' ' VAL . 26.5 tt0 65.89 152.93 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.711 0.767 . . . . 73.23 112.123 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG21 HD23 ' A' ' 28' ' ' LEU . 71.2 t -91.12 137.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.668 -0.697 . . . . 61.02 110.462 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.78 -55.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.245 -0.65 . . . . 74.43 109.245 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.9 m -159.45 155.32 26.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.243 -0.89 . . . . 75.12 109.097 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.475 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 7.7 pt-20 -124.91 141.97 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.962 0.41 . . . . 60.42 111.01 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.27 159.52 7.29 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.791 -0.641 . . . . 72.23 109.859 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 27.51 16.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.013 0.745 . . . . 72.04 113.013 158.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.83 -50.6 0.83 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.518 -0.849 . . . . 72.21 113.271 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -123.0 162.33 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.466 0.65 . . . . 72.42 111.251 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB3' HD11 ' A' ' 55' ' ' ILE . 20.8 t -103.45 120.47 40.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.194 -0.912 . . . . 71.42 108.687 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 54' ' ' TYR . 31.2 ttpt -82.45 137.01 34.8 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.529 0.566 . . . . 70.24 112.529 -171.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.7 170.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.192 -0.913 . . . . 63.53 110.547 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 24.4 t-20 -127.8 113.89 16.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.336 -0.616 . . . . 73.54 109.336 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.673 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 34.1 t80 -125.87 112.85 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.478 -0.328 . . . . 75.32 110.554 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.98 37.31 18.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.702 0.763 . . . . 73.31 110.509 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -17.45 58.52 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.634 -0.712 . . . . 73.03 114.022 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 29.7 pt20 -98.9 155.71 17.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.416 0.608 . . . . 74.12 110.789 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.8 m -97.57 114.06 25.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.759 -0.655 . . . . 71.54 109.773 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.06 -176.69 15.93 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.82 -0.705 . . . . 72.13 112.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 73.3 m-85 -136.89 139.31 41.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.18 -0.674 . . . . 72.34 109.18 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.687 HD12 HD22 ' A' ' 60' ' ' LEU . 2.8 pp -120.18 155.58 23.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.881 -0.414 . . . . 60.05 109.881 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.66 116.37 4.35 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.03 -1.081 . . . . 38.39 111.553 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -12.36 25.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.692 0.397 . . . . 74.21 111.869 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -69.57 -34.77 74.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.387 -0.369 . . . . 74.12 111.508 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.76 120.01 26.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.086 0.47 . . . . 75.52 111.918 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD22 HD12 ' A' ' 55' ' ' ILE . 56.4 mt -155.66 152.1 28.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.21 108.907 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -92.92 120.3 33.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.211 -0.663 . . . . 73.03 109.211 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.34 159.06 18.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.357 -0.383 . . . . 74.31 110.56 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.57 -4.26 57.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.583 . . . . 54.22 110.57 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.7 tm-20 -88.99 152.54 21.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.441 -0.8 . . . . 75.21 108.953 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 14.5 m80 71.06 29.3 2.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.365 0.602 . . . . 74.11 109.76 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -77.62 140.29 39.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.157 -0.928 . . . . 73.33 110.496 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -114.17 138.92 49.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.517 -0.31 . . . . 74.54 110.645 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -117.1 -38.76 3.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.551 -0.537 . . . . 73.53 109.551 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -72.75 130.87 41.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 72.13 109.755 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 m170 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.102 -0.951 . . . . 73.04 109.721 179.913 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.114 -0.698 . . . . 75.21 109.114 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.748 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -92.26 118.65 38.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.193 0.521 . . . . 73.42 112.007 -174.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.36 -63.3 1.87 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.928 -0.869 . . . . 54.42 110.928 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 70.58 -56.07 0.61 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.879 0.872 . . . . 73.21 112.803 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.75 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 87.5 t80 -78.84 123.48 27.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.015 0.436 . . . . 73.12 111.637 -174.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -110.65 164.95 12.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 62.51 109.882 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -131.18 122.31 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 73.34 110.538 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.775 HD21 ' HA ' ' A' ' 13' ' ' ASN . 1.6 m-20 -84.49 163.02 19.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.673 . . . . 74.43 111.615 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.48 166.13 32.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.881 -1.054 . . . . 74.44 108.615 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m 65.45 33.08 9.09 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.783 0.677 . . . . 75.53 110.373 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.51 -155.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.791 -0.64 . . . . 53.33 110.323 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HB2' ' HA3' ' A' ' 17' ' ' GLY . 27.1 tp 58.93 27.72 16.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.209 0.528 . . . . 72.13 110.71 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.775 ' HA ' HD21 ' A' ' 8' ' ' ASN . 27.1 t-20 -58.41 -42.27 86.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.719 -0.673 . . . . 54.52 110.87 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.18 -65.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 107.697 -1.223 . . . . 72.14 107.697 170.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.664 ' HG2' HG23 ' A' ' 55' ' ' ILE . 4.3 mmp_? -138.57 -164.42 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.847 -1.069 . . . . 74.44 108.482 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 34.5 t 65.63 74.65 0.37 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.419 0.628 . . . . 64.21 110.699 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.589 ' HA3' ' HB2' ' A' ' 12' ' ' LEU . . . -176.2 -173.71 42.09 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.49 -0.777 . . . . 72.13 111.2 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.13 84.14 1.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.391 0.615 . . . . 71.3 110.807 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.15 -86.8 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.345 -0.843 . . . . 43.45 111.311 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -123.52 -65.23 1.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.915 0.388 . . . . 73.2 110.661 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -130.86 133.06 45.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.602 -0.888 . . . . 71.41 108.602 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.7 p90 -108.91 8.4 26.44 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.124 0.416 . . . . 73.15 112.124 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 38.0 ttt180 -115.25 -2.44 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.787 -0.365 . . . . 74.35 111.633 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -58.41 -56.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.093 0.405 . . . . 75.33 112.093 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.502 HD11 ' HG3' ' A' ' 15' ' ' ARG . 2.7 mp -129.13 -78.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 63.32 110.23 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 16' ' ' SER . . . 148.69 -171.23 29.06 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.217 -0.753 . . . . 72.23 111.217 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.28 94.41 4.33 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 71.32 110.543 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 28' ' ' LEU . 1.5 pt? -120.52 85.37 37.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.375 0.607 . . . . 75.02 110.122 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.56 5.14 6.56 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.557 2.838 . . . . 64.52 113.029 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.36 59.52 4.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.719 . . . . 75.14 111.615 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.43 -33.88 5.04 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.808 -0.633 . . . . 72.13 113.432 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.47 -164.91 0.95 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.045 0.422 . . . . 74.54 110.35 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.748 ' HG3' ' H ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -175.55 -85.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.52 0.512 . . . . 75.21 110.373 175.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.748 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 36.9 t -142.12 -85.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 34' ' ' VAL . 12.4 mm100 -157.89 -39.31 0.07 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 72.24 110.111 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.598 ' HA ' HG21 ' A' ' 46' ' ' ILE . 7.4 p 44.35 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.417 1.087 . . . . 70.34 112.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.57 -57.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 74.45 111.278 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 t -167.29 169.16 12.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.43 109.762 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.0 pt-20 -123.52 161.89 24.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.194 0.521 . . . . 75.54 111.418 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.21 115.3 4.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.25 -0.886 . . . . 65.03 109.528 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 t 68.67 26.3 6.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 71.41 111.419 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.28 -22.1 25.45 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.283 -0.961 . . . . 73.25 113.564 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -109.73 145.16 37.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.874 0.337 . . . . 73.23 110.942 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.6 m -109.59 132.11 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 74.12 109.742 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -84.45 132.5 34.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.849 0.356 . . . . 75.23 111.17 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.598 HG21 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -139.26 144.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.126 -0.488 . . . . 72.52 109.921 173.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.85 114.12 26.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.587 . . . . 71.12 109.414 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 60.5 t80 -110.79 107.71 17.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.574 -0.528 . . . . 74.21 109.574 -177.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m120 61.87 34.71 16.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.557 -0.747 . . . . 72.34 110.66 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 -17.89 58.24 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.67 -0.696 . . . . 61.34 113.995 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.5 pt20 -95.99 154.96 16.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.026 0.913 . . . . 74.4 110.788 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -87.42 123.92 32.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.916 -0.584 . . . . 74.45 110.791 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.97 169.66 21.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.65 -0.58 . . . . 63.12 111.65 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 99.3 m-85 -136.39 143.11 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.897 0.348 . . . . 75.24 110.818 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.832 HD12 HD22 ' A' ' 60' ' ' LEU . 2.8 pp -119.52 166.36 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 72.05 109.581 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 132.97 11.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.374 -0.917 . . . . 70.52 112.458 -176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 m -67.61 -17.64 64.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.788 0.328 . . . . 65.31 111.151 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 58' ' ' ARG . 5.3 mmt85 -53.98 -50.23 67.03 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.238 -0.437 . . . . 65.12 111.196 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.651 ' HB3' ' ND2' ' A' ' 8' ' ' ASN . 22.5 m-85 -121.38 118.86 30.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.975 -0.379 . . . . 75.22 109.975 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.832 HD22 HD12 ' A' ' 55' ' ' ILE . 26.3 mt -155.66 148.29 24.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.843 0.354 . . . . 73.33 110.663 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.621 ' HB3' HD22 ' A' ' 13' ' ' ASN . 31.7 p -108.25 121.74 45.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.215 -0.448 . . . . 70.13 110.675 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.75 ' HB2' ' HD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -66.86 147.51 53.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.012 -0.736 . . . . 74.32 109.012 171.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HG ' ' HE2' ' A' ' 33' ' ' LYS . 5.8 mp -77.5 5.5 8.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.143 0.794 . . . . 65.13 113.143 -166.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -79.22 78.81 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.327 0.584 . . . . 73.42 109.941 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.49 170.72 15.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.807 -0.633 . . . . 74.4 110.133 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -76.39 153.52 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 73.43 110.913 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 81.8 m-70 -119.64 169.29 10.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 73.03 110.012 174.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 8.5 m-70 69.76 87.22 0.12 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.892 0.745 . . . . 72.12 111.274 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -119.81 129.68 54.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.317 -0.856 . . . . 73.13 109.359 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 74.14 110.173 176.626 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 25.8 ttt . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 111.087 0.032 . . . . 73.5 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 1' ' ' MET . 44.1 mm 70.13 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 123.484 0.49 . . . . 52.51 110.588 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.49 63.42 0.9 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.271 -1.132 . . . . 73.13 110.271 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.524 . . . . 74.23 112.371 -173.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -170.37 -68.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 74.44 110.532 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 11.2 t80 -158.29 -69.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 74.32 109.511 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.726 HG21 ' HB3' ' A' ' 11' ' ' ALA . 54.8 mt 72.22 142.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.261 0.553 . . . . 75.3 112.223 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -113.97 85.79 2.28 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.957 -0.565 . . . . 71.12 110.501 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.21 -82.03 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.312 -0.858 . . . . 44.44 113.289 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -81.12 -62.8 1.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.143 0.423 . . . . 63.31 112.143 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.726 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . 63.92 -179.45 0.16 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.123 -0.49 . . . . 63.23 112.08 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.498 HD21 HD21 ' A' ' 28' ' ' LEU . 87.2 mt 65.13 1.23 1.47 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.264 0.839 . . . . 74.53 113.264 173.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -118.94 9.81 12.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.337 0.495 . . . . 73.35 112.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 17' ' ' GLY . 46.8 t -65.92 -59.96 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.937 0.347 . . . . 62.41 111.937 -170.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.572 ' NH1' ' HA ' ' A' ' 65' ' ' HIS . 20.0 ttm105 65.84 74.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.11 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 24' ' ' ILE . 37.8 p 49.38 31.65 4.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.417 -0.811 . . . . 72.34 113.176 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -80.51 -7.03 88.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.742 . . . . 70.22 112.104 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.76 107.49 3.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 61.32 109.78 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.72 -173.27 43.91 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.538 -0.625 . . . . 73.32 111.538 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -83.56 -24.17 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.093 0.473 . . . . 74.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -124.99 133.32 53.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.69 -0.856 . . . . 71.22 108.69 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.96 8.03 43.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.997 0.427 . . . . 74.32 110.973 -173.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -115.96 -0.79 12.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 71.42 111.18 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.442 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 2.3 pp -88.54 0.12 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.682 0.623 . . . . 72.2 112.682 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 26' ' ' GLY . 1.6 mt 68.54 172.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.109 0.48 . . . . 73.02 111.345 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 25' ' ' ILE . . . 177.46 49.36 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.037 -1.225 . . . . 72.54 110.037 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.53 9.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.883 0.373 . . . . 75.24 111.443 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 0.8 OUTLIER -128.58 69.12 79.08 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.586 -0.894 . . . . 60.11 108.586 172.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.66 67.39 6.42 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.342 2.695 . . . . 64.33 112.503 -168.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 69.18 119.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.937 -1.028 . . . . 60.32 112.002 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.1 -6.95 37.32 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.091 -0.804 . . . . 64.15 111.091 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.655 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -147.77 134.72 20.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.756 . . . . 72.31 108.96 179.102 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -128.03 92.77 3.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 71.41 111.118 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 28' ' ' LEU . 27.5 m -100.72 176.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.196 -0.668 . . . . 75.01 109.196 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -137.76 146.26 43.41 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.681 -0.408 . . . . 74.03 110.547 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.2 113.04 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.341 -0.39 . . . . 74.23 110.138 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD11 ' H ' ' A' ' 37' ' ' ILE . 4.0 mp -71.42 -56.74 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 64.51 110.481 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -170.36 165.76 8.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.585 -0.734 . . . . 61.31 110.693 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -118.02 169.32 9.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.111 -0.949 . . . . 63.14 110.094 178.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -173.48 123.38 0.37 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.106 0.254 . . . . 71.24 110.789 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t 70.65 32.44 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 54.22 110.874 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.37 -36.29 4.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.749 -0.739 . . . . 45.03 112.617 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -100.32 155.7 17.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.913 0.387 . . . . 73.41 110.779 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 25.6 t -110.11 139.94 44.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.939 -0.573 . . . . 72.02 109.904 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.681 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 14.6 ttmt -89.67 129.21 36.13 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.096 -0.502 . . . . 73.24 111.207 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.85 143.2 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.598 -0.728 . . . . 73.33 110.598 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -109.73 114.59 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.623 -0.88 . . . . 75.21 108.623 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 1.8 t80 -122.84 110.22 15.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.304 -0.407 . . . . 73.44 110.457 -174.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.71 34.28 22.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.561 0.696 . . . . 73.33 110.676 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.87 73.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 72.21 113.671 174.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 2.8 pt20 -118.8 156.08 30.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.437 0.619 . . . . 73.14 110.257 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m -98.6 128.11 44.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 72.12 111.302 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' HA2' ' HB ' ' A' ' 24' ' ' ILE . . . -116.12 162.47 12.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.091 -0.576 . . . . 36.87 111.803 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.681 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 91.1 m-85 -138.3 139.09 38.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.848 -0.427 . . . . 72.42 109.848 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.566 HD11 HD23 ' A' ' 60' ' ' LEU . 2.4 pp -137.75 154.95 29.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 74.14 110.907 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 110.45 3.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.362 -0.695 . . . . 60.53 111.362 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -4.39 53.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.575 0.226 . . . . 74.43 111.479 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 70.4 mtt180 -61.72 -53.57 54.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.17 0.509 . . . . 64.14 109.989 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.51 118.97 21.9 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.038 -0.528 . . . . 74.43 110.291 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 55' ' ' ILE . 95.8 mt -114.36 127.49 55.87 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.578 -0.737 . . . . 71.4 109.052 176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.4 t -148.61 159.82 43.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.034 -0.53 . . . . 62.12 110.091 -171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -75.6 113.17 12.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.763 -0.199 . . . . 72.21 110.819 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 17' ' ' GLY . 10.1 mp -96.77 -65.56 0.96 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.833 -0.347 . . . . 62.34 110.809 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -159.16 167.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.809 0.338 . . . . 74.1 111.196 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.572 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 51.8 p-80 -125.47 11.52 8.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.786 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.27 136.82 7.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.41 109.747 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 15.0 t60 -133.19 -72.26 0.51 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.951 -0.299 . . . . 73.23 111.293 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 67' ' ' HIS . 78.8 t60 70.72 121.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.905 0.753 . . . . 73.45 110.461 -171.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -74.54 121.31 21.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.153 -0.476 . . . . 74.52 109.956 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.366 -0.826 . . . . 70.55 110.252 179.147 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.652 0.263 . . . . 72.03 110.539 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.41 16.3 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.891 0.33 . . . . 74.11 111.891 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.33 -14.48 28.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.516 -0.849 . . . . 63.2 112.751 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.567 ' HB3' HD12 ' A' ' 7' ' ' ILE . 22.5 m-20 -80.97 104.74 11.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.658 0.266 . . . . 73.33 110.512 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.59 133.58 55.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.418 -0.355 . . . . 72.44 110.774 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 56.83 86.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.669 0.606 . . . . 75.33 110.993 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.567 HD12 ' HB3' ' A' ' 4' ' ' ASP . 43.6 mm -82.28 89.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 73.43 111.791 -172.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 73.77 -64.55 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.339 -0.846 . . . . 74.21 113.28 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.18 -163.98 0.25 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.413 0.446 . . . . 71.34 110.094 -171.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 p -97.66 18.48 15.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.981 0.42 . . . . 72.4 110.735 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.42 -82.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.41 -0.359 . . . . 65.23 111.656 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 5.3 mp -76.35 92.9 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 74.44 110.792 -174.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 61' ' ' SER . 29.6 m-80 -117.56 -58.31 2.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.931 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' CE2' ' A' ' 48' ' ' TYR . 2.6 t -121.14 37.31 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.441 0.639 . . . . 73.44 110.314 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -75.41 32.73 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.874 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 33.0 t 60.69 37.42 19.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.675 0.75 . . . . 74.01 109.822 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 90.34 -57.89 3.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.179 -0.919 . . . . 71.41 111.372 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 20' ' ' THR . 0.3 OUTLIER -161.64 168.76 22.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.47 -0.937 . . . . 74.34 108.47 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.44 36.91 0.82 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.371 -0.442 . . . . 75.22 113.437 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 18' ' ' GLU . 25.1 m -90.34 -34.08 15.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.338 -0.615 . . . . 74.43 109.338 174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.452 HD21 HG12 ' A' ' 24' ' ' ILE . 4.2 t30 -142.74 52.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.541 -0.911 . . . . 72.22 108.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -62.5 -6.36 3.33 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.477 -1.238 . . . . 73.1 113.422 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -11.99 60.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.198 0.444 . . . . 74.44 112.198 -174.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.872 HG22 HG13 ' A' ' 25' ' ' ILE . 47.5 mm -70.62 -55.79 13.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.301 0.482 . . . . 72.15 112.301 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.872 HG13 HG22 ' A' ' 24' ' ' ILE . 18.7 mt -135.98 -83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 121.035 -0.266 . . . . 75.54 111.239 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.96 -169.24 16.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.578 -0.82 . . . . 62.41 112.465 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.51 92.67 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.456 -0.438 . . . . 39.47 110.693 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.76 87.8 2.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.649 -0.705 . . . . 73.22 109.743 176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.67 72.81 3.66 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.991 2.46 . . . . 73.0 112.459 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -168.5 98.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.563 . . . . 74.35 110.453 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.37 167.44 12.37 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 111.103 -0.799 . . . . 60.41 111.103 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.59 80.77 5.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.269 0.557 . . . . 74.52 110.953 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 3.7 mptp? 58.75 62.44 1.92 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.017 -0.992 . . . . 63.21 111.264 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.09 125.62 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.336 -0.847 . . . . 71.43 110.56 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -133.31 -68.46 0.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 71.31 109.989 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -141.02 126.62 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 72.24 109.899 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.8 mt -114.44 -56.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 64.11 111.494 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.0 t -141.06 155.43 46.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 74.31 110.383 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 14.3 mp0 -114.8 135.94 53.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.697 -0.683 . . . . 74.33 110.526 -175.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -107.59 174.86 5.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.129 -0.693 . . . . 70.13 109.129 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.0 m -71.12 75.16 0.68 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.745 -0.661 . . . . 71.53 110.563 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.79 -61.25 0.48 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.728 -0.669 . . . . 75.41 111.621 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -126.69 162.67 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.092 0.472 . . . . 75.04 110.276 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 37.9 t -96.77 129.23 44.23 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.968 -0.753 . . . . 70.25 108.968 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -90.73 130.69 36.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.558 -0.292 . . . . 65.32 111.115 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.639 HD13 HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.98 148.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 64.3 110.175 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.01 112.55 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.851 -0.796 . . . . 74.52 108.851 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CE2' HG11 ' A' ' 14' ' ' VAL . 11.9 t80 -109.8 98.99 8.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.465 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.41 40.52 24.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.36 0.6 . . . . 71.33 110.861 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 -17.57 59.06 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.858 -0.61 . . . . 60.43 114.405 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.84 154.88 24.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.077 0.939 . . . . 73.43 110.994 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.4 m -76.52 119.03 19.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 74.45 110.793 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.686 ' HA2' HG23 ' A' ' 24' ' ' ILE . . . -122.31 175.45 16.39 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.032 -0.604 . . . . 62.34 111.914 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' SER . 81.3 m-85 -135.68 151.44 50.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.107 0.48 . . . . 74.44 111.198 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.639 HG12 HD13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.59 146.41 27.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.458 -0.792 . . . . 71.1 109.988 175.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.518 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -85.15 159.84 34.37 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.428 -0.892 . . . . 71.12 112.054 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -42.2 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.116 0.484 . . . . 74.43 110.227 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -76.86 -51.84 10.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.651 -0.704 . . . . 73.1 110.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CD2' ' HB2' ' A' ' 12' ' ' LEU . 63.1 m-85 -107.84 119.26 38.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.745 . . . . 75.21 108.99 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.676 HD21 ' N ' ' A' ' 61' ' ' SER . 4.8 tt -154.11 157.52 39.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.797 -1.092 . . . . 72.13 108.154 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.676 ' N ' HD21 ' A' ' 60' ' ' LEU . 14.0 p -81.83 117.54 22.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.372 0.606 . . . . 71.01 110.667 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -127.66 114.15 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 74.33 109.761 176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.65 -36.58 82.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.597 -0.729 . . . . 75.04 110.998 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 72.4 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.399 0.619 . . . . 73.4 110.269 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -128.11 4.66 5.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.909 -1.145 . . . . 71.43 107.909 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -143.93 102.66 3.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.597 -1.183 . . . . 74.21 109.885 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -65.22 158.48 26.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 64.3 109.994 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -120.08 102.84 8.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.544 0.688 . . . . 70.53 111.285 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 12.7 t-160 -80.52 148.61 30.33 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.812 -1.181 . . . . 74.22 107.812 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 57.2 m-70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.828 -0.606 . . . . 74.53 109.725 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' OD1' ' A' ' 4' ' ' ASP . 26.2 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 110.068 -0.345 . . . . 72.32 110.068 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.61 -19.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.493 0.664 . . . . 54.41 110.191 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.91 49.27 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.316 -1.514 . . . . 74.01 109.316 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.491 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -82.66 156.67 23.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.328 -0.936 . . . . 75.01 111.374 -167.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 62.21 74.16 0.45 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.339 -0.846 . . . . 73.53 111.405 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.628 ' HB2' ' HH ' ' A' ' 59' ' ' TYR . 16.3 p90 -96.41 98.13 10.01 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.559 0.695 . . . . 74.12 109.251 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.4 tp -147.2 100.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 75.34 111.258 -172.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.07 -86.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.308 -0.86 . . . . 71.53 112.093 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.09 -154.01 0.3 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.401 0.438 . . . . 63.02 110.106 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 p -124.65 80.91 1.9 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.313 0.578 . . . . 73.42 109.672 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.35 167.83 21.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.63 -0.714 . . . . 63.21 110.598 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.729 HD21 ' H ' ' A' ' 12' ' ' LEU . 2.0 pt? -113.98 118.87 35.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.38 0.61 . . . . 73.33 110.944 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.583 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.2 t-20 -83.82 -15.89 46.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.784 -0.643 . . . . 64.13 110.326 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 12.3 p -68.91 -12.68 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.376 -0.829 . . . . 71.11 113.144 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -101.79 67.25 1.09 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.801 -0.76 . . . . 74.05 110.193 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p 47.49 47.31 17.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.997 -1.001 . . . . 70.11 111.53 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.31 -91.35 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.018 -0.61 . . . . 44.01 112.833 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.24 111.7 1.71 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.108 0.48 . . . . 73.41 110.847 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.45 26.11 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.564 -1.015 . . . . 63.14 110.564 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 54' ' ' TYR . 5.2 m -70.11 -44.93 67.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.243 0.522 . . . . 73.04 109.873 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.77 90.18 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.13 -0.693 . . . . 70.55 109.13 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -108.96 10.33 26.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.481 -0.781 . . . . 75.52 110.99 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -44.56 -59.05 2.64 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.629 0.581 . . . . 72.42 112.516 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.532 ' O ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -121.89 -20.86 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 72.41 110.972 -179.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.0 pp -138.16 -164.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.51 -0.314 . . . . 72.53 111.708 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 177.35 -79.28 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 72.5 113.041 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . . . -74.55 172.08 12.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 72.22 111.719 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.9 89.09 8.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.695 -0.684 . . . . 71.3 109.515 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 43.3 Cg_endo -69.53 -55.76 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.495 2.13 . . . . 52.55 112.667 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -118.88 -39.44 2.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.77 2.63 58.44 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.567 -0.742 . . . . 71.33 112.037 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -78.27 66.95 3.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.954 0.407 . . . . 70.23 110.793 -175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 179.2 -49.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.522 -0.763 . . . . 74.11 109.601 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.724 ' HB ' ' HD1' ' A' ' 48' ' ' TYR . 10.9 p -97.84 -39.51 8.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.625 -0.716 . . . . 75.32 110.733 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 64.45 174.32 0.19 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.174 0.59 . . . . 74.44 111.74 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -86.7 121.58 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.332 0.587 . . . . 73.23 111.223 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 46' ' ' ILE . 5.7 mt -107.47 -53.23 6.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 72.35 110.701 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -164.56 149.85 10.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 72.44 110.894 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.93 143.65 46.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.54 -0.755 . . . . 74.15 110.626 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.64 173.46 8.97 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.379 0.609 . . . . 75.34 109.52 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.2 m -84.43 80.36 9.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.024 -0.989 . . . . 55.14 110.059 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.64 -53.62 0.68 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 63.32 112.112 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -120.85 152.87 37.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 75.24 110.662 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.06 119.97 40.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.768 -0.827 . . . . 61.45 108.768 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.9 ttmt -82.89 121.04 26.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.588 -0.733 . . . . 60.2 111.377 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.611 ' HB ' HG23 ' A' ' 34' ' ' VAL . 32.7 pt -142.3 153.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.598 -0.728 . . . . 75.22 111.54 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -116.95 114.06 23.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.501 -0.926 . . . . 73.34 108.501 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.724 ' HD1' ' HB ' ' A' ' 34' ' ' VAL . 28.8 t80 -119.34 114.28 22.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.47 -0.332 . . . . 63.34 110.823 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 t30 58.4 34.53 24.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.476 0.655 . . . . 63.15 110.994 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.24 69.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.603 -0.808 . . . . 71.22 113.69 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.1 pt20 -103.94 148.06 26.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.618 0.709 . . . . 73.2 110.984 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -85.7 117.16 24.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.769 . . . . 63.24 109.777 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.39 150.03 18.02 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.185 -1.007 . . . . 75.33 112.496 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' HB ' ' A' ' 20' ' ' THR . 49.5 m-85 -127.67 140.07 52.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.079 -0.712 . . . . 72.14 109.079 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.497 HG22 ' HA2' ' A' ' 26' ' ' GLY . 2.7 pp -135.61 160.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.94 -0.393 . . . . 55.42 109.94 177.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.12 124.35 6.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.299 -0.953 . . . . 62.25 112.145 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 m -61.43 -18.75 60.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.505 0.669 . . . . 75.54 110.202 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -69.3 -9.12 51.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.392 -0.822 . . . . 72.34 111.447 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.628 ' HH ' ' HB2' ' A' ' 6' ' ' TYR . 7.4 m-85 -131.58 115.06 15.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.803 0.335 . . . . 72.32 110.122 171.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -157.74 174.15 15.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.803 -0.635 . . . . 72.0 109.742 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 15.4 t -108.28 118.93 38.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.52 -0.918 . . . . 65.41 108.52 172.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -119.05 79.97 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.47 -0.567 . . . . 52.44 109.47 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 65' ' ' HIS . 0.6 OUTLIER -138.02 -48.64 0.55 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 71.55 110.649 -174.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.25 77.87 0.18 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.811 0.694 . . . . 72.13 109.18 -166.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.429 ' HB3' HD12 ' A' ' 63' ' ' LEU . 8.6 p80 -89.92 151.06 21.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 74.12 110.841 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 67.65 98.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.186 0.929 . . . . 75.35 111.575 -173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -82.81 -37.66 24.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.413 -0.958 . . . . 72.04 108.413 172.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -90.2 142.71 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.32 -0.854 . . . . 71.43 109.668 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 30.7 p-80 -117.99 73.94 0.92 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.146 -0.687 . . . . 72.3 109.146 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 34.1 m80 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 114.777 -1.101 . . . . 65.15 110.281 -170.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.848 -0.427 . . . . 71.109999999999999 109.848 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 87.2 mt -71.05 90.67 0.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.571 -0.529 . . . . 71.319999999999993 109.571 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 12.6 m120 -97.96 -29.94 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 75.129999999999995 112.131 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 55' ' ' ILE . 63.6 t -64.86 -51.39 67.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.718 -0.475 . . . . 72.319999999999993 109.718 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.898 ' HG3' HD12 ' A' ' 25' ' ' ILE . 6.5 mtp180 -155.31 -177.01 6.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.151 -0.931 . . . . 70.030000000000001 108.528 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 22.9 t 75.16 3.96 4.14 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.977 0.798 . . . . 71.209999999999994 110.246 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.57 16.91 31.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.002 -0.618 . . . . 63.350000000000001 111.968 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -99.69 -46.71 5.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.002 -0.74 . . . . 75.409999999999997 109.002 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.52 4.87 49.29 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.72 -1.127 . . . . 72.319999999999993 110.57 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -101.34 -51.39 3.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.275 -0.462 . . . . 73.439999999999998 110.717 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.5 88.6 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.379 -0.6 . . . . 74.209999999999994 109.379 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 19.6 p90 -95.82 4.7 52.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.879 0.696 . . . . 64.439999999999998 112.879 -169.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -106.37 -0.06 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.252 -0.579 . . . . 71.310000000000002 111.513 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.794 HG22 HG13 ' A' ' 25' ' ' ILE . 54.2 mt -77.41 -55.82 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.338 -0.392 . . . . 44.439999999999998 111.854 -174.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.898 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.0 mt -140.54 178.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.554 -0.535 . . . . 72.510000000000005 109.554 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -125.83 -118.1 2.22 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.954 -0.641 . . . . 71.049999999999997 112.534 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.912 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -139.81 105.68 5.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.022 0.439 . . . . 62.140000000000001 111.933 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -152.32 57.68 2.26 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.842 -0.617 . . . . 64.450000000000003 111.054 173.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 28' ' ' LEU . 19.7 Cg_endo -95.66 166.29 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.19 2.594 . . . . 64.219999999999999 112.172 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 63.44 104.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.4 0.619 . . . . 73.120000000000005 111.373 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.94 -32.58 7.36 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.394 -0.682 . . . . 72.430000000000007 111.394 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.33 -172.71 2.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 64.519999999999996 110.021 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 38.7 ttpt -85.98 157.66 20.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.196 -0.456 . . . . 72.450000000000003 110.299 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 94.2 t 76.23 126.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.695 0.759 . . . . 72.439999999999998 112.056 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.83 175.45 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 64.349999999999994 109.839 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 46' ' ' ILE . 17.3 m -76.06 125.67 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.961 -0.385 . . . . 55.210000000000001 109.961 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -81.63 -55.97 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.46 -0.337 . . . . 51.210000000000001 110.515 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -171.07 150.82 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 31.149999999999999 110.9 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -80.02 131.43 35.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.577 -0.738 . . . . 73.049999999999997 110.193 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -134.96 114.49 12.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.615 0.245 . . . . 74.340000000000003 110.956 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t 71.84 5.52 5.38 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.453 -0.794 . . . . 73.439999999999998 111.779 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.4 -48.76 0.95 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 64.219999999999999 111.854 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -84.67 160.53 20.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 73.519999999999996 110.315 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 68.5 m -96.28 140.25 31.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 110.766 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -82.86 118.69 23.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.682 -0.69 . . . . 64.030000000000001 111.07 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -133.81 144.55 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 64.219999999999999 110.232 173.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -122.03 113.55 19.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.975 -1.12 . . . . 64.430000000000007 107.975 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 69.3 t80 -105.56 86.1 2.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 110.908 -170.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 62.32 46.33 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.229 0.538 . . . . 74.409999999999997 110.826 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.46 -17.57 58.75 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 73.319999999999993 113.512 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.3 pt20 -103.48 128.1 50.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.38 0.609 . . . . 74.099999999999994 110.225 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 151.82 21.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 40.32 111.067 -172.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.96 173.7 38.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.403 -0.903 . . . . 54.009999999999998 113.353 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 72.1 m-85 -132.97 144.74 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 74.209999999999994 109.269 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 15' ' ' ARG . 2.8 pp -136.03 161.69 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.618 0.247 . . . . 74.439999999999998 110.946 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.36 123.31 6.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.601 -0.809 . . . . 44.240000000000002 111.814 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -64.76 -7.07 9.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.009 0.433 . . . . 71.420000000000002 111.7 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -65.76 -37.57 86.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.454 -0.339 . . . . 75.209999999999994 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -124.32 120.64 32.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.523 0.678 . . . . 75.400000000000006 111.744 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 66.6 mt -155.89 175.64 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.112 -1.44 . . . . 73.329999999999998 107.112 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 29' ' ' PRO . 6.1 p -111.47 118.14 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.607 -0.837 . . . . 55.229999999999997 111.456 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.029 -0.987 . . . . 71.349999999999994 109.206 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.285 0 CA-C-O 121.054 0.454 . . . . 70.439999999999998 110.389 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -79.95 69.6 6.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.82 0.819 . . . . 73.010000000000005 109.499 174.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -117.61 -44.73 2.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.787 -1.097 . . . . 71.510000000000005 110.578 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.413 HG12 ' NE ' ' A' ' 15' ' ' ARG . 18.9 t -124.68 -67.11 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.32 -0.4 . . . . 71.109999999999999 111.04 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.581 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -130.59 142.47 50.46 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.553 -0.294 . . . . 74.120000000000005 110.894 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 53.9 p 45.92 74.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 124.087 0.867 . . . . 65.420000000000002 112.654 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . -127.49 -14.69 2.58 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.421 -0.895 . . . . 43.530000000000001 111.992 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -163.5 115.62 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.076 -0.713 . . . . 60.130000000000003 109.076 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.51 -152.95 24.96 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.5 -0.857 . . . . 73.450000000000003 112.402 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -68.91 -31.92 71.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 75.030000000000001 111.571 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -133.04 123.57 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.337 -0.616 . . . . 73.150000000000006 109.337 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 14.6 p90 -130.12 8.59 5.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.731 0.641 . . . . 75.340000000000003 112.731 -171.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -116.79 -11.16 10.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.329 0.862 . . . . 72.510000000000005 113.329 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 25' ' ' ILE . 5.0 pt -67.15 -56.45 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 114.365 1.246 . . . . 74.030000000000001 114.365 -167.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 15' ' ' ARG . 3.3 mp -111.73 -63.58 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.428 1.013 . . . . 54.229999999999997 111.664 -176.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.8 -151.61 16.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.212 -0.994 . . . . 52.450000000000003 112.944 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.3 97.71 6.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 55.140000000000001 111.28 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.2 tp -160.75 87.68 1.75 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.95 -0.568 . . . . 71.530000000000001 110.086 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -82.56 81.67 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.874 2.383 . . . . 63.420000000000002 111.549 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -104.3 -48.36 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 74.129999999999995 110.39 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.12 104.66 0.39 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 72.310000000000002 112.031 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.91 98.65 11.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.46 . . . . 62.009999999999998 110.246 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -149.43 42.7 0.92 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.964 -0.754 . . . . 42.43 108.964 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG11 ' CE1' ' A' ' 48' ' ' TYR . 6.2 p -123.14 -46.78 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.743 -0.662 . . . . 75.420000000000002 111.677 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.482 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -83.54 76.71 9.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.497 0.665 . . . . 45.140000000000001 110.629 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.66 3.32 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.771 -1.104 . . . . 64.409999999999997 109.15 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -77.06 -57.76 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.81 -0.632 . . . . 72.019999999999996 110.631 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 p -178.62 149.98 0.51 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.475 0.655 . . . . 42.229999999999997 111.661 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.67 127.23 56.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.987 -1.006 . . . . 71.530000000000001 108.55 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.94 171.43 7.52 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.541 -0.464 . . . . 75.25 110.776 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.3 t -64.57 -22.27 66.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 34.340000000000003 110.826 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.87 -73.78 0.99 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.971 -0.633 . . . . 41.439999999999998 111.972 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -117.23 161.91 18.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.151 0.501 . . . . 73.019999999999996 110.877 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 57' ' ' THR . 35.4 t -87.97 126.72 35.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.012 -0.736 . . . . 64.239999999999995 109.012 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 35.9 ttmt -83.97 123.05 29.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.133 0.492 . . . . 64.209999999999994 111.326 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 35' ' ' GLN . 20.0 pt -139.91 156.8 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 61.200000000000003 110.648 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -126.3 113.75 17.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 73.299999999999997 109.074 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CE1' ' HD3' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -101.26 84.11 2.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.619 -0.432 . . . . 74.319999999999993 110.832 -178.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.29 56.15 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 74.129999999999995 112.098 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.74 56.57 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.09 -0.576 . . . . 42.219999999999999 114.16 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.22 128.72 54.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.653 0.726 . . . . 62.210000000000001 110.501 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -73.18 133.55 44.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.169 -0.923 . . . . 74.439999999999998 110.577 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.8 159.02 23.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.812 -0.708 . . . . 52.409999999999997 111.671 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -138.48 139.8 38.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.61 -0.515 . . . . 74.530000000000001 109.61 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 60' ' ' LEU . 2.6 pp -137.52 149.12 25.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.517 -0.311 . . . . 71.230000000000004 110.453 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 123.1 8.21 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.638 -0.791 . . . . 74.200000000000003 111.943 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -62.3 -18.15 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 73.530000000000001 112.058 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.51 -32.98 74.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.026 -0.533 . . . . 75.239999999999995 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.87 114.37 26.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.615 0.245 . . . . 73.219999999999999 110.354 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 55' ' ' ILE . 32.3 mt -159.22 151.51 21.22 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.884 -0.598 . . . . 73.409999999999997 111.206 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -97.25 118.82 34.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.602 -1.259 . . . . 74.349999999999994 107.602 164.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.797 0.332 . . . . 65.019999999999996 111.108 -173.352 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 111.999 0.37 . . . . 60.119999999999997 111.999 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 6.4 mp -80.69 44.94 0.76 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.75 0.31 . . . . 71.040000000000006 111.459 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 22.4 m120 -74.98 -31.01 61.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 64.030000000000001 111.569 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.488 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -95.11 30.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 74.400000000000006 111.603 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.841 HH11 ' HA2' ' A' ' 26' ' ' GLY . 17.8 tpt180 -80.48 47.88 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.709 0.29 . . . . 74.099999999999994 111.463 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 t 64.51 4.87 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.494 0.717 . . . . 62.009999999999998 112.616 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.32 80.73 0.7 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.393 -0.908 . . . . 63.409999999999997 111.484 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 19' ' ' GLY . 35.6 tt0 70.93 175.9 0.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.946 0.498 . . . . 62.219999999999999 109.74 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -79.01 59.1 4.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.818 -0.706 . . . . 63.439999999999998 112.879 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -93.79 -33.33 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.104 0.478 . . . . 65.340000000000003 110.148 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' A' ' 24' ' ' ILE . 22.2 t-20 -153.3 145.2 23.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.257 -1.016 . . . . 75.129999999999995 108.257 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 7.11 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.959 -0.697 . . . . 74.439999999999998 111.755 -173.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -116.68 -32.78 5.06 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.832 -0.747 . . . . 74.430000000000007 112.738 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.501 HG22 HG13 ' A' ' 25' ' ' ILE . 70.4 mt -61.4 -55.96 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 72.540000000000006 111.19 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.596 HG23 ' CZ ' ' A' ' 48' ' ' TYR . 12.9 mt -129.7 158.75 42.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.791 -0.818 . . . . 74.439999999999998 108.791 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.841 ' HA2' HH11 ' A' ' 15' ' ' ARG . . . -131.42 -105.02 1.01 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.968 -1.111 . . . . 43.439999999999998 113.924 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -147.22 93.58 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.617 -0.512 . . . . 63.130000000000003 109.617 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 28' ' ' LEU . 1.3 tm? -154.09 80.54 4.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.488 -0.56 . . . . 63.520000000000003 109.488 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 10.3 Cg_exo -75.23 89.09 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.107 2.538 . . . . 73.099999999999994 112.115 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.81 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tt0 -117.51 -49.33 2.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.675 -0.693 . . . . 72.310000000000002 109.391 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.85 17.08 79.21 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.781 -0.645 . . . . 54.409999999999997 114.291 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.81 ' HG3' ' HG2' ' A' ' 30' ' ' GLN . 31.5 mt-30 -80.94 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.618 0.709 . . . . 71.129999999999995 110.152 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 4.3 mptp? -101.14 0.1 37.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.381 0.61 . . . . 54.329999999999998 109.935 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 41.3 t -93.26 92.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 72.140000000000001 109.093 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -112.69 141.22 46.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.853 -0.612 . . . . 74.519999999999996 110.965 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 46' ' ' ILE . 16.9 m -84.53 126.24 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.801 -0.636 . . . . 72.329999999999998 109.824 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.12 -49.63 12.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.125 0.488 . . . . 65.340000000000003 110.181 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -163.52 168.39 20.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.533 -0.758 . . . . 71.409999999999997 108.97 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 pp20? -139.91 152.36 46.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.831 0.348 . . . . 74.530000000000001 110.815 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -156.15 129.33 8.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 75.239999999999995 109.649 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.7 t 71.8 -0.55 3.15 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.09 -0.505 . . . . 65.129999999999995 112.004 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.98 -21.62 10.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.809 -0.71 . . . . 74.439999999999998 111.838 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -95.74 150.5 20.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.666 -0.494 . . . . 74.109999999999999 109.666 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.4 t -117.34 140.17 49.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.157 0.503 . . . . 60.420000000000002 110.99 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.98 108.74 16.51 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.228 -0.896 . . . . 74.019999999999996 108.77 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.64 HD12 HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -130.06 163.21 36.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.028 0.442 . . . . 72.230000000000004 111.351 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 9.1 t30 -101.57 113.13 25.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.375 -0.829 . . . . 71.219999999999999 108.859 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.596 ' CZ ' HG23 ' A' ' 25' ' ' ILE . 90.0 t80 -105.6 98.2 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.504 -0.317 . . . . 63.130000000000003 110.241 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t30 56.21 34.68 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.206 0.526 . . . . 74.519999999999996 111.007 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.49 62.42 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.77 -0.729 . . . . 44.200000000000003 113.908 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.1 pt20 -124.2 155.73 38.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.453 0.627 . . . . 55.32 110.24 174.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -90.5 142.12 28.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.442 -0.345 . . . . 55.039999999999999 110.649 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.99 25.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.635 -0.793 . . . . 74.120000000000005 112.218 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.8 146.76 51.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.764 -0.458 . . . . 63.329999999999998 109.764 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 46' ' ' ILE . 2.7 pp -144.38 171.76 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.146 0.279 . . . . 72.150000000000006 110.365 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.64 109.92 3.53 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.718 -0.753 . . . . 62.109999999999999 111.839 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 1.4 m -63.78 -24.0 67.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.993 0.368 . . . . 74.349999999999994 111.993 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -67.79 -43.84 78.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.297 -0.41 . . . . 74.129999999999995 111.885 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -122.79 117.66 26.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.985 0.421 . . . . 51.43 110.656 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 85.7 mt -155.05 153.82 31.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.09 -0.959 . . . . 71.120000000000005 110.124 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.761 ' HB2' ' HB3' ' A' ' 29' ' ' PRO . 34.8 m -109.24 120.8 43.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.482 -0.933 . . . . 63.450000000000003 108.482 171.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 111.428 -169.296 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 62.229999999999997 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt 61.05 21.21 11.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.551 -0.75 . . . . 71.0 111.945 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 16.7 m120 -53.54 -43.6 68.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.071 -0.513 . . . . 71.510000000000005 112.064 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.89 48.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.172 0.511 . . . . 74.019999999999996 110.822 177.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HG3' ' HA2' ' A' ' 19' ' ' GLY . 10.9 tpt180 -80.19 27.38 0.33 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.035 -0.529 . . . . 74.420000000000002 111.074 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.492 ' HA ' HG22 ' A' ' 55' ' ' ILE . 11.8 t 56.86 32.61 21.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 74.200000000000003 111.292 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 110.16 -124.25 7.03 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.487 -0.863 . . . . 53.509999999999998 112.057 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 21.6 mm-40 -86.29 11.68 11.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 73.329999999999998 110.449 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 15' ' ' ARG . . . 86.89 16.58 61.09 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.374 -1.091 . . . . 64.400000000000006 110.374 -170.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.1 m -62.57 -54.26 42.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.028 -0.586 . . . . 72.129999999999995 110.711 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -102.4 100.47 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.139 -0.689 . . . . 73.329999999999998 109.139 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -93.48 5.32 51.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.732 -0.667 . . . . 73.120000000000005 111.45 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -100.98 -38.41 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.466 0.543 . . . . 73.510000000000005 112.466 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 25' ' ' ILE . 12.7 tt -82.86 -55.33 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.943 0.72 . . . . 64.340000000000003 112.943 -169.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 48' ' ' TYR . 16.6 mt -126.82 148.76 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.976 -0.379 . . . . 74.019999999999996 109.976 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -150.25 159.0 27.93 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.007 -0.837 . . . . 62.140000000000001 111.007 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -75.98 96.97 3.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.492 . . . . 73.25 111.78 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -149.84 72.11 9.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.651 -0.704 . . . . 63.32 109.768 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.5 90.48 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.727 2.284 . . . . 72.040000000000006 112.055 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 30' ' ' GLN . 6.4 pt20 -97.33 59.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.51 -0.768 . . . . 74.25 110.141 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.39 -78.05 1.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.493 -1.043 . . . . 63.130000000000003 110.493 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -73.16 137.03 44.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.032 -0.729 . . . . 61.039999999999999 109.032 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 46.6 mttp -116.05 -75.94 0.58 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.022 0.439 . . . . 74.209999999999994 110.108 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 ' HD1' ' A' ' 48' ' ' TYR . 8.3 p 174.3 -29.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.179 -0.919 . . . . 75.209999999999994 108.619 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 72.58 127.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.414 -1.266 . . . . 72.349999999999994 111.491 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 44' ' ' SER . 58.1 t -82.96 108.26 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.652 -0.704 . . . . 75.219999999999999 110.179 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 46' ' ' ILE . 4.7 mt -75.28 -49.53 27.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.836 -0.62 . . . . 75.109999999999999 111.346 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 m -153.24 150.95 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.054 0.454 . . . . 72.030000000000001 110.937 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.63 123.88 47.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.464 -0.789 . . . . 64.439999999999998 109.245 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.34 140.73 26.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.516 -0.179 . . . . 73.340000000000003 110.516 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t 75.24 -54.33 0.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.857 0.723 . . . . 74.310000000000002 111.662 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.11 -51.84 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.514 -0.634 . . . . 62.420000000000002 111.514 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.622 ' HZ2' ' HG2' ' A' ' 18' ' ' GLU . 25.5 m0 -87.61 160.14 18.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.089 0.471 . . . . 74.450000000000003 110.691 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.57 ' HB3' HG13 ' A' ' 36' ' ' VAL . 44.4 m -91.34 140.79 29.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.63 -0.714 . . . . 74.230000000000004 109.352 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -105.45 129.88 53.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 120.935 0.398 . . . . 73.319999999999993 109.939 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -142.91 170.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.704 . . . . 74.329999999999998 110.315 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -108.79 115.11 29.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.253 -0.647 . . . . 74.409999999999997 109.253 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 25' ' ' ILE . 5.8 t80 -113.47 101.23 9.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 72.239999999999995 110.156 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t30 63.02 41.79 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 53.539999999999999 110.35 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.21 56.86 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.555 -0.748 . . . . 53.310000000000002 113.65 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 8.1 pt20 -111.79 145.86 38.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.388 0.594 . . . . 74.349999999999994 111.689 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 m -72.52 123.21 22.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 111.002 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.5 168.58 18.6 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.779 -0.724 . . . . 72.329999999999998 111.75 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.39 144.4 51.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.817 0.341 . . . . 73.329999999999998 110.434 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.92 156.26 31.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.74 -0.664 . . . . 54.210000000000001 109.668 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -72.36 129.1 14.13 Favored Glycine 0 C--O 1.219 -0.815 0 C-N-CA 120.631 -0.795 . . . . 73.430000000000007 112.137 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -77.24 -13.57 59.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.322 0.582 . . . . 71.209999999999994 110.428 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.575 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 17.3 ptt85 -85.65 -16.84 37.86 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.382 -0.372 . . . . 75.430000000000007 111.271 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' A' ' 58' ' ' ARG . 30.9 m-85 -127.12 116.33 20.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.204 -0.665 . . . . 74.0 109.204 171.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.1 mt -140.96 173.83 11.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.279 0.561 . . . . 75.019999999999996 110.876 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . 10.1 t -109.26 127.44 54.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.696 -0.684 . . . . 73.340000000000003 109.174 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.162 -0.472 . . . . 65.230000000000004 110.718 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.234 -0.654 . . . . 65.0 109.234 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 15' ' ' ARG . 4.3 mm? 67.19 28.69 8.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.471 0.482 . . . . 73.219999999999999 110.079 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.639 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 14.6 m120 -63.19 -50.08 71.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.439 -0.801 . . . . 71.340000000000003 111.727 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.02 6.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.482 -0.562 . . . . 72.239999999999995 109.482 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 12' ' ' LEU . 37.6 mtp180 -69.41 176.89 3.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.793 -0.64 . . . . 65.129999999999995 110.911 -172.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.969 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 3.9 m 69.97 44.63 0.79 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.683 -0.689 . . . . 62.0 111.044 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.877 ' HA3' HD12 ' A' ' 25' ' ' ILE . . . -56.49 -35.84 68.05 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 114.246 0.458 . . . . 71.400000000000006 114.246 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 21' ' ' ASN . 42.2 mt-10 -90.3 9.93 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.213 0.507 . . . . 71.239999999999995 110.532 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 43' ' ' TRP . . . 76.73 -65.69 2.83 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 116.097 -0.501 . . . . 63.509999999999998 112.229 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.9 p -82.41 -28.31 31.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.854 0.359 . . . . 75.310000000000002 110.763 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 27.5 t30 -100.17 118.11 35.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.359 -0.608 . . . . 74.319999999999993 109.359 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.969 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 24.2 m-85 -93.8 -36.88 12.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.869 -0.605 . . . . 63.439999999999998 111.807 -170.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -73.88 -6.61 48.23 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.068 0.766 . . . . 74.040000000000006 113.068 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.44 -35.88 64.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 73.019999999999996 111.935 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.877 HD12 ' HA3' ' A' ' 17' ' ' GLY . 33.2 mt -124.13 156.32 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.3 -0.259 . . . . 74.209999999999994 110.3 -173.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.45 -135.91 6.1 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.191 -0.528 . . . . 74.310000000000002 112.2 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 13' ' ' ASN . . . -148.88 99.18 2.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.066 0.433 . . . . 75.450000000000003 112.098 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.9 tp -157.1 69.5 4.44 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.976 0.417 . . . . 75.349999999999994 110.776 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -97.94 63.73 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.106 2.537 . . . . 34.210000000000001 112.506 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.7 -77.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 110.024 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.9 3.49 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.508 -0.637 . . . . 73.329999999999998 111.508 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.79 153.26 14.47 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.904 -1.147 . . . . 75.230000000000004 107.904 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -80.07 15.09 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.111 0.481 . . . . 72.430000000000007 111.213 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 89.0 t -76.61 97.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 54.399999999999999 110.034 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -138.98 169.7 17.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.837 -0.619 . . . . 62.130000000000003 110.69 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.63 125.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.685 -0.689 . . . . 74.439999999999998 109.547 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.523 HD12 ' H ' ' A' ' 37' ' ' ILE . 3.6 mp -78.29 -55.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.511 0.672 . . . . 72.219999999999999 109.618 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 t -147.06 155.74 42.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.925 -1.034 . . . . 62.119999999999997 109.18 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.74 159.21 35.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.255 0.55 . . . . 74.450000000000003 111.412 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -132.53 174.24 10.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.574 -0.739 . . . . 64.439999999999998 109.337 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 t -74.66 78.89 2.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.708 0.766 . . . . 64.019999999999996 110.538 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.03 -70.99 0.31 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.12 -0.946 . . . . 73.409999999999997 111.465 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.3 m0 -115.42 146.07 41.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 110.425 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.1 m -115.32 135.8 53.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 73.439999999999998 110.094 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 35.7 ttmt -82.57 125.29 30.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.356 0.598 . . . . 73.239999999999995 111.355 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 pt -128.08 171.04 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.484 -0.78 . . . . 74.420000000000002 110.858 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 t-20 -126.58 113.92 17.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.036 -0.727 . . . . 71.340000000000003 109.036 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.764 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 31.2 t80 -103.72 77.79 1.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 74.230000000000004 109.885 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 58.47 48.02 12.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.140000000000001 111.863 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.76 -17.21 59.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.584 -0.817 . . . . 71.420000000000002 113.66 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.764 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.8 pt20 -100.37 148.39 24.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.659 0.73 . . . . 71.439999999999998 110.344 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.3 m -86.74 140.7 29.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.595 -0.729 . . . . 75.200000000000003 111.306 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.17 161.39 31.99 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.915 -0.659 . . . . 62.240000000000002 112.133 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.39 139.03 47.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.308 -0.997 . . . . 75.420000000000002 108.308 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 2.9 pp -121.53 167.52 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.019 -0.273 . . . . 75.409999999999997 111.713 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.33 118.86 5.02 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.87 -0.681 . . . . 64.019999999999996 111.773 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -58.56 -17.39 21.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.648 0.61 . . . . 55.409999999999997 112.648 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -72.06 -25.85 61.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.914 0.338 . . . . 72.120000000000005 111.914 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -121.04 119.31 32.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.049 0.452 . . . . 54.140000000000001 110.767 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.6 mt -156.87 160.87 39.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.48 -0.782 . . . . 73.439999999999998 110.192 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -100.29 120.26 39.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 53.109999999999999 110.549 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 108.365 -0.976 . . . . 73.340000000000003 108.365 174.837 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.609 ' HA ' ' OG ' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.11 0.781 . . . . 73.25 113.11 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 54.4 mt -84.17 22.91 1.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.008 0.373 . . . . 74.540000000000006 112.008 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -117.94 6.78 12.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.913 0.338 . . . . 72.519999999999996 111.913 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' ILE . 6.0 t -82.87 49.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 121.885 -0.509 . . . . 63.439999999999998 110.395 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.852 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 9.1 ptt180 -120.2 83.16 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.347 0.594 . . . . 72.310000000000002 111.965 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 21' ' ' ASN . 13.4 m 59.29 25.78 14.48 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.189 -0.914 . . . . 72.129999999999995 111.621 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 56' ' ' GLY . . . 113.85 -143.06 17.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.836 -0.697 . . . . 72.140000000000001 111.46 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.22 -27.29 68.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 53.329999999999998 110.887 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.92 63.62 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.348 -0.701 . . . . 72.140000000000001 111.348 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 m -87.69 -61.55 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 64.219999999999999 111.033 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HB2' ' A' ' 16' ' ' SER . 71.7 m-20 -123.93 127.23 47.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.168 -0.679 . . . . 53.350000000000001 109.168 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -97.56 6.6 47.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.849 -0.614 . . . . 74.430000000000007 111.265 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -107.72 -54.66 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.338 -0.392 . . . . 71.510000000000005 111.643 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.536 HG12 HG13 ' A' ' 25' ' ' ILE . 8.1 tt -59.94 -41.88 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 74.430000000000007 111.627 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.673 HG23 ' CE1' ' A' ' 48' ' ' TYR . 28.3 mt -136.53 165.07 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.32 -0.992 . . . . 73.129999999999995 108.32 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.852 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 179.9 -166.33 35.37 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.362 -0.923 . . . . 72.329999999999998 112.176 -171.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.566 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -81.07 91.78 6.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.05 0.452 . . . . 72.239999999999995 111.851 -174.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 33' ' ' LYS . 1.8 pt? -173.71 77.42 0.38 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.4 -0.818 . . . . 65.040000000000006 109.613 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -88.09 85.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.161 2.574 . . . . 75.150000000000006 112.401 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -165.35 155.22 12.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 75.099999999999994 109.823 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.8 174.75 50.48 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.934 -0.65 . . . . 72.329999999999998 113.317 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -92.45 7.32 43.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 62.299999999999997 110.802 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HE2' HD12 ' A' ' 28' ' ' LEU . 22.9 pttp -66.96 -15.71 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 73.319999999999993 110.995 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 4.4 p -146.63 123.2 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.336 0.589 . . . . 72.109999999999999 110.532 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -130.69 132.19 45.26 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.424 -0.584 . . . . 65.209999999999994 109.424 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.6 p -75.95 126.66 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.099 0.476 . . . . 60.329999999999998 110.553 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.43 -56.61 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.664 -0.495 . . . . 74.409999999999997 109.664 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -179.17 159.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.629 -0.714 . . . . 64.450000000000003 109.7 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -85.24 144.96 27.8 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.573 -0.739 . . . . 74.420000000000002 109.813 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -146.65 113.36 6.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.9 0.381 . . . . 72.310000000000002 110.698 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 t 57.9 62.92 1.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 111.314 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 -59.3 3.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.961 -0.638 . . . . 73.140000000000001 112.921 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.507 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 14.4 m0 -91.09 159.61 16.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.786 0.326 . . . . 60.030000000000001 110.629 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.804 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 9.6 t -105.22 142.42 35.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.277 -0.42 . . . . 64.310000000000002 110.035 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 54' ' ' TYR . 2.9 mtpt -87.88 127.34 35.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 116.178 -0.465 . . . . 62.340000000000003 110.829 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 36' ' ' VAL . 46.0 pt -143.23 164.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.723 -0.672 . . . . 64.219999999999999 110.954 -177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 26.6 t-20 -112.97 117.34 31.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.454 -0.943 . . . . 71.230000000000004 108.454 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.673 ' CE1' HG23 ' A' ' 25' ' ' ILE . 5.8 t80 -110.23 105.04 13.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.703 0.287 . . . . 74.040000000000006 110.515 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.9 t30 62.21 35.29 15.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.675 -0.693 . . . . 65.329999999999998 110.919 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.97 -17.48 59.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.887 -0.673 . . . . 54.310000000000002 113.234 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.92 133.78 51.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.35 0.575 . . . . 71.340000000000003 110.601 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -73.93 130.83 40.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.896 -0.593 . . . . 65.219999999999999 110.808 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.02 -172.19 12.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.833 -0.699 . . . . 74.430000000000007 112.405 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.506 ' CE2' ' HG2' ' A' ' 45' ' ' LYS . 97.0 m-85 -136.06 144.93 45.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.224 -0.287 . . . . 72.310000000000002 110.224 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 2.6 pp -135.29 162.43 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.348 -0.387 . . . . 71.439999999999998 110.239 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.626 ' H ' ' HA2' ' A' ' 17' ' ' GLY . . . -79.71 143.55 25.71 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 45.329999999999998 112.055 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.793 ' HA ' HD11 ' A' ' 60' ' ' LEU . 8.7 m -85.07 -5.4 59.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.757 0.789 . . . . 74.209999999999994 109.332 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -34.37 57.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.361 -0.836 . . . . 74.340000000000003 110.809 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -135.87 118.62 16.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.038 0.447 . . . . 73.299999999999997 111.457 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' A' ' 57' ' ' THR . 5.2 mp -140.38 173.86 11.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.856 . . . . 72.409999999999997 109.062 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.609 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 45.9 m -142.39 124.33 15.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.658 -0.497 . . . . 71.239999999999995 109.658 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tttt . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 75.400000000000006 109.737 -177.665 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 121.015 0.436 . . . . 73.319999999999993 110.782 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.709 HD13 ' HE1' ' A' ' 22' ' ' TYR . 59.2 mt -88.48 133.25 34.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.165 -0.47 . . . . 64.319999999999993 110.422 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.94 -60.35 1.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.978 0.362 . . . . 61.329999999999998 111.978 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 55' ' ' ILE . 4.7 t -74.55 -65.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 73.510000000000005 111.385 -172.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 58.33 17.96 5.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.934 0.716 . . . . 42.43 112.934 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 21' ' ' ASN . 37.9 t 62.33 25.21 15.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.212 0.53 . . . . 63.420000000000002 110.189 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.36 -108.48 0.67 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.112 -0.795 . . . . 74.519999999999996 111.112 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.407 ' OE1' ' HD3' ' A' ' 58' ' ' ARG . 40.4 mt-10 -118.14 14.59 14.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 71.230000000000004 110.201 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.17 48.69 0.18 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.588 -0.733 . . . . 73.200000000000003 111.467 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.4 m -94.2 -34.97 12.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 74.030000000000001 109.913 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' H ' ' HB3' ' A' ' 16' ' ' SER . 18.5 m-80 -140.24 142.06 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.195 -0.912 . . . . 73.239999999999995 109.591 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.709 ' HE1' HD13 ' A' ' 12' ' ' LEU . 55.7 m-85 -129.53 -13.95 4.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.543 0.687 . . . . 75.140000000000001 110.274 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -71.73 -49.9 35.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.913 -1.039 . . . . 73.209999999999994 111.109 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -97.09 -55.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 72.409999999999997 111.526 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' A' ' 48' ' ' TYR . 60.6 mt -101.23 127.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.715 -0.476 . . . . 42.149999999999999 109.715 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.47 -108.54 1.01 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.552 -0.832 . . . . 31.309999999999999 111.762 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -132.63 92.25 3.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.443 . . . . 55.0 110.164 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.5 pt? -173.39 86.43 0.39 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.352 -0.84 . . . . 72.120000000000005 109.834 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.82 71.37 4.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.699 2.266 . . . . 62.109999999999999 110.835 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.75 140.97 29.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.163 -0.926 . . . . 64.239999999999995 111.088 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.83 177.35 28.17 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.678 -0.773 . . . . 75.439999999999998 112.129 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -90.92 51.01 1.88 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 72.120000000000005 110.045 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG3' HG23 ' A' ' 34' ' ' VAL . 47.1 pttt -175.36 -156.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.263 -0.881 . . . . 42.140000000000001 109.341 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.511 HG23 ' HG3' ' A' ' 33' ' ' LYS . 82.2 t 75.89 -28.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.24 0.616 . . . . 65.140000000000001 112.091 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -59.67 -66.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 75.400000000000006 110.9 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -174.38 125.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 72.5 110.65 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.2 mt -113.77 -54.06 4.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.227 0.537 . . . . 73.549999999999997 110.061 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.9 t -143.06 171.81 13.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.125 -0.694 . . . . 73.349999999999994 109.125 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 39.9 mt-10 -137.95 149.71 46.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.052 -0.351 . . . . 62.5 110.052 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -162.86 117.58 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 65.430000000000007 111.628 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 t 63.43 33.05 14.03 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.585 -0.734 . . . . 75.430000000000007 112.457 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.55 -32.85 6.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.666 -0.778 . . . . 73.230000000000004 112.956 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -102.17 155.13 18.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 110.302 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.689 ' HB2' HG13 ' A' ' 55' ' ' ILE . 25.0 m -106.02 143.46 34.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.135 -0.484 . . . . 64.450000000000003 110.689 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD2' ' CE1' ' A' ' 54' ' ' TYR . 19.1 mmmt -82.8 117.53 22.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.508 -0.769 . . . . 73.010000000000005 110.363 -177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.723 ' HA ' HD12 ' A' ' 37' ' ' ILE . 31.4 pt -137.65 171.65 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.966 0.413 . . . . 73.340000000000003 110.94 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -115.04 114.68 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.068 -0.716 . . . . 72.340000000000003 109.068 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.656 ' CE2' HG23 ' A' ' 25' ' ' ILE . 6.0 t80 -111.05 113.1 25.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.456 -0.338 . . . . 64.450000000000003 110.351 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.85 35.06 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.264 0.554 . . . . 74.299999999999997 111.109 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.23 64.52 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 63.43 114.033 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -131.12 167.6 18.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.572 0.686 . . . . 61.119999999999997 110.782 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.8 m -70.17 119.98 15.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 64.129999999999995 110.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.63 169.27 15.79 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.814 -0.707 . . . . 70.519999999999996 111.689 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 97.5 m-85 -139.02 150.62 46.02 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.637 -0.505 . . . . 73.349999999999994 109.637 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.784 HG22 HG13 ' A' ' 14' ' ' VAL . 2.5 pp -130.33 154.01 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 123.088 0.243 . . . . 72.200000000000003 110.681 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.34 108.76 3.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.705 -0.958 . . . . 74.120000000000005 110.705 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -59.56 -15.04 15.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.661 0.615 . . . . 60.340000000000003 112.661 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HD3' ' OE1' ' A' ' 18' ' ' GLU . 11.6 ptm180 -73.4 -16.49 61.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.691 0.282 . . . . 75.420000000000002 111.499 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 118.62 15.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.321 -0.251 . . . . 73.329999999999998 110.321 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 HD13 ' A' ' 55' ' ' ILE . 36.4 mt -153.37 156.1 37.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.568 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 t -155.27 121.84 5.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 72.239999999999995 109.174 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.3 mttp . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 116.078 -0.51 . . . . 72.120000000000005 109.935 178.215 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.307 0 CA-C-O 120.371 0.129 . . . . 54.109999999999999 110.764 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt 56.42 42.18 27.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.093 0.473 . . . . 65.239999999999995 111.312 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -68.21 -52.88 29.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.761 -0.654 . . . . 44.229999999999997 111.362 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG13 HG21 ' A' ' 55' ' ' ILE . 4.8 t -87.85 48.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 74.430000000000007 110.589 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.851 ' HD2' ' HB2' ' A' ' 22' ' ' TYR . 3.0 mmt180 -74.79 37.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.647 0.61 . . . . 72.230000000000004 112.647 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 4.5 m 49.64 73.82 0.23 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.484 0.659 . . . . 64.519999999999996 112.525 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.719 ' H ' ' HA ' ' A' ' 55' ' ' ILE . . . 101.97 -139.34 14.37 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.572 -0.74 . . . . 25.219999999999999 111.472 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -110.59 39.37 2.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.605 -0.887 . . . . 64.239999999999995 108.605 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.01 21.25 33.71 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -1.0 . . . . 74.510000000000005 111.055 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -87.08 -61.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 61.420000000000002 111.508 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.401 ' C ' ' HB2' ' A' ' 16' ' ' SER . 15.7 m120 -108.95 34.92 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 64.549999999999997 109.582 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.851 ' HB2' ' HD2' ' A' ' 15' ' ' ARG . 28.7 p90 -50.71 -21.99 1.87 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.926 -1.034 . . . . 74.200000000000003 113.646 -168.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 23' ' ' ARG . 24.6 ttt-85 -58.5 -35.46 72.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.321 0.489 . . . . 75.219999999999999 112.321 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.72 -56.94 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 61.219999999999999 111.895 -170.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.593 HG12 ' CD2' ' A' ' 48' ' ' TYR . 1.7 mt -128.27 157.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.338 -0.616 . . . . 61.32 109.338 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -144.79 -77.94 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.703 -1.237 . . . . 45.109999999999999 114.34 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.745 ' O ' ' HD3' ' A' ' 29' ' ' PRO . . . -81.35 -153.32 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.677 0.621 . . . . 64.040000000000006 112.677 -168.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 61' ' ' SER . 56.9 tp -91.16 90.03 0.33 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.355 -0.839 . . . . 75.450000000000003 110.762 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 68.2 Cg_endo -85.59 -7.16 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.574 2.182 . . . . 72.310000000000002 112.56 -173.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 67.43 166.0 0.23 Allowed 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.638 0.586 . . . . 71.310000000000002 110.633 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.2 67.53 2.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.074 -0.584 . . . . 72.319999999999993 112.637 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.63 -67.69 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.358 0.599 . . . . 70.150000000000006 110.022 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -139.97 -36.7 0.49 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.848 -1.069 . . . . 72.019999999999996 108.785 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -78.46 115.88 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.336 -0.847 . . . . 75.200000000000003 110.521 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 3.9 pm0 -122.79 13.83 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.371 -0.377 . . . . 55.009999999999998 110.57 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.92 ' HA ' HG22 ' A' ' 46' ' ' ILE . 95.2 t 73.67 118.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.651 -0.704 . . . . 73.230000000000004 109.891 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.25 -51.07 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.129 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -168.65 150.72 4.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.606 -0.724 . . . . 71.530000000000001 110.394 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.4 mp0 -90.72 125.84 35.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.499 -0.773 . . . . 65.349999999999994 110.195 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -97.62 177.72 5.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.884 -0.598 . . . . 53.210000000000001 109.857 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 p -62.36 76.54 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.011 -0.995 . . . . 71.239999999999995 111.411 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.08 -68.41 0.55 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.363 -0.835 . . . . 74.120000000000005 112.001 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 42.0 m0 -112.61 160.21 18.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 74.349999999999994 110.731 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.2 m -103.55 129.32 50.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.891 -0.595 . . . . 75.299999999999997 109.7 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 38.0 ttmt -83.08 132.28 35.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.168 0.509 . . . . 74.340000000000003 111.738 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.92 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -140.02 153.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.592 -0.731 . . . . 75.140000000000001 109.954 176.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -111.98 113.77 26.27 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.428 -0.953 . . . . 74.099999999999994 108.428 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 11.8 t80 -115.53 110.96 20.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.253 -0.431 . . . . 62.409999999999997 110.137 -172.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.25 33.75 16.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 72.230000000000004 110.711 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 -10.2 75.26 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 75.510000000000005 113.808 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 14.0 pt20 -106.86 147.01 30.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.751 0.775 . . . . 74.140000000000001 110.982 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -84.88 131.29 34.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 62.329999999999998 111.418 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.84 174.17 26.77 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.786 -0.721 . . . . 62.5 111.849 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 66.6 m-85 -134.02 147.45 50.96 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.27 -0.641 . . . . 75.319999999999993 109.27 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.719 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 2.8 pp -126.86 154.65 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.529 0.204 . . . . 73.099999999999994 110.709 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 130.57 11.37 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.556 -0.831 . . . . 72.109999999999999 111.817 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 m -69.16 -9.12 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.14 0.495 . . . . 55.200000000000003 111.331 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.02 -47.22 86.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.109 0.481 . . . . 71.409999999999997 110.189 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.2 118.99 22.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.765 -0.652 . . . . 74.530000000000001 110.489 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 36' ' ' VAL . 5.0 tt -138.07 134.98 35.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.314 -0.857 . . . . 75.299999999999997 108.817 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' HD12 ' A' ' 28' ' ' LEU . 71.1 m -83.86 119.59 25.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 75.409999999999997 111.237 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 C--N 1.319 -0.728 0 N-CA-C 107.952 -1.129 . . . . 70.150000000000006 107.952 174.441 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.305 0.574 . . . . 72.239999999999995 110.551 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.603 ' HA ' ' HD3' ' A' ' 15' ' ' ARG . 85.9 mt -89.63 69.58 7.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 65.120000000000005 110.631 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -119.18 -59.14 1.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.064 0.459 . . . . 75.540000000000006 111.455 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.35 49.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 72.25 110.352 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.603 ' HD3' ' HA ' ' A' ' 12' ' ' LEU . 22.0 mmm180 -81.23 42.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.129999999999995 112.363 -171.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.8 p 54.22 22.62 3.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.748 0.819 . . . . 75.540000000000006 112.777 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 109.3 -116.05 4.46 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 72.209999999999994 111.721 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 2.4 mm-40 -79.03 -72.41 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.633 -0.877 . . . . 73.219999999999999 108.633 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.32 30.39 0.37 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.324 -1.51 . . . . 64.030000000000001 109.324 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -50.49 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.162 -1.019 . . . . 72.5 111.994 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.4 t30 -166.86 60.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.032 -0.729 . . . . 72.310000000000002 109.032 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -74.63 7.18 3.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.89 -0.595 . . . . 75.0 111.762 -173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.56 -24.1 56.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.582 . . . . 74.400000000000006 110.127 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 25' ' ' ILE . 29.5 pt -79.19 -45.26 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.402 -0.363 . . . . 74.019999999999996 111.698 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 24' ' ' ILE . 10.2 mt -132.66 138.05 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.908 -0.405 . . . . 74.430000000000007 109.908 -176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.46 -75.42 0.69 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.008 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.09 101.31 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.794 0.331 . . . . 44.409999999999997 110.722 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -140.05 75.75 28.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.458 -0.571 . . . . 50.299999999999997 109.458 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 6.1 Cg_exo -79.85 117.68 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.238 2.625 . . . . 63.350000000000001 111.305 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 29' ' ' PRO . 24.1 tm0? 75.37 113.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 124.2 0.938 . . . . 74.150000000000006 109.953 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.11 -51.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.509 -0.769 . . . . 42.109999999999999 111.32 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -134.83 -86.03 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.745 -0.465 . . . . 60.100000000000001 109.745 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.93 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 64.1 mttm -127.43 10.53 6.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.609 0.719 . . . . 74.5 109.529 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.74 82.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 122.072 0.939 . . . . 75.510000000000005 110.373 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -161.85 44.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.864 -1.062 . . . . 65.430000000000007 109.465 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m 43.82 86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.1 0.96 . . . . 70.299999999999997 113.164 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -74.74 -55.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.925 -0.58 . . . . 70.230000000000004 110.389 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -141.61 172.2 13.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 73.5 109.169 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.14 137.57 47.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.593 0.235 . . . . 65.230000000000004 110.485 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -155.56 132.99 11.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.707 -0.479 . . . . 64.430000000000007 109.707 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t 71.87 8.42 6.03 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.557 0.536 . . . . 62.140000000000001 111.297 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.98 -32.42 6.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.897 -0.668 . . . . 44.25 112.368 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 18.1 m0 -92.58 158.29 16.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.98 0.419 . . . . 72.019999999999996 110.723 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 54' ' ' TYR . 15.2 m -99.56 143.31 29.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.93 -0.577 . . . . 64.540000000000006 111.14 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 19.3 mmmt -82.46 121.75 27.15 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.559 -0.746 . . . . 74.329999999999998 110.968 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.0 pt -139.57 156.53 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 55.420000000000002 110.157 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 22.8 t-20 -123.41 118.24 27.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.852 -0.425 . . . . 62.32 109.852 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.712 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 40.3 t80 -121.89 112.07 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.785 -0.643 . . . . 72.430000000000007 109.806 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.66 32.53 21.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.386 0.612 . . . . 73.420000000000002 111.153 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.16 56.96 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.827 -0.624 . . . . 33.219999999999999 113.637 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 5.1 pt20 -92.77 140.1 29.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.714 0.757 . . . . 72.129999999999995 110.902 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.2 m -78.79 123.71 27.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.997 -1.001 . . . . 52.530000000000001 110.12 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.81 22.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.72 -0.752 . . . . 54.520000000000003 112.331 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.765 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 95.9 m-85 -130.96 147.25 52.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.564 -0.532 . . . . 72.439999999999998 109.564 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 2.6 pp -134.84 160.96 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.407 -0.22 . . . . 71.329999999999998 110.407 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.516 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -83.78 132.48 11.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.669 -0.777 . . . . 74.409999999999997 112.153 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -63.39 -17.05 62.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 74.129999999999995 112.025 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 58' ' ' ARG . 58.4 mtt85 -59.12 -48.82 80.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.413 -0.358 . . . . 72.400000000000006 111.616 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' O ' HD22 ' A' ' 60' ' ' LEU . 7.4 m-85 -117.11 116.77 27.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.312 0.577 . . . . 74.209999999999994 111.513 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD22 ' O ' ' A' ' 59' ' ' TYR . 1.2 mm? -142.12 175.28 9.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 60.340000000000003 108.187 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -83.1 119.53 24.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.626 -0.509 . . . . 74.25 109.626 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 108.701 -0.851 . . . . 74.519999999999996 108.701 178.023 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' N ' ' HG ' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.971 0.415 . . . . 74.299999999999997 110.786 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.2 mm? -73.06 10.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.59 -0.732 . . . . 72.129999999999995 112.473 -170.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -95.01 1.2 55.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.277 0.473 . . . . 75.25 112.277 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 5.7 t -91.5 32.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.045 0.926 . . . . 64.230000000000004 108.706 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' TYR . 13.2 tpt180 -78.12 3.67 14.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.856 -1.065 . . . . 63.530000000000001 110.829 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.701 ' HB2' HD12 ' A' ' 25' ' ' ILE . 22.4 t 71.59 16.44 5.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.659 -0.701 . . . . 72.209999999999994 111.449 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.74 -122.23 1.4 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.424 -0.893 . . . . 62.0 112.719 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -160.99 -69.38 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.5 -0.555 . . . . 62.520000000000003 109.5 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.18 -32.77 0.48 Allowed Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.142 -0.783 . . . . 45.530000000000001 111.142 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 ' CZ2' ' A' ' 43' ' ' TRP . 4.7 t -55.76 -31.75 62.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.204 0.526 . . . . 74.450000000000003 111.09 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 23' ' ' ARG . 24.8 t30 -171.83 114.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.088 -0.708 . . . . 73.310000000000002 109.088 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ARG . 42.5 p90 -132.15 7.74 4.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.054 0.454 . . . . 75.549999999999997 110.804 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 23' ' ' ARG . 12.5 ptt180 -88.16 -24.57 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.015 0.746 . . . . 73.310000000000002 113.015 -169.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mm -69.92 -55.69 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.734 -0.387 . . . . 73.140000000000001 111.872 -171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.1 mp -132.26 -169.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.651 -0.5 . . . . 74.439999999999998 109.651 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -145.99 -65.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 72.319999999999993 112.516 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -151.75 94.14 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.729 -0.277 . . . . 52.409999999999997 111.01 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 28' ' ' LEU . 1.2 tm? -166.32 86.29 0.9 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.26 -0.644 . . . . 61.420000000000002 109.26 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.86 76.73 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.065 2.51 . . . . 71.310000000000002 113.314 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.874 ' HG2' ' H ' ' A' ' 31' ' ' GLY . 8.4 tt0 59.64 -154.43 0.37 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 75.010000000000005 110.587 173.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.874 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 90.59 -83.05 1.32 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.26 -0.495 . . . . 75.209999999999994 112.292 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.74 -47.35 75.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.155 0.502 . . . . 72.319999999999993 111.216 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 26.5 tptp -154.17 168.71 25.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.006 -1.109 . . . . 73.109999999999999 108.006 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 48' ' ' TYR . 72.7 t 75.8 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.305 0.574 . . . . 73.349999999999994 111.462 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -136.32 148.06 47.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.993 -0.549 . . . . 75.129999999999995 110.468 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.3 p -92.04 143.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 73.450000000000003 110.065 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -93.84 -56.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.791 0.329 . . . . 72.530000000000001 110.369 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 p -173.6 151.18 1.86 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.021 -0.536 . . . . 72.340000000000003 110.007 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -110.59 137.85 47.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.603 -0.726 . . . . 71.109999999999999 111.623 -176.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -95.73 174.14 7.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.092 -1.077 . . . . 64.109999999999999 108.092 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -70.66 -11.25 60.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.011 0.434 . . . . 64.150000000000006 110.536 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.94 -74.68 0.97 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.983 -0.627 . . . . 63.130000000000003 111.567 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CZ2' HG21 ' A' ' 20' ' ' THR . 52.0 m0 -117.61 159.48 22.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 74.409999999999997 110.745 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.0 t -109.9 142.91 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.29 -0.414 . . . . 60.049999999999997 110.053 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -89.49 116.26 27.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.904 0.383 . . . . 65.510000000000005 111.697 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 36' ' ' VAL . 40.8 pt -131.61 156.72 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 71.109999999999999 110.106 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.543 ' O ' HG13 ' A' ' 34' ' ' VAL . 5.4 p30 -115.15 113.83 24.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.299999999999997 109.594 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.651 ' CD1' HG21 ' A' ' 34' ' ' VAL . 16.0 t80 -98.91 84.72 3.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.785 -0.45 . . . . 74.239999999999995 109.785 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.95 55.11 8.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.097 -0.956 . . . . 75.230000000000004 111.663 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.17 59.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.847 -0.692 . . . . 55.329999999999998 113.139 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.31 152.27 21.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.951 0.405 . . . . 60.310000000000002 110.407 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.1 m -93.57 114.44 26.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.563 -0.744 . . . . 75.340000000000003 109.389 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.37 148.35 18.49 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.278 -0.963 . . . . 75.510000000000005 112.983 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' SER . 95.8 m-85 -128.79 144.96 51.3 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.234 -1.024 . . . . 71.25 108.234 172.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 60' ' ' LEU . 2.7 pp -133.19 158.73 43.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 110.024 -0.362 . . . . 65.299999999999997 110.024 175.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 127.19 8.19 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.511 -0.852 . . . . 52.409999999999997 112.317 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -75.29 -6.73 51.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.622 0.725 . . . . 74.510000000000005 110.496 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -74.02 -49.69 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.589 -0.732 . . . . 62.350000000000001 110.546 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.12 120.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.984 -0.553 . . . . 75.439999999999998 110.305 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 55' ' ' ILE . 6.1 mt -134.59 174.15 10.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.872 -0.603 . . . . 74.409999999999997 111.067 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HG ' ' N ' ' A' ' 11' ' ' ALA . 20.5 m -148.98 145.83 27.52 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.58 -0.896 . . . . 34.240000000000002 108.58 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tptt . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.842 -0.429 . . . . 74.049999999999997 109.842 -177.138 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 N-CA-C 111.971 0.36 . . . . 70.530000000000001 111.971 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 15' ' ' ARG . 3.7 pp -112.3 139.82 47.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 42.229999999999997 111.021 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 27' ' ' ALA . 37.1 m-80 -117.63 -59.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.764 -0.653 . . . . 65.25 110.652 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 55' ' ' ILE . 7.1 t -119.5 13.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.107 -1.072 . . . . 75.299999999999997 108.107 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.669 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 3.2 tmt_? -63.66 110.83 2.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.772 -1.104 . . . . 65.340000000000003 109.55 -175.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.792 ' CB ' ' HA ' ' A' ' 23' ' ' ARG . 45.9 p 55.71 15.27 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.17 -0.923 . . . . 74.319999999999993 112.548 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 53.92 -109.36 1.09 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.468 -0.653 . . . . 73.420000000000002 111.468 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -117.77 161.16 20.16 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.729 -0.841 . . . . 73.310000000000002 108.729 169.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 58.93 2.26 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.178 -0.534 . . . . 60.399999999999999 114.2 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 21' ' ' ASN . 6.3 t -103.1 -60.03 1.62 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.086 0.443 . . . . 75.129999999999995 110.839 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.493 ' H ' HG23 ' A' ' 20' ' ' THR . 7.9 t30 -161.27 -4.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.673 0.749 . . . . 71.519999999999996 110.487 177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.5 m-85 -83.47 15.33 3.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.621 -0.718 . . . . 71.430000000000007 112.524 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 98.7 mtt180 -44.64 -23.54 0.13 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.659 0.985 . . . . 74.200000000000003 113.659 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 pt -77.4 -5.41 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.732 0.641 . . . . 61.229999999999997 112.732 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.585 HG23 ' CE1' ' A' ' 48' ' ' TYR . 53.7 mt -90.09 167.63 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.425 -0.583 . . . . 74.409999999999997 109.425 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 15' ' ' ARG . . . -150.83 176.62 29.3 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 73.140000000000001 111.439 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 13' ' ' ASN . . . -95.32 93.39 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.92 0.36 . . . . 74.230000000000004 110.941 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -171.3 62.61 0.36 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 64.409999999999997 110.874 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.02 -40.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.799 1.666 . . . . 70.25 111.631 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 30.0 pt20 44.71 25.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.866 1.266 . . . . 64.340000000000003 113.21 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.46 19.57 57.9 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.371 -0.442 . . . . 73.140000000000001 112.624 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -82.41 -57.64 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.206 -0.294 . . . . 72.129999999999995 110.206 -175.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 24.0 ttmm -143.63 -70.57 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.621 -0.432 . . . . 64.519999999999996 111.769 -177.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.49 100.89 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.708 0.766 . . . . 62.409999999999997 111.582 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -140.01 -179.45 5.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 72.310000000000002 109.629 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 60' ' ' LEU . 31.8 m -76.11 138.83 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.21 0.529 . . . . 74.150000000000006 111.872 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.52 -55.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.67 -0.695 . . . . 64.049999999999997 109.955 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.5 t -160.05 155.19 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 74.310000000000002 109.98 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -106.9 153.15 22.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.946 -0.57 . . . . 74.140000000000001 110.918 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -170.19 131.05 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 45.32 110.364 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.0 t 69.35 17.35 8.2 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.033 -0.53 . . . . 71.140000000000001 111.415 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.98 -18.66 55.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.676 -0.773 . . . . 74.219999999999999 112.049 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.462 ' HD1' ' HA2' ' A' ' 56' ' ' GLY . 22.1 m0 -105.65 157.48 17.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.86 0.362 . . . . 74.349999999999994 110.499 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.1 t -121.81 146.55 46.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.947 -0.57 . . . . 63.329999999999998 110.092 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -80.61 123.12 27.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.63 -0.713 . . . . 72.310000000000002 110.88 -176.403 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 pt -134.1 156.73 41.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.724 -0.671 . . . . 75.099999999999994 110.115 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -115.0 114.68 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.59 -0.522 . . . . 72.430000000000007 109.59 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' CE1' HG23 ' A' ' 25' ' ' ILE . 59.8 t80 -112.46 106.18 14.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.425 -0.352 . . . . 72.230000000000004 110.192 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 60.32 34.68 20.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.985 -0.552 . . . . 73.409999999999997 111.502 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.31 84.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.649 -0.786 . . . . 23.100000000000001 112.918 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -106.48 156.52 18.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.924 0.392 . . . . 55.310000000000002 110.586 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -76.8 128.4 34.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.674 -0.694 . . . . 64.109999999999999 109.886 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 22' ' ' TYR . . . -131.14 156.75 21.94 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.31 -0.948 . . . . 42.200000000000003 112.436 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 45' ' ' LYS . 73.9 m-85 -128.26 140.55 51.83 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.038 -0.356 . . . . 64.510000000000005 110.038 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 17' ' ' GLY . 2.7 pp -135.52 151.99 30.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.032 -0.531 . . . . 55.399999999999999 109.621 173.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' HD1' ' A' ' 43' ' ' TRP . . . -76.5 140.0 24.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.27 -0.967 . . . . 65.340000000000003 111.743 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 m -65.74 -10.8 40.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.32 0.581 . . . . 74.230000000000004 110.55 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -81.17 -11.67 59.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.607 -0.724 . . . . 73.109999999999999 111.222 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.16 118.44 16.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.222 0.534 . . . . 72.420000000000002 112.031 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.497 HD11 HG11 ' A' ' 36' ' ' VAL . 18.7 mt -157.51 173.27 17.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 73.120000000000005 108.969 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.4 m -82.99 119.09 24.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.402 -0.592 . . . . 71.019999999999996 109.402 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 12.4 tmtt? . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.646 -0.706 . . . . 75.010000000000005 110.441 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.069 0.461 . . . . 72.319999999999993 110.781 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.877 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.4 pt? -75.02 39.88 0.14 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.871 0.367 . . . . 72.230000000000004 111.654 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -68.41 -54.68 15.52 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.349 0.5 . . . . 73.019999999999996 112.349 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.08 21.31 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.641 0.734 . . . . 64.349999999999994 109.203 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.725 ' CG ' ' HA ' ' A' ' 12' ' ' LEU . 19.0 mmt180 -54.62 -38.52 66.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 73.099999999999994 112.797 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.6 ' HB2' HD12 ' A' ' 25' ' ' ILE . 23.2 m 65.23 28.61 12.0 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.531 0.519 . . . . 62.229999999999997 111.677 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.87 133.77 27.22 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.667 -0.778 . . . . 51.340000000000003 111.914 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.14 -31.34 69.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.125 0.488 . . . . 71.129999999999995 110.281 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.06 -109.44 1.27 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.722 -0.951 . . . . 50.140000000000001 110.722 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.8 p -99.7 -4.81 29.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.353 0.597 . . . . 74.340000000000003 109.5 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -77.68 86.64 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.322 -0.854 . . . . 74.25 110.496 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.586 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 38.3 m-85 -93.9 5.78 50.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 71.109999999999999 111.548 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -90.26 -0.54 57.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.510000000000005 109.551 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.487 HG23 HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -52.4 -42.38 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.179 -0.919 . . . . 72.439999999999998 110.208 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' SER . 68.1 mt -132.58 -79.66 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 110.441 -0.207 . . . . 72.400000000000006 110.441 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . 140.08 169.76 11.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.21 -0.995 . . . . 70.140000000000001 112.643 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -92.91 94.46 8.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.102 -0.333 . . . . 71.400000000000006 110.102 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.605 ' HG ' HE22 ' A' ' 30' ' ' GLN . 19.4 tp -122.51 85.18 48.24 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.315 -0.624 . . . . 74.439999999999998 109.315 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.77 93.81 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.292 2.661 . . . . 72.319999999999993 113.378 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.605 HE22 ' HG ' ' A' ' 28' ' ' LEU . 2.5 mp0 -85.79 160.05 19.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 74.5 109.777 171.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.03 83.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.362 -0.446 . . . . 74.200000000000003 112.47 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 74.409999999999997 109.713 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' ' H ' ' A' ' 35' ' ' GLN . 4.1 ttmp? 71.94 143.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 55.219999999999999 111.895 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -77.13 -19.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.918 -0.583 . . . . 75.319999999999993 111.388 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.709 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 23.3 tt0 70.79 174.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.668 -0.696 . . . . 73.239999999999995 110.946 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 7.5 p -102.58 143.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.142 -0.481 . . . . 42.5 110.547 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' ASN . 5.3 mt -76.65 -56.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.828 -0.434 . . . . 72.439999999999998 109.828 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -172.18 161.67 5.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.585 -0.734 . . . . 71.140000000000001 109.599 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -117.15 139.8 50.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.74 -0.664 . . . . 54.009999999999998 110.289 -177.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -173.62 156.85 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.185 -0.461 . . . . 60.140000000000001 109.922 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.115 -0.493 . . . . 73.209999999999994 111.691 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.78 27.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.96 -0.638 . . . . 71.230000000000004 113.181 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -125.49 162.33 25.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.446 0.641 . . . . 74.409999999999997 111.479 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 36.6 m -101.17 122.57 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.254 -0.884 . . . . 70.409999999999997 109.609 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.0 ttmt -82.53 124.19 29.89 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.095 -0.502 . . . . 61.43 110.716 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 36' ' ' VAL . 9.7 pt -126.19 148.55 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.922 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.715 ' HB2' HD11 ' A' ' 37' ' ' ILE . 26.2 t-20 -109.54 113.39 26.14 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.294 -0.632 . . . . 70.409999999999997 109.294 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.603 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 32.7 t80 -104.03 85.69 2.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.124 0.488 . . . . 53.509999999999998 109.705 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.88 50.03 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 73.200000000000003 111.107 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.67 -17.66 58.87 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.059 -0.591 . . . . 64.530000000000001 114.213 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -103.41 147.39 27.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.075 0.937 . . . . 75.439999999999998 110.753 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -93.65 129.46 39.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 63.409999999999997 111.45 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.17 170.69 22.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.585 -0.606 . . . . 53.43 111.585 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.79 151.38 51.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 72.340000000000003 110.538 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 2.5 pp -143.69 153.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.801 -0.636 . . . . 73.519999999999996 109.919 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.622 ' H ' HD12 ' A' ' 12' ' ' LEU . . . -74.62 128.4 10.32 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.502 -0.856 . . . . 70.120000000000005 111.392 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 m -64.23 -4.5 3.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.406 0.521 . . . . 74.400000000000006 112.406 -174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -68.65 -34.37 75.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.169 -0.308 . . . . 64.310000000000002 110.169 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.05 119.43 23.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.011 0.434 . . . . 71.329999999999998 110.378 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' SER . 3.6 tt -155.53 129.81 8.89 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.715 -0.846 . . . . 73.129999999999995 108.715 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.41 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.7 t -87.51 120.67 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.461 -0.57 . . . . 53.020000000000003 109.461 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.938 -0.574 . . . . 64.299999999999997 110.534 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 N-CA-C 109.644 -0.502 . . . . 75.120000000000005 109.644 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.786 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 mm? -82.33 75.26 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.338 -0.986 . . . . 65.319999999999993 108.338 172.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 -38.24 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.599 0.592 . . . . 72.040000000000006 112.599 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 16' ' ' SER . 47.8 t -77.26 -66.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.454 -0.498 . . . . 74.230000000000004 111.463 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 31.4 mmt180 53.86 20.86 2.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.599 0.592 . . . . 44.409999999999997 112.599 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.686 ' H ' HG12 ' A' ' 14' ' ' VAL . 14.9 m 61.47 25.94 15.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.853 0.461 . . . . 55.229999999999997 111.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.38 -113.31 3.5 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.645 -0.788 . . . . 73.140000000000001 112.573 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 15.3 mm-40 -73.69 -5.83 43.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.641 0.258 . . . . 72.329999999999998 111.192 -175.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 94.58 29.11 9.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.052 -0.594 . . . . 62.439999999999998 112.2 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 p -75.42 -62.01 1.71 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 72.549999999999997 110.955 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.444 ' HB3' HG22 ' A' ' 24' ' ' ILE . 39.1 m-80 -103.58 93.34 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.841 -0.618 . . . . 70.239999999999995 110.354 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -93.03 -1.13 56.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 111.055 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -82.89 -24.08 33.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 111.267 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 25' ' ' ILE . 4.8 tt -93.16 -55.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.233 . . . . 75.319999999999993 111.317 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.671 HG13 HG12 ' A' ' 24' ' ' ILE . 7.2 mt -129.54 138.65 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.313 -0.625 . . . . 64.310000000000002 109.313 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -143.21 -71.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.103 -1.046 . . . . 35.240000000000002 113.622 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.786 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . . . -74.69 -162.03 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.386 0.513 . . . . 74.329999999999998 112.386 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.91 90.16 0.37 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 75.519999999999996 109.352 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 52.3 Cg_endo -82.26 6.74 5.53 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.906 2.404 . . . . 73.019999999999996 113.105 -169.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 18.1 mm100 70.59 -67.1 0.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.481 0.712 . . . . 73.109999999999999 111.251 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.77 77.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.724 -0.751 . . . . 63.539999999999999 112.713 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.76 -50.94 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 72.239999999999995 110.664 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -139.98 19.19 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.414 -0.958 . . . . 63.340000000000003 108.414 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' ASN . 15.2 t -129.97 116.39 37.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.785 -1.098 . . . . 70.430000000000007 111.217 -169.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.938 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 4.3 pm0 -145.22 -86.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.774 -0.37 . . . . 72.420000000000002 110.519 169.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.938 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 75.4 t -144.43 114.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.827 -0.434 . . . . 71.099999999999994 109.827 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.4 mt -99.85 -56.69 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.857 -0.337 . . . . 73.319999999999993 110.39 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -167.56 153.27 7.44 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.905 0.383 . . . . 53.32 110.213 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 5.5 pt-20 -117.38 149.47 40.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.461 -0.79 . . . . 74.319999999999993 110.384 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -160.24 130.59 5.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.524 . . . . 70.239999999999995 109.798 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t 71.84 24.55 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.348 0.594 . . . . 74.230000000000004 111.106 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.89 44.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 64.120000000000005 112.853 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.473 ' HE1' ' HG2' ' A' ' 18' ' ' GLU . 9.6 m0 -119.09 152.7 36.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.921 0.391 . . . . 74.129999999999995 110.912 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.2 m -97.05 137.1 36.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.896 -0.593 . . . . 72.239999999999995 109.547 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.79 131.0 45.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.881 -0.414 . . . . 73.019999999999996 109.881 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 37' ' ' ILE . 25.2 pt -145.0 171.24 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 65.120000000000005 110.949 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 34' ' ' VAL . 23.7 t-20 -113.01 113.65 25.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.942 -0.762 . . . . 64.230000000000004 108.942 172.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.638 ' CD2' HG12 ' A' ' 25' ' ' ILE . 50.7 t80 -110.1 106.9 16.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.597 -0.274 . . . . 71.310000000000002 110.336 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.5 t30 63.05 34.43 13.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.68 0.753 . . . . 75.120000000000005 110.654 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.92 73.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.936 -0.649 . . . . 74.209999999999994 113.571 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -120.45 157.57 29.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.382 0.591 . . . . 75.239999999999995 110.882 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 m -73.02 125.26 27.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 74.439999999999998 110.752 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.7 166.03 24.37 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.575 -0.821 . . . . 50.240000000000002 112.313 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -132.81 148.19 52.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.805 -0.443 . . . . 62.549999999999997 109.805 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -137.18 168.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.098 177.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.38 155.03 19.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.347 -0.93 . . . . 73.430000000000007 111.981 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -85.87 -21.76 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 32.530000000000001 109.682 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.0 -41.93 13.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.69 -0.687 . . . . 62.119999999999997 110.448 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -95.14 113.07 24.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.4 -0.963 . . . . 75.230000000000004 108.4 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -158.68 174.1 15.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 110.648 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -121.17 117.64 27.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.454 -0.943 . . . . 65.329999999999998 108.454 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 tptt . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 107.733 -1.21 . . . . 71.409999999999997 107.733 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.837 0.351 . . . . 75.150000000000006 111.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 53.7 mt -97.54 128.06 43.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.249 -0.649 . . . . 75.099999999999994 109.249 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.69 -42.23 5.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.922 0.392 . . . . 55.130000000000003 111.072 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.65 49.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 71.439999999999998 109.813 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.546 ' HD2' ' OD1' ' A' ' 21' ' ' ASN . 5.7 mmm180 -43.99 -72.62 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.731 -1.122 . . . . 63.130000000000003 112.938 -173.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.985 ' HB2' HD12 ' A' ' 25' ' ' ILE . 2.2 m 57.64 37.66 27.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.239 0.543 . . . . 73.409999999999997 110.257 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -83.91 168.87 45.76 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.801 -0.714 . . . . 71.340000000000003 113.429 -172.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -70.88 -42.36 70.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.489 0.661 . . . . 64.25 109.512 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.4 -65.25 0.16 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.186 -0.916 . . . . 73.340000000000003 111.583 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 4.5 p -123.82 -6.53 7.94 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.638 -0.331 . . . . 72.209999999999994 111.811 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.546 ' OD1' ' HD2' ' A' ' 15' ' ' ARG . 10.8 t-20 75.13 122.82 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.992 0.808 . . . . 73.209999999999994 111.807 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.418 ' HE1' ' HG1' ' A' ' 20' ' ' THR . 31.3 m-85 -129.62 -60.81 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.556 -0.747 . . . . 71.109999999999999 111.008 175.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -119.06 -13.51 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.317 0.858 . . . . 75.010000000000005 113.317 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG12 HG13 ' A' ' 25' ' ' ILE . 11.6 tt -61.79 -55.89 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.72 -0.392 . . . . 53.32 112.022 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.985 HD12 ' HB2' ' A' ' 16' ' ' SER . 59.4 mt -138.44 155.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.079 -0.712 . . . . 71.200000000000003 109.079 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.9 -113.05 2.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.492 -0.861 . . . . 73.409999999999997 112.37 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.81 94.55 4.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.197 0.522 . . . . 51.439999999999998 110.975 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 tp -147.43 84.98 6.93 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.67 -0.696 . . . . 61.310000000000002 109.41 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -92.6 -10.85 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.005 2.47 . . . . 73.230000000000004 113.398 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -94.67 97.37 10.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.629 0.728 . . . . 72.340000000000003 110.694 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.0 150.06 21.26 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.413 -0.812 . . . . 64.299999999999997 111.435 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -68.91 -24.14 64.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.12 0.486 . . . . 73.129999999999995 110.381 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -122.13 22.14 10.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.363 0.601 . . . . 73.310000000000002 109.521 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.72 108.0 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.677 . . . . 55.009999999999998 110.793 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -166.23 156.81 12.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.150000000000006 109.888 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 46' ' ' ILE . 61.9 t -73.8 125.14 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.031 -0.359 . . . . 71.299999999999997 110.031 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.63 -56.34 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.774 0.321 . . . . 75.530000000000001 110.586 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -144.45 159.31 42.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.406 -0.361 . . . . 72.230000000000004 110.179 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 9.7 pt-20 -129.01 142.61 50.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.161 -0.472 . . . . 71.040000000000006 110.799 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -112.03 173.36 6.4 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.499 -0.926 . . . . 75.019999999999996 108.499 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -74.51 69.18 1.67 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 54.240000000000002 109.749 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.77 -75.65 0.21 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.243 -0.743 . . . . 62.539999999999999 111.243 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -118.46 144.88 45.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.087 0.47 . . . . 73.340000000000003 110.782 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 27.4 m -101.39 139.38 37.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.724 -0.671 . . . . 74.319999999999993 110.678 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD2' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -82.03 114.69 20.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.401 0.68 . . . . 63.109999999999999 110.16 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 36' ' ' VAL . 20.1 pt -132.19 167.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.184 0.516 . . . . 73.540000000000006 111.551 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.84 114.63 14.92 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.574 -0.899 . . . . 74.310000000000002 108.574 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.673 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 43.3 t80 -99.7 88.37 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.864 0.364 . . . . 74.519999999999996 110.247 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 58.6 47.1 13.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.537 0.684 . . . . 52.219999999999999 110.88 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.35 -6.07 74.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.678 -0.772 . . . . 71.140000000000001 113.856 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 2.4 pt20 -113.24 162.41 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.678 0.739 . . . . 73.310000000000002 111.237 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -73.82 143.32 45.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.484 -0.78 . . . . 73.150000000000006 111.887 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . -161.92 155.58 26.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.541 -0.838 . . . . 51.32 112.508 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' HE1' ' HD2' ' A' ' 45' ' ' LYS . 78.8 m-85 -141.71 145.28 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.301 -0.629 . . . . 72.420000000000002 109.301 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 15' ' ' ARG . 2.5 pp -131.12 145.35 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 121.243 -0.183 . . . . 75.230000000000004 110.589 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.28 126.55 22.8 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.408 -0.901 . . . . 74.319999999999993 111.148 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -57.07 -22.06 36.38 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.507 0.323 . . . . 54.240000000000002 111.823 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -55.91 -34.63 65.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.463 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.68 119.15 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.011 0.434 . . . . 72.420000000000002 111.216 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -144.6 156.16 43.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.82 -0.807 . . . . 73.340000000000003 108.82 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.632 ' H ' HD23 ' A' ' 60' ' ' LEU . 34.5 t -98.84 141.78 31.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.931 0.395 . . . . 61.340000000000003 110.26 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 115.363 -0.835 . . . . 74.120000000000005 110.404 176.912 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 112.691 0.626 . . . . 64.019999999999996 112.691 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.7 mt 56.42 30.41 16.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.372 -0.831 . . . . 73.25 112.763 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' OD1' ' HB ' ' A' ' 55' ' ' ILE . 38.3 t30 -110.58 -59.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.162 0.506 . . . . 55.310000000000002 111.478 -176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.724 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 4.3 t -86.04 48.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 71.209999999999994 110.823 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 14.6 mmt180 -77.92 -1.11 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.08 -0.509 . . . . 73.400000000000006 112.235 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t 66.47 28.18 9.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.615 -1.254 . . . . 71.230000000000004 107.615 -167.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . 160.14 -170.36 36.21 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.421 -1.872 . . . . 71.219999999999999 108.421 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -110.56 -73.93 0.66 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.359 1.08 . . . . 75.239999999999995 109.619 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.79 -7.61 17.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 44.450000000000003 111.233 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.34 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.445 . . . . 72.010000000000005 111.271 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -141.78 130.96 23.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.909 -0.774 . . . . 61.530000000000001 108.909 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 49.8 p90 -130.02 8.2 5.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.085 -0.507 . . . . 72.310000000000002 110.675 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -79.18 -48.84 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.239 0.829 . . . . 71.319999999999993 113.239 -166.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.4 mp -77.47 -56.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.56 -0.456 . . . . 61.409999999999997 112.224 -167.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -130.3 163.71 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.79 -0.448 . . . . 72.340000000000003 109.79 -176.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.785 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -121.17 -67.13 0.26 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.059 -0.591 . . . . 20.010000000000002 112.019 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . . . -151.17 94.15 2.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.777 0.322 . . . . 73.439999999999998 110.401 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -157.59 86.04 2.68 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 72.129999999999995 109.926 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.732 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 51.3 Cg_endo -106.26 -164.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.81 3.006 . . . . 74.120000000000005 113.194 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 75.39 109.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.311 -0.859 . . . . 75.420000000000002 112.567 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.89 -102.63 2.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.352 -0.84 . . . . 63.310000000000002 113.649 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.59 -13.17 60.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.269 0.557 . . . . 74.209999999999994 110.643 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD2' ' HE2' ' A' ' 48' ' ' TYR . 45.7 mmtm -126.46 136.57 52.8 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.502 -0.772 . . . . 73.510000000000005 109.405 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.67 148.46 5.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.974 0.416 . . . . 61.039999999999999 110.59 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.795 ' HG3' HG12 ' A' ' 36' ' ' VAL . 12.5 pt20 -124.2 -34.17 2.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 72.129999999999995 111.643 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.795 HG12 ' HG3' ' A' ' 35' ' ' GLN . 5.5 p -165.76 125.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.35 . . . . 75.209999999999994 111.079 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.6 mt -113.68 -56.24 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.45 -0.341 . . . . 72.239999999999995 110.601 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.3 t -155.22 149.25 25.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.033 0.444 . . . . 54.229999999999997 110.311 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -104.95 146.35 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.603 -0.726 . . . . 73.209999999999994 110.399 -173.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.49 119.51 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.461 -0.336 . . . . 74.310000000000002 110.784 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t 65.99 24.86 11.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.672 -0.695 . . . . 75.439999999999998 111.756 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.29 -46.63 1.13 Allowed Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.664 -0.779 . . . . 73.299999999999997 112.676 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 47.9 m0 -90.08 161.4 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 73.209999999999994 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 22.8 t -111.22 134.24 52.96 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.239 -1.022 . . . . 55.130000000000003 108.239 171.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 32.4 ttmt -82.09 130.93 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.983 -0.553 . . . . 74.239999999999995 111.889 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.747 ' HA ' HD12 ' A' ' 37' ' ' ILE . 23.2 pt -134.99 171.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.494 -0.776 . . . . 73.319999999999993 109.121 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.91 117.79 16.22 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.662 -0.415 . . . . 74.319999999999993 110.507 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 7.0 m-85 -122.48 114.18 20.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.003 0.43 . . . . 75.5 111.067 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.29 34.37 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.871 -1.059 . . . . 74.349999999999994 110.955 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.4 -17.76 46.24 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.833 -0.621 . . . . 51.219999999999999 113.693 173.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 4.1 pt20 -93.53 153.53 18.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.303 0.552 . . . . 71.420000000000002 110.197 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -75.0 118.06 17.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.172 -0.467 . . . . 33.439999999999998 110.856 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.92 168.57 13.07 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.748 -0.739 . . . . 73.430000000000007 111.883 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 84.7 m-85 -144.0 166.47 24.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.56 -0.533 . . . . 71.129999999999995 109.56 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 2.7 pp -123.79 143.42 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 108.702 -0.851 . . . . 72.239999999999995 108.702 166.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' A' ' 43' ' ' TRP . . . -96.55 100.31 2.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.15 -1.024 . . . . 71.129999999999995 111.251 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -50.52 -20.84 1.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.283 0.846 . . . . 63.450000000000003 113.283 -172.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 58' ' ' ARG . 13.9 mtm180 -53.11 -37.19 61.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.766 0.317 . . . . 74.319999999999993 110.593 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.78 147.95 45.92 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.072 0.463 . . . . 72.439999999999998 109.846 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.0 mt -152.59 135.79 15.75 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.479 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 3.4 p -129.08 135.87 49.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.759 -0.655 . . . . 73.519999999999996 109.686 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 109.892 -0.41 . . . . 75.239999999999995 109.892 -178.714 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 70.329999999999998 111.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 129.39 34.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 111.639 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.13 6.93 20.53 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.657 0.741 . . . . 65.340000000000003 110.175 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.61 -3.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.775 1.028 . . . . 74.530000000000001 113.775 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HA ' HG22 ' A' ' 25' ' ' ILE . 17.9 mtm180 -121.41 -46.04 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.039 0.381 . . . . 74.049999999999997 111.113 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB2' HG23 ' A' ' 24' ' ' ILE . 66.4 m 64.91 4.25 2.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.481 0.919 . . . . 65.150000000000006 113.481 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.84 -109.58 1.71 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.964 -0.636 . . . . 74.109999999999999 112.272 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -157.63 154.61 28.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.474 -0.565 . . . . 65.340000000000003 109.474 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.94 -135.83 2.02 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.622 -0.799 . . . . 71.430000000000007 112.308 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -72.68 -8.11 53.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.919 0.39 . . . . 75.420000000000002 111.515 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -136.11 138.93 42.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.943 -0.762 . . . . 62.109999999999999 108.943 172.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.2 -16.39 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.776 0.798 . . . . 74.400000000000006 110.086 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 23' ' ' ARG . 61.3 mtt85 -89.16 6.54 39.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.732 -1.122 . . . . 74.530000000000001 109.871 172.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 55' ' ' ILE . 10.4 tp -55.83 -9.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 114.903 -1.044 . . . . 73.140000000000001 113.679 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 15' ' ' ARG . 1.3 pp -59.74 135.1 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 63.109999999999999 112.123 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.25 148.8 5.31 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.585 -0.816 . . . . 40.520000000000003 113.904 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.698 ' HA ' HD22 ' A' ' 60' ' ' LEU . . . -146.98 -178.51 6.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.655 -0.498 . . . . 62.450000000000003 109.655 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 36' ' ' VAL . 41.2 mt -128.67 65.84 73.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 111.861 0.319 . . . . 71.540000000000006 111.861 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 27' ' ' ALA . 3.6 Cg_endo -86.0 -55.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.29 1.993 . . . . 75.430000000000007 111.044 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 179.37 131.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.281 -0.872 . . . . 74.230000000000004 109.486 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.14 168.73 11.35 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.192 -1.004 . . . . 74.510000000000005 113.225 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.38 15.0 11.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.139 0.495 . . . . 73.200000000000003 110.532 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -25.44 62.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.77 -0.65 . . . . 75.310000000000002 110.264 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.869 HG13 ' H ' ' A' ' 35' ' ' GLN . 2.4 p -135.85 -80.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.029 -0.532 . . . . 64.030000000000001 110.092 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.869 ' H ' HG13 ' A' ' 34' ' ' VAL . 26.5 tt0 65.89 152.93 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.711 0.767 . . . . 73.230000000000004 112.123 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 28' ' ' LEU . 71.2 t -91.12 137.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.668 -0.697 . . . . 51.140000000000001 110.462 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.78 -55.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.245 -0.65 . . . . 74.430000000000007 109.245 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.9 m -159.45 155.32 26.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.243 -0.89 . . . . 75.120000000000005 109.097 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 7.7 pt-20 -124.91 141.97 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.962 0.41 . . . . 24.449999999999999 111.01 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.27 159.52 7.29 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.791 -0.641 . . . . 72.230000000000004 109.859 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 27.51 16.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.013 0.745 . . . . 72.040000000000006 113.013 158.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.83 -50.6 0.83 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.518 -0.849 . . . . 53.240000000000002 113.271 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -123.0 162.33 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.466 0.65 . . . . 65.230000000000004 111.251 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 20.8 t -103.45 120.47 40.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.194 -0.912 . . . . 64.030000000000001 108.687 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HD3' ' CE2' ' A' ' 54' ' ' TYR . 31.2 ttpt -82.45 137.01 34.8 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.529 0.566 . . . . 70.239999999999995 112.529 -171.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.7 170.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.192 -0.913 . . . . 63.530000000000001 110.547 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 24.4 t-20 -127.8 113.89 16.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.336 -0.616 . . . . 53.240000000000002 109.336 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.687 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 34.1 t80 -125.87 112.85 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.478 -0.328 . . . . 73.209999999999994 110.554 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.98 37.31 18.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.702 0.763 . . . . 73.310000000000002 110.509 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -17.45 58.52 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.634 -0.712 . . . . 73.030000000000001 114.022 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 29.7 pt20 -98.9 155.71 17.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.416 0.608 . . . . 74.120000000000005 110.789 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.8 m -97.57 114.06 25.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.759 -0.655 . . . . 71.540000000000006 109.773 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.06 -176.69 15.93 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.82 -0.705 . . . . 72.129999999999995 112.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 73.3 m-85 -136.89 139.31 41.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.18 -0.674 . . . . 71.049999999999997 109.18 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -120.18 155.58 23.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.881 -0.414 . . . . 60.049999999999997 109.881 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.66 116.37 4.35 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.03 -1.081 . . . . 35.240000000000002 111.553 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -12.36 25.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.692 0.397 . . . . 64.299999999999997 111.869 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -69.57 -34.77 74.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.387 -0.369 . . . . 74.120000000000005 111.508 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.76 120.01 26.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.086 0.47 . . . . 75.519999999999996 111.918 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 27' ' ' ALA . 56.4 mt -155.66 152.1 28.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.209999999999994 108.907 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -92.92 120.3 33.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.211 -0.663 . . . . 63.420000000000002 109.211 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 116.357 -0.383 . . . . 74.310000000000002 110.56 -179.87 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 110.323 -0.251 . . . . 53.329999999999998 110.323 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HB2' ' HA3' ' A' ' 17' ' ' GLY . 27.1 tp 58.93 27.72 16.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.209 0.528 . . . . 72.129999999999995 110.71 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.444 HD21 HG23 ' A' ' 14' ' ' VAL . 5.8 t30 -58.41 -42.27 86.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.719 -0.673 . . . . 54.520000000000003 110.87 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.444 HG23 HD21 ' A' ' 13' ' ' ASN . 46.6 t -117.18 -65.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 107.697 -1.223 . . . . 72.140000000000001 107.697 170.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.678 ' HG2' HG22 ' A' ' 55' ' ' ILE . 4.3 mmp_? -138.57 -164.42 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.847 -1.069 . . . . 74.439999999999998 108.482 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 34.5 t 65.63 74.65 0.37 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.419 0.628 . . . . 64.209999999999994 110.699 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 12' ' ' LEU . . . -176.2 -173.71 42.09 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.49 -0.777 . . . . 72.129999999999995 111.2 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.13 84.14 1.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.391 0.615 . . . . 53.130000000000003 110.807 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.15 -86.8 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.345 -0.843 . . . . 43.450000000000003 111.311 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -123.52 -65.23 1.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.915 0.388 . . . . 73.200000000000003 110.661 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -130.86 133.06 45.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.602 -0.888 . . . . 71.409999999999997 108.602 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.7 p90 -108.91 8.4 26.44 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.124 0.416 . . . . 73.150000000000006 112.124 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 38.0 ttt180 -115.25 -2.44 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.787 -0.365 . . . . 74.349999999999994 111.633 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -58.41 -56.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.093 0.405 . . . . 75.329999999999998 112.093 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.7 mp -129.13 -78.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 63.32 110.23 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' A' ' 16' ' ' SER . . . 148.69 -171.23 29.06 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.217 -0.753 . . . . 72.230000000000004 111.217 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.28 94.41 4.33 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 65.140000000000001 110.543 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.5 pt? -120.52 85.37 37.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.375 0.607 . . . . 75.019999999999996 110.122 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.56 5.14 6.56 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.557 2.838 . . . . 64.519999999999996 113.029 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -81.36 59.52 4.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.719 . . . . 74.430000000000007 111.615 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.43 -33.88 5.04 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.808 -0.633 . . . . 72.129999999999995 113.432 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.47 -164.91 0.95 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.045 0.422 . . . . 74.540000000000006 110.35 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.758 ' HG3' ' H ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -175.55 -85.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.52 0.512 . . . . 75.209999999999994 110.373 175.121 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.758 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 36.9 t -142.12 -85.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.412 -0.588 . . . . 73.329999999999998 109.412 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.425 ' H ' ' HB ' ' A' ' 34' ' ' VAL . 21.3 mm-40 -157.89 -39.31 0.07 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 72.150000000000006 110.111 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.4 p 44.35 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.417 1.087 . . . . 70.340000000000003 112.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.57 -57.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 73.430000000000007 111.278 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 t -167.29 169.16 12.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 109.762 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.0 pt-20 -123.52 161.89 24.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.194 0.521 . . . . 75.540000000000006 111.418 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.21 115.3 4.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.25 -0.886 . . . . 65.030000000000001 109.528 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 t 68.67 26.3 6.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 43.450000000000003 111.419 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.28 -22.1 25.45 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.283 -0.961 . . . . 73.25 113.564 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -109.73 145.16 37.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.874 0.337 . . . . 73.230000000000004 110.942 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.6 m -109.59 132.11 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 71.109999999999999 109.742 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -84.45 132.5 34.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.849 0.356 . . . . 75.230000000000004 111.17 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -139.26 144.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.126 -0.488 . . . . 64.219999999999999 109.921 173.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.85 114.12 26.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.587 . . . . 71.120000000000005 109.414 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 60.5 t80 -110.79 107.71 17.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.574 -0.528 . . . . 74.209999999999994 109.574 -177.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.87 34.71 16.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.557 -0.747 . . . . 63.049999999999997 110.66 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 -17.89 58.24 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.67 -0.696 . . . . 52.240000000000002 113.995 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -95.99 154.96 16.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.026 0.913 . . . . 74.400000000000006 110.788 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -87.42 123.92 32.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.916 -0.584 . . . . 74.450000000000003 110.791 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.97 169.66 21.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.65 -0.58 . . . . 63.119999999999997 111.65 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 99.3 m-85 -136.39 143.11 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.897 0.348 . . . . 75.239999999999995 110.818 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -119.52 166.36 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 72.049999999999997 109.581 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 132.97 11.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.374 -0.917 . . . . 70.519999999999996 112.458 -176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 m -67.61 -17.64 64.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.788 0.328 . . . . 65.310000000000002 111.151 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 58' ' ' ARG . 5.3 mmt85 -53.98 -50.23 67.03 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.238 -0.437 . . . . 65.120000000000005 111.196 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -121.38 118.86 30.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.975 -0.379 . . . . 75.219999999999999 109.975 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 55' ' ' ILE . 26.3 mt -155.66 148.29 24.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.843 0.354 . . . . 45.5 110.663 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 p -108.25 121.74 45.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.215 -0.448 . . . . 52.039999999999999 110.675 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 109.012 -0.736 . . . . 74.319999999999993 109.012 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.08 0.4 . . . . 63.229999999999997 112.08 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.539 HD22 HD21 ' A' ' 28' ' ' LEU . 87.2 mt 65.13 1.23 1.47 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.264 0.839 . . . . 63.219999999999999 113.264 173.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -118.94 9.81 12.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' H ' ' A' ' 17' ' ' GLY . 46.8 t -65.92 -59.96 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.937 0.347 . . . . 62.409999999999997 111.937 -170.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.504 ' HA ' ' N ' ' A' ' 26' ' ' GLY . 20.0 ttm105 65.84 74.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.711 -0.677 . . . . 73.530000000000001 111.11 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 24' ' ' ILE . 37.8 p 49.38 31.65 4.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.417 -0.811 . . . . 71.439999999999998 113.176 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.636 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -80.51 -7.03 88.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.742 . . . . 70.219999999999999 112.104 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.76 107.49 3.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 61.32 109.78 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.72 -173.27 43.91 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.538 -0.625 . . . . 73.319999999999993 111.538 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -83.56 -24.17 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 110.906 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -124.99 133.32 53.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.69 -0.856 . . . . 53.530000000000001 108.69 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.96 8.03 43.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 110.973 -173.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -115.96 -0.79 12.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 61.409999999999997 111.18 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.457 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 2.3 pp -88.54 0.12 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.682 0.623 . . . . 72.200000000000003 112.682 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.6 mt 68.54 172.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.109 0.48 . . . . 72.209999999999994 111.345 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 25' ' ' ILE . . . 177.46 49.36 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.037 -1.225 . . . . 72.540000000000006 110.037 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.53 9.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.883 0.373 . . . . 75.239999999999995 111.443 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD21 HD22 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.58 69.12 79.08 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.586 -0.894 . . . . 53.229999999999997 108.586 172.078 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.66 67.39 6.42 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.342 2.695 . . . . 64.329999999999998 112.503 -168.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 69.18 119.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.937 -1.028 . . . . 60.32 112.002 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.1 -6.95 37.32 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.091 -0.804 . . . . 64.150000000000006 111.091 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 28' ' ' LEU . 7.6 tp60 -147.77 134.72 20.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.756 . . . . 72.310000000000002 108.96 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -128.03 92.77 3.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 71.409999999999997 111.118 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 28' ' ' LEU . 27.5 m -100.72 176.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.196 -0.668 . . . . 75.010000000000005 109.196 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -137.76 146.26 43.41 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.681 -0.408 . . . . 74.030000000000001 110.547 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.2 113.04 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.341 -0.39 . . . . 74.230000000000004 110.138 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 37' ' ' ILE . 4.0 mp -71.42 -56.74 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 64.510000000000005 110.481 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -170.36 165.76 8.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.585 -0.734 . . . . 61.310000000000002 110.693 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -118.02 169.32 9.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.111 -0.949 . . . . 63.140000000000001 110.094 178.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -173.48 123.38 0.37 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.106 0.254 . . . . 71.239999999999995 110.789 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t 70.65 32.44 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 54.219999999999999 110.874 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.37 -36.29 4.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.749 -0.739 . . . . 45.030000000000001 112.617 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -100.32 155.7 17.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.913 0.387 . . . . 73.409999999999997 110.779 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 25.6 t -110.11 139.94 44.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.939 -0.573 . . . . 72.019999999999996 109.904 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.693 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 14.6 ttmt -89.67 129.21 36.13 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.096 -0.502 . . . . 73.239999999999995 111.207 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.85 143.2 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.598 -0.728 . . . . 71.049999999999997 110.598 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -109.73 114.59 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.623 -0.88 . . . . 75.209999999999994 108.623 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 1.8 t80 -122.84 110.22 15.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.304 -0.407 . . . . 73.439999999999998 110.457 -174.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.71 34.28 22.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.561 0.696 . . . . 73.329999999999998 110.676 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.87 73.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 72.209999999999994 113.671 174.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.9 pt20 -118.8 156.08 30.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.437 0.619 . . . . 64.239999999999995 110.257 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m -98.6 128.11 44.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 72.120000000000005 111.302 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 24' ' ' ILE . . . -116.12 162.47 12.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.091 -0.576 . . . . 20.350000000000001 111.803 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 91.1 m-85 -138.3 139.09 38.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.848 -0.427 . . . . 72.420000000000002 109.848 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.587 HD13 HD21 ' A' ' 60' ' ' LEU . 2.4 pp -137.75 154.95 29.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 74.140000000000001 110.907 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 110.45 3.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.362 -0.695 . . . . 60.530000000000001 111.362 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -4.39 53.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.575 0.226 . . . . 70.450000000000003 111.479 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -61.72 -53.57 54.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.17 0.509 . . . . 64.140000000000001 109.989 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.51 118.97 21.9 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.038 -0.528 . . . . 74.430000000000007 110.291 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 55' ' ' ILE . 95.8 mt -114.36 127.49 55.87 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.578 -0.737 . . . . 71.400000000000006 109.052 176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 14' ' ' VAL . 25.4 t -148.61 159.82 43.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.034 -0.53 . . . . 61.32 110.091 -171.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.2 tttt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.763 -0.199 . . . . 72.209999999999994 110.819 177.7 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.613 0.244 . . . . 65.230000000000004 111.656 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 5.3 mp -76.35 92.9 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 74.439999999999998 110.792 -174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 61' ' ' SER . 29.6 m-80 -117.56 -58.31 2.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 73.329999999999998 111.931 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 48' ' ' TYR . 2.6 t -121.14 37.31 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.441 0.639 . . . . 72.430000000000007 110.314 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 20.0 mmm180 -75.41 32.73 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 75.430000000000007 111.874 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 33.0 t 60.69 37.42 19.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.675 0.75 . . . . 60.32 109.822 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 90.34 -57.89 3.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.179 -0.919 . . . . 71.409999999999997 111.372 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.64 168.76 22.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.47 -0.937 . . . . 74.340000000000003 108.47 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.44 36.91 0.82 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.371 -0.442 . . . . 75.219999999999999 113.437 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.1 m -90.34 -34.08 15.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.338 -0.615 . . . . 74.430000000000007 109.338 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -142.74 52.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.541 -0.911 . . . . 72.219999999999999 108.541 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -62.5 -6.36 3.33 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.477 -1.238 . . . . 73.099999999999994 113.422 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -72.19 -11.99 60.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.198 0.444 . . . . 74.439999999999998 112.198 -174.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.887 HG22 HG13 ' A' ' 25' ' ' ILE . 47.5 mm -70.62 -55.79 13.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.301 0.482 . . . . 72.150000000000006 112.301 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.887 HG13 HG22 ' A' ' 24' ' ' ILE . 18.7 mt -135.98 -83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 121.035 -0.266 . . . . 75.540000000000006 111.239 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 15' ' ' ARG . . . 124.96 -169.24 16.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.578 -0.82 . . . . 30.449999999999999 112.465 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.51 92.67 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.456 -0.438 . . . . 31.039999999999999 110.693 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.76 87.8 2.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.649 -0.705 . . . . 73.219999999999999 109.743 176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.67 72.81 3.66 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.991 2.46 . . . . 73.0 112.459 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -168.5 98.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.563 . . . . 74.349999999999994 110.453 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.37 167.44 12.37 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 111.103 -0.799 . . . . 60.409999999999997 111.103 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.59 80.77 5.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.269 0.557 . . . . 74.519999999999996 110.953 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 3.7 mptp? 58.75 62.44 1.92 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.017 -0.992 . . . . 63.210000000000001 111.264 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.09 125.62 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.336 -0.847 . . . . 71.430000000000007 110.56 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' HG21 ' A' ' 46' ' ' ILE . 24.2 mp0 -133.31 -68.46 0.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 71.310000000000002 109.989 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -141.02 126.62 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 109.899 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.8 mt -114.44 -56.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 64.109999999999999 111.494 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.0 t -141.06 155.43 46.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 74.310000000000002 110.383 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 14.3 mp0 -114.8 135.94 53.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 110.526 -175.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -107.59 174.86 5.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.129 -0.693 . . . . 70.129999999999995 109.129 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.0 m -71.12 75.16 0.68 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.745 -0.661 . . . . 71.530000000000001 110.563 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.79 -61.25 0.48 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.728 -0.669 . . . . 75.409999999999997 111.621 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -126.69 162.67 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.092 0.472 . . . . 63.399999999999999 110.276 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 37.9 t -96.77 129.23 44.23 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.968 -0.753 . . . . 70.25 108.968 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -90.73 130.69 36.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.558 -0.292 . . . . 65.319999999999993 111.115 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.98 148.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 64.299999999999997 110.175 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.01 112.55 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.851 -0.796 . . . . 74.519999999999996 108.851 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 14' ' ' VAL . 11.9 t80 -109.8 98.99 8.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.088 -0.505 . . . . 74.420000000000002 110.465 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.41 40.52 24.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.36 0.6 . . . . 71.329999999999998 110.861 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 -17.57 59.06 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.858 -0.61 . . . . 60.43 114.405 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.84 154.88 24.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.077 0.939 . . . . 73.430000000000007 110.994 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.4 m -76.52 119.03 19.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 74.450000000000003 110.793 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.727 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -122.31 175.45 16.39 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.032 -0.604 . . . . 62.340000000000003 111.914 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' SER . 81.3 m-85 -135.68 151.44 50.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.107 0.48 . . . . 74.439999999999998 111.198 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.672 HG12 HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.59 146.41 27.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.458 -0.792 . . . . 71.099999999999994 109.988 175.059 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -85.15 159.84 34.37 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.428 -0.892 . . . . 71.120000000000005 112.054 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -42.2 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.116 0.484 . . . . 73.219999999999999 110.227 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -76.86 -51.84 10.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.651 -0.704 . . . . 73.099999999999994 110.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 12' ' ' LEU . 63.1 m-85 -107.84 119.26 38.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.745 . . . . 75.209999999999994 108.99 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 61' ' ' SER . 4.8 tt -154.11 157.52 39.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.797 -1.092 . . . . 64.519999999999996 108.154 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 14.0 p -81.83 117.54 22.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.372 0.606 . . . . 62.119999999999997 110.667 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 74.329999999999998 109.761 176.811 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.861 0.362 . . . . 63.210000000000001 110.598 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.0 pt? -113.98 118.87 35.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.38 0.61 . . . . 73.329999999999998 110.944 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.2 t-20 -83.82 -15.89 46.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.784 -0.643 . . . . 64.129999999999995 110.326 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 12.3 p -68.91 -12.68 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.376 -0.829 . . . . 71.109999999999999 113.144 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -101.79 67.25 1.09 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.801 -0.76 . . . . 74.049999999999997 110.193 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p 47.49 47.31 17.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.997 -1.001 . . . . 70.109999999999999 111.53 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.31 -91.35 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.018 -0.61 . . . . 43.439999999999998 112.833 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.24 111.7 1.71 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.108 0.48 . . . . 73.409999999999997 110.847 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.45 26.11 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.564 -1.015 . . . . 52.100000000000001 110.564 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 54' ' ' TYR . 5.2 m -70.11 -44.93 67.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.243 0.522 . . . . 72.299999999999997 109.873 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.77 90.18 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.13 -0.693 . . . . 70.549999999999997 109.13 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -108.96 10.33 26.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.481 -0.781 . . . . 75.519999999999996 110.99 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -44.56 -59.05 2.64 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.629 0.581 . . . . 72.420000000000002 112.516 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -121.89 -20.86 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 72.409999999999997 110.972 -179.14 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.0 pp -138.16 -164.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.51 -0.314 . . . . 72.530000000000001 111.708 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA2' HG21 ' A' ' 55' ' ' ILE . . . 177.35 -79.28 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 72.5 113.041 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.623 ' H ' ' N ' ' A' ' 14' ' ' VAL . . . -74.55 172.08 12.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 72.219999999999999 111.719 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.9 89.09 8.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.695 -0.684 . . . . 71.299999999999997 109.515 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 43.3 Cg_endo -69.53 -55.76 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.495 2.13 . . . . 52.340000000000003 112.667 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -118.88 -39.44 2.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.32 -0.622 . . . . 63.420000000000002 109.32 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.77 2.63 58.44 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.567 -0.742 . . . . 71.329999999999998 112.037 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -78.27 66.95 3.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.954 0.407 . . . . 61.32 110.793 -175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 179.2 -49.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.522 -0.763 . . . . 74.109999999999999 109.601 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.729 ' HB ' ' HD1' ' A' ' 48' ' ' TYR . 10.9 p -97.84 -39.51 8.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.625 -0.716 . . . . 73.129999999999995 110.733 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 64.45 174.32 0.19 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.174 0.59 . . . . 62.329999999999998 111.74 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -86.7 121.58 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.332 0.587 . . . . 71.219999999999999 111.223 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.7 mt -107.47 -53.23 6.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 72.349999999999994 110.701 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -164.56 149.85 10.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 72.439999999999998 110.894 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.93 143.65 46.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.54 -0.755 . . . . 74.150000000000006 110.626 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -125.64 173.46 8.97 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.379 0.609 . . . . 75.340000000000003 109.52 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.2 m -84.43 80.36 9.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.024 -0.989 . . . . 55.140000000000001 110.059 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.64 -53.62 0.68 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 63.32 112.112 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -120.85 152.87 37.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 75.239999999999995 110.662 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.06 119.97 40.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.768 -0.827 . . . . 61.450000000000003 108.768 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.9 ttmt -82.89 121.04 26.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.588 -0.733 . . . . 60.200000000000003 111.377 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.627 ' HB ' HG21 ' A' ' 34' ' ' VAL . 32.7 pt -142.3 153.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.598 -0.728 . . . . 75.219999999999999 111.54 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -116.95 114.06 23.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.501 -0.926 . . . . 73.340000000000003 108.501 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.729 ' HD1' ' HB ' ' A' ' 34' ' ' VAL . 28.8 t80 -119.34 114.28 22.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.47 -0.332 . . . . 63.340000000000003 110.823 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 t30 58.4 34.53 24.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.476 0.655 . . . . 63.009999999999998 110.994 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.24 69.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.603 -0.808 . . . . 71.219999999999999 113.69 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.1 pt20 -103.94 148.06 26.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.618 0.709 . . . . 73.200000000000003 110.984 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -85.7 117.16 24.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.769 . . . . 62.020000000000003 109.777 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.39 150.03 18.02 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.185 -1.007 . . . . 75.329999999999998 112.496 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' THR . 49.5 m-85 -127.67 140.07 52.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.079 -0.712 . . . . 72.140000000000001 109.079 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 ' HA2' ' A' ' 26' ' ' GLY . 2.7 pp -135.61 160.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.94 -0.393 . . . . 55.420000000000002 109.94 177.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.12 124.35 6.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.299 -0.953 . . . . 62.25 112.145 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 m -61.43 -18.75 60.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.505 0.669 . . . . 62.100000000000001 110.202 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -69.3 -9.12 51.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.392 -0.822 . . . . 72.340000000000003 111.447 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 13' ' ' ASN . 7.4 m-85 -131.58 115.06 15.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.803 0.335 . . . . 71.430000000000007 110.122 171.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -157.74 174.15 15.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.803 -0.635 . . . . 72.0 109.742 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 15.4 t -108.28 118.93 38.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.52 -0.918 . . . . 65.409999999999997 108.52 172.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.47 -0.567 . . . . 52.439999999999998 109.47 -177.223 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.657 ' HG2' HG13 ' A' ' 2' ' ' ILE . 52.1 ttm . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.798 -0.445 . . . . 75.129999999999995 109.798 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.657 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.5 mt 67.6 16.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.078 0.942 . . . . 71.510000000000005 109.606 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 5.91 58.02 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.476 -0.784 . . . . 55.149999999999999 111.19 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.73 99.46 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.115 0.483 . . . . 73.239999999999995 109.937 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -131.09 30.1 4.6 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 61.0 108.691 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -68.72 149.92 48.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 74.450000000000003 110.455 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.71 -46.79 95.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.244 -0.65 . . . . 73.519999999999996 109.244 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.499 ' ND2' ' HG3' ' A' ' 62' ' ' LYS . 12.3 t-20 67.47 -74.64 0.07 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.152 -0.931 . . . . 62.329999999999998 110.977 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.94 -153.88 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.209 0.528 . . . . 73.150000000000006 111.772 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.6 m -143.19 98.2 3.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.069 -0.514 . . . . 73.010000000000005 109.964 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.06 -155.44 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.53 . . . . 71.109999999999999 109.848 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 87.2 mt -71.05 90.67 0.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.571 -0.529 . . . . 71.319999999999993 109.571 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 72.5 m-20 -97.96 -29.94 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 75.129999999999995 112.131 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 55' ' ' ILE . 63.6 t -64.86 -51.39 67.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.718 -0.475 . . . . 72.319999999999993 109.718 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.898 ' HG3' HD12 ' A' ' 25' ' ' ILE . 6.5 mtp180 -155.31 -177.01 6.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.151 -0.931 . . . . 70.030000000000001 108.528 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 22.9 t 75.16 3.96 4.14 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.977 0.798 . . . . 71.209999999999994 110.246 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.57 16.91 31.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.002 -0.618 . . . . 63.350000000000001 111.968 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -99.69 -46.71 5.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.002 -0.74 . . . . 75.409999999999997 109.002 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.52 4.87 49.29 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.72 -1.127 . . . . 72.319999999999993 110.57 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -101.34 -51.39 3.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.275 -0.462 . . . . 73.439999999999998 110.717 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.5 88.6 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.379 -0.6 . . . . 74.209999999999994 109.379 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 19.6 p90 -95.82 4.7 52.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.879 0.696 . . . . 64.439999999999998 112.879 -169.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -106.37 -0.06 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.252 -0.579 . . . . 71.310000000000002 111.513 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.794 HG22 HG13 ' A' ' 25' ' ' ILE . 54.2 mt -77.41 -55.82 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.338 -0.392 . . . . 44.439999999999998 111.854 -174.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.898 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.0 mt -140.54 178.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.554 -0.535 . . . . 72.510000000000005 109.554 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -125.83 -118.1 2.22 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.954 -0.641 . . . . 71.049999999999997 112.534 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.912 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -139.81 105.68 5.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.022 0.439 . . . . 62.140000000000001 111.933 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -152.32 57.68 2.26 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.842 -0.617 . . . . 64.450000000000003 111.054 173.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 28' ' ' LEU . 19.7 Cg_endo -95.66 166.29 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.19 2.594 . . . . 64.219999999999999 112.172 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 63.44 104.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.4 0.619 . . . . 73.120000000000005 111.373 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.94 -32.58 7.36 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.394 -0.682 . . . . 72.430000000000007 111.394 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.33 -172.71 2.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 64.519999999999996 110.021 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 38.7 ttpt -85.98 157.66 20.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.196 -0.456 . . . . 72.450000000000003 110.299 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 94.2 t 76.23 126.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.695 0.759 . . . . 72.439999999999998 112.056 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.83 175.45 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 64.349999999999994 109.839 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 46' ' ' ILE . 17.3 m -76.06 125.67 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.961 -0.385 . . . . 55.210000000000001 109.961 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -81.63 -55.97 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.46 -0.337 . . . . 51.210000000000001 110.515 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -171.07 150.82 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 31.149999999999999 110.9 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -80.02 131.43 35.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.577 -0.738 . . . . 73.049999999999997 110.193 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -134.96 114.49 12.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.615 0.245 . . . . 74.340000000000003 110.956 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t 71.84 5.52 5.38 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.453 -0.794 . . . . 73.439999999999998 111.779 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.4 -48.76 0.95 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 64.219999999999999 111.854 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -84.67 160.53 20.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 73.519999999999996 110.315 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 68.5 m -96.28 140.25 31.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 110.766 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -82.86 118.69 23.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.682 -0.69 . . . . 64.030000000000001 111.07 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -133.81 144.55 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 64.219999999999999 110.232 173.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -122.03 113.55 19.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.975 -1.12 . . . . 64.430000000000007 107.975 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 69.3 t80 -105.56 86.1 2.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 110.908 -170.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 62.32 46.33 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.229 0.538 . . . . 74.409999999999997 110.826 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.46 -17.57 58.75 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 73.319999999999993 113.512 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.3 pt20 -103.48 128.1 50.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.38 0.609 . . . . 74.099999999999994 110.225 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 151.82 21.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 40.32 111.067 -172.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.96 173.7 38.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.403 -0.903 . . . . 54.009999999999998 113.353 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 72.1 m-85 -132.97 144.74 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 74.209999999999994 109.269 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 15' ' ' ARG . 2.8 pp -136.03 161.69 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.618 0.247 . . . . 74.439999999999998 110.946 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.36 123.31 6.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.601 -0.809 . . . . 44.240000000000002 111.814 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -64.76 -7.07 9.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.009 0.433 . . . . 71.420000000000002 111.7 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -65.76 -37.57 86.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.454 -0.339 . . . . 75.209999999999994 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -124.32 120.64 32.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.523 0.678 . . . . 75.400000000000006 111.744 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 66.6 mt -155.89 175.64 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.112 -1.44 . . . . 73.329999999999998 107.112 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 29' ' ' PRO . 6.1 p -111.47 118.14 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.607 -0.837 . . . . 55.229999999999997 111.456 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -166.88 -22.12 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.029 -0.987 . . . . 71.349999999999994 109.206 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 39.5 tp -83.81 34.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.503 -0.771 . . . . 65.030000000000001 109.565 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 66' ' ' HIS . 6.7 pt-20 -71.31 177.92 3.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.746 -0.661 . . . . 71.030000000000001 109.8 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER 69.93 23.77 5.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.282 0.563 . . . . 75.530000000000001 109.734 -168.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 26.7 p80 -91.15 134.42 34.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.345 -0.843 . . . . 64.340000000000003 110.175 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -86.2 146.13 26.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 75.049999999999997 110.962 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -95.25 36.95 1.19 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.803 -0.635 . . . . 75.430000000000007 109.545 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 66.53 87.87 0.12 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.854 -0.795 . . . . 71.109999999999999 108.854 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 C--O 1.25 1.087 0 CA-C-N 114.875 -1.057 . . . . 72.319999999999993 110.494 -175.054 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HB2' ' OD1' ' A' ' 4' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.781 -0.451 . . . . 75.519999999999996 109.781 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.622 HG13 ' H ' ' A' ' 3' ' ' GLY . 19.3 pt -98.8 -56.28 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.97 0.414 . . . . 73.430000000000007 110.373 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.622 ' H ' HG13 ' A' ' 2' ' ' ILE . . . -161.6 24.61 0.24 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.739 -0.944 . . . . 33.340000000000003 110.739 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 2.3 m-20 -60.25 109.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.534 -0.833 . . . . 64.340000000000003 110.492 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -100.83 95.2 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.022 -0.536 . . . . 71.099999999999994 111.027 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -120.24 -58.2 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.692 -0.685 . . . . 70.209999999999994 109.407 174.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt 56.72 82.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.655 -1.157 . . . . 61.32 110.465 -173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 67.05 -179.45 0.21 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.187 -0.915 . . . . 73.510000000000005 110.8 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.88 33.19 10.22 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.133 0.492 . . . . 44.530000000000001 111.096 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 14.2 t -154.75 -176.57 5.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.208 -0.664 . . . . 63.299999999999997 109.208 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.38 97.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.054 0.454 . . . . 70.439999999999998 110.389 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.886 HD23 ' H ' ' A' ' 12' ' ' LEU . 0.8 OUTLIER -79.95 69.6 6.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.82 0.819 . . . . 73.010000000000005 109.499 174.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.7 t30 -117.61 -44.73 2.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.787 -1.097 . . . . 71.510000000000005 110.578 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.413 HG12 ' NE ' ' A' ' 15' ' ' ARG . 18.9 t -124.68 -67.11 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.32 -0.4 . . . . 71.109999999999999 111.04 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.581 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -130.59 142.47 50.46 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.553 -0.294 . . . . 74.120000000000005 110.894 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 53.9 p 45.92 74.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 124.087 0.867 . . . . 65.420000000000002 112.654 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . -127.49 -14.69 2.58 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.421 -0.895 . . . . 43.530000000000001 111.992 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -163.5 115.62 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.076 -0.713 . . . . 60.130000000000003 109.076 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.51 -152.95 24.96 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.5 -0.857 . . . . 73.450000000000003 112.402 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -68.91 -31.92 71.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 75.030000000000001 111.571 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -133.04 123.57 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.337 -0.616 . . . . 73.150000000000006 109.337 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 14.6 p90 -130.12 8.59 5.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.731 0.641 . . . . 75.340000000000003 112.731 -171.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -116.79 -11.16 10.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.329 0.862 . . . . 72.510000000000005 113.329 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 25' ' ' ILE . 5.0 pt -67.15 -56.45 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 114.365 1.246 . . . . 74.030000000000001 114.365 -167.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 15' ' ' ARG . 3.3 mp -111.73 -63.58 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.428 1.013 . . . . 54.229999999999997 111.664 -176.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.8 -151.61 16.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.212 -0.994 . . . . 52.450000000000003 112.944 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.3 97.71 6.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 55.140000000000001 111.28 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.2 tp -160.75 87.68 1.75 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.95 -0.568 . . . . 71.530000000000001 110.086 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -82.56 81.67 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.874 2.383 . . . . 63.420000000000002 111.549 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -104.3 -48.36 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 74.129999999999995 110.39 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.12 104.66 0.39 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 72.310000000000002 112.031 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.91 98.65 11.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.46 . . . . 62.009999999999998 110.246 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -149.43 42.7 0.92 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.964 -0.754 . . . . 42.43 108.964 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG11 ' CE1' ' A' ' 48' ' ' TYR . 6.2 p -123.14 -46.78 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.743 -0.662 . . . . 75.420000000000002 111.677 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.482 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -83.54 76.71 9.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.497 0.665 . . . . 45.140000000000001 110.629 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.66 3.32 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.771 -1.104 . . . . 64.409999999999997 109.15 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -77.06 -57.76 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.81 -0.632 . . . . 72.019999999999996 110.631 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 p -178.62 149.98 0.51 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.475 0.655 . . . . 42.229999999999997 111.661 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.67 127.23 56.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.987 -1.006 . . . . 71.530000000000001 108.55 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.94 171.43 7.52 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.541 -0.464 . . . . 75.25 110.776 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.3 t -64.57 -22.27 66.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 34.340000000000003 110.826 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.87 -73.78 0.99 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.971 -0.633 . . . . 41.439999999999998 111.972 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -117.23 161.91 18.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.151 0.501 . . . . 73.019999999999996 110.877 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 57' ' ' THR . 35.4 t -87.97 126.72 35.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.012 -0.736 . . . . 64.239999999999995 109.012 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.9 ttmt -83.97 123.05 29.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.133 0.492 . . . . 64.209999999999994 111.326 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 35' ' ' GLN . 20.0 pt -139.91 156.8 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 61.200000000000003 110.648 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -126.3 113.75 17.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 73.299999999999997 109.074 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CE1' ' HD3' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -101.26 84.11 2.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.619 -0.432 . . . . 74.319999999999993 110.832 -178.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.29 56.15 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 74.129999999999995 112.098 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.74 56.57 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.09 -0.576 . . . . 42.219999999999999 114.16 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.22 128.72 54.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.653 0.726 . . . . 62.210000000000001 110.501 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -73.18 133.55 44.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.169 -0.923 . . . . 74.439999999999998 110.577 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.8 159.02 23.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.812 -0.708 . . . . 52.409999999999997 111.671 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -138.48 139.8 38.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.61 -0.515 . . . . 74.530000000000001 109.61 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 60' ' ' LEU . 2.6 pp -137.52 149.12 25.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.517 -0.311 . . . . 71.230000000000004 110.453 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 123.1 8.21 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.638 -0.791 . . . . 74.200000000000003 111.943 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -62.3 -18.15 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 73.530000000000001 112.058 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.51 -32.98 74.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.026 -0.533 . . . . 75.239999999999995 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.87 114.37 26.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.615 0.245 . . . . 73.219999999999999 110.354 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 55' ' ' ILE . 32.3 mt -159.22 151.51 21.22 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.884 -0.598 . . . . 73.409999999999997 111.206 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -97.25 118.82 34.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.602 -1.259 . . . . 74.349999999999994 107.602 164.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -98.52 163.3 12.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.797 0.332 . . . . 65.019999999999996 111.108 -173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.9 tp -88.62 17.2 5.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 75.319999999999993 110.462 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.19 66.78 9.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.527 0.679 . . . . 75.430000000000007 110.656 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -128.39 70.44 1.37 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.232 -1.025 . . . . 55.439999999999998 108.232 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.05 -20.56 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.516 -1.22 . . . . 74.450000000000003 109.41 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.86 83.34 0.15 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.028 -0.987 . . . . 71.430000000000007 110.28 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -60.0 124.23 19.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 63.530000000000001 110.301 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -76.92 118.11 19.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.092 -0.504 . . . . 73.120000000000005 109.917 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.441 -0.79 . . . . 65.430000000000007 109.679 -177.243 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' HG2' HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.189 -0.3 . . . . 41.340000000000003 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.577 HG12 ' HG2' ' A' ' 1' ' ' MET . 35.5 mm 69.07 52.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 122.374 1.083 . . . . 64.150000000000006 109.376 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.74 37.82 0.32 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 108.82 -1.712 . . . . 61.409999999999997 108.82 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.33 50.26 0.81 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.095 -1.053 . . . . 73.209999999999994 111.182 -167.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -74.42 109.24 7.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.511 0.672 . . . . 73.0 109.496 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 33.5 m-85 -106.44 93.36 4.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.209 0.528 . . . . 75.319999999999993 111.319 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 11.6 tt -75.02 -19.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.894 0.854 . . . . 73.329999999999998 109.186 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -89.93 24.26 2.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.781 -1.1 . . . . 71.349999999999994 110.477 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . . . -107.6 -162.04 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.744 -0.662 . . . . 71.420000000000002 110.06 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -109.76 27.19 9.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.295 . . . . 75.340000000000003 111.011 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -67.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.999 0.37 . . . . 60.119999999999997 111.999 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 6.4 mp -80.69 44.94 0.76 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.75 0.31 . . . . 71.040000000000006 111.459 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 22.4 m120 -74.98 -31.01 61.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 64.030000000000001 111.569 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.488 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -95.11 30.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 74.400000000000006 111.603 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.841 HH11 ' HA2' ' A' ' 26' ' ' GLY . 17.8 tpt180 -80.48 47.88 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.709 0.29 . . . . 74.099999999999994 111.463 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 t 64.51 4.87 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.494 0.717 . . . . 62.009999999999998 112.616 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.32 80.73 0.7 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.393 -0.908 . . . . 63.409999999999997 111.484 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 19' ' ' GLY . 35.6 tt0 70.93 175.9 0.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.946 0.498 . . . . 62.219999999999999 109.74 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -79.01 59.1 4.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.818 -0.706 . . . . 63.439999999999998 112.879 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -93.79 -33.33 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.104 0.478 . . . . 65.340000000000003 110.148 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' A' ' 24' ' ' ILE . 22.2 t-20 -153.3 145.2 23.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.257 -1.016 . . . . 75.129999999999995 108.257 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 7.11 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.959 -0.697 . . . . 74.439999999999998 111.755 -173.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -116.68 -32.78 5.06 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.832 -0.747 . . . . 74.430000000000007 112.738 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.501 HG22 HG13 ' A' ' 25' ' ' ILE . 70.4 mt -61.4 -55.96 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 72.540000000000006 111.19 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.596 HG23 ' CZ ' ' A' ' 48' ' ' TYR . 12.9 mt -129.7 158.75 42.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.791 -0.818 . . . . 74.439999999999998 108.791 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.841 ' HA2' HH11 ' A' ' 15' ' ' ARG . . . -131.42 -105.02 1.01 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.968 -1.111 . . . . 43.439999999999998 113.924 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -147.22 93.58 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.617 -0.512 . . . . 63.130000000000003 109.617 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 28' ' ' LEU . 1.3 tm? -154.09 80.54 4.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.488 -0.56 . . . . 63.520000000000003 109.488 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 10.3 Cg_exo -75.23 89.09 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.107 2.538 . . . . 73.099999999999994 112.115 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.81 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tt0 -117.51 -49.33 2.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.675 -0.693 . . . . 72.310000000000002 109.391 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.85 17.08 79.21 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.781 -0.645 . . . . 54.409999999999997 114.291 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.81 ' HG3' ' HG2' ' A' ' 30' ' ' GLN . 31.5 mt-30 -80.94 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.618 0.709 . . . . 71.129999999999995 110.152 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 4.3 mptp? -101.14 0.1 37.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.381 0.61 . . . . 54.329999999999998 109.935 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 41.3 t -93.26 92.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 72.140000000000001 109.093 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -112.69 141.22 46.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.853 -0.612 . . . . 74.519999999999996 110.965 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 46' ' ' ILE . 16.9 m -84.53 126.24 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.801 -0.636 . . . . 72.329999999999998 109.824 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.12 -49.63 12.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.125 0.488 . . . . 65.340000000000003 110.181 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -163.52 168.39 20.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.533 -0.758 . . . . 71.409999999999997 108.97 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 pp20? -139.91 152.36 46.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.831 0.348 . . . . 74.530000000000001 110.815 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -156.15 129.33 8.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 75.239999999999995 109.649 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.7 t 71.8 -0.55 3.15 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.09 -0.505 . . . . 65.129999999999995 112.004 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.98 -21.62 10.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.809 -0.71 . . . . 74.439999999999998 111.838 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -95.74 150.5 20.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.666 -0.494 . . . . 74.109999999999999 109.666 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.4 t -117.34 140.17 49.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.157 0.503 . . . . 60.420000000000002 110.99 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.98 108.74 16.51 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.228 -0.896 . . . . 74.019999999999996 108.77 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.64 HD12 HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -130.06 163.21 36.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.028 0.442 . . . . 72.230000000000004 111.351 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 9.1 t30 -101.57 113.13 25.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.375 -0.829 . . . . 71.219999999999999 108.859 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.596 ' CZ ' HG23 ' A' ' 25' ' ' ILE . 90.0 t80 -105.6 98.2 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.504 -0.317 . . . . 63.130000000000003 110.241 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t30 56.21 34.68 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.206 0.526 . . . . 74.519999999999996 111.007 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.49 62.42 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.77 -0.729 . . . . 44.200000000000003 113.908 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.1 pt20 -124.2 155.73 38.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.453 0.627 . . . . 55.32 110.24 174.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -90.5 142.12 28.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.442 -0.345 . . . . 55.039999999999999 110.649 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.99 25.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.635 -0.793 . . . . 74.120000000000005 112.218 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.8 146.76 51.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.764 -0.458 . . . . 63.329999999999998 109.764 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 46' ' ' ILE . 2.7 pp -144.38 171.76 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.146 0.279 . . . . 72.150000000000006 110.365 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.64 109.92 3.53 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.718 -0.753 . . . . 62.109999999999999 111.839 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 1.4 m -63.78 -24.0 67.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.993 0.368 . . . . 74.349999999999994 111.993 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -67.79 -43.84 78.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.297 -0.41 . . . . 74.129999999999995 111.885 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -122.79 117.66 26.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.985 0.421 . . . . 51.43 110.656 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 85.7 mt -155.05 153.82 31.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.09 -0.959 . . . . 71.120000000000005 110.124 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.761 ' HB2' ' HB3' ' A' ' 29' ' ' PRO . 34.8 m -109.24 120.8 43.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.482 -0.933 . . . . 63.450000000000003 108.482 171.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HG2' HD23 ' A' ' 63' ' ' LEU . 28.8 ttpt -100.45 179.82 4.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 111.428 -169.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 63' ' ' LEU . 2.5 pt? -90.63 14.72 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.463 . . . . 74.510000000000005 111.754 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -82.09 -5.79 58.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.129 0.49 . . . . 74.140000000000001 110.521 178.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -114.28 163.18 15.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.619 -0.719 . . . . 64.340000000000003 109.749 172.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -61.12 136.21 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.089 0.471 . . . . 72.439999999999998 110.658 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.4 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 2.5 m-70 -79.18 98.19 6.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.508 -0.769 . . . . 73.109999999999999 111.112 -170.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -80.28 102.96 9.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.922 -0.581 . . . . 73.400000000000006 110.58 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -92.25 154.21 18.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.563 -0.532 . . . . 63.329999999999998 109.563 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.768 -0.634 . . . . 75.25 110.237 -177.875 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.765 0.317 . . . . 53.100000000000001 110.335 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 pt -65.19 139.43 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 73.409999999999997 111.37 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.1 -19.41 51.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.996 -0.621 . . . . 73.230000000000004 111.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 66.08 176.97 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.178 0.591 . . . . 75.099999999999994 111.483 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.67 -32.78 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.122 -0.49 . . . . 70.409999999999997 110.919 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -109.72 103.03 11.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 75.120000000000005 111.417 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -120.54 -170.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.964 -1.016 . . . . 61.549999999999997 109.218 174.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 60' ' ' LEU . 37.2 t-20 60.08 49.23 7.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.741 0.781 . . . . 53.049999999999997 109.615 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.35 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.067 -0.969 . . . . 41.219999999999999 110.158 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.1 t -114.24 122.44 46.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 70.200000000000003 110.56 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.9 146.58 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.1 0.875 . . . . 62.229999999999997 112.684 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt 61.05 21.21 11.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.551 -0.75 . . . . 71.0 111.945 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 16.7 m120 -53.54 -43.6 68.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.071 -0.513 . . . . 71.510000000000005 112.064 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.89 48.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.172 0.511 . . . . 74.019999999999996 110.822 177.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HG3' ' HA2' ' A' ' 19' ' ' GLY . 10.9 tpt180 -80.19 27.38 0.33 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.035 -0.529 . . . . 74.420000000000002 111.074 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.492 ' HA ' HG22 ' A' ' 55' ' ' ILE . 11.8 t 56.86 32.61 21.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 74.200000000000003 111.292 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 110.16 -124.25 7.03 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.487 -0.863 . . . . 53.509999999999998 112.057 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 21.6 mm-40 -86.29 11.68 11.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 73.329999999999998 110.449 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 15' ' ' ARG . . . 86.89 16.58 61.09 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.374 -1.091 . . . . 64.400000000000006 110.374 -170.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.1 m -62.57 -54.26 42.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.028 -0.586 . . . . 72.129999999999995 110.711 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -102.4 100.47 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.139 -0.689 . . . . 73.329999999999998 109.139 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -93.48 5.32 51.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.732 -0.667 . . . . 73.120000000000005 111.45 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -100.98 -38.41 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.466 0.543 . . . . 73.510000000000005 112.466 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 25' ' ' ILE . 12.7 tt -82.86 -55.33 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.943 0.72 . . . . 64.340000000000003 112.943 -169.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 48' ' ' TYR . 16.6 mt -126.82 148.76 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.976 -0.379 . . . . 74.019999999999996 109.976 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -150.25 159.0 27.93 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.007 -0.837 . . . . 62.140000000000001 111.007 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -75.98 96.97 3.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.492 . . . . 73.25 111.78 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -149.84 72.11 9.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.651 -0.704 . . . . 63.32 109.768 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.5 90.48 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.727 2.284 . . . . 72.040000000000006 112.055 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 30' ' ' GLN . 6.4 pt20 -97.33 59.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.51 -0.768 . . . . 74.25 110.141 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.39 -78.05 1.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.493 -1.043 . . . . 63.130000000000003 110.493 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -73.16 137.03 44.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.032 -0.729 . . . . 61.039999999999999 109.032 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 46.6 mttp -116.05 -75.94 0.58 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.022 0.439 . . . . 74.209999999999994 110.108 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 ' HD1' ' A' ' 48' ' ' TYR . 8.3 p 174.3 -29.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.179 -0.919 . . . . 75.209999999999994 108.619 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 72.58 127.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.414 -1.266 . . . . 72.349999999999994 111.491 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 44' ' ' SER . 58.1 t -82.96 108.26 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.652 -0.704 . . . . 75.219999999999999 110.179 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 46' ' ' ILE . 4.7 mt -75.28 -49.53 27.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.836 -0.62 . . . . 75.109999999999999 111.346 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 m -153.24 150.95 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.054 0.454 . . . . 72.030000000000001 110.937 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.63 123.88 47.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.464 -0.789 . . . . 64.439999999999998 109.245 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.34 140.73 26.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.516 -0.179 . . . . 73.340000000000003 110.516 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t 75.24 -54.33 0.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.857 0.723 . . . . 74.310000000000002 111.662 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.11 -51.84 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.514 -0.634 . . . . 62.420000000000002 111.514 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.622 ' HZ2' ' HG2' ' A' ' 18' ' ' GLU . 25.5 m0 -87.61 160.14 18.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.089 0.471 . . . . 74.450000000000003 110.691 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.57 ' HB3' HG13 ' A' ' 36' ' ' VAL . 44.4 m -91.34 140.79 29.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.63 -0.714 . . . . 74.230000000000004 109.352 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -105.45 129.88 53.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 120.935 0.398 . . . . 73.319999999999993 109.939 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -142.91 170.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.704 . . . . 74.329999999999998 110.315 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -108.79 115.11 29.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.253 -0.647 . . . . 74.409999999999997 109.253 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 25' ' ' ILE . 5.8 t80 -113.47 101.23 9.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 72.239999999999995 110.156 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t30 63.02 41.79 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 53.539999999999999 110.35 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.21 56.86 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.555 -0.748 . . . . 53.310000000000002 113.65 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 8.1 pt20 -111.79 145.86 38.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.388 0.594 . . . . 74.349999999999994 111.689 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 m -72.52 123.21 22.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 74.219999999999999 111.002 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.5 168.58 18.6 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.779 -0.724 . . . . 72.329999999999998 111.75 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.39 144.4 51.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.817 0.341 . . . . 73.329999999999998 110.434 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.92 156.26 31.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.74 -0.664 . . . . 54.210000000000001 109.668 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -72.36 129.1 14.13 Favored Glycine 0 C--O 1.219 -0.815 0 C-N-CA 120.631 -0.795 . . . . 73.430000000000007 112.137 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -77.24 -13.57 59.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.322 0.582 . . . . 71.209999999999994 110.428 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.575 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 17.3 ptt85 -85.65 -16.84 37.86 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.382 -0.372 . . . . 75.430000000000007 111.271 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' A' ' 58' ' ' ARG . 30.9 m-85 -127.12 116.33 20.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.204 -0.665 . . . . 74.0 109.204 171.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 97.1 mt -140.96 173.83 11.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.279 0.561 . . . . 75.019999999999996 110.876 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . 10.1 t -109.26 127.44 54.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.696 -0.684 . . . . 73.340000000000003 109.174 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 8' ' ' ASN . 75.3 mmtt -79.89 158.22 26.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.162 -0.472 . . . . 65.230000000000004 110.718 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.892 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.6 -5.83 41.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.155 -0.475 . . . . 75.239999999999995 110.669 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 74.34 142.23 0.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.368 -0.833 . . . . 70.319999999999993 111.273 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -109.83 -3.49 16.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.128 0.418 . . . . 70.219999999999999 112.128 -171.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -71.94 148.03 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.991 -0.683 . . . . 74.340000000000003 110.54 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -136.01 152.5 50.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.282 -0.636 . . . . 73.040000000000006 109.282 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -93.96 110.13 21.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.205 0.526 . . . . 75.140000000000001 112.173 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -82.61 -28.25 30.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.114 -1.069 . . . . 72.109999999999999 108.114 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 p80 . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.732 -1.122 . . . . 75.140000000000001 109.527 173.91 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.882 -0.414 . . . . 55.210000000000001 109.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.8 pt 47.94 -169.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.443 1.097 . . . . 62.25 112.625 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.31 87.38 0.11 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.525 -0.845 . . . . 61.200000000000003 112.473 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -165.3 -35.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 52.310000000000002 110.706 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -114.92 131.39 56.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.324 . . . . 71.409999999999997 111.637 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 62.48 19.22 11.04 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.402 -0.817 . . . . 74.209999999999994 112.657 171.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 16.5 tt -146.07 147.18 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.019 -0.734 . . . . 73.510000000000005 109.019 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 18.7 m120 73.02 -59.45 0.57 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.701 0.626 . . . . 74.420000000000002 110.44 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.47 -158.72 0.32 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.691 0.619 . . . . 43.310000000000002 111.321 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.1 m -132.12 27.49 4.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 63.219999999999999 109.864 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -139.66 145.31 38.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.206 -0.906 . . . . 65.0 109.234 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 15' ' ' ARG . 4.3 mm? 67.19 28.69 8.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.471 0.482 . . . . 73.219999999999999 110.079 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.639 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-20 -63.19 -50.08 71.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.439 -0.801 . . . . 71.340000000000003 111.727 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.02 6.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.482 -0.562 . . . . 72.239999999999995 109.482 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 12' ' ' LEU . 37.6 mtp180 -69.41 176.89 3.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.793 -0.64 . . . . 65.129999999999995 110.911 -172.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.969 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 3.9 m 69.97 44.63 0.79 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.683 -0.689 . . . . 62.0 111.044 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.877 ' HA3' HD12 ' A' ' 25' ' ' ILE . . . -56.49 -35.84 68.05 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 114.246 0.458 . . . . 71.400000000000006 114.246 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 21' ' ' ASN . 42.2 mt-10 -90.3 9.93 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.213 0.507 . . . . 71.239999999999995 110.532 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 43' ' ' TRP . . . 76.73 -65.69 2.83 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 116.097 -0.501 . . . . 63.509999999999998 112.229 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.9 p -82.41 -28.31 31.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.854 0.359 . . . . 75.310000000000002 110.763 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 27.5 t30 -100.17 118.11 35.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.359 -0.608 . . . . 74.319999999999993 109.359 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.969 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 24.2 m-85 -93.8 -36.88 12.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.869 -0.605 . . . . 63.439999999999998 111.807 -170.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -73.88 -6.61 48.23 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.068 0.766 . . . . 74.040000000000006 113.068 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.44 -35.88 64.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 73.019999999999996 111.935 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.877 HD12 ' HA3' ' A' ' 17' ' ' GLY . 33.2 mt -124.13 156.32 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.3 -0.259 . . . . 74.209999999999994 110.3 -173.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.45 -135.91 6.1 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.191 -0.528 . . . . 74.310000000000002 112.2 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 13' ' ' ASN . . . -148.88 99.18 2.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.066 0.433 . . . . 75.450000000000003 112.098 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.9 tp -157.1 69.5 4.44 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.976 0.417 . . . . 75.349999999999994 110.776 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -97.94 63.73 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.106 2.537 . . . . 34.210000000000001 112.506 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.7 -77.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 73.219999999999999 110.024 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.9 3.49 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.508 -0.637 . . . . 73.329999999999998 111.508 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.79 153.26 14.47 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.904 -1.147 . . . . 75.230000000000004 107.904 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -80.07 15.09 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.111 0.481 . . . . 72.430000000000007 111.213 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 89.0 t -76.61 97.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 54.399999999999999 110.034 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -138.98 169.7 17.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.837 -0.619 . . . . 62.130000000000003 110.69 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.63 125.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.685 -0.689 . . . . 74.439999999999998 109.547 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.523 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -78.29 -55.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.511 0.672 . . . . 72.219999999999999 109.618 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 t -147.06 155.74 42.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.925 -1.034 . . . . 62.119999999999997 109.18 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.74 159.21 35.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.255 0.55 . . . . 74.450000000000003 111.412 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -132.53 174.24 10.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.574 -0.739 . . . . 64.439999999999998 109.337 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 t -74.66 78.89 2.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.708 0.766 . . . . 64.019999999999996 110.538 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.03 -70.99 0.31 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.12 -0.946 . . . . 73.409999999999997 111.465 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.3 m0 -115.42 146.07 41.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 110.425 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.1 m -115.32 135.8 53.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 73.439999999999998 110.094 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.7 ttmt -82.57 125.29 30.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.356 0.598 . . . . 73.239999999999995 111.355 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 pt -128.08 171.04 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.484 -0.78 . . . . 74.420000000000002 110.858 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 t-20 -126.58 113.92 17.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.036 -0.727 . . . . 71.340000000000003 109.036 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.764 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 31.2 t80 -103.72 77.79 1.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 74.230000000000004 109.885 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 58.47 48.02 12.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.140000000000001 111.863 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.76 -17.21 59.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.584 -0.817 . . . . 71.420000000000002 113.66 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.764 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.8 pt20 -100.37 148.39 24.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.659 0.73 . . . . 71.439999999999998 110.344 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.3 m -86.74 140.7 29.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.595 -0.729 . . . . 75.200000000000003 111.306 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.17 161.39 31.99 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.915 -0.659 . . . . 62.240000000000002 112.133 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.39 139.03 47.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.308 -0.997 . . . . 75.420000000000002 108.308 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 2.9 pp -121.53 167.52 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.019 -0.273 . . . . 75.409999999999997 111.713 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.33 118.86 5.02 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.87 -0.681 . . . . 64.019999999999996 111.773 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -58.56 -17.39 21.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.648 0.61 . . . . 55.409999999999997 112.648 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -72.06 -25.85 61.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.914 0.338 . . . . 72.120000000000005 111.914 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -121.04 119.31 32.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.049 0.452 . . . . 54.140000000000001 110.767 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.6 mt -156.87 160.87 39.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.48 -0.782 . . . . 73.439999999999998 110.192 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -100.29 120.26 39.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 53.109999999999999 110.549 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -112.24 142.91 44.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.365 -0.976 . . . . 73.340000000000003 108.365 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.35 -48.72 66.67 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.126 0.266 . . . . 71.310000000000002 111.056 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HG2' ' N ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER 43.59 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.065 1.346 . . . . 70.230000000000004 111.331 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.582 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 7.1 p80 -136.35 67.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.843 0.83 . . . . 73.439999999999998 110.554 170.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 67' ' ' HIS . 64.4 m-70 -129.85 -39.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.905 -1.043 . . . . 74.019999999999996 110.245 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 25.4 m-70 67.23 96.87 0.06 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.562 -0.745 . . . . 72.129999999999995 109.192 -169.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -46.58 134.16 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.993 -1.003 . . . . 62.450000000000003 112.064 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 95.2 m-70 -60.69 -40.09 90.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.721 -1.127 . . . . 75.510000000000005 112.677 -167.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 84.2 t60 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.154 -0.926 . . . . 74.439999999999998 109.856 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.863 0.363 . . . . 65.549999999999997 110.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.75 158.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.984 -0.553 . . . . 65.540000000000006 110.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.72 -15.64 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.024 -0.608 . . . . 74.150000000000006 112.083 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' HB3' ' HD1' ' A' ' 6' ' ' TYR . 4.2 m-20 -90.81 89.78 7.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.818 0.342 . . . . 73.5 110.506 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -94.4 60.65 2.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.201 0.524 . . . . 71.040000000000006 110.028 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 46.0 p90 -82.45 36.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.594 -0.73 . . . . 72.340000000000003 111.473 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 6' ' ' TYR . 47.1 mm 74.53 147.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 123.497 0.498 . . . . 73.340000000000003 110.196 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 75.24 -38.28 0.36 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.72 0.808 . . . . 54.240000000000002 111.663 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 1.72 3.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.732 0.642 . . . . 74.420000000000002 112.732 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -72.81 -31.87 65.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.488 -0.19 . . . . 54.350000000000001 110.488 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.609 ' HA ' ' OG ' ' A' ' 61' ' ' SER . . . 70.4 -39.05 0.43 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.738 0.815 . . . . 73.25 113.11 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 54.4 mt -84.17 22.91 1.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.008 0.373 . . . . 74.540000000000006 112.008 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -117.94 6.78 12.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.913 0.338 . . . . 72.519999999999996 111.913 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' ILE . 6.0 t -82.87 49.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 121.885 -0.509 . . . . 63.439999999999998 110.395 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.852 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 9.1 ptt180 -120.2 83.16 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.347 0.594 . . . . 72.310000000000002 111.965 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 21' ' ' ASN . 13.4 m 59.29 25.78 14.48 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.189 -0.914 . . . . 72.129999999999995 111.621 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 56' ' ' GLY . . . 113.85 -143.06 17.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.836 -0.697 . . . . 72.140000000000001 111.46 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.22 -27.29 68.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 53.329999999999998 110.887 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.92 63.62 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.348 -0.701 . . . . 72.140000000000001 111.348 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 m -87.69 -61.55 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 64.219999999999999 111.033 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HB2' ' A' ' 16' ' ' SER . 71.7 m-20 -123.93 127.23 47.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.168 -0.679 . . . . 53.350000000000001 109.168 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -97.56 6.6 47.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.849 -0.614 . . . . 74.430000000000007 111.265 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -107.72 -54.66 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.338 -0.392 . . . . 71.510000000000005 111.643 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.536 HG12 HG13 ' A' ' 25' ' ' ILE . 8.1 tt -59.94 -41.88 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 74.430000000000007 111.627 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.673 HG23 ' CE1' ' A' ' 48' ' ' TYR . 28.3 mt -136.53 165.07 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.32 -0.992 . . . . 73.129999999999995 108.32 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.852 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 179.9 -166.33 35.37 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.362 -0.923 . . . . 72.329999999999998 112.176 -171.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.566 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -81.07 91.78 6.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.05 0.452 . . . . 72.239999999999995 111.851 -174.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 33' ' ' LYS . 1.8 pt? -173.71 77.42 0.38 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.4 -0.818 . . . . 65.040000000000006 109.613 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -88.09 85.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.161 2.574 . . . . 75.150000000000006 112.401 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -165.35 155.22 12.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 75.099999999999994 109.823 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.8 174.75 50.48 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.934 -0.65 . . . . 72.329999999999998 113.317 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -92.45 7.32 43.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 62.299999999999997 110.802 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HE2' HD12 ' A' ' 28' ' ' LEU . 22.9 pttp -66.96 -15.71 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 73.319999999999993 110.995 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 4.4 p -146.63 123.2 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.336 0.589 . . . . 72.109999999999999 110.532 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -130.69 132.19 45.26 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.424 -0.584 . . . . 65.209999999999994 109.424 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.6 p -75.95 126.66 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.099 0.476 . . . . 60.329999999999998 110.553 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.43 -56.61 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.664 -0.495 . . . . 74.409999999999997 109.664 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -179.17 159.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.629 -0.714 . . . . 64.450000000000003 109.7 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -85.24 144.96 27.8 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.573 -0.739 . . . . 74.420000000000002 109.813 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -146.65 113.36 6.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.9 0.381 . . . . 72.310000000000002 110.698 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 t 57.9 62.92 1.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 111.314 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 -59.3 3.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.961 -0.638 . . . . 73.140000000000001 112.921 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.507 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 14.4 m0 -91.09 159.61 16.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.786 0.326 . . . . 60.030000000000001 110.629 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.804 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 9.6 t -105.22 142.42 35.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.277 -0.42 . . . . 64.310000000000002 110.035 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 54' ' ' TYR . 2.9 mtpt -87.88 127.34 35.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 116.178 -0.465 . . . . 62.340000000000003 110.829 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 36' ' ' VAL . 46.0 pt -143.23 164.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.723 -0.672 . . . . 64.219999999999999 110.954 -177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 26.6 t-20 -112.97 117.34 31.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.454 -0.943 . . . . 71.230000000000004 108.454 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.673 ' CE1' HG23 ' A' ' 25' ' ' ILE . 5.8 t80 -110.23 105.04 13.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.703 0.287 . . . . 74.040000000000006 110.515 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.9 t30 62.21 35.29 15.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.675 -0.693 . . . . 65.329999999999998 110.919 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.97 -17.48 59.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.887 -0.673 . . . . 54.310000000000002 113.234 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -107.92 133.78 51.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.35 0.575 . . . . 71.340000000000003 110.601 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -73.93 130.83 40.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.896 -0.593 . . . . 65.219999999999999 110.808 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.02 -172.19 12.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.833 -0.699 . . . . 74.430000000000007 112.405 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.506 ' CE2' ' HG2' ' A' ' 45' ' ' LYS . 97.0 m-85 -136.06 144.93 45.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.224 -0.287 . . . . 72.310000000000002 110.224 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 2.6 pp -135.29 162.43 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.348 -0.387 . . . . 71.439999999999998 110.239 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.626 ' H ' ' HA2' ' A' ' 17' ' ' GLY . . . -79.71 143.55 25.71 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 45.329999999999998 112.055 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.793 ' HA ' HD11 ' A' ' 60' ' ' LEU . 8.7 m -85.07 -5.4 59.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.757 0.789 . . . . 74.209999999999994 109.332 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -34.37 57.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.361 -0.836 . . . . 74.340000000000003 110.809 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -135.87 118.62 16.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.038 0.447 . . . . 73.299999999999997 111.457 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' A' ' 57' ' ' THR . 5.2 mp -140.38 173.86 11.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.856 . . . . 72.409999999999997 109.062 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.609 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 45.9 m -142.39 124.33 15.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.658 -0.497 . . . . 71.239999999999995 109.658 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -72.96 137.1 45.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 75.400000000000006 109.737 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 1.7 pp -66.29 -11.28 49.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.19 0.441 . . . . 64.400000000000006 112.19 -174.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.91 98.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.083 0.772 . . . . 62.149999999999999 113.083 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -90.5 73.43 6.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.627 -0.879 . . . . 73.030000000000001 108.627 171.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.12 141.28 50.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 74.299999999999997 111.185 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -90.09 79.83 6.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.584 -0.734 . . . . 71.099999999999994 111.097 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 58.45 88.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.431 -0.804 . . . . 74.319999999999993 110.813 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -155.91 146.38 21.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.983 -0.747 . . . . 74.310000000000002 108.983 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.158 -0.925 . . . . 73.420000000000002 110.426 177.206 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HG2' HG22 ' A' ' 2' ' ' ILE . 52.6 ttm . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.537 -0.171 . . . . 65.340000000000003 110.537 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.61 HG22 ' HG2' ' A' ' 1' ' ' MET . 8.4 tp 43.27 86.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.22 1.008 . . . . 74.409999999999997 112.455 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.58 41.11 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.484 -0.78 . . . . 71.239999999999995 111.646 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -116.18 121.61 42.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.196 0.522 . . . . 72.120000000000005 110.77 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -148.92 10.54 0.81 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.527 -0.761 . . . . 72.420000000000002 109.235 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.514 -0.767 . . . . 65.109999999999999 110.019 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt 177.32 137.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.922 -1.035 . . . . 61.539999999999999 109.189 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 m120 62.14 -85.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.964 0.412 . . . . 73.5 111.928 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.35 84.7 3.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.219 0.533 . . . . 63.420000000000002 111.007 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.1 m -125.21 -54.43 1.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.714 -0.676 . . . . 73.120000000000005 110.162 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.6 -85.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.015 0.436 . . . . 73.319999999999993 110.782 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.709 HD13 ' HE1' ' A' ' 22' ' ' TYR . 59.2 mt -88.48 133.25 34.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.165 -0.47 . . . . 64.319999999999993 110.422 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.94 -60.35 1.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.978 0.362 . . . . 61.329999999999998 111.978 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 55' ' ' ILE . 4.7 t -74.55 -65.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 73.510000000000005 111.385 -172.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 58.33 17.96 5.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.934 0.716 . . . . 42.43 112.934 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 21' ' ' ASN . 37.9 t 62.33 25.21 15.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.212 0.53 . . . . 63.420000000000002 110.189 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.36 -108.48 0.67 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.112 -0.795 . . . . 74.519999999999996 111.112 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' OE1' ' HD3' ' A' ' 58' ' ' ARG . 40.4 mt-10 -118.14 14.59 14.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 71.230000000000004 110.201 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.17 48.69 0.18 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.588 -0.733 . . . . 73.200000000000003 111.467 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.4 m -94.2 -34.97 12.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 74.030000000000001 109.913 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' H ' ' HB3' ' A' ' 16' ' ' SER . 18.5 m-80 -140.24 142.06 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.195 -0.912 . . . . 73.239999999999995 109.591 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.709 ' HE1' HD13 ' A' ' 12' ' ' LEU . 55.7 m-85 -129.53 -13.95 4.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.543 0.687 . . . . 75.140000000000001 110.274 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -71.73 -49.9 35.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.913 -1.039 . . . . 73.209999999999994 111.109 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -97.09 -55.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 72.409999999999997 111.526 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' A' ' 48' ' ' TYR . 60.6 mt -101.23 127.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.715 -0.476 . . . . 42.149999999999999 109.715 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.47 -108.54 1.01 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.552 -0.832 . . . . 31.309999999999999 111.762 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -132.63 92.25 3.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.443 . . . . 55.0 110.164 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.5 pt? -173.39 86.43 0.39 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.352 -0.84 . . . . 72.120000000000005 109.834 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.82 71.37 4.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.699 2.266 . . . . 62.109999999999999 110.835 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.75 140.97 29.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.163 -0.926 . . . . 64.239999999999995 111.088 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.83 177.35 28.17 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.678 -0.773 . . . . 75.439999999999998 112.129 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -90.92 51.01 1.88 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 72.120000000000005 110.045 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG3' HG23 ' A' ' 34' ' ' VAL . 47.1 pttt -175.36 -156.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.263 -0.881 . . . . 42.140000000000001 109.341 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.511 HG23 ' HG3' ' A' ' 33' ' ' LYS . 82.2 t 75.89 -28.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.24 0.616 . . . . 65.140000000000001 112.091 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -59.67 -66.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 75.400000000000006 110.9 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -174.38 125.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 72.5 110.65 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.2 mt -113.77 -54.06 4.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.227 0.537 . . . . 73.549999999999997 110.061 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.9 t -143.06 171.81 13.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.125 -0.694 . . . . 73.349999999999994 109.125 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 39.9 mt-10 -137.95 149.71 46.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.052 -0.351 . . . . 62.5 110.052 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -162.86 117.58 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 65.430000000000007 111.628 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 t 63.43 33.05 14.03 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.585 -0.734 . . . . 75.430000000000007 112.457 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.55 -32.85 6.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.666 -0.778 . . . . 73.230000000000004 112.956 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -102.17 155.13 18.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 110.302 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.689 ' HB2' HG13 ' A' ' 55' ' ' ILE . 25.0 m -106.02 143.46 34.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.135 -0.484 . . . . 64.450000000000003 110.689 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD2' ' CE1' ' A' ' 54' ' ' TYR . 19.1 mmmt -82.8 117.53 22.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.508 -0.769 . . . . 73.010000000000005 110.363 -177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.723 ' HA ' HD12 ' A' ' 37' ' ' ILE . 31.4 pt -137.65 171.65 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.966 0.413 . . . . 73.340000000000003 110.94 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -115.04 114.68 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.068 -0.716 . . . . 72.340000000000003 109.068 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.656 ' CE2' HG23 ' A' ' 25' ' ' ILE . 6.0 t80 -111.05 113.1 25.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.456 -0.338 . . . . 64.450000000000003 110.351 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.85 35.06 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.264 0.554 . . . . 74.299999999999997 111.109 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.23 64.52 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 63.43 114.033 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -131.12 167.6 18.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.572 0.686 . . . . 61.119999999999997 110.782 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.8 m -70.17 119.98 15.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 64.129999999999995 110.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.63 169.27 15.79 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.814 -0.707 . . . . 70.519999999999996 111.689 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 97.5 m-85 -139.02 150.62 46.02 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.637 -0.505 . . . . 73.349999999999994 109.637 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.784 HG22 HG13 ' A' ' 14' ' ' VAL . 2.5 pp -130.33 154.01 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 123.088 0.243 . . . . 72.200000000000003 110.681 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.34 108.76 3.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.705 -0.958 . . . . 74.120000000000005 110.705 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -59.56 -15.04 15.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.661 0.615 . . . . 60.340000000000003 112.661 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HD3' ' OE1' ' A' ' 18' ' ' GLU . 11.6 ptm180 -73.4 -16.49 61.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.691 0.282 . . . . 75.420000000000002 111.499 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 118.62 15.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.321 -0.251 . . . . 73.329999999999998 110.321 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 HD13 ' A' ' 55' ' ' ILE . 36.4 mt -153.37 156.1 37.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.568 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 t -155.27 121.84 5.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 72.239999999999995 109.174 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HB2' ' HG3' ' A' ' 64' ' ' GLU . 49.3 mttp -89.07 -163.05 0.93 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.078 -0.51 . . . . 72.120000000000005 109.935 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' HIS . 7.4 mp -85.13 32.06 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.225 0.536 . . . . 71.340000000000003 109.914 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 39.3 mt-10 -80.89 158.33 25.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.485 -0.78 . . . . 74.430000000000007 109.42 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 61.4 24.46 14.56 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.052 0.93 . . . . 73.120000000000005 108.76 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 8.8 t-80 -151.05 131.82 14.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 72.219999999999999 108.725 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -67.23 139.95 57.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.587 -0.445 . . . . 71.120000000000005 109.942 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -92.75 150.78 20.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.77 -0.455 . . . . 74.209999999999994 109.77 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -96.57 94.03 7.11 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.895 -1.15 . . . . 74.120000000000005 107.895 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 . . . . . 0 C--O 1.249 1.068 0 O-C-N 123.959 0.787 . . . . 65.329999999999998 109.549 -168.564 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.913 -0.403 . . . . 62.409999999999997 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt -121.99 109.6 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 74.129999999999995 111.2 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 13.16 7.48 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.404 -1.078 . . . . 44.219999999999999 110.404 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.94 111.13 23.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.918 -0.641 . . . . 64.209999999999994 110.193 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -131.09 82.41 2.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.775 -0.454 . . . . 73.420000000000002 109.775 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.57 ' HD2' HG13 ' A' ' 7' ' ' ILE . 17.7 t80 -157.18 152.87 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 74.209999999999994 109.777 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.57 HG13 ' HD2' ' A' ' 6' ' ' TYR . 57.3 mt 68.19 -78.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.095 0.558 . . . . 61.200000000000003 111.032 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 3.3 m-20 -85.97 -41.99 14.41 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.422 -0.214 . . . . 62.439999999999998 110.422 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.42 -159.88 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.911 -0.586 . . . . 52.539999999999999 110.582 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.5 t -74.77 -12.92 60.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.901 0.334 . . . . 72.040000000000006 111.901 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.98 160.53 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.295 -0.162 . . . . 54.109999999999999 110.764 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt 56.42 42.18 27.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.093 0.473 . . . . 65.239999999999995 111.312 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -68.21 -52.88 29.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.761 -0.654 . . . . 44.229999999999997 111.362 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG13 HG21 ' A' ' 55' ' ' ILE . 4.8 t -87.85 48.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 74.430000000000007 110.589 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.851 ' HD2' ' HB2' ' A' ' 22' ' ' TYR . 3.0 mmt180 -74.79 37.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.647 0.61 . . . . 72.230000000000004 112.647 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 4.5 m 49.64 73.82 0.23 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.484 0.659 . . . . 64.519999999999996 112.525 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.719 ' H ' ' HA ' ' A' ' 55' ' ' ILE . . . 101.97 -139.34 14.37 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.572 -0.74 . . . . 25.219999999999999 111.472 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -110.59 39.37 2.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.605 -0.887 . . . . 64.239999999999995 108.605 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.01 21.25 33.71 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -1.0 . . . . 74.510000000000005 111.055 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -87.08 -61.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 61.420000000000002 111.508 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.401 ' C ' ' HB2' ' A' ' 16' ' ' SER . 15.7 m120 -108.95 34.92 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 64.549999999999997 109.582 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.851 ' HB2' ' HD2' ' A' ' 15' ' ' ARG . 28.7 p90 -50.71 -21.99 1.87 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.926 -1.034 . . . . 74.200000000000003 113.646 -168.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 23' ' ' ARG . 24.6 ttt-85 -58.5 -35.46 72.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.321 0.489 . . . . 75.219999999999999 112.321 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.72 -56.94 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 61.219999999999999 111.895 -170.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.593 HG12 ' CD2' ' A' ' 48' ' ' TYR . 1.7 mt -128.27 157.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.338 -0.616 . . . . 61.32 109.338 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -144.79 -77.94 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.703 -1.237 . . . . 45.109999999999999 114.34 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.745 ' O ' ' HD3' ' A' ' 29' ' ' PRO . . . -81.35 -153.32 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.677 0.621 . . . . 64.040000000000006 112.677 -168.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 61' ' ' SER . 56.9 tp -91.16 90.03 0.33 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.355 -0.839 . . . . 75.450000000000003 110.762 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 68.2 Cg_endo -85.59 -7.16 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.574 2.182 . . . . 72.310000000000002 112.56 -173.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 67.43 166.0 0.23 Allowed 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.638 0.586 . . . . 71.310000000000002 110.633 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.2 67.53 2.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.074 -0.584 . . . . 72.319999999999993 112.637 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.63 -67.69 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.358 0.599 . . . . 70.150000000000006 110.022 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -139.97 -36.7 0.49 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.848 -1.069 . . . . 72.019999999999996 108.785 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -78.46 115.88 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.336 -0.847 . . . . 75.200000000000003 110.521 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 3.9 pm0 -122.79 13.83 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.371 -0.377 . . . . 55.009999999999998 110.57 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.92 ' HA ' HG22 ' A' ' 46' ' ' ILE . 95.2 t 73.67 118.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.651 -0.704 . . . . 73.230000000000004 109.891 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.25 -51.07 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.129 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -168.65 150.72 4.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.606 -0.724 . . . . 71.530000000000001 110.394 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.4 mp0 -90.72 125.84 35.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.499 -0.773 . . . . 65.349999999999994 110.195 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -97.62 177.72 5.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.884 -0.598 . . . . 53.210000000000001 109.857 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 p -62.36 76.54 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.011 -0.995 . . . . 71.239999999999995 111.411 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.08 -68.41 0.55 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.363 -0.835 . . . . 74.120000000000005 112.001 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 42.0 m0 -112.61 160.21 18.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 74.349999999999994 110.731 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.2 m -103.55 129.32 50.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.891 -0.595 . . . . 75.299999999999997 109.7 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 38.0 ttmt -83.08 132.28 35.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.168 0.509 . . . . 74.340000000000003 111.738 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.92 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -140.02 153.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.592 -0.731 . . . . 75.140000000000001 109.954 176.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -111.98 113.77 26.27 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.428 -0.953 . . . . 74.099999999999994 108.428 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 11.8 t80 -115.53 110.96 20.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.253 -0.431 . . . . 62.409999999999997 110.137 -172.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.25 33.75 16.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 72.230000000000004 110.711 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 -10.2 75.26 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 75.510000000000005 113.808 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 14.0 pt20 -106.86 147.01 30.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.751 0.775 . . . . 74.140000000000001 110.982 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -84.88 131.29 34.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 62.329999999999998 111.418 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.84 174.17 26.77 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.786 -0.721 . . . . 62.5 111.849 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 66.6 m-85 -134.02 147.45 50.96 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.27 -0.641 . . . . 75.319999999999993 109.27 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.719 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 2.8 pp -126.86 154.65 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.529 0.204 . . . . 73.099999999999994 110.709 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 130.57 11.37 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.556 -0.831 . . . . 72.109999999999999 111.817 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 m -69.16 -9.12 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.14 0.495 . . . . 55.200000000000003 111.331 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.02 -47.22 86.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.109 0.481 . . . . 71.409999999999997 110.189 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CG ' ' HB2' ' A' ' 8' ' ' ASN . 7.7 m-85 -130.2 118.99 22.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.765 -0.652 . . . . 74.530000000000001 110.489 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 36' ' ' VAL . 5.0 tt -138.07 134.98 35.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.314 -0.857 . . . . 75.299999999999997 108.817 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' HD12 ' A' ' 28' ' ' LEU . 71.1 m -83.86 119.59 25.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 75.409999999999997 111.237 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.471 ' HG3' ' H ' ' A' ' 63' ' ' LEU . 15.0 tppt? -110.8 175.34 5.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.952 -1.129 . . . . 70.150000000000006 107.952 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' H ' ' HG3' ' A' ' 62' ' ' LYS . 4.4 mm? -67.42 -65.12 0.73 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.149 -0.22 . . . . 73.040000000000006 111.441 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 65' ' ' HIS . 0.1 OUTLIER 61.83 -178.08 0.12 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.184 -0.673 . . . . 71.340000000000003 109.184 -176.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.444 ' H ' ' CD ' ' A' ' 64' ' ' GLU . 1.5 t-80 -120.48 77.29 1.26 Allowed 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.901 -0.499 . . . . 71.420000000000002 110.298 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -100.79 96.81 7.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.716 -0.675 . . . . 74.340000000000003 110.401 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 14.7 t60 -77.54 133.62 38.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.601 -0.889 . . . . 73.519999999999996 108.601 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 43.9 t-80 70.88 12.66 7.11 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.861 0.362 . . . . 63.520000000000003 110.666 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 51.1 m-70 70.06 -65.93 0.3 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.251 0.62 . . . . 74.099999999999994 110.27 -173.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.0 p80 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.924 -1.036 . . . . 70.109999999999999 109.791 176.197 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.365 0.603 . . . . 72.209999999999994 110.622 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -132.63 120.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 73.430000000000007 111.215 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.45 -75.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.121 -1.192 . . . . 70.409999999999997 110.121 170.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 44.07 60.13 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.745 0.818 . . . . 72.310000000000002 113.177 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 p90 49.84 15.87 0.19 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.262 1.208 . . . . 72.319999999999993 114.262 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -105.33 -42.53 5.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.030000000000001 109.734 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 49.6 mm -71.5 128.74 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.468 -0.787 . . . . 73.549999999999997 110.025 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 8.4 t30 71.42 104.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.939 0.775 . . . . 63.039999999999999 111.043 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.64 -80.2 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.215 -0.448 . . . . 72.230000000000004 110.172 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -141.5 -70.19 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 74.120000000000005 110.427 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.47 11.29 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.305 0.574 . . . . 72.239999999999995 110.551 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.603 ' HA ' ' HD3' ' A' ' 15' ' ' ARG . 85.9 mt -89.63 69.58 7.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 65.120000000000005 110.631 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -119.18 -59.14 1.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.064 0.459 . . . . 75.540000000000006 111.455 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.35 49.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 72.25 110.352 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.603 ' HD3' ' HA ' ' A' ' 12' ' ' LEU . 22.0 mmm180 -81.23 42.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.129999999999995 112.363 -171.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.8 p 54.22 22.62 3.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.748 0.819 . . . . 75.540000000000006 112.777 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 109.3 -116.05 4.46 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 72.209999999999994 111.721 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 2.4 mm-40 -79.03 -72.41 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.633 -0.877 . . . . 73.219999999999999 108.633 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.32 30.39 0.37 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.324 -1.51 . . . . 64.030000000000001 109.324 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -50.49 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.162 -1.019 . . . . 72.5 111.994 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.4 t30 -166.86 60.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.032 -0.729 . . . . 72.310000000000002 109.032 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -74.63 7.18 3.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.89 -0.595 . . . . 75.0 111.762 -173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.56 -24.1 56.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.582 . . . . 74.400000000000006 110.127 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 25' ' ' ILE . 29.5 pt -79.19 -45.26 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.402 -0.363 . . . . 74.019999999999996 111.698 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 24' ' ' ILE . 10.2 mt -132.66 138.05 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.908 -0.405 . . . . 74.430000000000007 109.908 -176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.46 -75.42 0.69 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.008 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.09 101.31 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.794 0.331 . . . . 44.409999999999997 110.722 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -140.05 75.75 28.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.458 -0.571 . . . . 50.299999999999997 109.458 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 6.1 Cg_exo -79.85 117.68 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.238 2.625 . . . . 63.350000000000001 111.305 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 29' ' ' PRO . 24.1 tm0? 75.37 113.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 124.2 0.938 . . . . 74.150000000000006 109.953 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.11 -51.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.509 -0.769 . . . . 42.109999999999999 111.32 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -134.83 -86.03 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.745 -0.465 . . . . 60.100000000000001 109.745 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.93 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 64.1 mttm -127.43 10.53 6.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.609 0.719 . . . . 74.5 109.529 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.74 82.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 122.072 0.939 . . . . 75.510000000000005 110.373 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -161.85 44.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.864 -1.062 . . . . 65.430000000000007 109.465 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m 43.82 86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.1 0.96 . . . . 70.299999999999997 113.164 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -74.74 -55.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.925 -0.58 . . . . 70.230000000000004 110.389 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -141.61 172.2 13.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 73.5 109.169 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.14 137.57 47.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.593 0.235 . . . . 65.230000000000004 110.485 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -155.56 132.99 11.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.707 -0.479 . . . . 64.430000000000007 109.707 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t 71.87 8.42 6.03 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.557 0.536 . . . . 62.140000000000001 111.297 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.98 -32.42 6.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.897 -0.668 . . . . 44.25 112.368 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 18.1 m0 -92.58 158.29 16.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.98 0.419 . . . . 72.019999999999996 110.723 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 54' ' ' TYR . 15.2 m -99.56 143.31 29.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.93 -0.577 . . . . 64.540000000000006 111.14 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 19.3 mmmt -82.46 121.75 27.15 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.559 -0.746 . . . . 74.329999999999998 110.968 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.0 pt -139.57 156.53 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 55.420000000000002 110.157 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 22.8 t-20 -123.41 118.24 27.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.852 -0.425 . . . . 62.32 109.852 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.712 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 40.3 t80 -121.89 112.07 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.785 -0.643 . . . . 72.430000000000007 109.806 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.66 32.53 21.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.386 0.612 . . . . 73.420000000000002 111.153 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.16 56.96 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.827 -0.624 . . . . 33.219999999999999 113.637 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 5.1 pt20 -92.77 140.1 29.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.714 0.757 . . . . 72.129999999999995 110.902 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.2 m -78.79 123.71 27.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.997 -1.001 . . . . 52.530000000000001 110.12 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.81 22.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.72 -0.752 . . . . 54.520000000000003 112.331 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.765 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 95.9 m-85 -130.96 147.25 52.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.564 -0.532 . . . . 72.439999999999998 109.564 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 2.6 pp -134.84 160.96 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.407 -0.22 . . . . 71.329999999999998 110.407 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.516 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -83.78 132.48 11.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.669 -0.777 . . . . 74.409999999999997 112.153 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -63.39 -17.05 62.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 74.129999999999995 112.025 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 58' ' ' ARG . 58.4 mtt85 -59.12 -48.82 80.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.413 -0.358 . . . . 72.400000000000006 111.616 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' O ' HD22 ' A' ' 60' ' ' LEU . 7.4 m-85 -117.11 116.77 27.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.312 0.577 . . . . 74.209999999999994 111.513 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD22 ' O ' ' A' ' 59' ' ' TYR . 1.2 mm? -142.12 175.28 9.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 60.340000000000003 108.187 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -83.1 119.53 24.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.626 -0.509 . . . . 74.25 109.626 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -97.98 141.08 31.38 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.701 -0.851 . . . . 74.519999999999996 108.701 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.59 -21.3 64.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.007 -0.277 . . . . 65.129999999999995 111.243 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.49 92.57 3.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.052 0.453 . . . . 63.43 110.056 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -111.2 -72.91 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 110.603 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.8 172.23 0.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.382 -0.826 . . . . 74.420000000000002 111.15 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -117.74 92.91 3.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.764 0.792 . . . . 74.219999999999999 109.01 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -92.45 2.75 56.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 74.409999999999997 109.215 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 56.47 131.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.383 1.473 . . . . 74.299999999999997 112.587 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.492 -0.766 . . . . 73.019999999999996 109.864 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.066 -0.346 . . . . 64.129999999999995 110.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.736 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -117.45 179.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 61.43 111.961 -172.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.95 61.27 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.336 -1.106 . . . . 75.200000000000003 110.336 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 6' ' ' TYR . 3.5 m-20 66.77 116.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.335 0.654 . . . . 71.349999999999994 110.79 -172.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.44 72.08 4.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.524 0.678 . . . . 62.439999999999998 111.6 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.451 ' HD2' ' HB3' ' A' ' 4' ' ' ASP . 89.5 m-85 -140.56 -179.9 6.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.028 -1.101 . . . . 74.150000000000006 108.028 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.26 89.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.829 -1.175 . . . . 54.340000000000003 107.829 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -139.38 136.12 34.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.805 . . . . 74.129999999999995 110.613 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.97 93.8 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.767 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 10.5 t -165.18 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 54.340000000000003 109.486 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -179.47 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.647 -0.706 . . . . 74.299999999999997 110.786 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' H ' HD22 ' A' ' 12' ' ' LEU . 2.2 mm? -73.06 10.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.59 -0.732 . . . . 72.129999999999995 112.473 -170.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -95.01 1.2 55.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.277 0.473 . . . . 75.25 112.277 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 5.7 t -91.5 32.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.045 0.926 . . . . 64.230000000000004 108.706 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' TYR . 13.2 tpt180 -78.12 3.67 14.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.856 -1.065 . . . . 63.530000000000001 110.829 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.701 ' HB2' HD12 ' A' ' 25' ' ' ILE . 22.4 t 71.59 16.44 5.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.659 -0.701 . . . . 72.209999999999994 111.449 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.74 -122.23 1.4 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.424 -0.893 . . . . 62.0 112.719 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -160.99 -69.38 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.5 -0.555 . . . . 62.520000000000003 109.5 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.18 -32.77 0.48 Allowed Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.142 -0.783 . . . . 45.530000000000001 111.142 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 ' CZ2' ' A' ' 43' ' ' TRP . 4.7 t -55.76 -31.75 62.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.204 0.526 . . . . 74.450000000000003 111.09 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 23' ' ' ARG . 24.8 t30 -171.83 114.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.088 -0.708 . . . . 73.310000000000002 109.088 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ARG . 42.5 p90 -132.15 7.74 4.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.054 0.454 . . . . 75.549999999999997 110.804 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 23' ' ' ARG . 12.5 ptt180 -88.16 -24.57 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.015 0.746 . . . . 73.310000000000002 113.015 -169.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mm -69.92 -55.69 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.734 -0.387 . . . . 73.140000000000001 111.872 -171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.1 mp -132.26 -169.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.651 -0.5 . . . . 74.439999999999998 109.651 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -145.99 -65.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 72.319999999999993 112.516 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -151.75 94.14 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.729 -0.277 . . . . 52.409999999999997 111.01 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 28' ' ' LEU . 1.2 tm? -166.32 86.29 0.9 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.26 -0.644 . . . . 61.420000000000002 109.26 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.86 76.73 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.065 2.51 . . . . 71.310000000000002 113.314 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.874 ' HG2' ' H ' ' A' ' 31' ' ' GLY . 8.4 tt0 59.64 -154.43 0.37 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 75.010000000000005 110.587 173.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.874 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 90.59 -83.05 1.32 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.26 -0.495 . . . . 75.209999999999994 112.292 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -65.74 -47.35 75.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.155 0.502 . . . . 72.319999999999993 111.216 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 26.5 tptp -154.17 168.71 25.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.006 -1.109 . . . . 73.109999999999999 108.006 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 48' ' ' TYR . 72.7 t 75.8 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.305 0.574 . . . . 73.349999999999994 111.462 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -136.32 148.06 47.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.993 -0.549 . . . . 75.129999999999995 110.468 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.3 p -92.04 143.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 73.450000000000003 110.065 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -93.84 -56.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.791 0.329 . . . . 72.530000000000001 110.369 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 p -173.6 151.18 1.86 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.021 -0.536 . . . . 72.340000000000003 110.007 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -110.59 137.85 47.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.603 -0.726 . . . . 71.109999999999999 111.623 -176.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -95.73 174.14 7.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.092 -1.077 . . . . 64.109999999999999 108.092 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -70.66 -11.25 60.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.011 0.434 . . . . 64.150000000000006 110.536 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.94 -74.68 0.97 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.983 -0.627 . . . . 63.130000000000003 111.567 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CZ2' HG21 ' A' ' 20' ' ' THR . 52.0 m0 -117.61 159.48 22.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 74.409999999999997 110.745 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.0 t -109.9 142.91 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.29 -0.414 . . . . 60.049999999999997 110.053 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -89.49 116.26 27.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.904 0.383 . . . . 65.510000000000005 111.697 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 36' ' ' VAL . 40.8 pt -131.61 156.72 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 71.109999999999999 110.106 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.543 ' O ' HG13 ' A' ' 34' ' ' VAL . 5.4 p30 -115.15 113.83 24.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.299999999999997 109.594 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' CD1' HG21 ' A' ' 34' ' ' VAL . 16.0 t80 -98.91 84.72 3.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.785 -0.45 . . . . 74.239999999999995 109.785 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.95 55.11 8.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.097 -0.956 . . . . 75.230000000000004 111.663 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.17 59.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.847 -0.692 . . . . 55.329999999999998 113.139 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.31 152.27 21.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.951 0.405 . . . . 60.310000000000002 110.407 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.1 m -93.57 114.44 26.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.563 -0.744 . . . . 75.340000000000003 109.389 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.37 148.35 18.49 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.278 -0.963 . . . . 75.510000000000005 112.983 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' SER . 95.8 m-85 -128.79 144.96 51.3 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.234 -1.024 . . . . 71.25 108.234 172.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 60' ' ' LEU . 2.7 pp -133.19 158.73 43.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 110.024 -0.362 . . . . 65.299999999999997 110.024 175.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 127.19 8.19 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.511 -0.852 . . . . 52.409999999999997 112.317 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -75.29 -6.73 51.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.622 0.725 . . . . 74.510000000000005 110.496 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -74.02 -49.69 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.589 -0.732 . . . . 62.350000000000001 110.546 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.12 120.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.984 -0.553 . . . . 75.439999999999998 110.305 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 55' ' ' ILE . 6.1 mt -134.59 174.15 10.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.872 -0.603 . . . . 74.409999999999997 111.067 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -148.98 145.83 27.52 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.58 -0.896 . . . . 34.240000000000002 108.58 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -117.19 -67.76 0.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.842 -0.429 . . . . 74.049999999999997 109.842 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -137.03 -58.11 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.352 -0.61 . . . . 75.209999999999994 109.352 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER 60.97 -179.64 0.11 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.344 -0.844 . . . . 74.510000000000005 112.542 174.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 59.09 35.88 23.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.455 -0.793 . . . . 72.239999999999995 110.829 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -95.31 130.04 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.173 -0.921 . . . . 71.530000000000001 110.043 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 61.08 93.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.632 0.583 . . . . 74.230000000000004 111.356 -176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.82 -27.47 60.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.68 -0.859 . . . . 73.420000000000002 108.68 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -178.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.092 -1.413 . . . . 64.329999999999998 107.782 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 C--O 1.242 0.685 0 CA-C-N 114.725 -1.125 . . . . 62.240000000000002 108.68 172.917 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.606 0.241 . . . . 73.310000000000002 110.368 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 4' ' ' ASP . 43.5 mm -122.91 -63.9 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 71.510000000000005 109.957 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.5 61.16 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 62.299999999999997 112.604 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.618 ' H ' HG22 ' A' ' 2' ' ' ILE . 5.4 m-20 -81.14 0.68 35.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.06 0.457 . . . . 54.229999999999997 111.312 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -110.37 23.39 14.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.133 0.492 . . . . 74.109999999999999 110.96 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 81.9 m-85 -111.02 110.71 21.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.679 -0.691 . . . . 74.129999999999995 109.747 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.2 mp -72.38 -52.97 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.673 -0.694 . . . . 72.319999999999993 110.714 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m120 61.97 36.3 15.72 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.487 -0.778 . . . . 62.530000000000001 111.241 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.55 164.64 22.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 54.240000000000002 110.518 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 m 66.85 13.99 9.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 111.007 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.36 25.42 14.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.636 -0.711 . . . . 70.530000000000001 111.971 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 15' ' ' ARG . 3.7 pp -112.3 139.82 47.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 42.229999999999997 111.021 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 27' ' ' ALA . 37.1 m-80 -117.63 -59.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.764 -0.653 . . . . 65.25 110.652 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 55' ' ' ILE . 7.1 t -119.5 13.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.107 -1.072 . . . . 75.299999999999997 108.107 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.669 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 3.2 tmt_? -63.66 110.83 2.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.772 -1.104 . . . . 65.340000000000003 109.55 -175.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.792 ' CB ' ' HA ' ' A' ' 23' ' ' ARG . 45.9 p 55.71 15.27 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.17 -0.923 . . . . 74.319999999999993 112.548 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 53.92 -109.36 1.09 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.468 -0.653 . . . . 73.420000000000002 111.468 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -117.77 161.16 20.16 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.729 -0.841 . . . . 73.310000000000002 108.729 169.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 58.93 2.26 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.178 -0.534 . . . . 60.399999999999999 114.2 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 21' ' ' ASN . 6.3 t -103.1 -60.03 1.62 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.086 0.443 . . . . 75.129999999999995 110.839 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.493 ' H ' HG23 ' A' ' 20' ' ' THR . 7.9 t30 -161.27 -4.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.673 0.749 . . . . 71.519999999999996 110.487 177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.5 m-85 -83.47 15.33 3.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.621 -0.718 . . . . 71.430000000000007 112.524 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 98.7 mtt180 -44.64 -23.54 0.13 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.659 0.985 . . . . 74.200000000000003 113.659 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 pt -77.4 -5.41 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.732 0.641 . . . . 61.229999999999997 112.732 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.585 HG23 ' CE1' ' A' ' 48' ' ' TYR . 53.7 mt -90.09 167.63 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.425 -0.583 . . . . 74.409999999999997 109.425 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 15' ' ' ARG . . . -150.83 176.62 29.3 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 73.140000000000001 111.439 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 13' ' ' ASN . . . -95.32 93.39 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.92 0.36 . . . . 74.230000000000004 110.941 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -171.3 62.61 0.36 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 64.409999999999997 110.874 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.02 -40.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.799 1.666 . . . . 70.25 111.631 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 30.0 pt20 44.71 25.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.866 1.266 . . . . 64.340000000000003 113.21 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.46 19.57 57.9 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.371 -0.442 . . . . 73.140000000000001 112.624 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -82.41 -57.64 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.206 -0.294 . . . . 72.129999999999995 110.206 -175.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' ' HE2' ' A' ' 33' ' ' LYS . 24.0 ttmm -143.63 -70.57 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.621 -0.432 . . . . 64.519999999999996 111.769 -177.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.49 100.89 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.708 0.766 . . . . 62.409999999999997 111.582 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -140.01 -179.45 5.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 72.310000000000002 109.629 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 60' ' ' LEU . 31.8 m -76.11 138.83 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.21 0.529 . . . . 74.150000000000006 111.872 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.52 -55.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.67 -0.695 . . . . 64.049999999999997 109.955 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.5 t -160.05 155.19 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 74.310000000000002 109.98 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -106.9 153.15 22.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.946 -0.57 . . . . 74.140000000000001 110.918 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -170.19 131.05 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 45.32 110.364 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.0 t 69.35 17.35 8.2 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.033 -0.53 . . . . 71.140000000000001 111.415 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.98 -18.66 55.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.676 -0.773 . . . . 74.219999999999999 112.049 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.462 ' HD1' ' HA2' ' A' ' 56' ' ' GLY . 22.1 m0 -105.65 157.48 17.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.86 0.362 . . . . 74.349999999999994 110.499 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.1 t -121.81 146.55 46.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.947 -0.57 . . . . 63.329999999999998 110.092 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -80.61 123.12 27.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.63 -0.713 . . . . 72.310000000000002 110.88 -176.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 pt -134.1 156.73 41.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.724 -0.671 . . . . 75.099999999999994 110.115 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -115.0 114.68 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.59 -0.522 . . . . 72.430000000000007 109.59 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.585 ' CE1' HG23 ' A' ' 25' ' ' ILE . 59.8 t80 -112.46 106.18 14.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.425 -0.352 . . . . 72.230000000000004 110.192 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 60.32 34.68 20.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.985 -0.552 . . . . 73.409999999999997 111.502 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.31 84.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.649 -0.786 . . . . 23.100000000000001 112.918 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -106.48 156.52 18.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.924 0.392 . . . . 55.310000000000002 110.586 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -76.8 128.4 34.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.674 -0.694 . . . . 64.109999999999999 109.886 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 22' ' ' TYR . . . -131.14 156.75 21.94 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.31 -0.948 . . . . 42.200000000000003 112.436 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 45' ' ' LYS . 73.9 m-85 -128.26 140.55 51.83 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.038 -0.356 . . . . 64.510000000000005 110.038 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 17' ' ' GLY . 2.7 pp -135.52 151.99 30.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.032 -0.531 . . . . 55.399999999999999 109.621 173.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' HD1' ' A' ' 43' ' ' TRP . . . -76.5 140.0 24.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.27 -0.967 . . . . 65.340000000000003 111.743 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 m -65.74 -10.8 40.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.32 0.581 . . . . 74.230000000000004 110.55 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -81.17 -11.67 59.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.607 -0.724 . . . . 73.109999999999999 111.222 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.16 118.44 16.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.222 0.534 . . . . 72.420000000000002 112.031 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.497 HD11 HG11 ' A' ' 36' ' ' VAL . 18.7 mt -157.51 173.27 17.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 73.120000000000005 108.969 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.4 m -82.99 119.09 24.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.402 -0.592 . . . . 71.019999999999996 109.402 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 12.4 tmtt? -97.26 -51.54 4.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.646 -0.706 . . . . 75.010000000000005 110.441 -173.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 63' ' ' LEU . 2.5 tm? -79.17 -22.65 44.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 64.230000000000004 110.294 -176.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 11.8 tt0 -79.75 54.58 1.85 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.717 -0.674 . . . . 72.0 111.756 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -149.82 -171.69 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.826 -0.805 . . . . 74.25 108.826 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.9 t60 69.8 163.45 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.422 0.451 . . . . 73.439999999999998 111.291 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 74.39 6.84 4.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.614 . . . . 74.439999999999998 111.71 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.22 142.68 43.11 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.072 -0.392 . . . . 74.140000000000001 110.126 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -119.84 152.82 36.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.269 -0.423 . . . . 65.129999999999995 111.079 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.9 m170 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.532 -0.747 . . . . 73.340000000000003 109.238 172.374 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.41 -0.589 . . . . 71.340000000000003 109.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt 63.19 102.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.5 0.667 . . . . 75.209999999999994 111.387 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.97 -9.9 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 65.140000000000001 112.189 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.43 124.12 31.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.236 0.541 . . . . 65.299999999999997 110.178 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 81.0 m-85 -130.85 35.48 3.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.618 -0.719 . . . . 75.150000000000006 109.571 -176.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 75.8 t80 75.43 143.58 0.08 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.26 0.975 . . . . 74.140000000000001 109.854 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.0 123.3 39.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 61.210000000000001 111.003 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.3 t30 70.38 175.77 0.29 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.174 -0.921 . . . . 72.540000000000006 110.163 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.8 75.67 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.748 0.419 . . . . 65.430000000000007 110.673 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 m 63.43 49.3 3.21 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.331 -0.849 . . . . 54.100000000000001 110.634 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -77.58 -152.17 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.207 -0.906 . . . . 72.319999999999993 110.781 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.877 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.4 pt? -75.02 39.88 0.14 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.871 0.367 . . . . 72.230000000000004 111.654 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -68.41 -54.68 15.52 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.349 0.5 . . . . 73.019999999999996 112.349 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.08 21.31 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.641 0.734 . . . . 64.349999999999994 109.203 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.725 ' CG ' ' HA ' ' A' ' 12' ' ' LEU . 19.0 mmt180 -54.62 -38.52 66.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 73.099999999999994 112.797 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.6 ' HB2' HD12 ' A' ' 25' ' ' ILE . 23.2 m 65.23 28.61 12.0 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.531 0.519 . . . . 62.229999999999997 111.677 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.87 133.77 27.22 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.667 -0.778 . . . . 51.340000000000003 111.914 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.14 -31.34 69.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.125 0.488 . . . . 71.129999999999995 110.281 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.06 -109.44 1.27 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.722 -0.951 . . . . 50.140000000000001 110.722 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.8 p -99.7 -4.81 29.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.353 0.597 . . . . 74.340000000000003 109.5 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -77.68 86.64 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.322 -0.854 . . . . 74.25 110.496 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.586 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 38.3 m-85 -93.9 5.78 50.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 71.109999999999999 111.548 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -90.26 -0.54 57.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.510000000000005 109.551 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.487 HG23 HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -52.4 -42.38 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.179 -0.919 . . . . 72.439999999999998 110.208 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' SER . 68.1 mt -132.58 -79.66 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 110.441 -0.207 . . . . 72.400000000000006 110.441 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . 140.08 169.76 11.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.21 -0.995 . . . . 70.140000000000001 112.643 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -92.91 94.46 8.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.102 -0.333 . . . . 71.400000000000006 110.102 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.605 ' HG ' HE22 ' A' ' 30' ' ' GLN . 19.4 tp -122.51 85.18 48.24 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.315 -0.624 . . . . 74.439999999999998 109.315 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.77 93.81 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.292 2.661 . . . . 72.319999999999993 113.378 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.605 HE22 ' HG ' ' A' ' 28' ' ' LEU . 2.5 mp0 -85.79 160.05 19.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 74.5 109.777 171.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.03 83.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.362 -0.446 . . . . 74.200000000000003 112.47 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 74.409999999999997 109.713 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' ' H ' ' A' ' 35' ' ' GLN . 4.1 ttmp? 71.94 143.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 55.219999999999999 111.895 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -77.13 -19.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.918 -0.583 . . . . 75.319999999999993 111.388 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.709 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 23.3 tt0 70.79 174.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.668 -0.696 . . . . 73.239999999999995 110.946 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 7.5 p -102.58 143.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.142 -0.481 . . . . 42.5 110.547 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' ASN . 5.3 mt -76.65 -56.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.828 -0.434 . . . . 72.439999999999998 109.828 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -172.18 161.67 5.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.585 -0.734 . . . . 71.140000000000001 109.599 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -117.15 139.8 50.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.74 -0.664 . . . . 54.009999999999998 110.289 -177.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -173.62 156.85 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.185 -0.461 . . . . 60.140000000000001 109.922 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.115 -0.493 . . . . 73.209999999999994 111.691 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.78 27.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.96 -0.638 . . . . 71.230000000000004 113.181 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -125.49 162.33 25.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.446 0.641 . . . . 74.409999999999997 111.479 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 36.6 m -101.17 122.57 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.254 -0.884 . . . . 70.409999999999997 109.609 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.0 ttmt -82.53 124.19 29.89 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.095 -0.502 . . . . 61.43 110.716 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 36' ' ' VAL . 9.7 pt -126.19 148.55 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.571 -0.74 . . . . 73.310000000000002 110.922 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.715 ' HB2' HD11 ' A' ' 37' ' ' ILE . 26.2 t-20 -109.54 113.39 26.14 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.294 -0.632 . . . . 70.409999999999997 109.294 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 32.7 t80 -104.03 85.69 2.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.124 0.488 . . . . 53.509999999999998 109.705 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.88 50.03 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 73.200000000000003 111.107 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.67 -17.66 58.87 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.059 -0.591 . . . . 64.530000000000001 114.213 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -103.41 147.39 27.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.075 0.937 . . . . 75.439999999999998 110.753 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -93.65 129.46 39.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 63.409999999999997 111.45 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.17 170.69 22.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.585 -0.606 . . . . 53.43 111.585 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.79 151.38 51.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 72.340000000000003 110.538 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 2.5 pp -143.69 153.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.801 -0.636 . . . . 73.519999999999996 109.919 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.622 ' H ' HD12 ' A' ' 12' ' ' LEU . . . -74.62 128.4 10.32 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.502 -0.856 . . . . 70.120000000000005 111.392 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 m -64.23 -4.5 3.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.406 0.521 . . . . 74.400000000000006 112.406 -174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -68.65 -34.37 75.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.169 -0.308 . . . . 64.310000000000002 110.169 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.05 119.43 23.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.011 0.434 . . . . 71.329999999999998 110.378 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' SER . 3.6 tt -155.53 129.81 8.89 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.715 -0.846 . . . . 73.129999999999995 108.715 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.41 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.7 t -87.51 120.67 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.461 -0.57 . . . . 53.020000000000003 109.461 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HG2' ' H ' ' A' ' 63' ' ' LEU . 12.5 ttmm -75.96 -163.65 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.938 -0.574 . . . . 64.299999999999997 110.534 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 2.8 pp -67.47 -31.48 71.66 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.335 -0.228 . . . . 71.140000000000001 110.752 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' N ' HD12 ' A' ' 63' ' ' LEU . 13.7 mm-40 46.78 65.5 1.21 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.7 1.0 . . . . 71.120000000000005 113.7 171.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 52.86 92.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.439 -0.8 . . . . 70.420000000000002 112.579 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -116.59 164.78 14.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 73.420000000000002 110.109 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.99 135.59 37.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.083 0.468 . . . . 64.319999999999993 110.318 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -97.05 106.32 18.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.034 -0.53 . . . . 72.420000000000002 109.756 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -85.9 113.9 22.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.961 0.41 . . . . 63.5 110.54 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.681 -0.676 . . . . 73.230000000000004 109.598 178.935 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.343 -0.243 . . . . 74.420000000000002 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.07 84.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.49 -0.93 . . . . 71.340000000000003 108.49 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . -109.96 0.77 30.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.207 -0.997 . . . . 60.210000000000001 113.357 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 m-20 71.89 -51.05 0.7 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.934 0.494 . . . . 65.209999999999994 112.036 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -79.1 -37.04 39.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 75.329999999999998 110.544 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.33 74.6 3.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.62 . . . . 73.420000000000002 110.687 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 tt -174.53 154.5 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.299 -0.864 . . . . 74.400000000000006 108.997 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.577 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 60.7 t30 -93.49 91.0 6.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.595 0.236 . . . . 72.450000000000003 110.539 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.28 98.74 5.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 72.340000000000003 111.128 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 m -151.69 -71.78 0.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.109 -0.496 . . . . 72.219999999999999 110.123 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.64 -57.49 0.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.789 -0.641 . . . . 75.120000000000005 109.644 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.786 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 mm? -82.33 75.26 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.338 -0.986 . . . . 65.319999999999993 108.338 172.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 -38.24 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.599 0.592 . . . . 72.040000000000006 112.599 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 16' ' ' SER . 47.8 t -77.26 -66.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.454 -0.498 . . . . 74.230000000000004 111.463 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 31.4 mmt180 53.86 20.86 2.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.599 0.592 . . . . 44.409999999999997 112.599 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.686 ' H ' HG12 ' A' ' 14' ' ' VAL . 14.9 m 61.47 25.94 15.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.853 0.461 . . . . 55.229999999999997 111.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.38 -113.31 3.5 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.645 -0.788 . . . . 73.140000000000001 112.573 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 15.3 mm-40 -73.69 -5.83 43.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.641 0.258 . . . . 72.329999999999998 111.192 -175.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 94.58 29.11 9.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.052 -0.594 . . . . 62.439999999999998 112.2 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 p -75.42 -62.01 1.71 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 72.549999999999997 110.955 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.444 ' HB3' HG22 ' A' ' 24' ' ' ILE . 39.1 m-80 -103.58 93.34 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.841 -0.618 . . . . 70.239999999999995 110.354 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -93.03 -1.13 56.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 111.055 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -82.89 -24.08 33.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 111.267 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 25' ' ' ILE . 4.8 tt -93.16 -55.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.233 . . . . 75.319999999999993 111.317 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.671 HG13 HG12 ' A' ' 24' ' ' ILE . 7.2 mt -129.54 138.65 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.313 -0.625 . . . . 64.310000000000002 109.313 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -143.21 -71.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.103 -1.046 . . . . 35.240000000000002 113.622 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.786 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . . . -74.69 -162.03 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.386 0.513 . . . . 74.329999999999998 112.386 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.91 90.16 0.37 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 75.519999999999996 109.352 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 52.3 Cg_endo -82.26 6.74 5.53 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.906 2.404 . . . . 73.019999999999996 113.105 -169.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 18.1 mm100 70.59 -67.1 0.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.481 0.712 . . . . 73.109999999999999 111.251 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.77 77.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.724 -0.751 . . . . 63.539999999999999 112.713 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.76 -50.94 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 72.239999999999995 110.664 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -139.98 19.19 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.414 -0.958 . . . . 63.340000000000003 108.414 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' ASN . 15.2 t -129.97 116.39 37.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.785 -1.098 . . . . 70.430000000000007 111.217 -169.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.938 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 4.3 pm0 -145.22 -86.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.774 -0.37 . . . . 72.420000000000002 110.519 169.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.938 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 75.4 t -144.43 114.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.827 -0.434 . . . . 71.099999999999994 109.827 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.4 mt -99.85 -56.69 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.857 -0.337 . . . . 73.319999999999993 110.39 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -167.56 153.27 7.44 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.905 0.383 . . . . 53.32 110.213 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 5.5 pt-20 -117.38 149.47 40.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.461 -0.79 . . . . 74.319999999999993 110.384 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -160.24 130.59 5.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.524 . . . . 70.239999999999995 109.798 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t 71.84 24.55 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.348 0.594 . . . . 74.230000000000004 111.106 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.89 44.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 64.120000000000005 112.853 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.473 ' HE1' ' HG2' ' A' ' 18' ' ' GLU . 9.6 m0 -119.09 152.7 36.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.921 0.391 . . . . 74.129999999999995 110.912 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.2 m -97.05 137.1 36.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.896 -0.593 . . . . 72.239999999999995 109.547 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.79 131.0 45.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.881 -0.414 . . . . 73.019999999999996 109.881 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 37' ' ' ILE . 25.2 pt -145.0 171.24 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 65.120000000000005 110.949 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 34' ' ' VAL . 23.7 t-20 -113.01 113.65 25.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.942 -0.762 . . . . 64.230000000000004 108.942 172.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.638 ' CD2' HG12 ' A' ' 25' ' ' ILE . 50.7 t80 -110.1 106.9 16.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.597 -0.274 . . . . 71.310000000000002 110.336 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.5 t30 63.05 34.43 13.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.68 0.753 . . . . 75.120000000000005 110.654 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.92 73.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.936 -0.649 . . . . 74.209999999999994 113.571 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -120.45 157.57 29.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.382 0.591 . . . . 75.239999999999995 110.882 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 m -73.02 125.26 27.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 74.439999999999998 110.752 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.7 166.03 24.37 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.575 -0.821 . . . . 50.240000000000002 112.313 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -132.81 148.19 52.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.805 -0.443 . . . . 62.549999999999997 109.805 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -137.18 168.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.098 177.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.38 155.03 19.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.347 -0.93 . . . . 73.430000000000007 111.981 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -85.87 -21.76 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 32.530000000000001 109.682 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.0 -41.93 13.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.69 -0.687 . . . . 62.119999999999997 110.448 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 8' ' ' ASN . 20.5 m-85 -95.14 113.07 24.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.4 -0.963 . . . . 75.230000000000004 108.4 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -158.68 174.1 15.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 110.648 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -121.17 117.64 27.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.454 -0.943 . . . . 65.329999999999998 108.454 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.759 ' HG3' ' H ' ' A' ' 63' ' ' LEU . 41.6 tptt -114.12 -154.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.733 -1.21 . . . . 71.409999999999997 107.733 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.759 ' H ' ' HG3' ' A' ' 62' ' ' LYS . 57.0 tp -77.41 -62.97 1.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.566 -0.531 . . . . 71.109999999999999 109.566 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' OE1' ' HB3' ' A' ' 62' ' ' LYS . 2.3 mp0 56.15 -175.08 0.05 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.864 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -129.75 93.22 3.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.75 -0.833 . . . . 72.519999999999996 108.75 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.27 128.56 22.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 64.409999999999997 110.73 -173.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -89.46 123.16 33.34 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.493 -0.776 . . . . 74.340000000000003 111.117 -175.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -62.47 134.78 56.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.486 -0.325 . . . . 75.239999999999995 110.422 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -88.78 142.45 27.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.055 -0.35 . . . . 74.319999999999993 110.055 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--O 1.248 0.993 0 O-C-N 123.969 0.793 . . . . 72.420000000000002 110.278 -176.277 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.715 0.293 . . . . 74.109999999999999 110.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.719 HD12 ' HA3' ' A' ' 19' ' ' GLY . 1.7 pp -143.6 14.91 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.43 . . . . 72.420000000000002 111.434 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.59 6.05 66.7 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.999 -0.619 . . . . 51.310000000000002 112.723 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.44 -4.73 57.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.533 . . . . 72.140000000000001 111.085 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.416 ' O ' HG13 ' A' ' 7' ' ' ILE . 93.7 m-85 -87.27 -39.15 15.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.36 . . . . 72.230000000000004 111.234 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 59.23 27.16 16.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.15 0.426 . . . . 72.420000000000002 112.15 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 5' ' ' TYR . 71.2 mt -102.49 114.91 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.273 0.559 . . . . 44.229999999999997 112.219 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 59' ' ' TYR . 4.9 m-20 -93.73 92.01 7.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.591 -0.731 . . . . 74.239999999999995 109.593 171.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.33 84.1 0.78 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.0 0.429 . . . . 64.310000000000002 110.893 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -157.01 24.71 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.785 -0.643 . . . . 64.140000000000001 109.78 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.98 -6.36 1.1 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.666 -0.697 . . . . 75.150000000000006 111.515 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 53.7 mt -97.54 128.06 43.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.249 -0.649 . . . . 75.099999999999994 109.249 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.69 -42.23 5.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.922 0.392 . . . . 55.130000000000003 111.072 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.65 49.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 71.439999999999998 109.813 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.546 ' HD2' ' OD1' ' A' ' 21' ' ' ASN . 5.7 mmm180 -43.99 -72.62 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.731 -1.122 . . . . 63.130000000000003 112.938 -173.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.985 ' HB2' HD12 ' A' ' 25' ' ' ILE . 2.2 m 57.64 37.66 27.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.239 0.543 . . . . 73.409999999999997 110.257 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -83.91 168.87 45.76 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.801 -0.714 . . . . 71.340000000000003 113.429 -172.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -70.88 -42.36 70.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.489 0.661 . . . . 64.25 109.512 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 2' ' ' ILE . . . -126.4 -65.25 0.16 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.186 -0.916 . . . . 73.340000000000003 111.583 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 4.5 p -123.82 -6.53 7.94 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.638 -0.331 . . . . 72.209999999999994 111.811 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.546 ' OD1' ' HD2' ' A' ' 15' ' ' ARG . 10.8 t-20 75.13 122.82 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.992 0.808 . . . . 73.209999999999994 111.807 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.418 ' HE1' ' HG1' ' A' ' 20' ' ' THR . 31.3 m-85 -129.62 -60.81 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.556 -0.747 . . . . 71.109999999999999 111.008 175.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -119.06 -13.51 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.317 0.858 . . . . 75.010000000000005 113.317 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG12 HG13 ' A' ' 25' ' ' ILE . 11.6 tt -61.79 -55.89 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.72 -0.392 . . . . 53.32 112.022 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.985 HD12 ' HB2' ' A' ' 16' ' ' SER . 59.4 mt -138.44 155.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.079 -0.712 . . . . 71.200000000000003 109.079 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.9 -113.05 2.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.492 -0.861 . . . . 73.409999999999997 112.37 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.81 94.55 4.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.197 0.522 . . . . 51.439999999999998 110.975 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 tp -147.43 84.98 6.93 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.67 -0.696 . . . . 61.310000000000002 109.41 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -92.6 -10.85 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.005 2.47 . . . . 73.230000000000004 113.398 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -94.67 97.37 10.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.629 0.728 . . . . 72.340000000000003 110.694 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.0 150.06 21.26 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.413 -0.812 . . . . 64.299999999999997 111.435 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -68.91 -24.14 64.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.12 0.486 . . . . 73.129999999999995 110.381 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -122.13 22.14 10.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.363 0.601 . . . . 73.310000000000002 109.521 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.72 108.0 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.677 . . . . 55.009999999999998 110.793 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -166.23 156.81 12.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.150000000000006 109.888 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 46' ' ' ILE . 61.9 t -73.8 125.14 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.031 -0.359 . . . . 71.299999999999997 110.031 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.63 -56.34 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.774 0.321 . . . . 75.530000000000001 110.586 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -144.45 159.31 42.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.406 -0.361 . . . . 72.230000000000004 110.179 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 9.7 pt-20 -129.01 142.61 50.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.161 -0.472 . . . . 71.040000000000006 110.799 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -112.03 173.36 6.4 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.499 -0.926 . . . . 75.019999999999996 108.499 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -74.51 69.18 1.67 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 54.240000000000002 109.749 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.77 -75.65 0.21 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.243 -0.743 . . . . 62.539999999999999 111.243 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -118.46 144.88 45.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.087 0.47 . . . . 73.340000000000003 110.782 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 27.4 m -101.39 139.38 37.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.724 -0.671 . . . . 74.319999999999993 110.678 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD2' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -82.03 114.69 20.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.401 0.68 . . . . 63.109999999999999 110.16 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 36' ' ' VAL . 20.1 pt -132.19 167.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.184 0.516 . . . . 73.540000000000006 111.551 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.84 114.63 14.92 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.574 -0.899 . . . . 74.310000000000002 108.574 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.673 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 43.3 t80 -99.7 88.37 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.864 0.364 . . . . 74.519999999999996 110.247 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 58.6 47.1 13.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.537 0.684 . . . . 52.219999999999999 110.88 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.35 -6.07 74.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.678 -0.772 . . . . 71.140000000000001 113.856 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 2.4 pt20 -113.24 162.41 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.678 0.739 . . . . 73.310000000000002 111.237 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -73.82 143.32 45.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.484 -0.78 . . . . 73.150000000000006 111.887 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . -161.92 155.58 26.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.541 -0.838 . . . . 51.32 112.508 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' HE1' ' HD2' ' A' ' 45' ' ' LYS . 78.8 m-85 -141.71 145.28 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.301 -0.629 . . . . 72.420000000000002 109.301 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 15' ' ' ARG . 2.5 pp -131.12 145.35 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 121.243 -0.183 . . . . 75.230000000000004 110.589 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.28 126.55 22.8 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.408 -0.901 . . . . 74.319999999999993 111.148 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -57.07 -22.06 36.38 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.507 0.323 . . . . 54.240000000000002 111.823 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -55.91 -34.63 65.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.463 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.726 ' HB2' ' HB3' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -127.68 119.15 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.011 0.434 . . . . 72.420000000000002 111.216 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -144.6 156.16 43.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.82 -0.807 . . . . 73.340000000000003 108.82 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.632 ' H ' HD23 ' A' ' 60' ' ' LEU . 34.5 t -98.84 141.78 31.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.931 0.395 . . . . 61.340000000000003 110.26 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -68.53 138.4 55.14 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.363 -0.835 . . . . 74.120000000000005 110.404 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.0 mt -102.8 -49.18 3.87 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.964 -0.754 . . . . 74.340000000000003 108.964 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 44.84 83.16 0.03 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.382 1.051 . . . . 74.549999999999997 111.989 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -63.56 126.61 28.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.406 -0.59 . . . . 65.340000000000003 109.406 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.9 146.73 37.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 64.299999999999997 110.444 -171.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -107.73 127.72 53.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 70.319999999999993 110.556 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -108.14 136.14 48.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.189 -0.671 . . . . 72.209999999999994 109.189 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -66.31 153.74 41.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 74.040000000000006 110.855 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.742 -0.647 . . . . 54.520000000000003 110.007 176.366 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.889 0.376 . . . . 74.420000000000002 110.183 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tt -147.3 112.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.561 0.696 . . . . 74.120000000000005 110.787 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.63 18.33 6.37 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.786 -0.926 . . . . 72.140000000000001 110.786 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 41.22 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.997 -0.602 . . . . 75.420000000000002 111.011 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -82.12 -52.67 6.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.376 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 60.85 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.692 0.758 . . . . 75.319999999999993 110.314 -172.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -106.49 -166.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.235 -0.893 . . . . 73.109999999999999 112.004 -169.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 9.0 p30 59.41 131.13 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.262 1.425 . . . . 75.209999999999994 113.27 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.59 -85.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.88 -1.055 . . . . 62.329999999999998 109.275 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 t -174.96 160.31 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 75.120000000000005 109.185 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.609 ' H ' ' HB3' ' A' ' 61' ' ' SER . . . 65.0 168.6 0.19 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.909 0.756 . . . . 64.019999999999996 112.691 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.7 mt 56.42 30.41 16.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.372 -0.831 . . . . 73.25 112.763 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' OD1' ' HB ' ' A' ' 55' ' ' ILE . 38.3 t30 -110.58 -59.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.162 0.506 . . . . 55.310000000000002 111.478 -176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.724 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 4.3 t -86.04 48.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 71.209999999999994 110.823 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 14.6 mmt180 -77.92 -1.11 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.08 -0.509 . . . . 73.400000000000006 112.235 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t 66.47 28.18 9.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.615 -1.254 . . . . 71.230000000000004 107.615 -167.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . 160.14 -170.36 36.21 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.421 -1.872 . . . . 71.219999999999999 108.421 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -110.56 -73.93 0.66 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.359 1.08 . . . . 75.239999999999995 109.619 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.79 -7.61 17.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 44.450000000000003 111.233 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.34 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.445 . . . . 72.010000000000005 111.271 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -141.78 130.96 23.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.909 -0.774 . . . . 61.530000000000001 108.909 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 49.8 p90 -130.02 8.2 5.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.085 -0.507 . . . . 72.310000000000002 110.675 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -79.18 -48.84 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.239 0.829 . . . . 71.319999999999993 113.239 -166.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.4 mp -77.47 -56.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.56 -0.456 . . . . 61.409999999999997 112.224 -167.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -130.3 163.71 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.79 -0.448 . . . . 72.340000000000003 109.79 -176.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.785 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -121.17 -67.13 0.26 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.059 -0.591 . . . . 20.010000000000002 112.019 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . . . -151.17 94.15 2.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.777 0.322 . . . . 73.439999999999998 110.401 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -157.59 86.04 2.68 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 72.129999999999995 109.926 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.732 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 51.3 Cg_endo -106.26 -164.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.81 3.006 . . . . 74.120000000000005 113.194 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.739 ' HG3' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER 75.39 109.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.311 -0.859 . . . . 75.420000000000002 112.567 170.126 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.89 -102.63 2.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.352 -0.84 . . . . 63.310000000000002 113.649 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.59 -13.17 60.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.269 0.557 . . . . 74.209999999999994 110.643 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD2' ' HE2' ' A' ' 48' ' ' TYR . 45.7 mmtm -126.46 136.57 52.8 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.502 -0.772 . . . . 73.510000000000005 109.405 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.67 148.46 5.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.974 0.416 . . . . 61.039999999999999 110.59 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.795 ' HG3' HG12 ' A' ' 36' ' ' VAL . 12.5 pt20 -124.2 -34.17 2.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 72.129999999999995 111.643 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.795 HG12 ' HG3' ' A' ' 35' ' ' GLN . 5.5 p -165.76 125.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.35 . . . . 75.209999999999994 111.079 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.6 mt -113.68 -56.24 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.45 -0.341 . . . . 72.239999999999995 110.601 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.3 t -155.22 149.25 25.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.033 0.444 . . . . 54.229999999999997 110.311 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -104.95 146.35 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.603 -0.726 . . . . 73.209999999999994 110.399 -173.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.49 119.51 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.461 -0.336 . . . . 74.310000000000002 110.784 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t 65.99 24.86 11.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.672 -0.695 . . . . 75.439999999999998 111.756 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.29 -46.63 1.13 Allowed Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.664 -0.779 . . . . 73.299999999999997 112.676 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 47.9 m0 -90.08 161.4 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 73.209999999999994 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 22.8 t -111.22 134.24 52.96 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.239 -1.022 . . . . 55.130000000000003 108.239 171.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 32.4 ttmt -82.09 130.93 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.983 -0.553 . . . . 74.239999999999995 111.889 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.747 ' HA ' HD12 ' A' ' 37' ' ' ILE . 23.2 pt -134.99 171.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.494 -0.776 . . . . 73.319999999999993 109.121 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.91 117.79 16.22 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.662 -0.415 . . . . 74.319999999999993 110.507 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 7.0 m-85 -122.48 114.18 20.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.003 0.43 . . . . 75.5 111.067 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.29 34.37 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.871 -1.059 . . . . 74.349999999999994 110.955 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.4 -17.76 46.24 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.833 -0.621 . . . . 51.219999999999999 113.693 173.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 4.1 pt20 -93.53 153.53 18.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.303 0.552 . . . . 71.420000000000002 110.197 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -75.0 118.06 17.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.172 -0.467 . . . . 33.439999999999998 110.856 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.92 168.57 13.07 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.748 -0.739 . . . . 73.430000000000007 111.883 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 84.7 m-85 -144.0 166.47 24.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.56 -0.533 . . . . 71.129999999999995 109.56 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 2.7 pp -123.79 143.42 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 108.702 -0.851 . . . . 72.239999999999995 108.702 166.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' A' ' 43' ' ' TRP . . . -96.55 100.31 2.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.15 -1.024 . . . . 71.129999999999995 111.251 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -50.52 -20.84 1.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.283 0.846 . . . . 63.450000000000003 113.283 -172.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.477 ' HA ' HG22 ' A' ' 7' ' ' ILE . 13.9 mtm180 -53.11 -37.19 61.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.766 0.317 . . . . 74.319999999999993 110.593 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.78 147.95 45.92 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.072 0.463 . . . . 72.439999999999998 109.846 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 8' ' ' ASN . 73.0 mt -152.59 135.79 15.75 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.479 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.609 ' HB3' ' H ' ' A' ' 11' ' ' ALA . 3.4 p -129.08 135.87 49.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.759 -0.655 . . . . 73.519999999999996 109.686 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -140.28 114.83 9.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.892 -0.41 . . . . 75.239999999999995 109.892 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.39 -42.86 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.509 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.739 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 11.6 pt-20 46.5 -163.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.108 0.88 . . . . 74.219999999999999 111.777 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -70.08 145.5 51.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.884 -0.413 . . . . 64.420000000000002 109.884 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -76.38 126.89 31.8 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.775 -0.454 . . . . 74.150000000000006 109.775 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.56 145.69 38.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.711 -0.396 . . . . 73.150000000000006 110.757 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 134.83 38.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 72.129999999999995 110.355 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -96.84 -34.66 11.2 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.418 -0.586 . . . . 71.439999999999998 109.418 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.202 -0.904 . . . . 37.850000000000001 109.674 174.101 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.575 0.226 . . . . 73.030000000000001 110.768 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.3 mp 50.12 87.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.515 -0.766 . . . . 62.149999999999999 111.942 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -20.01 75.29 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.361 -0.923 . . . . 61.130000000000003 111.415 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.6 t0 63.63 41.39 7.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.764 0.792 . . . . 62.409999999999997 110.204 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -80.98 95.58 6.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 74.439999999999998 110.657 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -68.47 124.29 23.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.827 -0.624 . . . . 73.140000000000001 109.962 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 16' ' ' SER . 4.0 mp -77.64 -72.41 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.842 -0.429 . . . . 61.109999999999999 109.842 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 69.69 -60.56 0.47 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.673 -0.694 . . . . 70.409999999999997 111.232 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.43 27.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.665 0.603 . . . . 72.219999999999999 111.301 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 t 72.4 -40.38 0.47 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.328 -0.851 . . . . 55.210000000000001 111.504 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.68 -61.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 70.329999999999998 111.18 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 129.39 34.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 111.639 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.13 6.93 20.53 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.657 0.741 . . . . 65.340000000000003 110.175 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.61 -3.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.775 1.028 . . . . 74.530000000000001 113.775 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HA ' HG22 ' A' ' 25' ' ' ILE . 17.9 mtm180 -121.41 -46.04 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.039 0.381 . . . . 74.049999999999997 111.113 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.621 ' HA ' HG21 ' A' ' 7' ' ' ILE . 66.4 m 64.91 4.25 2.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.481 0.919 . . . . 65.150000000000006 113.481 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.84 -109.58 1.71 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.964 -0.636 . . . . 74.109999999999999 112.272 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -157.63 154.61 28.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.474 -0.565 . . . . 65.340000000000003 109.474 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.94 -135.83 2.02 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.622 -0.799 . . . . 71.430000000000007 112.308 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -72.68 -8.11 53.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.919 0.39 . . . . 75.420000000000002 111.515 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -136.11 138.93 42.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.943 -0.762 . . . . 62.109999999999999 108.943 172.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.2 -16.39 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.776 0.798 . . . . 74.400000000000006 110.086 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 23' ' ' ARG . 61.3 mtt85 -89.16 6.54 39.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.732 -1.122 . . . . 74.530000000000001 109.871 172.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 55' ' ' ILE . 10.4 tp -55.83 -9.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 114.903 -1.044 . . . . 73.140000000000001 113.679 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 15' ' ' ARG . 1.3 pp -59.74 135.1 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 63.109999999999999 112.123 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.25 148.8 5.31 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.585 -0.816 . . . . 40.520000000000003 113.904 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.698 ' HA ' HD22 ' A' ' 60' ' ' LEU . . . -146.98 -178.51 6.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.655 -0.498 . . . . 62.450000000000003 109.655 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 36' ' ' VAL . 41.2 mt -128.67 65.84 73.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 111.861 0.319 . . . . 71.540000000000006 111.861 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 27' ' ' ALA . 3.6 Cg_endo -86.0 -55.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.29 1.993 . . . . 75.430000000000007 111.044 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 179.37 131.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.281 -0.872 . . . . 74.230000000000004 109.486 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.14 168.73 11.35 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.192 -1.004 . . . . 74.510000000000005 113.225 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.38 15.0 11.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.139 0.495 . . . . 73.200000000000003 110.532 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -25.44 62.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.77 -0.65 . . . . 75.310000000000002 110.264 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.869 HG13 ' H ' ' A' ' 35' ' ' GLN . 2.4 p -135.85 -80.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.029 -0.532 . . . . 64.030000000000001 110.092 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.869 ' H ' HG13 ' A' ' 34' ' ' VAL . 26.5 tt0 65.89 152.93 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.711 0.767 . . . . 73.230000000000004 112.123 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 28' ' ' LEU . 71.2 t -91.12 137.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.668 -0.697 . . . . 51.140000000000001 110.462 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.78 -55.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.245 -0.65 . . . . 74.430000000000007 109.245 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.9 m -159.45 155.32 26.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.243 -0.89 . . . . 75.120000000000005 109.097 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 7.7 pt-20 -124.91 141.97 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.962 0.41 . . . . 24.449999999999999 111.01 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.27 159.52 7.29 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.791 -0.641 . . . . 72.230000000000004 109.859 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 27.51 16.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.013 0.745 . . . . 72.040000000000006 113.013 158.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.83 -50.6 0.83 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.518 -0.849 . . . . 53.240000000000002 113.271 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -123.0 162.33 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.466 0.65 . . . . 65.230000000000004 111.251 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 20.8 t -103.45 120.47 40.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.194 -0.912 . . . . 64.030000000000001 108.687 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HD3' ' CE2' ' A' ' 54' ' ' TYR . 31.2 ttpt -82.45 137.01 34.8 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.529 0.566 . . . . 70.239999999999995 112.529 -171.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.7 170.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.192 -0.913 . . . . 63.530000000000001 110.547 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 24.4 t-20 -127.8 113.89 16.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.336 -0.616 . . . . 53.240000000000002 109.336 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.687 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 34.1 t80 -125.87 112.85 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.478 -0.328 . . . . 73.209999999999994 110.554 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.98 37.31 18.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.702 0.763 . . . . 73.310000000000002 110.509 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -17.45 58.52 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.634 -0.712 . . . . 73.030000000000001 114.022 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 29.7 pt20 -98.9 155.71 17.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.416 0.608 . . . . 74.120000000000005 110.789 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.8 m -97.57 114.06 25.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.759 -0.655 . . . . 71.540000000000006 109.773 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.06 -176.69 15.93 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.82 -0.705 . . . . 72.129999999999995 112.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 73.3 m-85 -136.89 139.31 41.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.18 -0.674 . . . . 71.049999999999997 109.18 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -120.18 155.58 23.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.881 -0.414 . . . . 60.049999999999997 109.881 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.66 116.37 4.35 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.03 -1.081 . . . . 35.240000000000002 111.553 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -12.36 25.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.692 0.397 . . . . 64.299999999999997 111.869 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -69.57 -34.77 74.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.387 -0.369 . . . . 74.120000000000005 111.508 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.76 120.01 26.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.086 0.47 . . . . 75.519999999999996 111.918 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 27' ' ' ALA . 56.4 mt -155.66 152.1 28.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.209999999999994 108.907 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -92.92 120.3 33.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.211 -0.663 . . . . 63.420000000000002 109.211 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.34 159.06 18.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.357 -0.383 . . . . 74.310000000000002 110.56 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.1 pp -82.57 -4.26 57.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.583 . . . . 54.219999999999999 110.57 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.7 tm-20 -88.99 152.54 21.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.441 -0.8 . . . . 75.209999999999994 108.953 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 14.5 m80 71.06 29.3 2.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.365 0.602 . . . . 74.109999999999999 109.76 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -77.62 140.29 39.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.157 -0.928 . . . . 73.329999999999998 110.496 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -114.17 138.92 49.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.517 -0.31 . . . . 74.540000000000006 110.645 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -117.1 -38.76 3.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.551 -0.537 . . . . 73.530000000000001 109.551 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -72.75 130.87 41.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 72.129999999999995 109.755 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 m170 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.102 -0.951 . . . . 73.040000000000006 109.721 179.913 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.114 -0.698 . . . . 75.209999999999994 109.114 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.86 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -92.26 118.65 38.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.193 0.521 . . . . 73.329999999999998 112.007 -174.244 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.36 -63.3 1.87 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.928 -0.869 . . . . 52.049999999999997 110.928 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 70.58 -56.07 0.61 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.879 0.872 . . . . 73.209999999999994 112.803 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.763 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 87.5 t80 -78.84 123.48 27.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.015 0.436 . . . . 70.219999999999999 111.637 -174.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -110.65 164.95 12.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 62.509999999999998 109.882 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -131.18 122.31 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 73.340000000000003 110.538 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.653 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.5 OUTLIER -84.49 163.02 19.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.673 . . . . 74.430000000000007 111.615 -176.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.48 166.13 32.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.881 -1.054 . . . . 74.439999999999998 108.615 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m 65.45 33.08 9.09 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.783 0.677 . . . . 75.530000000000001 110.373 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.51 -155.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.791 -0.64 . . . . 53.329999999999998 110.323 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HB2' ' HA3' ' A' ' 17' ' ' GLY . 27.1 tp 58.93 27.72 16.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.209 0.528 . . . . 72.129999999999995 110.71 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.545 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 5.8 t30 -58.41 -42.27 86.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.719 -0.673 . . . . 54.520000000000003 110.87 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.444 HG23 HD21 ' A' ' 13' ' ' ASN . 46.6 t -117.18 -65.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 107.697 -1.223 . . . . 72.140000000000001 107.697 170.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.678 ' HG2' HG22 ' A' ' 55' ' ' ILE . 4.3 mmp_? -138.57 -164.42 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.847 -1.069 . . . . 74.439999999999998 108.482 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 34.5 t 65.63 74.65 0.37 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.419 0.628 . . . . 64.209999999999994 110.699 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 12' ' ' LEU . . . -176.2 -173.71 42.09 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.49 -0.777 . . . . 72.129999999999995 111.2 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.13 84.14 1.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.391 0.615 . . . . 53.130000000000003 110.807 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.15 -86.8 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.345 -0.843 . . . . 43.450000000000003 111.311 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -123.52 -65.23 1.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.915 0.388 . . . . 73.200000000000003 110.661 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -130.86 133.06 45.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.602 -0.888 . . . . 71.409999999999997 108.602 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.7 p90 -108.91 8.4 26.44 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.124 0.416 . . . . 73.150000000000006 112.124 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 38.0 ttt180 -115.25 -2.44 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.787 -0.365 . . . . 74.349999999999994 111.633 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -58.41 -56.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.093 0.405 . . . . 75.329999999999998 112.093 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.7 mp -129.13 -78.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 63.32 110.23 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' A' ' 16' ' ' SER . . . 148.69 -171.23 29.06 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.217 -0.753 . . . . 72.230000000000004 111.217 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.28 94.41 4.33 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 65.140000000000001 110.543 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.5 pt? -120.52 85.37 37.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.375 0.607 . . . . 75.019999999999996 110.122 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.56 5.14 6.56 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.557 2.838 . . . . 64.519999999999996 113.029 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -81.36 59.52 4.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.719 . . . . 74.430000000000007 111.615 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.43 -33.88 5.04 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.808 -0.633 . . . . 72.129999999999995 113.432 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.47 -164.91 0.95 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.045 0.422 . . . . 74.540000000000006 110.35 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.758 ' HG3' ' H ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -175.55 -85.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.52 0.512 . . . . 75.209999999999994 110.373 175.121 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.758 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 36.9 t -142.12 -85.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.412 -0.588 . . . . 73.329999999999998 109.412 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.425 ' H ' ' HB ' ' A' ' 34' ' ' VAL . 21.3 mm-40 -157.89 -39.31 0.07 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 72.150000000000006 110.111 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.4 p 44.35 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.417 1.087 . . . . 70.340000000000003 112.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.57 -57.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 73.430000000000007 111.278 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 t -167.29 169.16 12.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 109.762 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.0 pt-20 -123.52 161.89 24.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.194 0.521 . . . . 75.540000000000006 111.418 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.21 115.3 4.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.25 -0.886 . . . . 65.030000000000001 109.528 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 t 68.67 26.3 6.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 43.450000000000003 111.419 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.28 -22.1 25.45 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.283 -0.961 . . . . 73.25 113.564 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -109.73 145.16 37.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.874 0.337 . . . . 73.230000000000004 110.942 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.6 m -109.59 132.11 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 71.109999999999999 109.742 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -84.45 132.5 34.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.849 0.356 . . . . 75.230000000000004 111.17 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -139.26 144.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.126 -0.488 . . . . 64.219999999999999 109.921 173.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.85 114.12 26.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.587 . . . . 71.120000000000005 109.414 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 60.5 t80 -110.79 107.71 17.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.574 -0.528 . . . . 74.209999999999994 109.574 -177.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 61.87 34.71 16.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.557 -0.747 . . . . 63.049999999999997 110.66 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 -17.89 58.24 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.67 -0.696 . . . . 52.240000000000002 113.995 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -95.99 154.96 16.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.026 0.913 . . . . 74.400000000000006 110.788 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -87.42 123.92 32.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.916 -0.584 . . . . 74.450000000000003 110.791 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.97 169.66 21.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.65 -0.58 . . . . 63.119999999999997 111.65 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 99.3 m-85 -136.39 143.11 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.897 0.348 . . . . 75.239999999999995 110.818 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -119.52 166.36 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 72.049999999999997 109.581 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 132.97 11.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.374 -0.917 . . . . 70.519999999999996 112.458 -176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 m -67.61 -17.64 64.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.788 0.328 . . . . 65.310000000000002 111.151 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 58' ' ' ARG . 5.3 mmt85 -53.98 -50.23 67.03 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.238 -0.437 . . . . 65.120000000000005 111.196 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' HB3' ' OD1' ' A' ' 8' ' ' ASN . 22.5 m-85 -121.38 118.86 30.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.975 -0.379 . . . . 75.219999999999999 109.975 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 55' ' ' ILE . 26.3 mt -155.66 148.29 24.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.843 0.354 . . . . 45.5 110.663 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 p -108.25 121.74 45.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.215 -0.448 . . . . 52.039999999999999 110.675 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.763 ' HB2' ' HD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -66.86 147.51 53.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.012 -0.736 . . . . 74.319999999999993 109.012 171.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HG ' ' HE2' ' A' ' 33' ' ' LYS . 5.8 mp -77.5 5.5 8.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.143 0.794 . . . . 65.129999999999995 113.143 -166.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -79.22 78.81 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.327 0.584 . . . . 61.039999999999999 109.941 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.49 170.72 15.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.807 -0.633 . . . . 73.329999999999998 110.133 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -76.39 153.52 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 73.430000000000007 110.913 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 81.8 m-70 -119.64 169.29 10.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 73.019999999999996 110.012 174.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 8.5 m-70 69.76 87.22 0.12 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.892 0.745 . . . . 72.120000000000005 111.274 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -119.81 129.68 54.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.317 -0.856 . . . . 73.129999999999995 109.359 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 74.140000000000001 110.173 176.626 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 25.8 ttt . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 111.087 0.032 . . . . 72.019999999999996 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 1' ' ' MET . 44.1 mm 70.13 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 123.484 0.49 . . . . 52.340000000000003 110.588 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.49 63.42 0.9 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.271 -1.132 . . . . 73.129999999999995 110.271 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.524 . . . . 74.230000000000004 112.371 -173.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -170.37 -68.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 72.310000000000002 110.532 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.566 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 11.2 t80 -158.29 -69.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 72.010000000000005 109.511 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 11' ' ' ALA . 54.8 mt 72.22 142.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.261 0.553 . . . . 74.450000000000003 112.223 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -113.97 85.79 2.28 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.957 -0.565 . . . . 54.25 110.501 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.21 -82.03 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.312 -0.858 . . . . 44.439999999999998 113.289 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -81.12 -62.8 1.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.143 0.423 . . . . 54.140000000000001 112.143 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 7' ' ' ILE . . . 63.92 -179.45 0.16 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.123 -0.49 . . . . 63.229999999999997 112.08 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.539 HD22 HD21 ' A' ' 28' ' ' LEU . 87.2 mt 65.13 1.23 1.47 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.264 0.839 . . . . 63.219999999999999 113.264 173.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -118.94 9.81 12.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.337 0.495 . . . . 73.349999999999994 112.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' H ' ' A' ' 17' ' ' GLY . 46.8 t -65.92 -59.96 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.937 0.347 . . . . 62.409999999999997 111.937 -170.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.579 ' NH1' ' HA ' ' A' ' 65' ' ' HIS . 20.0 ttm105 65.84 74.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.711 -0.677 . . . . 73.530000000000001 111.11 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 24' ' ' ILE . 37.8 p 49.38 31.65 4.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.417 -0.811 . . . . 71.439999999999998 113.176 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.636 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -80.51 -7.03 88.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.742 . . . . 70.219999999999999 112.104 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.76 107.49 3.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 61.32 109.78 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.72 -173.27 43.91 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.538 -0.625 . . . . 73.319999999999993 111.538 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -83.56 -24.17 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.093 0.473 . . . . 74.439999999999998 110.906 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -124.99 133.32 53.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.69 -0.856 . . . . 53.530000000000001 108.69 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.96 8.03 43.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 110.973 -173.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -115.96 -0.79 12.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 61.409999999999997 111.18 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.457 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 2.3 pp -88.54 0.12 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.682 0.623 . . . . 72.200000000000003 112.682 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.6 mt 68.54 172.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.109 0.48 . . . . 72.209999999999994 111.345 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 25' ' ' ILE . . . 177.46 49.36 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.037 -1.225 . . . . 72.540000000000006 110.037 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.53 9.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.883 0.373 . . . . 75.239999999999995 111.443 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD21 HD22 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.58 69.12 79.08 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.586 -0.894 . . . . 53.229999999999997 108.586 172.078 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.66 67.39 6.42 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.342 2.695 . . . . 64.329999999999998 112.503 -168.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 69.18 119.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.937 -1.028 . . . . 60.32 112.002 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.1 -6.95 37.32 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.091 -0.804 . . . . 64.150000000000006 111.091 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 28' ' ' LEU . 7.6 tp60 -147.77 134.72 20.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.756 . . . . 72.310000000000002 108.96 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -128.03 92.77 3.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 71.409999999999997 111.118 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 28' ' ' LEU . 27.5 m -100.72 176.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.196 -0.668 . . . . 75.010000000000005 109.196 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -137.76 146.26 43.41 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.681 -0.408 . . . . 74.030000000000001 110.547 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.2 113.04 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.341 -0.39 . . . . 74.230000000000004 110.138 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 37' ' ' ILE . 4.0 mp -71.42 -56.74 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 64.510000000000005 110.481 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -170.36 165.76 8.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.585 -0.734 . . . . 61.310000000000002 110.693 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -118.02 169.32 9.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.111 -0.949 . . . . 63.140000000000001 110.094 178.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -173.48 123.38 0.37 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.106 0.254 . . . . 71.239999999999995 110.789 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t 70.65 32.44 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 54.219999999999999 110.874 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.37 -36.29 4.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.749 -0.739 . . . . 45.030000000000001 112.617 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -100.32 155.7 17.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.913 0.387 . . . . 73.409999999999997 110.779 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 25.6 t -110.11 139.94 44.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.939 -0.573 . . . . 72.019999999999996 109.904 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.693 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 14.6 ttmt -89.67 129.21 36.13 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.096 -0.502 . . . . 73.239999999999995 111.207 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.85 143.2 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.598 -0.728 . . . . 71.049999999999997 110.598 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -109.73 114.59 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.623 -0.88 . . . . 75.209999999999994 108.623 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 1.8 t80 -122.84 110.22 15.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.304 -0.407 . . . . 73.439999999999998 110.457 -174.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.71 34.28 22.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.561 0.696 . . . . 73.329999999999998 110.676 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.87 73.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 72.209999999999994 113.671 174.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.9 pt20 -118.8 156.08 30.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.437 0.619 . . . . 64.239999999999995 110.257 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m -98.6 128.11 44.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 72.120000000000005 111.302 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 24' ' ' ILE . . . -116.12 162.47 12.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.091 -0.576 . . . . 20.350000000000001 111.803 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 91.1 m-85 -138.3 139.09 38.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.848 -0.427 . . . . 72.420000000000002 109.848 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.587 HD13 HD21 ' A' ' 60' ' ' LEU . 2.4 pp -137.75 154.95 29.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 74.140000000000001 110.907 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 110.45 3.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.362 -0.695 . . . . 60.530000000000001 111.362 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -4.39 53.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.575 0.226 . . . . 70.450000000000003 111.479 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.566 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 70.4 mtt180 -61.72 -53.57 54.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.17 0.509 . . . . 64.140000000000001 109.989 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.51 118.97 21.9 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.038 -0.528 . . . . 74.430000000000007 110.291 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 55' ' ' ILE . 95.8 mt -114.36 127.49 55.87 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.578 -0.737 . . . . 71.400000000000006 109.052 176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 14' ' ' VAL . 25.4 t -148.61 159.82 43.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.034 -0.53 . . . . 61.32 110.091 -171.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -75.6 113.17 12.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.763 -0.199 . . . . 72.209999999999994 110.819 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD22 ' HA3' ' A' ' 17' ' ' GLY . 10.1 mp -96.77 -65.56 0.96 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.833 -0.347 . . . . 62.340000000000003 110.809 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -159.16 167.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.809 0.338 . . . . 74.099999999999994 111.196 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.579 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 51.8 p-80 -125.47 11.52 8.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 75.310000000000002 110.786 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.27 136.82 7.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 109.747 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.44 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 15.0 t60 -133.19 -72.26 0.51 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.951 -0.299 . . . . 73.230000000000004 111.293 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 67' ' ' HIS . 78.8 t60 70.72 121.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.905 0.753 . . . . 73.450000000000003 110.461 -171.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -74.54 121.31 21.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 109.956 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.366 -0.826 . . . . 70.549999999999997 110.252 179.147 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.652 0.263 . . . . 62.329999999999998 110.539 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.41 16.3 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.891 0.33 . . . . 73.329999999999998 111.891 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.33 -14.48 28.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.516 -0.849 . . . . 63.200000000000003 112.751 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.586 ' HB3' HD11 ' A' ' 7' ' ' ILE . 22.5 m-20 -80.97 104.74 11.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.658 0.266 . . . . 63.539999999999999 110.512 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.59 133.58 55.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.418 -0.355 . . . . 72.439999999999998 110.774 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 56.83 86.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.669 0.606 . . . . 75.329999999999998 110.993 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 4' ' ' ASP . 43.6 mm -82.28 89.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 71.299999999999997 111.791 -172.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 73.77 -64.55 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.339 -0.846 . . . . 74.209999999999994 113.28 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.18 -163.98 0.25 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.413 0.446 . . . . 71.340000000000003 110.094 -171.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 p -97.66 18.48 15.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.981 0.42 . . . . 72.400000000000006 110.735 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.42 -82.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.41 -0.359 . . . . 65.230000000000004 111.656 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 5.3 mp -76.35 92.9 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 74.439999999999998 110.792 -174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 61' ' ' SER . 29.6 m-80 -117.56 -58.31 2.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 73.329999999999998 111.931 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 48' ' ' TYR . 2.6 t -121.14 37.31 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.441 0.639 . . . . 72.430000000000007 110.314 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 20.0 mmm180 -75.41 32.73 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 75.430000000000007 111.874 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 33.0 t 60.69 37.42 19.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.675 0.75 . . . . 60.32 109.822 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 90.34 -57.89 3.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.179 -0.919 . . . . 71.409999999999997 111.372 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.64 168.76 22.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.47 -0.937 . . . . 74.340000000000003 108.47 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.44 36.91 0.82 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.371 -0.442 . . . . 75.219999999999999 113.437 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.1 m -90.34 -34.08 15.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.338 -0.615 . . . . 74.430000000000007 109.338 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -142.74 52.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.541 -0.911 . . . . 72.219999999999999 108.541 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -62.5 -6.36 3.33 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.477 -1.238 . . . . 73.099999999999994 113.422 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -72.19 -11.99 60.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.198 0.444 . . . . 74.439999999999998 112.198 -174.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.887 HG22 HG13 ' A' ' 25' ' ' ILE . 47.5 mm -70.62 -55.79 13.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.301 0.482 . . . . 72.150000000000006 112.301 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.887 HG13 HG22 ' A' ' 24' ' ' ILE . 18.7 mt -135.98 -83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 121.035 -0.266 . . . . 75.540000000000006 111.239 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 15' ' ' ARG . . . 124.96 -169.24 16.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.578 -0.82 . . . . 30.449999999999999 112.465 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.51 92.67 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.456 -0.438 . . . . 31.039999999999999 110.693 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.76 87.8 2.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.649 -0.705 . . . . 73.219999999999999 109.743 176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.67 72.81 3.66 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.991 2.46 . . . . 73.0 112.459 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -168.5 98.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.563 . . . . 74.349999999999994 110.453 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.37 167.44 12.37 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 111.103 -0.799 . . . . 60.409999999999997 111.103 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.59 80.77 5.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.269 0.557 . . . . 74.519999999999996 110.953 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 3.7 mptp? 58.75 62.44 1.92 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.017 -0.992 . . . . 63.210000000000001 111.264 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.09 125.62 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.336 -0.847 . . . . 71.430000000000007 110.56 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' HG21 ' A' ' 46' ' ' ILE . 24.2 mp0 -133.31 -68.46 0.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 71.310000000000002 109.989 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -141.02 126.62 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 109.899 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.8 mt -114.44 -56.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 64.109999999999999 111.494 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.0 t -141.06 155.43 46.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 74.310000000000002 110.383 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 14.3 mp0 -114.8 135.94 53.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 110.526 -175.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -107.59 174.86 5.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.129 -0.693 . . . . 70.129999999999995 109.129 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.0 m -71.12 75.16 0.68 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.745 -0.661 . . . . 71.530000000000001 110.563 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.79 -61.25 0.48 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.728 -0.669 . . . . 75.409999999999997 111.621 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -126.69 162.67 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.092 0.472 . . . . 63.399999999999999 110.276 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 37.9 t -96.77 129.23 44.23 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.968 -0.753 . . . . 70.25 108.968 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -90.73 130.69 36.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.558 -0.292 . . . . 65.319999999999993 111.115 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.98 148.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 64.299999999999997 110.175 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.01 112.55 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.851 -0.796 . . . . 74.519999999999996 108.851 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 14' ' ' VAL . 11.9 t80 -109.8 98.99 8.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.088 -0.505 . . . . 74.420000000000002 110.465 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.41 40.52 24.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.36 0.6 . . . . 71.329999999999998 110.861 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 -17.57 59.06 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.858 -0.61 . . . . 60.43 114.405 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.84 154.88 24.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.077 0.939 . . . . 73.430000000000007 110.994 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.4 m -76.52 119.03 19.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 74.450000000000003 110.793 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.727 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -122.31 175.45 16.39 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.032 -0.604 . . . . 62.340000000000003 111.914 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' SER . 81.3 m-85 -135.68 151.44 50.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.107 0.48 . . . . 74.439999999999998 111.198 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.672 HG12 HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.59 146.41 27.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.458 -0.792 . . . . 71.099999999999994 109.988 175.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -85.15 159.84 34.37 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.428 -0.892 . . . . 71.120000000000005 112.054 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -42.2 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.116 0.484 . . . . 73.219999999999999 110.227 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -76.86 -51.84 10.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.651 -0.704 . . . . 73.099999999999994 110.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 12' ' ' LEU . 63.1 m-85 -107.84 119.26 38.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.745 . . . . 75.209999999999994 108.99 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 61' ' ' SER . 4.8 tt -154.11 157.52 39.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.797 -1.092 . . . . 64.519999999999996 108.154 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 14.0 p -81.83 117.54 22.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.372 0.606 . . . . 62.119999999999997 110.667 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 60' ' ' LEU . 4.2 mppt? -127.66 114.15 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 74.329999999999998 109.761 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.65 -36.58 82.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.597 -0.729 . . . . 72.450000000000003 110.998 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 72.4 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.399 0.619 . . . . 73.400000000000006 110.269 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -128.11 4.66 5.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.909 -1.145 . . . . 71.430000000000007 107.909 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -143.93 102.66 3.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.597 -1.183 . . . . 74.209999999999994 109.885 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -65.22 158.48 26.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 64.299999999999997 109.994 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -120.08 102.84 8.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.544 0.688 . . . . 64.109999999999999 111.285 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 12.7 t-160 -80.52 148.61 30.33 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.812 -1.181 . . . . 74.219999999999999 107.812 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 57.2 m-70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.828 -0.606 . . . . 74.530000000000001 109.725 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' OD1' ' A' ' 4' ' ' ASP . 26.2 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 110.068 -0.345 . . . . 72.319999999999993 110.068 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.61 -19.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.493 0.664 . . . . 54.030000000000001 110.191 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.91 49.27 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.316 -1.514 . . . . 63.43 109.316 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -82.66 156.67 23.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.328 -0.936 . . . . 75.010000000000005 111.374 -167.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 62.21 74.16 0.45 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.339 -0.846 . . . . 73.530000000000001 111.405 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -96.41 98.13 10.01 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.559 0.695 . . . . 74.120000000000005 109.251 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.4 tp -147.2 100.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 75.340000000000003 111.258 -172.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.07 -86.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.308 -0.86 . . . . 71.349999999999994 112.093 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.09 -154.01 0.3 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.401 0.438 . . . . 63.020000000000003 110.106 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 p -124.65 80.91 1.9 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.313 0.578 . . . . 70.120000000000005 109.672 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.35 167.83 21.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.63 -0.714 . . . . 63.210000000000001 110.598 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.815 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.0 pt? -113.98 118.87 35.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.38 0.61 . . . . 73.329999999999998 110.944 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.2 t-20 -83.82 -15.89 46.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.784 -0.643 . . . . 64.129999999999995 110.326 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 12.3 p -68.91 -12.68 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.376 -0.829 . . . . 71.109999999999999 113.144 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -101.79 67.25 1.09 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.801 -0.76 . . . . 74.049999999999997 110.193 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p 47.49 47.31 17.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.997 -1.001 . . . . 70.109999999999999 111.53 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.31 -91.35 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.018 -0.61 . . . . 43.439999999999998 112.833 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.24 111.7 1.71 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.108 0.48 . . . . 73.409999999999997 110.847 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.45 26.11 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.564 -1.015 . . . . 52.100000000000001 110.564 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 54' ' ' TYR . 5.2 m -70.11 -44.93 67.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.243 0.522 . . . . 72.299999999999997 109.873 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.77 90.18 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.13 -0.693 . . . . 70.549999999999997 109.13 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -108.96 10.33 26.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.481 -0.781 . . . . 75.519999999999996 110.99 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -44.56 -59.05 2.64 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.629 0.581 . . . . 72.420000000000002 112.516 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -121.89 -20.86 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 72.409999999999997 110.972 -179.14 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.0 pp -138.16 -164.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.51 -0.314 . . . . 72.530000000000001 111.708 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA2' HG21 ' A' ' 55' ' ' ILE . . . 177.35 -79.28 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 72.5 113.041 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.623 ' H ' ' N ' ' A' ' 14' ' ' VAL . . . -74.55 172.08 12.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 72.219999999999999 111.719 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.9 89.09 8.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.695 -0.684 . . . . 71.299999999999997 109.515 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 43.3 Cg_endo -69.53 -55.76 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.495 2.13 . . . . 52.340000000000003 112.667 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -118.88 -39.44 2.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.32 -0.622 . . . . 63.420000000000002 109.32 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.77 2.63 58.44 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.567 -0.742 . . . . 71.329999999999998 112.037 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -78.27 66.95 3.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.954 0.407 . . . . 61.32 110.793 -175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 179.2 -49.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.522 -0.763 . . . . 74.109999999999999 109.601 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.729 ' HB ' ' HD1' ' A' ' 48' ' ' TYR . 10.9 p -97.84 -39.51 8.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.625 -0.716 . . . . 73.129999999999995 110.733 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 64.45 174.32 0.19 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.174 0.59 . . . . 62.329999999999998 111.74 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -86.7 121.58 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.332 0.587 . . . . 71.219999999999999 111.223 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.7 mt -107.47 -53.23 6.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 72.349999999999994 110.701 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -164.56 149.85 10.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 72.439999999999998 110.894 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.93 143.65 46.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.54 -0.755 . . . . 74.150000000000006 110.626 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -125.64 173.46 8.97 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.379 0.609 . . . . 75.340000000000003 109.52 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.2 m -84.43 80.36 9.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.024 -0.989 . . . . 55.140000000000001 110.059 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.64 -53.62 0.68 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 63.32 112.112 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -120.85 152.87 37.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 75.239999999999995 110.662 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.06 119.97 40.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.768 -0.827 . . . . 61.450000000000003 108.768 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.9 ttmt -82.89 121.04 26.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.588 -0.733 . . . . 60.200000000000003 111.377 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.627 ' HB ' HG21 ' A' ' 34' ' ' VAL . 32.7 pt -142.3 153.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.598 -0.728 . . . . 75.219999999999999 111.54 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -116.95 114.06 23.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.501 -0.926 . . . . 73.340000000000003 108.501 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.729 ' HD1' ' HB ' ' A' ' 34' ' ' VAL . 28.8 t80 -119.34 114.28 22.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.47 -0.332 . . . . 63.340000000000003 110.823 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 t30 58.4 34.53 24.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.476 0.655 . . . . 63.009999999999998 110.994 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.24 69.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.603 -0.808 . . . . 71.219999999999999 113.69 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.1 pt20 -103.94 148.06 26.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.618 0.709 . . . . 73.200000000000003 110.984 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -85.7 117.16 24.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.769 . . . . 62.020000000000003 109.777 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.39 150.03 18.02 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.185 -1.007 . . . . 75.329999999999998 112.496 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' THR . 49.5 m-85 -127.67 140.07 52.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.079 -0.712 . . . . 72.140000000000001 109.079 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 ' HA2' ' A' ' 26' ' ' GLY . 2.7 pp -135.61 160.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.94 -0.393 . . . . 55.420000000000002 109.94 177.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.12 124.35 6.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.299 -0.953 . . . . 62.25 112.145 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 m -61.43 -18.75 60.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.505 0.669 . . . . 62.100000000000001 110.202 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -69.3 -9.12 51.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.392 -0.822 . . . . 72.340000000000003 111.447 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 13' ' ' ASN . 7.4 m-85 -131.58 115.06 15.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.803 0.335 . . . . 71.430000000000007 110.122 171.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -157.74 174.15 15.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.803 -0.635 . . . . 72.0 109.742 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 15.4 t -108.28 118.93 38.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.52 -0.918 . . . . 65.409999999999997 108.52 172.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -119.05 79.97 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.47 -0.567 . . . . 52.439999999999998 109.47 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 65' ' ' HIS . 0.6 OUTLIER -138.02 -48.64 0.55 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 65.109999999999999 110.649 -174.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.25 77.87 0.18 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.811 0.694 . . . . 72.129999999999995 109.18 -166.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.438 ' HB3' HD12 ' A' ' 63' ' ' LEU . 33.8 p-80 -89.92 151.06 21.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 74.120000000000005 110.841 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 67.65 98.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.186 0.929 . . . . 75.349999999999994 111.575 -173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -82.81 -37.66 24.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.413 -0.958 . . . . 72.040000000000006 108.413 172.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -90.2 142.71 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.32 -0.854 . . . . 71.430000000000007 109.668 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 30.7 p-80 -117.99 73.94 0.92 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.146 -0.687 . . . . 72.299999999999997 109.146 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 34.1 m80 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 114.777 -1.101 . . . . 65.150000000000006 110.281 -170.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.848 -0.427 . . . . 71.11 109.848 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 87.2 mt -71.05 90.67 0.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.571 -0.529 . . . . 71.32 109.571 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 72.5 m-20 -97.96 -29.94 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 75.13 112.131 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 55' ' ' ILE . 63.6 t -64.86 -51.39 67.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.718 -0.475 . . . . 72.32 109.718 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.898 ' HG3' HD12 ' A' ' 25' ' ' ILE . 6.5 mtp180 -155.31 -177.01 6.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.151 -0.931 . . . . 70.03 108.528 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 22.9 t 75.16 3.96 4.14 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.977 0.798 . . . . 71.21 110.246 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.57 16.91 31.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.002 -0.618 . . . . 63.35 111.968 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -99.69 -46.71 5.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.002 -0.74 . . . . 75.41 109.002 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.52 4.87 49.29 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.72 -1.127 . . . . 72.32 110.57 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -101.34 -51.39 3.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.275 -0.462 . . . . 73.44 110.717 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.5 88.6 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.379 -0.6 . . . . 74.21 109.379 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 19.6 p90 -95.82 4.7 52.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.879 0.696 . . . . 64.44 112.879 -169.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -106.37 -0.06 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.252 -0.579 . . . . 71.31 111.513 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.794 HG22 HG13 ' A' ' 25' ' ' ILE . 54.2 mt -77.41 -55.82 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.338 -0.392 . . . . 44.44 111.854 -174.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.898 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.0 mt -140.54 178.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.554 -0.535 . . . . 72.51 109.554 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -125.83 -118.1 2.22 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.954 -0.641 . . . . 71.05 112.534 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.912 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -139.81 105.68 5.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.022 0.439 . . . . 62.14 111.933 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -152.32 57.68 2.26 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.842 -0.617 . . . . 64.45 111.054 173.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 28' ' ' LEU . 19.7 Cg_endo -95.66 166.29 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.19 2.594 . . . . 64.22 112.172 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 63.44 104.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.4 0.619 . . . . 73.12 111.373 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.94 -32.58 7.36 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.394 -0.682 . . . . 72.43 111.394 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.33 -172.71 2.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 64.52 110.021 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 38.7 ttpt -85.98 157.66 20.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.299 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 94.2 t 76.23 126.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.695 0.759 . . . . 72.44 112.056 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.83 175.45 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 64.35 109.839 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 46' ' ' ILE . 17.3 m -76.06 125.67 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.961 -0.385 . . . . 55.21 109.961 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -81.63 -55.97 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.46 -0.337 . . . . 51.21 110.515 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -171.07 150.82 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 31.15 110.9 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -80.02 131.43 35.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.577 -0.738 . . . . 73.05 110.193 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -134.96 114.49 12.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.615 0.245 . . . . 74.34 110.956 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t 71.84 5.52 5.38 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.453 -0.794 . . . . 73.44 111.779 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.4 -48.76 0.95 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 64.22 111.854 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -84.67 160.53 20.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 73.52 110.315 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 68.5 m -96.28 140.25 31.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.766 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -82.86 118.69 23.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.07 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -133.81 144.55 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 64.22 110.232 173.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -122.03 113.55 19.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.975 -1.12 . . . . 64.43 107.975 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 69.3 t80 -105.56 86.1 2.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.138 -0.483 . . . . 74.45 110.908 -170.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 62.32 46.33 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.229 0.538 . . . . 74.41 110.826 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.46 -17.57 58.75 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 73.32 113.512 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.3 pt20 -103.48 128.1 50.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.38 0.609 . . . . 74.1 110.225 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 151.82 21.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 40.32 111.067 -172.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.96 173.7 38.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.403 -0.903 . . . . 54.01 113.353 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 72.1 m-85 -132.97 144.74 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 74.21 109.269 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 15' ' ' ARG . 2.8 pp -136.03 161.69 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.618 0.247 . . . . 74.44 110.946 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.36 123.31 6.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.601 -0.809 . . . . 44.24 111.814 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -64.76 -7.07 9.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.009 0.433 . . . . 71.42 111.7 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -65.76 -37.57 86.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.454 -0.339 . . . . 75.21 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -124.32 120.64 32.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.523 0.678 . . . . 75.4 111.744 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 66.6 mt -155.89 175.64 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.112 -1.44 . . . . 73.33 107.112 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 29' ' ' PRO . 6.1 p -111.47 118.14 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.607 -0.837 . . . . 55.23 111.456 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.029 -0.987 . . . . 71.35 109.206 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.285 0 CA-C-O 121.054 0.454 . . . . 70.44 110.389 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -79.95 69.6 6.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.82 0.819 . . . . 73.01 109.499 174.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -117.61 -44.73 2.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.787 -1.097 . . . . 71.51 110.578 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.413 HG12 ' NE ' ' A' ' 15' ' ' ARG . 18.9 t -124.68 -67.11 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.32 -0.4 . . . . 71.11 111.04 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.581 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -130.59 142.47 50.46 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.553 -0.294 . . . . 74.12 110.894 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 53.9 p 45.92 74.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 124.087 0.867 . . . . 65.42 112.654 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . -127.49 -14.69 2.58 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.421 -0.895 . . . . 43.53 111.992 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -163.5 115.62 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.076 -0.713 . . . . 60.13 109.076 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.51 -152.95 24.96 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.5 -0.857 . . . . 73.45 112.402 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -68.91 -31.92 71.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 75.03 111.571 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -133.04 123.57 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 14.6 p90 -130.12 8.59 5.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.731 0.641 . . . . 75.34 112.731 -171.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -116.79 -11.16 10.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.329 0.862 . . . . 72.51 113.329 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 25' ' ' ILE . 5.0 pt -67.15 -56.45 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 114.365 1.246 . . . . 74.03 114.365 -167.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 15' ' ' ARG . 3.3 mp -111.73 -63.58 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.428 1.013 . . . . 54.23 111.664 -176.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.8 -151.61 16.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.212 -0.994 . . . . 52.45 112.944 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.3 97.71 6.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 55.14 111.28 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.2 tp -160.75 87.68 1.75 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.95 -0.568 . . . . 71.53 110.086 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -82.56 81.67 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.874 2.383 . . . . 63.42 111.549 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -104.3 -48.36 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 74.13 110.39 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.12 104.66 0.39 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 72.31 112.031 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.91 98.65 11.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.46 . . . . 62.01 110.246 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -149.43 42.7 0.92 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.964 -0.754 . . . . 42.43 108.964 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG11 ' CE1' ' A' ' 48' ' ' TYR . 6.2 p -123.14 -46.78 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.743 -0.662 . . . . 75.42 111.677 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.482 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -83.54 76.71 9.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.497 0.665 . . . . 45.14 110.629 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.66 3.32 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.771 -1.104 . . . . 64.41 109.15 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -77.06 -57.76 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.81 -0.632 . . . . 72.02 110.631 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 p -178.62 149.98 0.51 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.475 0.655 . . . . 42.23 111.661 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.67 127.23 56.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.987 -1.006 . . . . 71.53 108.55 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.94 171.43 7.52 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.541 -0.464 . . . . 75.25 110.776 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.3 t -64.57 -22.27 66.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 34.34 110.826 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.87 -73.78 0.99 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.971 -0.633 . . . . 41.44 111.972 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -117.23 161.91 18.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.151 0.501 . . . . 73.02 110.877 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 57' ' ' THR . 35.4 t -87.97 126.72 35.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.012 -0.736 . . . . 64.24 109.012 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.9 ttmt -83.97 123.05 29.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.133 0.492 . . . . 64.21 111.326 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 35' ' ' GLN . 20.0 pt -139.91 156.8 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 61.2 110.648 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -126.3 113.75 17.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 73.3 109.074 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CE1' ' HD3' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -101.26 84.11 2.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.619 -0.432 . . . . 74.32 110.832 -178.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.29 56.15 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 74.13 112.098 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.74 56.57 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.09 -0.576 . . . . 42.22 114.16 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.22 128.72 54.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.653 0.726 . . . . 62.21 110.501 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -73.18 133.55 44.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.169 -0.923 . . . . 74.44 110.577 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.8 159.02 23.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.812 -0.708 . . . . 52.41 111.671 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -138.48 139.8 38.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.61 -0.515 . . . . 74.53 109.61 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 60' ' ' LEU . 2.6 pp -137.52 149.12 25.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.517 -0.311 . . . . 71.23 110.453 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 123.1 8.21 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.638 -0.791 . . . . 74.2 111.943 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -62.3 -18.15 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 73.53 112.058 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.51 -32.98 74.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.026 -0.533 . . . . 75.24 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.87 114.37 26.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.615 0.245 . . . . 73.22 110.354 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 55' ' ' ILE . 32.3 mt -159.22 151.51 21.22 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.884 -0.598 . . . . 73.41 111.206 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -97.25 118.82 34.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 164.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.797 0.332 . . . . 65.02 111.108 -173.352 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 111.999 0.37 . . . . 60.12 111.999 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 6.4 mp -80.69 44.94 0.76 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.75 0.31 . . . . 71.04 111.459 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 22.4 m120 -74.98 -31.01 61.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 64.03 111.569 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.488 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -95.11 30.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 74.4 111.603 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.841 HH11 ' HA2' ' A' ' 26' ' ' GLY . 17.8 tpt180 -80.48 47.88 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.709 0.29 . . . . 74.1 111.463 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 t 64.51 4.87 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.494 0.717 . . . . 62.01 112.616 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.32 80.73 0.7 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.393 -0.908 . . . . 63.41 111.484 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 19' ' ' GLY . 35.6 tt0 70.93 175.9 0.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.946 0.498 . . . . 62.22 109.74 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -79.01 59.1 4.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.818 -0.706 . . . . 63.44 112.879 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -93.79 -33.33 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.104 0.478 . . . . 65.34 110.148 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' A' ' 24' ' ' ILE . 22.2 t-20 -153.3 145.2 23.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.257 -1.016 . . . . 75.13 108.257 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 7.11 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.959 -0.697 . . . . 74.44 111.755 -173.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -116.68 -32.78 5.06 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.832 -0.747 . . . . 74.43 112.738 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.501 HG22 HG13 ' A' ' 25' ' ' ILE . 70.4 mt -61.4 -55.96 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 72.54 111.19 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.596 HG23 ' CZ ' ' A' ' 48' ' ' TYR . 12.9 mt -129.7 158.75 42.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.841 ' HA2' HH11 ' A' ' 15' ' ' ARG . . . -131.42 -105.02 1.01 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.968 -1.111 . . . . 43.44 113.924 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -147.22 93.58 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.617 -0.512 . . . . 63.13 109.617 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 28' ' ' LEU . 1.3 tm? -154.09 80.54 4.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.488 -0.56 . . . . 63.52 109.488 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 10.3 Cg_exo -75.23 89.09 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.107 2.538 . . . . 73.1 112.115 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.81 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tt0 -117.51 -49.33 2.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.675 -0.693 . . . . 72.31 109.391 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.85 17.08 79.21 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.781 -0.645 . . . . 54.41 114.291 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.81 ' HG3' ' HG2' ' A' ' 30' ' ' GLN . 31.5 mt-30 -80.94 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.618 0.709 . . . . 71.13 110.152 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 4.3 mptp? -101.14 0.1 37.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.381 0.61 . . . . 54.33 109.935 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 41.3 t -93.26 92.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 72.14 109.093 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -112.69 141.22 46.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.853 -0.612 . . . . 74.52 110.965 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 46' ' ' ILE . 16.9 m -84.53 126.24 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.801 -0.636 . . . . 72.33 109.824 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.12 -49.63 12.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.125 0.488 . . . . 65.34 110.181 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -163.52 168.39 20.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.533 -0.758 . . . . 71.41 108.97 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 pp20? -139.91 152.36 46.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.831 0.348 . . . . 74.53 110.815 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -156.15 129.33 8.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 75.24 109.649 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.7 t 71.8 -0.55 3.15 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.09 -0.505 . . . . 65.13 112.004 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.98 -21.62 10.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.809 -0.71 . . . . 74.44 111.838 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -95.74 150.5 20.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.666 -0.494 . . . . 74.11 109.666 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.4 t -117.34 140.17 49.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.157 0.503 . . . . 60.42 110.99 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.98 108.74 16.51 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.228 -0.896 . . . . 74.02 108.77 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.64 HD12 HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -130.06 163.21 36.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.028 0.442 . . . . 72.23 111.351 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 9.1 t30 -101.57 113.13 25.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.375 -0.829 . . . . 71.22 108.859 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.596 ' CZ ' HG23 ' A' ' 25' ' ' ILE . 90.0 t80 -105.6 98.2 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.504 -0.317 . . . . 63.13 110.241 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t30 56.21 34.68 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.206 0.526 . . . . 74.52 111.007 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.49 62.42 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.77 -0.729 . . . . 44.2 113.908 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.1 pt20 -124.2 155.73 38.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.453 0.627 . . . . 55.32 110.24 174.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -90.5 142.12 28.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.442 -0.345 . . . . 55.04 110.649 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.99 25.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.635 -0.793 . . . . 74.12 112.218 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.8 146.76 51.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.764 -0.458 . . . . 63.33 109.764 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 46' ' ' ILE . 2.7 pp -144.38 171.76 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.146 0.279 . . . . 72.15 110.365 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.64 109.92 3.53 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.718 -0.753 . . . . 62.11 111.839 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 1.4 m -63.78 -24.0 67.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.993 0.368 . . . . 74.35 111.993 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -67.79 -43.84 78.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.297 -0.41 . . . . 74.13 111.885 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -122.79 117.66 26.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.985 0.421 . . . . 51.43 110.656 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 85.7 mt -155.05 153.82 31.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.09 -0.959 . . . . 71.12 110.124 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.761 ' HB2' ' HB3' ' A' ' 29' ' ' PRO . 34.8 m -109.24 120.8 43.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.482 -0.933 . . . . 63.45 108.482 171.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.428 -169.296 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 112.684 0.624 . . . . 62.23 112.684 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt 61.05 21.21 11.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.551 -0.75 . . . . 71.0 111.945 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 16.7 m120 -53.54 -43.6 68.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.071 -0.513 . . . . 71.51 112.064 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.89 48.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.172 0.511 . . . . 74.02 110.822 177.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HG3' ' HA2' ' A' ' 19' ' ' GLY . 10.9 tpt180 -80.19 27.38 0.33 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.035 -0.529 . . . . 74.42 111.074 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.492 ' HA ' HG22 ' A' ' 55' ' ' ILE . 11.8 t 56.86 32.61 21.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 74.2 111.292 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 110.16 -124.25 7.03 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.487 -0.863 . . . . 53.51 112.057 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 21.6 mm-40 -86.29 11.68 11.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 73.33 110.449 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 15' ' ' ARG . . . 86.89 16.58 61.09 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.374 -1.091 . . . . 64.4 110.374 -170.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.1 m -62.57 -54.26 42.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.028 -0.586 . . . . 72.13 110.711 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -102.4 100.47 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.139 -0.689 . . . . 73.33 109.139 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -93.48 5.32 51.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.732 -0.667 . . . . 73.12 111.45 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -100.98 -38.41 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.466 0.543 . . . . 73.51 112.466 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 25' ' ' ILE . 12.7 tt -82.86 -55.33 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.943 0.72 . . . . 64.34 112.943 -169.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 48' ' ' TYR . 16.6 mt -126.82 148.76 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.976 -0.379 . . . . 74.02 109.976 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -150.25 159.0 27.93 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.007 -0.837 . . . . 62.14 111.007 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -75.98 96.97 3.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.492 . . . . 73.25 111.78 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -149.84 72.11 9.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.651 -0.704 . . . . 63.32 109.768 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.5 90.48 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.727 2.284 . . . . 72.04 112.055 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 30' ' ' GLN . 6.4 pt20 -97.33 59.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.51 -0.768 . . . . 74.25 110.141 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.39 -78.05 1.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.493 -1.043 . . . . 63.13 110.493 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -73.16 137.03 44.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.032 -0.729 . . . . 61.04 109.032 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 46.6 mttp -116.05 -75.94 0.58 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.022 0.439 . . . . 74.21 110.108 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 ' HD1' ' A' ' 48' ' ' TYR . 8.3 p 174.3 -29.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.179 -0.919 . . . . 75.21 108.619 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 72.58 127.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.414 -1.266 . . . . 72.35 111.491 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 44' ' ' SER . 58.1 t -82.96 108.26 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.652 -0.704 . . . . 75.22 110.179 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 46' ' ' ILE . 4.7 mt -75.28 -49.53 27.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.836 -0.62 . . . . 75.11 111.346 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 m -153.24 150.95 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.054 0.454 . . . . 72.03 110.937 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.63 123.88 47.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.464 -0.789 . . . . 64.44 109.245 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.34 140.73 26.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.516 -0.179 . . . . 73.34 110.516 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t 75.24 -54.33 0.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.857 0.723 . . . . 74.31 111.662 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.11 -51.84 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.514 -0.634 . . . . 62.42 111.514 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.622 ' HZ2' ' HG2' ' A' ' 18' ' ' GLU . 25.5 m0 -87.61 160.14 18.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.089 0.471 . . . . 74.45 110.691 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.57 ' HB3' HG13 ' A' ' 36' ' ' VAL . 44.4 m -91.34 140.79 29.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.63 -0.714 . . . . 74.23 109.352 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -105.45 129.88 53.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 120.935 0.398 . . . . 73.32 109.939 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -142.91 170.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.704 . . . . 74.33 110.315 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -108.79 115.11 29.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.253 -0.647 . . . . 74.41 109.253 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 25' ' ' ILE . 5.8 t80 -113.47 101.23 9.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 72.24 110.156 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t30 63.02 41.79 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 53.54 110.35 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.21 56.86 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.555 -0.748 . . . . 53.31 113.65 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 8.1 pt20 -111.79 145.86 38.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.388 0.594 . . . . 74.35 111.689 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 m -72.52 123.21 22.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 74.22 111.002 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.5 168.58 18.6 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.779 -0.724 . . . . 72.33 111.75 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.39 144.4 51.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.817 0.341 . . . . 73.33 110.434 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.92 156.26 31.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.74 -0.664 . . . . 54.21 109.668 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -72.36 129.1 14.13 Favored Glycine 0 C--O 1.219 -0.815 0 C-N-CA 120.631 -0.795 . . . . 73.43 112.137 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -77.24 -13.57 59.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.322 0.582 . . . . 71.21 110.428 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.575 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 17.3 ptt85 -85.65 -16.84 37.86 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.382 -0.372 . . . . 75.43 111.271 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' A' ' 58' ' ' ARG . 30.9 m-85 -127.12 116.33 20.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.204 -0.665 . . . . 74.0 109.204 171.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.1 mt -140.96 173.83 11.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.279 0.561 . . . . 75.02 110.876 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . 10.1 t -109.26 127.44 54.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.696 -0.684 . . . . 73.34 109.174 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.718 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.234 -0.654 . . . . 65.0 109.234 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 15' ' ' ARG . 4.3 mm? 67.19 28.69 8.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.471 0.482 . . . . 73.22 110.079 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.639 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-20 -63.19 -50.08 71.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.439 -0.801 . . . . 71.34 111.727 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.02 6.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.482 -0.562 . . . . 72.24 109.482 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 12' ' ' LEU . 37.6 mtp180 -69.41 176.89 3.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.793 -0.64 . . . . 65.13 110.911 -172.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.969 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 3.9 m 69.97 44.63 0.79 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.683 -0.689 . . . . 62.0 111.044 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.877 ' HA3' HD12 ' A' ' 25' ' ' ILE . . . -56.49 -35.84 68.05 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 114.246 0.458 . . . . 71.4 114.246 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 21' ' ' ASN . 42.2 mt-10 -90.3 9.93 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.213 0.507 . . . . 71.24 110.532 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 43' ' ' TRP . . . 76.73 -65.69 2.83 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 116.097 -0.501 . . . . 63.51 112.229 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.9 p -82.41 -28.31 31.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.854 0.359 . . . . 75.31 110.763 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 27.5 t30 -100.17 118.11 35.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.969 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 24.2 m-85 -93.8 -36.88 12.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.869 -0.605 . . . . 63.44 111.807 -170.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -73.88 -6.61 48.23 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.068 0.766 . . . . 74.04 113.068 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.44 -35.88 64.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 73.02 111.935 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.877 HD12 ' HA3' ' A' ' 17' ' ' GLY . 33.2 mt -124.13 156.32 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.3 -0.259 . . . . 74.21 110.3 -173.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.45 -135.91 6.1 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.191 -0.528 . . . . 74.31 112.2 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 13' ' ' ASN . . . -148.88 99.18 2.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.066 0.433 . . . . 75.45 112.098 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.9 tp -157.1 69.5 4.44 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.976 0.417 . . . . 75.35 110.776 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -97.94 63.73 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.106 2.537 . . . . 34.21 112.506 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.7 -77.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 73.22 110.024 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.9 3.49 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.508 -0.637 . . . . 73.33 111.508 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.79 153.26 14.47 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.904 -1.147 . . . . 75.23 107.904 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -80.07 15.09 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.111 0.481 . . . . 72.43 111.213 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 89.0 t -76.61 97.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 54.4 110.034 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -138.98 169.7 17.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.837 -0.619 . . . . 62.13 110.69 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.63 125.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.685 -0.689 . . . . 74.44 109.547 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.523 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -78.29 -55.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.511 0.672 . . . . 72.22 109.618 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 t -147.06 155.74 42.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.925 -1.034 . . . . 62.12 109.18 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.74 159.21 35.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.255 0.55 . . . . 74.45 111.412 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -132.53 174.24 10.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.574 -0.739 . . . . 64.44 109.337 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 t -74.66 78.89 2.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.708 0.766 . . . . 64.02 110.538 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.03 -70.99 0.31 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.12 -0.946 . . . . 73.41 111.465 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.3 m0 -115.42 146.07 41.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.996 0.427 . . . . 72.44 110.425 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.1 m -115.32 135.8 53.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 73.44 110.094 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.7 ttmt -82.57 125.29 30.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.356 0.598 . . . . 73.24 111.355 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 pt -128.08 171.04 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.484 -0.78 . . . . 74.42 110.858 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 t-20 -126.58 113.92 17.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.036 -0.727 . . . . 71.34 109.036 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.764 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 31.2 t80 -103.72 77.79 1.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 74.23 109.885 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 58.47 48.02 12.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.14 111.863 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.76 -17.21 59.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.584 -0.817 . . . . 71.42 113.66 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.764 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.8 pt20 -100.37 148.39 24.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.659 0.73 . . . . 71.44 110.344 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.3 m -86.74 140.7 29.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.595 -0.729 . . . . 75.2 111.306 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.17 161.39 31.99 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.915 -0.659 . . . . 62.24 112.133 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.39 139.03 47.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 2.9 pp -121.53 167.52 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.019 -0.273 . . . . 75.41 111.713 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.33 118.86 5.02 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.87 -0.681 . . . . 64.02 111.773 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -58.56 -17.39 21.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.648 0.61 . . . . 55.41 112.648 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -72.06 -25.85 61.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.914 0.338 . . . . 72.12 111.914 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -121.04 119.31 32.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.049 0.452 . . . . 54.14 110.767 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.6 mt -156.87 160.87 39.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.48 -0.782 . . . . 73.44 110.192 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -100.29 120.26 39.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 53.11 110.549 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 174.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.609 ' HA ' ' OG ' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.11 0.781 . . . . 73.25 113.11 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 54.4 mt -84.17 22.91 1.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.008 0.373 . . . . 74.54 112.008 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 18' ' ' GLU . 2.5 t30 -117.94 6.78 12.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.913 0.338 . . . . 72.52 111.913 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' ILE . 6.0 t -82.87 49.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 121.885 -0.509 . . . . 63.44 110.395 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.852 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 9.1 ptt180 -120.2 83.16 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.347 0.594 . . . . 72.31 111.965 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 21' ' ' ASN . 13.4 m 59.29 25.78 14.48 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.189 -0.914 . . . . 72.13 111.621 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 56' ' ' GLY . . . 113.85 -143.06 17.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.836 -0.697 . . . . 72.14 111.46 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 13' ' ' ASN . 8.3 mm-40 -61.22 -27.29 68.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 53.33 110.887 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.92 63.62 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.348 -0.701 . . . . 72.14 111.348 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 m -87.69 -61.55 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 64.22 111.033 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HB2' ' A' ' 16' ' ' SER . 6.6 m120 -123.93 127.23 47.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.168 -0.679 . . . . 53.35 109.168 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -97.56 6.6 47.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.265 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -107.72 -54.66 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.338 -0.392 . . . . 71.51 111.643 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.536 HG12 HG13 ' A' ' 25' ' ' ILE . 8.1 tt -59.94 -41.88 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 74.43 111.627 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.673 HG23 ' CE1' ' A' ' 48' ' ' TYR . 28.3 mt -136.53 165.07 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.32 -0.992 . . . . 73.13 108.32 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.852 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 179.9 -166.33 35.37 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.362 -0.923 . . . . 72.33 112.176 -171.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.566 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -81.07 91.78 6.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.05 0.452 . . . . 72.24 111.851 -174.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 33' ' ' LYS . 1.8 pt? -173.71 77.42 0.38 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.4 -0.818 . . . . 65.04 109.613 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -88.09 85.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.161 2.574 . . . . 75.15 112.401 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -165.35 155.22 12.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 75.1 109.823 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.8 174.75 50.48 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.934 -0.65 . . . . 72.33 113.317 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -92.45 7.32 43.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 62.3 110.802 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HE2' HD12 ' A' ' 28' ' ' LEU . 22.9 pttp -66.96 -15.71 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 73.32 110.995 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 4.4 p -146.63 123.2 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.336 0.589 . . . . 72.11 110.532 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -130.69 132.19 45.26 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.424 -0.584 . . . . 65.21 109.424 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.6 p -75.95 126.66 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.099 0.476 . . . . 60.33 110.553 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.43 -56.61 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.664 -0.495 . . . . 74.41 109.664 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -179.17 159.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.629 -0.714 . . . . 64.45 109.7 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -85.24 144.96 27.8 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.573 -0.739 . . . . 74.42 109.813 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -146.65 113.36 6.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.9 0.381 . . . . 72.31 110.698 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 t 57.9 62.92 1.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 72.21 111.314 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 -59.3 3.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.961 -0.638 . . . . 73.14 112.921 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.507 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 14.4 m0 -91.09 159.61 16.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.786 0.326 . . . . 60.03 110.629 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.804 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 9.6 t -105.22 142.42 35.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.277 -0.42 . . . . 64.31 110.035 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 54' ' ' TYR . 2.9 mtpt -87.88 127.34 35.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 116.178 -0.465 . . . . 62.34 110.829 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 36' ' ' VAL . 46.0 pt -143.23 164.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.723 -0.672 . . . . 64.22 110.954 -177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 26.6 t-20 -112.97 117.34 31.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.454 -0.943 . . . . 71.23 108.454 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.673 ' CE1' HG23 ' A' ' 25' ' ' ILE . 5.8 t80 -110.23 105.04 13.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.703 0.287 . . . . 74.04 110.515 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.9 t30 62.21 35.29 15.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.675 -0.693 . . . . 65.33 110.919 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.97 -17.48 59.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.887 -0.673 . . . . 54.31 113.234 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -107.92 133.78 51.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.35 0.575 . . . . 71.34 110.601 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -73.93 130.83 40.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.896 -0.593 . . . . 65.22 110.808 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.02 -172.19 12.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.833 -0.699 . . . . 74.43 112.405 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.506 ' CE2' ' HG2' ' A' ' 45' ' ' LYS . 97.0 m-85 -136.06 144.93 45.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.224 -0.287 . . . . 72.31 110.224 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 2.6 pp -135.29 162.43 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.348 -0.387 . . . . 71.44 110.239 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.626 ' H ' ' HA2' ' A' ' 17' ' ' GLY . . . -79.71 143.55 25.71 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 45.33 112.055 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.793 ' HA ' HD11 ' A' ' 60' ' ' LEU . 8.7 m -85.07 -5.4 59.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.757 0.789 . . . . 74.21 109.332 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -34.37 57.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.361 -0.836 . . . . 74.34 110.809 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -135.87 118.62 16.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.038 0.447 . . . . 73.3 111.457 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' A' ' 57' ' ' THR . 5.2 mp -140.38 173.86 11.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.856 . . . . 72.41 109.062 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.609 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 45.9 m -142.39 124.33 15.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.658 -0.497 . . . . 71.24 109.658 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tttt . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 75.4 109.737 -177.665 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 121.015 0.436 . . . . 73.32 110.782 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.709 HD13 ' HE1' ' A' ' 22' ' ' TYR . 59.2 mt -88.48 133.25 34.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.165 -0.47 . . . . 64.32 110.422 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.94 -60.35 1.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.978 0.362 . . . . 61.33 111.978 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 55' ' ' ILE . 4.7 t -74.55 -65.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 73.51 111.385 -172.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 58.33 17.96 5.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.934 0.716 . . . . 42.43 112.934 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 21' ' ' ASN . 37.9 t 62.33 25.21 15.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.212 0.53 . . . . 63.42 110.189 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.36 -108.48 0.67 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.112 -0.795 . . . . 74.52 111.112 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.407 ' OE1' ' HD3' ' A' ' 58' ' ' ARG . 40.4 mt-10 -118.14 14.59 14.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 71.23 110.201 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.17 48.69 0.18 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.588 -0.733 . . . . 73.2 111.467 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.4 m -94.2 -34.97 12.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 74.03 109.913 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' H ' ' HB3' ' A' ' 16' ' ' SER . 18.5 m-80 -140.24 142.06 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.195 -0.912 . . . . 73.24 109.591 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.709 ' HE1' HD13 ' A' ' 12' ' ' LEU . 55.7 m-85 -129.53 -13.95 4.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.543 0.687 . . . . 75.14 110.274 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -71.73 -49.9 35.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.913 -1.039 . . . . 73.21 111.109 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -97.09 -55.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 72.41 111.526 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' A' ' 48' ' ' TYR . 60.6 mt -101.23 127.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.715 -0.476 . . . . 42.15 109.715 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.47 -108.54 1.01 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.552 -0.832 . . . . 31.31 111.762 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -132.63 92.25 3.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.443 . . . . 55.0 110.164 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.5 pt? -173.39 86.43 0.39 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.352 -0.84 . . . . 72.12 109.834 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.82 71.37 4.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.699 2.266 . . . . 62.11 110.835 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.75 140.97 29.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.163 -0.926 . . . . 64.24 111.088 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.83 177.35 28.17 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.678 -0.773 . . . . 75.44 112.129 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -90.92 51.01 1.88 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 72.12 110.045 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG3' HG23 ' A' ' 34' ' ' VAL . 47.1 pttt -175.36 -156.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.263 -0.881 . . . . 42.14 109.341 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.511 HG23 ' HG3' ' A' ' 33' ' ' LYS . 82.2 t 75.89 -28.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.24 0.616 . . . . 65.14 112.091 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -59.67 -66.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 75.4 110.9 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -174.38 125.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 72.5 110.65 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.2 mt -113.77 -54.06 4.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.227 0.537 . . . . 73.55 110.061 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.9 t -143.06 171.81 13.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.125 -0.694 . . . . 73.35 109.125 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 39.9 mt-10 -137.95 149.71 46.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.052 -0.351 . . . . 62.5 110.052 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -162.86 117.58 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 65.43 111.628 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 t 63.43 33.05 14.03 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.585 -0.734 . . . . 75.43 112.457 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.55 -32.85 6.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.666 -0.778 . . . . 73.23 112.956 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -102.17 155.13 18.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.992 0.425 . . . . 74.43 110.302 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.689 ' HB2' HG13 ' A' ' 55' ' ' ILE . 25.0 m -106.02 143.46 34.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.135 -0.484 . . . . 64.45 110.689 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD2' ' CE1' ' A' ' 54' ' ' TYR . 19.1 mmmt -82.8 117.53 22.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.508 -0.769 . . . . 73.01 110.363 -177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.723 ' HA ' HD12 ' A' ' 37' ' ' ILE . 31.4 pt -137.65 171.65 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.966 0.413 . . . . 73.34 110.94 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -115.04 114.68 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.068 -0.716 . . . . 72.34 109.068 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.656 ' CE2' HG23 ' A' ' 25' ' ' ILE . 6.0 t80 -111.05 113.1 25.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.456 -0.338 . . . . 64.45 110.351 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.85 35.06 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.264 0.554 . . . . 74.3 111.109 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.23 64.52 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 63.43 114.033 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -131.12 167.6 18.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.572 0.686 . . . . 61.12 110.782 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.8 m -70.17 119.98 15.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 64.13 110.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.63 169.27 15.79 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.814 -0.707 . . . . 70.52 111.689 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 97.5 m-85 -139.02 150.62 46.02 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.637 -0.505 . . . . 73.35 109.637 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.784 HG22 HG13 ' A' ' 14' ' ' VAL . 2.5 pp -130.33 154.01 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 123.088 0.243 . . . . 72.2 110.681 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.34 108.76 3.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.705 -0.958 . . . . 74.12 110.705 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -59.56 -15.04 15.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.661 0.615 . . . . 60.34 112.661 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HD3' ' OE1' ' A' ' 18' ' ' GLU . 11.6 ptm180 -73.4 -16.49 61.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.691 0.282 . . . . 75.42 111.499 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 118.62 15.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.321 -0.251 . . . . 73.33 110.321 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 HD13 ' A' ' 55' ' ' ILE . 36.4 mt -153.37 156.1 37.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.568 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 t -155.27 121.84 5.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.3 mttp . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 116.078 -0.51 . . . . 72.12 109.935 178.215 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.307 0 CA-C-O 120.371 0.129 . . . . 54.11 110.764 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt 56.42 42.18 27.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.093 0.473 . . . . 65.24 111.312 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -68.21 -52.88 29.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.761 -0.654 . . . . 44.23 111.362 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG13 HG21 ' A' ' 55' ' ' ILE . 4.8 t -87.85 48.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 74.43 110.589 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.851 ' HD2' ' HB2' ' A' ' 22' ' ' TYR . 3.0 mmt180 -74.79 37.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.647 0.61 . . . . 72.23 112.647 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 4.5 m 49.64 73.82 0.23 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.484 0.659 . . . . 64.52 112.525 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.719 ' H ' ' HA ' ' A' ' 55' ' ' ILE . . . 101.97 -139.34 14.37 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.572 -0.74 . . . . 25.22 111.472 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -110.59 39.37 2.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.605 -0.887 . . . . 64.24 108.605 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.01 21.25 33.71 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -1.0 . . . . 74.51 111.055 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -87.08 -61.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 61.42 111.508 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.401 ' C ' ' HB2' ' A' ' 16' ' ' SER . 15.7 m120 -108.95 34.92 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 64.55 109.582 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.851 ' HB2' ' HD2' ' A' ' 15' ' ' ARG . 28.7 p90 -50.71 -21.99 1.87 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.926 -1.034 . . . . 74.2 113.646 -168.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 23' ' ' ARG . 24.6 ttt-85 -58.5 -35.46 72.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.321 0.489 . . . . 75.22 112.321 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.72 -56.94 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 61.22 111.895 -170.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.593 HG12 ' CD2' ' A' ' 48' ' ' TYR . 1.7 mt -128.27 157.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.338 -0.616 . . . . 61.32 109.338 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -144.79 -77.94 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.703 -1.237 . . . . 45.11 114.34 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.745 ' O ' ' HD3' ' A' ' 29' ' ' PRO . . . -81.35 -153.32 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.677 0.621 . . . . 64.04 112.677 -168.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 61' ' ' SER . 56.9 tp -91.16 90.03 0.33 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.355 -0.839 . . . . 75.45 110.762 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 68.2 Cg_endo -85.59 -7.16 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.574 2.182 . . . . 72.31 112.56 -173.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 67.43 166.0 0.23 Allowed 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.638 0.586 . . . . 71.31 110.633 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.2 67.53 2.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.074 -0.584 . . . . 72.32 112.637 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.63 -67.69 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.358 0.599 . . . . 70.15 110.022 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -139.97 -36.7 0.49 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.848 -1.069 . . . . 72.02 108.785 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -78.46 115.88 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.336 -0.847 . . . . 75.2 110.521 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 3.9 pm0 -122.79 13.83 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.371 -0.377 . . . . 55.01 110.57 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.92 ' HA ' HG22 ' A' ' 46' ' ' ILE . 95.2 t 73.67 118.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.651 -0.704 . . . . 73.23 109.891 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.25 -51.07 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.129 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -168.65 150.72 4.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.606 -0.724 . . . . 71.53 110.394 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.4 mp0 -90.72 125.84 35.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.499 -0.773 . . . . 65.35 110.195 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -97.62 177.72 5.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.884 -0.598 . . . . 53.21 109.857 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 p -62.36 76.54 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.011 -0.995 . . . . 71.24 111.411 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.08 -68.41 0.55 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.363 -0.835 . . . . 74.12 112.001 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 42.0 m0 -112.61 160.21 18.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 74.35 110.731 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.2 m -103.55 129.32 50.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.891 -0.595 . . . . 75.3 109.7 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 38.0 ttmt -83.08 132.28 35.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.168 0.509 . . . . 74.34 111.738 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.92 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -140.02 153.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.592 -0.731 . . . . 75.14 109.954 176.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -111.98 113.77 26.27 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.428 -0.953 . . . . 74.1 108.428 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 11.8 t80 -115.53 110.96 20.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.253 -0.431 . . . . 62.41 110.137 -172.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.25 33.75 16.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 72.23 110.711 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 -10.2 75.26 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 75.51 113.808 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 14.0 pt20 -106.86 147.01 30.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.751 0.775 . . . . 74.14 110.982 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -84.88 131.29 34.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 62.33 111.418 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.84 174.17 26.77 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.786 -0.721 . . . . 62.5 111.849 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 66.6 m-85 -134.02 147.45 50.96 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.27 -0.641 . . . . 75.32 109.27 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.719 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 2.8 pp -126.86 154.65 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.529 0.204 . . . . 73.1 110.709 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 130.57 11.37 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.556 -0.831 . . . . 72.11 111.817 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 m -69.16 -9.12 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.14 0.495 . . . . 55.2 111.331 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.02 -47.22 86.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.109 0.481 . . . . 71.41 110.189 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.2 118.99 22.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.765 -0.652 . . . . 74.53 110.489 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 36' ' ' VAL . 5.0 tt -138.07 134.98 35.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.314 -0.857 . . . . 75.3 108.817 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' HD12 ' A' ' 28' ' ' LEU . 71.1 m -83.86 119.59 25.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 75.41 111.237 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? . . . . . 0 C--N 1.319 -0.728 0 N-CA-C 107.952 -1.129 . . . . 70.15 107.952 174.441 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.305 0.574 . . . . 72.24 110.551 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.603 ' HA ' ' HD3' ' A' ' 15' ' ' ARG . 85.9 mt -89.63 69.58 7.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 65.12 110.631 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -119.18 -59.14 1.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.064 0.459 . . . . 75.54 111.455 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.35 49.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 72.25 110.352 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.603 ' HD3' ' HA ' ' A' ' 12' ' ' LEU . 22.0 mmm180 -81.23 42.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.13 112.363 -171.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.8 p 54.22 22.62 3.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.748 0.819 . . . . 75.54 112.777 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 109.3 -116.05 4.46 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 72.21 111.721 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 2.4 mm-40 -79.03 -72.41 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.633 -0.877 . . . . 73.22 108.633 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.32 30.39 0.37 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.324 -1.51 . . . . 64.03 109.324 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -50.49 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.162 -1.019 . . . . 72.5 111.994 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.4 t30 -166.86 60.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.032 -0.729 . . . . 72.31 109.032 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -74.63 7.18 3.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.89 -0.595 . . . . 75.0 111.762 -173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.56 -24.1 56.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.582 . . . . 74.4 110.127 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 25' ' ' ILE . 29.5 pt -79.19 -45.26 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.402 -0.363 . . . . 74.02 111.698 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 24' ' ' ILE . 10.2 mt -132.66 138.05 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.908 -0.405 . . . . 74.43 109.908 -176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.46 -75.42 0.69 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.008 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.09 101.31 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.794 0.331 . . . . 44.41 110.722 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -140.05 75.75 28.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.458 -0.571 . . . . 50.3 109.458 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 6.1 Cg_exo -79.85 117.68 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.238 2.625 . . . . 63.35 111.305 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER 75.37 113.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 124.2 0.938 . . . . 74.15 109.953 -174.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.11 -51.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.509 -0.769 . . . . 42.11 111.32 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -134.83 -86.03 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.745 -0.465 . . . . 60.1 109.745 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.93 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 64.1 mttm -127.43 10.53 6.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.609 0.719 . . . . 74.5 109.529 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.74 82.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 122.072 0.939 . . . . 75.51 110.373 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -161.85 44.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.864 -1.062 . . . . 65.43 109.465 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m 43.82 86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.1 0.96 . . . . 70.3 113.164 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -74.74 -55.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.925 -0.58 . . . . 70.23 110.389 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -141.61 172.2 13.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 73.5 109.169 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.14 137.57 47.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.593 0.235 . . . . 65.23 110.485 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -155.56 132.99 11.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.707 -0.479 . . . . 64.43 109.707 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t 71.87 8.42 6.03 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.557 0.536 . . . . 62.14 111.297 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.98 -32.42 6.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.897 -0.668 . . . . 44.25 112.368 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 18.1 m0 -92.58 158.29 16.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.98 0.419 . . . . 72.02 110.723 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 54' ' ' TYR . 15.2 m -99.56 143.31 29.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.93 -0.577 . . . . 64.54 111.14 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 19.3 mmmt -82.46 121.75 27.15 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.559 -0.746 . . . . 74.33 110.968 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.0 pt -139.57 156.53 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 55.42 110.157 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 22.8 t-20 -123.41 118.24 27.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.852 -0.425 . . . . 62.32 109.852 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.712 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 40.3 t80 -121.89 112.07 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.785 -0.643 . . . . 72.43 109.806 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.66 32.53 21.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.386 0.612 . . . . 73.42 111.153 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.16 56.96 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.827 -0.624 . . . . 33.22 113.637 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 5.1 pt20 -92.77 140.1 29.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.714 0.757 . . . . 72.13 110.902 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.2 m -78.79 123.71 27.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.997 -1.001 . . . . 52.53 110.12 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.81 22.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.72 -0.752 . . . . 54.52 112.331 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.765 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 95.9 m-85 -130.96 147.25 52.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.564 -0.532 . . . . 72.44 109.564 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 2.6 pp -134.84 160.96 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.407 -0.22 . . . . 71.33 110.407 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.516 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -83.78 132.48 11.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.669 -0.777 . . . . 74.41 112.153 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -63.39 -17.05 62.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 74.13 112.025 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 58' ' ' ARG . 58.4 mtt85 -59.12 -48.82 80.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.413 -0.358 . . . . 72.4 111.616 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' O ' HD22 ' A' ' 60' ' ' LEU . 7.4 m-85 -117.11 116.77 27.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.312 0.577 . . . . 74.21 111.513 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD22 ' O ' ' A' ' 59' ' ' TYR . 1.2 mm? -142.12 175.28 9.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 60.34 108.187 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -83.1 119.53 24.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.626 -0.509 . . . . 74.25 109.626 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 108.701 -0.851 . . . . 74.52 108.701 178.023 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' N ' ' HG ' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.971 0.415 . . . . 74.3 110.786 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 12' ' ' LEU . 2.2 mm? -73.06 10.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.59 -0.732 . . . . 72.13 112.473 -170.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -95.01 1.2 55.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.277 0.473 . . . . 75.25 112.277 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 5.7 t -91.5 32.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.045 0.926 . . . . 64.23 108.706 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' TYR . 13.2 tpt180 -78.12 3.67 14.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.856 -1.065 . . . . 63.53 110.829 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.701 ' HB2' HD12 ' A' ' 25' ' ' ILE . 22.4 t 71.59 16.44 5.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.659 -0.701 . . . . 72.21 111.449 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.74 -122.23 1.4 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.424 -0.893 . . . . 62.0 112.719 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -160.99 -69.38 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.5 -0.555 . . . . 62.52 109.5 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.18 -32.77 0.48 Allowed Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.142 -0.783 . . . . 45.53 111.142 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 ' CZ2' ' A' ' 43' ' ' TRP . 4.7 t -55.76 -31.75 62.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.204 0.526 . . . . 74.45 111.09 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 23' ' ' ARG . 24.8 t30 -171.83 114.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.088 -0.708 . . . . 73.31 109.088 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ARG . 42.5 p90 -132.15 7.74 4.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.054 0.454 . . . . 75.55 110.804 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 23' ' ' ARG . 12.5 ptt180 -88.16 -24.57 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.015 0.746 . . . . 73.31 113.015 -169.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mm -69.92 -55.69 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.734 -0.387 . . . . 73.14 111.872 -171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.1 mp -132.26 -169.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.651 -0.5 . . . . 74.44 109.651 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -145.99 -65.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 72.32 112.516 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -151.75 94.14 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.729 -0.277 . . . . 52.41 111.01 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 28' ' ' LEU . 1.2 tm? -166.32 86.29 0.9 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.26 -0.644 . . . . 61.42 109.26 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.86 76.73 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.065 2.51 . . . . 71.31 113.314 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.874 ' HG2' ' H ' ' A' ' 31' ' ' GLY . 49.4 tt0 59.64 -154.43 0.37 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 75.01 110.587 173.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.874 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 90.59 -83.05 1.32 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.26 -0.495 . . . . 75.21 112.292 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.74 -47.35 75.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.155 0.502 . . . . 72.32 111.216 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 26.5 tptp -154.17 168.71 25.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.006 -1.109 . . . . 73.11 108.006 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 48' ' ' TYR . 72.7 t 75.8 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.305 0.574 . . . . 73.35 111.462 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -136.32 148.06 47.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.993 -0.549 . . . . 75.13 110.468 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.3 p -92.04 143.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 73.45 110.065 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -93.84 -56.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.791 0.329 . . . . 72.53 110.369 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 p -173.6 151.18 1.86 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.021 -0.536 . . . . 72.34 110.007 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -110.59 137.85 47.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.603 -0.726 . . . . 71.11 111.623 -176.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -95.73 174.14 7.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.092 -1.077 . . . . 64.11 108.092 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -70.66 -11.25 60.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.011 0.434 . . . . 64.15 110.536 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.94 -74.68 0.97 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.983 -0.627 . . . . 63.13 111.567 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CZ2' HG21 ' A' ' 20' ' ' THR . 52.0 m0 -117.61 159.48 22.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 74.41 110.745 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.0 t -109.9 142.91 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.29 -0.414 . . . . 60.05 110.053 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -89.49 116.26 27.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.904 0.383 . . . . 65.51 111.697 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 36' ' ' VAL . 40.8 pt -131.61 156.72 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 71.11 110.106 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.543 ' O ' HG13 ' A' ' 34' ' ' VAL . 5.4 p30 -115.15 113.83 24.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.3 109.594 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.651 ' CD1' HG21 ' A' ' 34' ' ' VAL . 16.0 t80 -98.91 84.72 3.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.785 -0.45 . . . . 74.24 109.785 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.95 55.11 8.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.097 -0.956 . . . . 75.23 111.663 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.17 59.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.847 -0.692 . . . . 55.33 113.139 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.31 152.27 21.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.951 0.405 . . . . 60.31 110.407 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.1 m -93.57 114.44 26.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.563 -0.744 . . . . 75.34 109.389 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.37 148.35 18.49 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.278 -0.963 . . . . 75.51 112.983 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' SER . 95.8 m-85 -128.79 144.96 51.3 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.234 -1.024 . . . . 71.25 108.234 172.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 60' ' ' LEU . 2.7 pp -133.19 158.73 43.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 110.024 -0.362 . . . . 65.3 110.024 175.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 127.19 8.19 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.511 -0.852 . . . . 52.41 112.317 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -75.29 -6.73 51.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.622 0.725 . . . . 74.51 110.496 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -74.02 -49.69 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.589 -0.732 . . . . 62.35 110.546 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.12 120.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.984 -0.553 . . . . 75.44 110.305 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 55' ' ' ILE . 6.1 mt -134.59 174.15 10.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.872 -0.603 . . . . 74.41 111.067 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HG ' ' N ' ' A' ' 11' ' ' ALA . 20.5 m -148.98 145.83 27.52 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.58 -0.896 . . . . 34.24 108.58 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tptt . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.842 -0.429 . . . . 74.05 109.842 -177.138 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.219 0 N-CA-C 111.971 0.36 . . . . 70.53 111.971 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 15' ' ' ARG . 3.7 pp -112.3 139.82 47.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 42.23 111.021 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 27' ' ' ALA . 37.1 m-80 -117.63 -59.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.764 -0.653 . . . . 65.25 110.652 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 55' ' ' ILE . 7.1 t -119.5 13.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.107 -1.072 . . . . 75.3 108.107 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.669 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 3.2 tmt_? -63.66 110.83 2.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.772 -1.104 . . . . 65.34 109.55 -175.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.792 ' CB ' ' HA ' ' A' ' 23' ' ' ARG . 45.9 p 55.71 15.27 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.17 -0.923 . . . . 74.32 112.548 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 53.92 -109.36 1.09 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.468 -0.653 . . . . 73.42 111.468 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -117.77 161.16 20.16 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.729 -0.841 . . . . 73.31 108.729 169.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 58.93 2.26 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.178 -0.534 . . . . 60.4 114.2 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 21' ' ' ASN . 6.3 t -103.1 -60.03 1.62 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.086 0.443 . . . . 75.13 110.839 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.493 ' H ' HG23 ' A' ' 20' ' ' THR . 7.9 t30 -161.27 -4.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.673 0.749 . . . . 71.52 110.487 177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.5 m-85 -83.47 15.33 3.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.621 -0.718 . . . . 71.43 112.524 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 98.7 mtt180 -44.64 -23.54 0.13 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.659 0.985 . . . . 74.2 113.659 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 pt -77.4 -5.41 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.732 0.641 . . . . 61.23 112.732 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.585 HG23 ' CE1' ' A' ' 48' ' ' TYR . 53.7 mt -90.09 167.63 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.425 -0.583 . . . . 74.41 109.425 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 15' ' ' ARG . . . -150.83 176.62 29.3 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 73.14 111.439 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 13' ' ' ASN . . . -95.32 93.39 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.92 0.36 . . . . 74.23 110.941 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -171.3 62.61 0.36 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 64.41 110.874 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.02 -40.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.799 1.666 . . . . 70.25 111.631 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 4.4 pt20 44.71 25.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.866 1.266 . . . . 64.34 113.21 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.46 19.57 57.9 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.371 -0.442 . . . . 73.14 112.624 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -82.41 -57.64 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.206 -0.294 . . . . 72.13 110.206 -175.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 24.0 ttmm -143.63 -70.57 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.621 -0.432 . . . . 64.52 111.769 -177.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.49 100.89 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.708 0.766 . . . . 62.41 111.582 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -140.01 -179.45 5.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 72.31 109.629 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 60' ' ' LEU . 31.8 m -76.11 138.83 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.21 0.529 . . . . 74.15 111.872 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.52 -55.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.67 -0.695 . . . . 64.05 109.955 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.5 t -160.05 155.19 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 74.31 109.98 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -106.9 153.15 22.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.946 -0.57 . . . . 74.14 110.918 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -170.19 131.05 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 45.32 110.364 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.0 t 69.35 17.35 8.2 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.033 -0.53 . . . . 71.14 111.415 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.98 -18.66 55.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.676 -0.773 . . . . 74.22 112.049 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.462 ' HD1' ' HA2' ' A' ' 56' ' ' GLY . 22.1 m0 -105.65 157.48 17.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.86 0.362 . . . . 74.35 110.499 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.1 t -121.81 146.55 46.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.947 -0.57 . . . . 63.33 110.092 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -80.61 123.12 27.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.88 -176.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 pt -134.1 156.73 41.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.724 -0.671 . . . . 75.1 110.115 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -115.0 114.68 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.59 -0.522 . . . . 72.43 109.59 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' CE1' HG23 ' A' ' 25' ' ' ILE . 59.8 t80 -112.46 106.18 14.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.425 -0.352 . . . . 72.23 110.192 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 60.32 34.68 20.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.985 -0.552 . . . . 73.41 111.502 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.31 84.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.649 -0.786 . . . . 23.1 112.918 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -106.48 156.52 18.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.924 0.392 . . . . 55.31 110.586 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -76.8 128.4 34.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.674 -0.694 . . . . 64.11 109.886 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 22' ' ' TYR . . . -131.14 156.75 21.94 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.31 -0.948 . . . . 42.2 112.436 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 45' ' ' LYS . 73.9 m-85 -128.26 140.55 51.83 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.038 -0.356 . . . . 64.51 110.038 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 17' ' ' GLY . 2.7 pp -135.52 151.99 30.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.032 -0.531 . . . . 55.4 109.621 173.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' HD1' ' A' ' 43' ' ' TRP . . . -76.5 140.0 24.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.27 -0.967 . . . . 65.34 111.743 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 m -65.74 -10.8 40.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.32 0.581 . . . . 74.23 110.55 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -81.17 -11.67 59.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.607 -0.724 . . . . 73.11 111.222 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.16 118.44 16.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.222 0.534 . . . . 72.42 112.031 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.497 HD11 HG11 ' A' ' 36' ' ' VAL . 18.7 mt -157.51 173.27 17.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 73.12 108.969 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.4 m -82.99 119.09 24.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.402 -0.592 . . . . 71.02 109.402 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' C ' ' HD3' ' A' ' 62' ' ' LYS . 12.4 tmtt? . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.646 -0.706 . . . . 75.01 110.441 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.069 0.461 . . . . 72.32 110.781 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.877 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.4 pt? -75.02 39.88 0.14 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.871 0.367 . . . . 72.23 111.654 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -68.41 -54.68 15.52 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.349 0.5 . . . . 73.02 112.349 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.08 21.31 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.641 0.734 . . . . 64.35 109.203 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.725 ' CG ' ' HA ' ' A' ' 12' ' ' LEU . 19.0 mmt180 -54.62 -38.52 66.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 73.1 112.797 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.6 ' HB2' HD12 ' A' ' 25' ' ' ILE . 23.2 m 65.23 28.61 12.0 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.531 0.519 . . . . 62.23 111.677 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.87 133.77 27.22 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.667 -0.778 . . . . 51.34 111.914 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.14 -31.34 69.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.125 0.488 . . . . 71.13 110.281 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.06 -109.44 1.27 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.722 -0.951 . . . . 50.14 110.722 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.8 p -99.7 -4.81 29.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.353 0.597 . . . . 74.34 109.5 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -77.68 86.64 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.322 -0.854 . . . . 74.25 110.496 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.586 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 38.3 m-85 -93.9 5.78 50.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 71.11 111.548 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -90.26 -0.54 57.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.51 109.551 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.487 HG23 HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -52.4 -42.38 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.179 -0.919 . . . . 72.44 110.208 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' SER . 68.1 mt -132.58 -79.66 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 110.441 -0.207 . . . . 72.4 110.441 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . 140.08 169.76 11.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.21 -0.995 . . . . 70.14 112.643 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -92.91 94.46 8.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.102 -0.333 . . . . 71.4 110.102 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.605 ' HG ' HE22 ' A' ' 30' ' ' GLN . 19.4 tp -122.51 85.18 48.24 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.315 -0.624 . . . . 74.44 109.315 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.77 93.81 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.292 2.661 . . . . 72.32 113.378 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.605 HE22 ' HG ' ' A' ' 28' ' ' LEU . 2.5 mp0 -85.79 160.05 19.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 74.5 109.777 171.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.03 83.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.362 -0.446 . . . . 74.2 112.47 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 74.41 109.713 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' ' H ' ' A' ' 35' ' ' GLN . 4.1 ttmp? 71.94 143.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 55.22 111.895 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -77.13 -19.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.918 -0.583 . . . . 75.32 111.388 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.709 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 23.3 tt0 70.79 174.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.668 -0.696 . . . . 73.24 110.946 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 7.5 p -102.58 143.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.142 -0.481 . . . . 42.5 110.547 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' ASN . 5.3 mt -76.65 -56.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.828 -0.434 . . . . 72.44 109.828 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -172.18 161.67 5.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.585 -0.734 . . . . 71.14 109.599 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -117.15 139.8 50.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.74 -0.664 . . . . 54.01 110.289 -177.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -173.62 156.85 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.185 -0.461 . . . . 60.14 109.922 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.115 -0.493 . . . . 73.21 111.691 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.78 27.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.96 -0.638 . . . . 71.23 113.181 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -125.49 162.33 25.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.446 0.641 . . . . 74.41 111.479 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 36.6 m -101.17 122.57 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.254 -0.884 . . . . 70.41 109.609 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.0 ttmt -82.53 124.19 29.89 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.095 -0.502 . . . . 61.43 110.716 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 36' ' ' VAL . 9.7 pt -126.19 148.55 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.571 -0.74 . . . . 73.31 110.922 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.715 ' HB2' HD11 ' A' ' 37' ' ' ILE . 26.2 t-20 -109.54 113.39 26.14 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.294 -0.632 . . . . 70.41 109.294 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.603 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 32.7 t80 -104.03 85.69 2.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.124 0.488 . . . . 53.51 109.705 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.88 50.03 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 73.2 111.107 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.67 -17.66 58.87 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.059 -0.591 . . . . 64.53 114.213 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -103.41 147.39 27.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.075 0.937 . . . . 75.44 110.753 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -93.65 129.46 39.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 63.41 111.45 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.17 170.69 22.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.585 -0.606 . . . . 53.43 111.585 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.79 151.38 51.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 72.34 110.538 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 2.5 pp -143.69 153.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.801 -0.636 . . . . 73.52 109.919 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.622 ' H ' HD12 ' A' ' 12' ' ' LEU . . . -74.62 128.4 10.32 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.502 -0.856 . . . . 70.12 111.392 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 m -64.23 -4.5 3.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.406 0.521 . . . . 74.4 112.406 -174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -68.65 -34.37 75.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.169 -0.308 . . . . 64.31 110.169 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.05 119.43 23.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.011 0.434 . . . . 71.33 110.378 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' SER . 3.6 tt -155.53 129.81 8.89 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.715 -0.846 . . . . 73.13 108.715 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.41 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.7 t -87.51 120.67 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.461 -0.57 . . . . 53.02 109.461 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.938 -0.574 . . . . 64.3 110.534 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 N-CA-C 109.644 -0.502 . . . . 75.12 109.644 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.786 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 mm? -82.33 75.26 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.338 -0.986 . . . . 65.32 108.338 172.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 -38.24 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.599 0.592 . . . . 72.04 112.599 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 16' ' ' SER . 47.8 t -77.26 -66.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.454 -0.498 . . . . 74.23 111.463 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 31.4 mmt180 53.86 20.86 2.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.599 0.592 . . . . 44.41 112.599 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.686 ' H ' HG12 ' A' ' 14' ' ' VAL . 14.9 m 61.47 25.94 15.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.853 0.461 . . . . 55.23 111.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.38 -113.31 3.5 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.645 -0.788 . . . . 73.14 112.573 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 15.3 mm-40 -73.69 -5.83 43.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.641 0.258 . . . . 72.33 111.192 -175.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 94.58 29.11 9.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.052 -0.594 . . . . 62.44 112.2 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 p -75.42 -62.01 1.71 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 72.55 110.955 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.444 ' HB3' HG22 ' A' ' 24' ' ' ILE . 39.1 m-80 -103.58 93.34 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.841 -0.618 . . . . 70.24 110.354 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -93.03 -1.13 56.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.055 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -82.89 -24.08 33.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 70.34 111.267 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 25' ' ' ILE . 4.8 tt -93.16 -55.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.233 . . . . 75.32 111.317 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.671 HG13 HG12 ' A' ' 24' ' ' ILE . 7.2 mt -129.54 138.65 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.313 -0.625 . . . . 64.31 109.313 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -143.21 -71.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.103 -1.046 . . . . 35.24 113.622 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.786 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . . . -74.69 -162.03 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.386 0.513 . . . . 74.33 112.386 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.466 HD22 HE21 ' A' ' 30' ' ' GLN . 1.4 tt -91.91 90.16 0.37 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 75.52 109.352 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 52.3 Cg_endo -82.26 6.74 5.53 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.906 2.404 . . . . 73.02 113.105 -169.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.466 HE21 HD22 ' A' ' 28' ' ' LEU . 33.2 mm-40 70.59 -67.1 0.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.481 0.712 . . . . 73.11 111.251 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.77 77.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.724 -0.751 . . . . 63.54 112.713 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.76 -50.94 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 72.24 110.664 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -139.98 19.19 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.414 -0.958 . . . . 63.34 108.414 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' ASN . 15.2 t -129.97 116.39 37.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.785 -1.098 . . . . 70.43 111.217 -169.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.938 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 4.3 pm0 -145.22 -86.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.774 -0.37 . . . . 72.42 110.519 169.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.938 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 75.4 t -144.43 114.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.827 -0.434 . . . . 71.1 109.827 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.4 mt -99.85 -56.69 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.857 -0.337 . . . . 73.32 110.39 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -167.56 153.27 7.44 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.905 0.383 . . . . 53.32 110.213 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 5.5 pt-20 -117.38 149.47 40.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.384 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -160.24 130.59 5.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.524 . . . . 70.24 109.798 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t 71.84 24.55 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.348 0.594 . . . . 74.23 111.106 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.89 44.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 64.12 112.853 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.473 ' HE1' ' HG2' ' A' ' 18' ' ' GLU . 9.6 m0 -119.09 152.7 36.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.921 0.391 . . . . 74.13 110.912 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.2 m -97.05 137.1 36.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.896 -0.593 . . . . 72.24 109.547 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.79 131.0 45.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.881 -0.414 . . . . 73.02 109.881 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 37' ' ' ILE . 25.2 pt -145.0 171.24 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 65.12 110.949 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 34' ' ' VAL . 23.7 t-20 -113.01 113.65 25.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.942 -0.762 . . . . 64.23 108.942 172.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.638 ' CD2' HG12 ' A' ' 25' ' ' ILE . 50.7 t80 -110.1 106.9 16.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.597 -0.274 . . . . 71.31 110.336 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.05 34.43 13.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.68 0.753 . . . . 75.12 110.654 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.92 73.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.936 -0.649 . . . . 74.21 113.571 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -120.45 157.57 29.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.382 0.591 . . . . 75.24 110.882 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 m -73.02 125.26 27.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 74.44 110.752 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.7 166.03 24.37 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.575 -0.821 . . . . 50.24 112.313 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -132.81 148.19 52.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.805 -0.443 . . . . 62.55 109.805 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -137.18 168.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.205 -0.452 . . . . 65.44 110.098 177.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.38 155.03 19.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.347 -0.93 . . . . 73.43 111.981 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -85.87 -21.76 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 32.53 109.682 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.0 -41.93 13.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.69 -0.687 . . . . 62.12 110.448 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -95.14 113.07 24.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.4 -0.963 . . . . 75.23 108.4 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -158.68 174.1 15.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.648 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -121.17 117.64 27.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.454 -0.943 . . . . 65.33 108.454 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 tptt . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 107.733 -1.21 . . . . 71.41 107.733 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.837 0.351 . . . . 75.15 111.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 53.7 mt -97.54 128.06 43.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.249 -0.649 . . . . 75.1 109.249 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.69 -42.23 5.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.922 0.392 . . . . 55.13 111.072 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.65 49.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 71.44 109.813 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.546 ' HD2' ' OD1' ' A' ' 21' ' ' ASN . 5.7 mmm180 -43.99 -72.62 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.731 -1.122 . . . . 63.13 112.938 -173.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.985 ' HB2' HD12 ' A' ' 25' ' ' ILE . 2.2 m 57.64 37.66 27.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.239 0.543 . . . . 73.41 110.257 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -83.91 168.87 45.76 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.801 -0.714 . . . . 71.34 113.429 -172.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -70.88 -42.36 70.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.489 0.661 . . . . 64.25 109.512 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.4 -65.25 0.16 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.186 -0.916 . . . . 73.34 111.583 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 4.5 p -123.82 -6.53 7.94 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.638 -0.331 . . . . 72.21 111.811 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.546 ' OD1' ' HD2' ' A' ' 15' ' ' ARG . 10.8 t-20 75.13 122.82 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.992 0.808 . . . . 73.21 111.807 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.418 ' HE1' ' HG1' ' A' ' 20' ' ' THR . 31.3 m-85 -129.62 -60.81 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.556 -0.747 . . . . 71.11 111.008 175.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -119.06 -13.51 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.317 0.858 . . . . 75.01 113.317 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG12 HG13 ' A' ' 25' ' ' ILE . 11.6 tt -61.79 -55.89 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.72 -0.392 . . . . 53.32 112.022 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.985 HD12 ' HB2' ' A' ' 16' ' ' SER . 59.4 mt -138.44 155.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.079 -0.712 . . . . 71.2 109.079 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.9 -113.05 2.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.492 -0.861 . . . . 73.41 112.37 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.81 94.55 4.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.197 0.522 . . . . 51.44 110.975 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 tp -147.43 84.98 6.93 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.67 -0.696 . . . . 61.31 109.41 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -92.6 -10.85 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.005 2.47 . . . . 73.23 113.398 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -94.67 97.37 10.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.629 0.728 . . . . 72.34 110.694 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.0 150.06 21.26 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.413 -0.812 . . . . 64.3 111.435 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -68.91 -24.14 64.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.12 0.486 . . . . 73.13 110.381 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -122.13 22.14 10.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.363 0.601 . . . . 73.31 109.521 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.72 108.0 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.677 . . . . 55.01 110.793 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -166.23 156.81 12.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.15 109.888 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 46' ' ' ILE . 61.9 t -73.8 125.14 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.031 -0.359 . . . . 71.3 110.031 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.63 -56.34 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.774 0.321 . . . . 75.53 110.586 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -144.45 159.31 42.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.406 -0.361 . . . . 72.23 110.179 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 9.7 pt-20 -129.01 142.61 50.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.161 -0.472 . . . . 71.04 110.799 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -112.03 173.36 6.4 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.499 -0.926 . . . . 75.02 108.499 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -74.51 69.18 1.67 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 54.24 109.749 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.77 -75.65 0.21 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.243 -0.743 . . . . 62.54 111.243 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -118.46 144.88 45.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.087 0.47 . . . . 73.34 110.782 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 27.4 m -101.39 139.38 37.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.724 -0.671 . . . . 74.32 110.678 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD2' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -82.03 114.69 20.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.401 0.68 . . . . 63.11 110.16 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 36' ' ' VAL . 20.1 pt -132.19 167.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.184 0.516 . . . . 73.54 111.551 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.84 114.63 14.92 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.574 -0.899 . . . . 74.31 108.574 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.673 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 43.3 t80 -99.7 88.37 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.864 0.364 . . . . 74.52 110.247 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 58.6 47.1 13.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.537 0.684 . . . . 52.22 110.88 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.35 -6.07 74.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.678 -0.772 . . . . 71.14 113.856 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -113.24 162.41 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.678 0.739 . . . . 73.31 111.237 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -73.82 143.32 45.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.484 -0.78 . . . . 73.15 111.887 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . -161.92 155.58 26.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.541 -0.838 . . . . 51.32 112.508 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' HE1' ' HD2' ' A' ' 45' ' ' LYS . 78.8 m-85 -141.71 145.28 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.301 -0.629 . . . . 72.42 109.301 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 15' ' ' ARG . 2.5 pp -131.12 145.35 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 121.243 -0.183 . . . . 75.23 110.589 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.28 126.55 22.8 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.408 -0.901 . . . . 74.32 111.148 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -57.07 -22.06 36.38 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.507 0.323 . . . . 54.24 111.823 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -55.91 -34.63 65.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.463 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.68 119.15 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.011 0.434 . . . . 72.42 111.216 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -144.6 156.16 43.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.82 -0.807 . . . . 73.34 108.82 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.632 ' H ' HD23 ' A' ' 60' ' ' LEU . 34.5 t -98.84 141.78 31.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.931 0.395 . . . . 61.34 110.26 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 115.363 -0.835 . . . . 74.12 110.404 176.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 112.691 0.626 . . . . 64.02 112.691 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.7 mt 56.42 30.41 16.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.372 -0.831 . . . . 73.25 112.763 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' OD1' ' HB ' ' A' ' 55' ' ' ILE . 38.3 t30 -110.58 -59.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.162 0.506 . . . . 55.31 111.478 -176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.724 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 4.3 t -86.04 48.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 71.21 110.823 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 14.6 mmt180 -77.92 -1.11 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.08 -0.509 . . . . 73.4 112.235 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t 66.47 28.18 9.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.615 -1.254 . . . . 71.23 107.615 -167.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . 160.14 -170.36 36.21 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.421 -1.872 . . . . 71.22 108.421 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -110.56 -73.93 0.66 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.359 1.08 . . . . 75.24 109.619 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.79 -7.61 17.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 44.45 111.233 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.34 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.445 . . . . 72.01 111.271 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -141.78 130.96 23.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.909 -0.774 . . . . 61.53 108.909 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 49.8 p90 -130.02 8.2 5.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.085 -0.507 . . . . 72.31 110.675 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -79.18 -48.84 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.239 0.829 . . . . 71.32 113.239 -166.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.4 mp -77.47 -56.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.56 -0.456 . . . . 61.41 112.224 -167.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -130.3 163.71 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.79 -0.448 . . . . 72.34 109.79 -176.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.785 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -121.17 -67.13 0.26 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.059 -0.591 . . . . 20.01 112.019 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . . . -151.17 94.15 2.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.777 0.322 . . . . 73.44 110.401 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -157.59 86.04 2.68 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 72.13 109.926 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.732 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 51.3 Cg_endo -106.26 -164.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.81 3.006 . . . . 74.12 113.194 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 75.39 109.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.311 -0.859 . . . . 75.42 112.567 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.89 -102.63 2.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.352 -0.84 . . . . 63.31 113.649 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.59 -13.17 60.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.269 0.557 . . . . 74.21 110.643 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD2' ' HE2' ' A' ' 48' ' ' TYR . 45.7 mmtm -126.46 136.57 52.8 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.502 -0.772 . . . . 73.51 109.405 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.67 148.46 5.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.974 0.416 . . . . 61.04 110.59 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.795 ' HG3' HG12 ' A' ' 36' ' ' VAL . 12.5 pt20 -124.2 -34.17 2.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 72.13 111.643 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.795 HG12 ' HG3' ' A' ' 35' ' ' GLN . 5.5 p -165.76 125.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.35 . . . . 75.21 111.079 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.6 mt -113.68 -56.24 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.45 -0.341 . . . . 72.24 110.601 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.3 t -155.22 149.25 25.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.033 0.444 . . . . 54.23 110.311 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -104.95 146.35 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.603 -0.726 . . . . 73.21 110.399 -173.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.49 119.51 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.461 -0.336 . . . . 74.31 110.784 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t 65.99 24.86 11.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.672 -0.695 . . . . 75.44 111.756 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.29 -46.63 1.13 Allowed Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.664 -0.779 . . . . 73.3 112.676 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 47.9 m0 -90.08 161.4 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 73.21 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 22.8 t -111.22 134.24 52.96 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.239 -1.022 . . . . 55.13 108.239 171.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 32.4 ttmt -82.09 130.93 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.983 -0.553 . . . . 74.24 111.889 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.747 ' HA ' HD12 ' A' ' 37' ' ' ILE . 23.2 pt -134.99 171.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.494 -0.776 . . . . 73.32 109.121 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.91 117.79 16.22 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.662 -0.415 . . . . 74.32 110.507 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 7.0 m-85 -122.48 114.18 20.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.003 0.43 . . . . 75.5 111.067 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.29 34.37 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.871 -1.059 . . . . 74.35 110.955 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.4 -17.76 46.24 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.833 -0.621 . . . . 51.22 113.693 173.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 20.8 pt20 -93.53 153.53 18.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.303 0.552 . . . . 71.42 110.197 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -75.0 118.06 17.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.172 -0.467 . . . . 33.44 110.856 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.92 168.57 13.07 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.748 -0.739 . . . . 73.43 111.883 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 84.7 m-85 -144.0 166.47 24.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.56 -0.533 . . . . 71.13 109.56 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 2.7 pp -123.79 143.42 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 108.702 -0.851 . . . . 72.24 108.702 166.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' A' ' 43' ' ' TRP . . . -96.55 100.31 2.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.15 -1.024 . . . . 71.13 111.251 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -50.52 -20.84 1.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.283 0.846 . . . . 63.45 113.283 -172.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 58' ' ' ARG . 13.9 mtm180 -53.11 -37.19 61.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.766 0.317 . . . . 74.32 110.593 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.78 147.95 45.92 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.072 0.463 . . . . 72.44 109.846 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.0 mt -152.59 135.79 15.75 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.479 -175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' ' N ' ' A' ' 11' ' ' ALA . 3.4 p -129.08 135.87 49.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.759 -0.655 . . . . 73.52 109.686 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 109.892 -0.41 . . . . 75.24 109.892 -178.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 70.33 111.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 129.39 34.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.24 111.639 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.13 6.93 20.53 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.657 0.741 . . . . 65.34 110.175 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.61 -3.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.775 1.028 . . . . 74.53 113.775 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HA ' HG22 ' A' ' 25' ' ' ILE . 17.9 mtm180 -121.41 -46.04 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.039 0.381 . . . . 74.05 111.113 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB2' HG23 ' A' ' 24' ' ' ILE . 66.4 m 64.91 4.25 2.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.481 0.919 . . . . 65.15 113.481 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.84 -109.58 1.71 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.964 -0.636 . . . . 74.11 112.272 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -157.63 154.61 28.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.474 -0.565 . . . . 65.34 109.474 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.94 -135.83 2.02 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.622 -0.799 . . . . 71.43 112.308 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -72.68 -8.11 53.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.919 0.39 . . . . 75.42 111.515 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -136.11 138.93 42.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.943 -0.762 . . . . 62.11 108.943 172.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.2 -16.39 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.776 0.798 . . . . 74.4 110.086 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 23' ' ' ARG . 61.3 mtt85 -89.16 6.54 39.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.732 -1.122 . . . . 74.53 109.871 172.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 55' ' ' ILE . 10.4 tp -55.83 -9.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 114.903 -1.044 . . . . 73.14 113.679 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 15' ' ' ARG . 1.3 pp -59.74 135.1 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 63.11 112.123 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.25 148.8 5.31 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.585 -0.816 . . . . 40.52 113.904 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.698 ' HA ' HD22 ' A' ' 60' ' ' LEU . . . -146.98 -178.51 6.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.655 -0.498 . . . . 62.45 109.655 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 36' ' ' VAL . 41.2 mt -128.67 65.84 73.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 111.861 0.319 . . . . 71.54 111.861 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 27' ' ' ALA . 3.6 Cg_endo -86.0 -55.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.29 1.993 . . . . 75.43 111.044 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 179.37 131.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.281 -0.872 . . . . 74.23 109.486 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.14 168.73 11.35 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.192 -1.004 . . . . 74.51 113.225 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.38 15.0 11.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.139 0.495 . . . . 73.2 110.532 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -25.44 62.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.77 -0.65 . . . . 75.31 110.264 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.869 HG13 ' H ' ' A' ' 35' ' ' GLN . 2.4 p -135.85 -80.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.029 -0.532 . . . . 64.03 110.092 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.869 ' H ' HG13 ' A' ' 34' ' ' VAL . 26.5 tt0 65.89 152.93 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.711 0.767 . . . . 73.23 112.123 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 28' ' ' LEU . 71.2 t -91.12 137.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.668 -0.697 . . . . 51.14 110.462 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.78 -55.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.245 -0.65 . . . . 74.43 109.245 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.9 m -159.45 155.32 26.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.243 -0.89 . . . . 75.12 109.097 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 7.7 pt-20 -124.91 141.97 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.962 0.41 . . . . 24.45 111.01 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.27 159.52 7.29 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.791 -0.641 . . . . 72.23 109.859 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 27.51 16.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.013 0.745 . . . . 72.04 113.013 158.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.83 -50.6 0.83 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.518 -0.849 . . . . 53.24 113.271 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -123.0 162.33 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.466 0.65 . . . . 65.23 111.251 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 20.8 t -103.45 120.47 40.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.194 -0.912 . . . . 64.03 108.687 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HD3' ' CE2' ' A' ' 54' ' ' TYR . 31.2 ttpt -82.45 137.01 34.8 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.529 0.566 . . . . 70.24 112.529 -171.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.7 170.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.192 -0.913 . . . . 63.53 110.547 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 24.4 t-20 -127.8 113.89 16.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.336 -0.616 . . . . 53.24 109.336 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.687 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 34.1 t80 -125.87 112.85 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.478 -0.328 . . . . 73.21 110.554 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.98 37.31 18.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.702 0.763 . . . . 73.31 110.509 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -17.45 58.52 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.634 -0.712 . . . . 73.03 114.022 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 29.7 pt20 -98.9 155.71 17.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.416 0.608 . . . . 74.12 110.789 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.8 m -97.57 114.06 25.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.759 -0.655 . . . . 71.54 109.773 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.06 -176.69 15.93 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.82 -0.705 . . . . 72.13 112.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 73.3 m-85 -136.89 139.31 41.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.18 -0.674 . . . . 71.05 109.18 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -120.18 155.58 23.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.881 -0.414 . . . . 60.05 109.881 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.66 116.37 4.35 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.03 -1.081 . . . . 35.24 111.553 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -12.36 25.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.692 0.397 . . . . 64.3 111.869 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -69.57 -34.77 74.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.387 -0.369 . . . . 74.12 111.508 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.76 120.01 26.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.086 0.47 . . . . 75.52 111.918 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 27' ' ' ALA . 56.4 mt -155.66 152.1 28.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.21 108.907 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -92.92 120.3 33.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.211 -0.663 . . . . 63.42 109.211 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 116.357 -0.383 . . . . 74.31 110.56 -179.87 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 110.323 -0.251 . . . . 53.33 110.323 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HB2' ' HA3' ' A' ' 17' ' ' GLY . 27.1 tp 58.93 27.72 16.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.209 0.528 . . . . 72.13 110.71 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.639 HD21 ' HB3' ' A' ' 61' ' ' SER . 27.1 t-20 -58.41 -42.27 86.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.719 -0.673 . . . . 54.52 110.87 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.18 -65.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 107.697 -1.223 . . . . 72.14 107.697 170.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.678 ' HG2' HG22 ' A' ' 55' ' ' ILE . 4.3 mmp_? -138.57 -164.42 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.847 -1.069 . . . . 74.44 108.482 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 34.5 t 65.63 74.65 0.37 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.419 0.628 . . . . 64.21 110.699 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 12' ' ' LEU . . . -176.2 -173.71 42.09 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.49 -0.777 . . . . 72.13 111.2 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.13 84.14 1.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.391 0.615 . . . . 53.13 110.807 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.15 -86.8 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.345 -0.843 . . . . 43.45 111.311 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -123.52 -65.23 1.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.915 0.388 . . . . 73.2 110.661 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -130.86 133.06 45.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.602 -0.888 . . . . 71.41 108.602 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.7 p90 -108.91 8.4 26.44 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.124 0.416 . . . . 73.15 112.124 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 38.0 ttt180 -115.25 -2.44 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.787 -0.365 . . . . 74.35 111.633 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -58.41 -56.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.093 0.405 . . . . 75.33 112.093 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.7 mp -129.13 -78.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 63.32 110.23 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' A' ' 16' ' ' SER . . . 148.69 -171.23 29.06 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.217 -0.753 . . . . 72.23 111.217 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.28 94.41 4.33 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 65.14 110.543 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.5 pt? -120.52 85.37 37.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.375 0.607 . . . . 75.02 110.122 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.56 5.14 6.56 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.557 2.838 . . . . 64.52 113.029 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.36 59.52 4.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.719 . . . . 74.43 111.615 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.43 -33.88 5.04 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.808 -0.633 . . . . 72.13 113.432 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.47 -164.91 0.95 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.045 0.422 . . . . 74.54 110.35 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.758 ' HG3' ' H ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -175.55 -85.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.52 0.512 . . . . 75.21 110.373 175.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.758 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 36.9 t -142.12 -85.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.425 ' H ' ' HB ' ' A' ' 34' ' ' VAL . 12.4 mm100 -157.89 -39.31 0.07 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 72.15 110.111 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.4 p 44.35 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.417 1.087 . . . . 70.34 112.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.57 -57.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 73.43 111.278 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 t -167.29 169.16 12.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.43 109.762 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.0 pt-20 -123.52 161.89 24.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.194 0.521 . . . . 75.54 111.418 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.21 115.3 4.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.25 -0.886 . . . . 65.03 109.528 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 t 68.67 26.3 6.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 43.45 111.419 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.28 -22.1 25.45 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.283 -0.961 . . . . 73.25 113.564 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -109.73 145.16 37.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.874 0.337 . . . . 73.23 110.942 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.6 m -109.59 132.11 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 71.11 109.742 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -84.45 132.5 34.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.849 0.356 . . . . 75.23 111.17 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -139.26 144.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.126 -0.488 . . . . 64.22 109.921 173.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.85 114.12 26.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.587 . . . . 71.12 109.414 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 60.5 t80 -110.79 107.71 17.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.574 -0.528 . . . . 74.21 109.574 -177.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m120 61.87 34.71 16.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.557 -0.747 . . . . 63.05 110.66 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 -17.89 58.24 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.67 -0.696 . . . . 52.24 113.995 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.5 pt20 -95.99 154.96 16.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.026 0.913 . . . . 74.4 110.788 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -87.42 123.92 32.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.916 -0.584 . . . . 74.45 110.791 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.97 169.66 21.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.65 -0.58 . . . . 63.12 111.65 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 99.3 m-85 -136.39 143.11 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.897 0.348 . . . . 75.24 110.818 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -119.52 166.36 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 72.05 109.581 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 132.97 11.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.374 -0.917 . . . . 70.52 112.458 -176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 m -67.61 -17.64 64.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.788 0.328 . . . . 65.31 111.151 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 58' ' ' ARG . 5.3 mmt85 -53.98 -50.23 67.03 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.238 -0.437 . . . . 65.12 111.196 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -121.38 118.86 30.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.975 -0.379 . . . . 75.22 109.975 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 55' ' ' ILE . 26.3 mt -155.66 148.29 24.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.843 0.354 . . . . 45.5 110.663 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB3' HD21 ' A' ' 13' ' ' ASN . 31.7 p -108.25 121.74 45.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.215 -0.448 . . . . 52.04 110.675 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 109.012 -0.736 . . . . 74.32 109.012 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.08 0.4 . . . . 63.23 112.08 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.539 HD22 HD21 ' A' ' 28' ' ' LEU . 87.2 mt 65.13 1.23 1.47 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.264 0.839 . . . . 63.22 113.264 173.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -118.94 9.81 12.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.337 0.495 . . . . 73.35 112.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' H ' ' A' ' 17' ' ' GLY . 46.8 t -65.92 -59.96 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.937 0.347 . . . . 62.41 111.937 -170.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.504 ' HA ' ' N ' ' A' ' 26' ' ' GLY . 20.0 ttm105 65.84 74.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.11 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 24' ' ' ILE . 37.8 p 49.38 31.65 4.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.417 -0.811 . . . . 71.44 113.176 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.636 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -80.51 -7.03 88.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.742 . . . . 70.22 112.104 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.76 107.49 3.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 61.32 109.78 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.72 -173.27 43.91 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.538 -0.625 . . . . 73.32 111.538 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -83.56 -24.17 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.093 0.473 . . . . 74.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -124.99 133.32 53.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.69 -0.856 . . . . 53.53 108.69 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.96 8.03 43.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.997 0.427 . . . . 73.24 110.973 -173.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -115.96 -0.79 12.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 61.41 111.18 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.457 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 2.3 pp -88.54 0.12 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.682 0.623 . . . . 72.2 112.682 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.6 mt 68.54 172.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.109 0.48 . . . . 72.21 111.345 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 25' ' ' ILE . . . 177.46 49.36 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.037 -1.225 . . . . 72.54 110.037 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.53 9.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.883 0.373 . . . . 75.24 111.443 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD21 HD22 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.58 69.12 79.08 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.586 -0.894 . . . . 53.23 108.586 172.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.66 67.39 6.42 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.342 2.695 . . . . 64.33 112.503 -168.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 69.18 119.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.937 -1.028 . . . . 60.32 112.002 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.1 -6.95 37.32 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.091 -0.804 . . . . 64.15 111.091 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.719 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -147.77 134.72 20.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.756 . . . . 72.31 108.96 179.102 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -128.03 92.77 3.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 71.41 111.118 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 28' ' ' LEU . 27.5 m -100.72 176.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.196 -0.668 . . . . 75.01 109.196 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -137.76 146.26 43.41 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.681 -0.408 . . . . 74.03 110.547 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.2 113.04 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.341 -0.39 . . . . 74.23 110.138 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 37' ' ' ILE . 4.0 mp -71.42 -56.74 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 64.51 110.481 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -170.36 165.76 8.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.585 -0.734 . . . . 61.31 110.693 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -118.02 169.32 9.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.111 -0.949 . . . . 63.14 110.094 178.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -173.48 123.38 0.37 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.106 0.254 . . . . 71.24 110.789 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t 70.65 32.44 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 54.22 110.874 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.37 -36.29 4.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.749 -0.739 . . . . 45.03 112.617 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -100.32 155.7 17.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.913 0.387 . . . . 73.41 110.779 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 25.6 t -110.11 139.94 44.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.939 -0.573 . . . . 72.02 109.904 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.693 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 14.6 ttmt -89.67 129.21 36.13 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.096 -0.502 . . . . 73.24 111.207 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.85 143.2 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.598 -0.728 . . . . 71.05 110.598 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -109.73 114.59 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.623 -0.88 . . . . 75.21 108.623 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 1.8 t80 -122.84 110.22 15.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.304 -0.407 . . . . 73.44 110.457 -174.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.71 34.28 22.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.561 0.696 . . . . 73.33 110.676 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.87 73.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 72.21 113.671 174.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 2.8 pt20 -118.8 156.08 30.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.437 0.619 . . . . 64.24 110.257 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m -98.6 128.11 44.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 72.12 111.302 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 24' ' ' ILE . . . -116.12 162.47 12.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.091 -0.576 . . . . 20.35 111.803 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 91.1 m-85 -138.3 139.09 38.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.848 -0.427 . . . . 72.42 109.848 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.587 HD13 HD21 ' A' ' 60' ' ' LEU . 2.4 pp -137.75 154.95 29.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 74.14 110.907 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 110.45 3.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.362 -0.695 . . . . 60.53 111.362 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -4.39 53.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.575 0.226 . . . . 70.45 111.479 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -61.72 -53.57 54.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.17 0.509 . . . . 64.14 109.989 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.51 118.97 21.9 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.038 -0.528 . . . . 74.43 110.291 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 55' ' ' ILE . 95.8 mt -114.36 127.49 55.87 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.578 -0.737 . . . . 71.4 109.052 176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 14' ' ' VAL . 25.4 t -148.61 159.82 43.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.034 -0.53 . . . . 61.32 110.091 -171.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.2 tttt . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.763 -0.199 . . . . 72.21 110.819 177.7 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.613 0.244 . . . . 65.23 111.656 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 5.3 mp -76.35 92.9 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 74.44 110.792 -174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 61' ' ' SER . 29.6 m-80 -117.56 -58.31 2.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.931 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 48' ' ' TYR . 2.6 t -121.14 37.31 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.441 0.639 . . . . 72.43 110.314 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 20.0 mmm180 -75.41 32.73 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.874 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 33.0 t 60.69 37.42 19.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.675 0.75 . . . . 60.32 109.822 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 90.34 -57.89 3.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.179 -0.919 . . . . 71.41 111.372 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.64 168.76 22.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.47 -0.937 . . . . 74.34 108.47 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.44 36.91 0.82 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.371 -0.442 . . . . 75.22 113.437 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.1 m -90.34 -34.08 15.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.338 -0.615 . . . . 74.43 109.338 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.514 HD22 HG12 ' A' ' 24' ' ' ILE . 4.2 t30 -142.74 52.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.541 -0.911 . . . . 72.22 108.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -62.5 -6.36 3.33 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.477 -1.238 . . . . 73.1 113.422 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -72.19 -11.99 60.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.198 0.444 . . . . 74.44 112.198 -174.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.887 HG22 HG13 ' A' ' 25' ' ' ILE . 47.5 mm -70.62 -55.79 13.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.301 0.482 . . . . 72.15 112.301 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.887 HG13 HG22 ' A' ' 24' ' ' ILE . 18.7 mt -135.98 -83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 121.035 -0.266 . . . . 75.54 111.239 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 15' ' ' ARG . . . 124.96 -169.24 16.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.578 -0.82 . . . . 30.45 112.465 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.51 92.67 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.456 -0.438 . . . . 31.04 110.693 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.76 87.8 2.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.649 -0.705 . . . . 73.22 109.743 176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.67 72.81 3.66 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.991 2.46 . . . . 73.0 112.459 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -168.5 98.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.563 . . . . 74.35 110.453 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.37 167.44 12.37 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 111.103 -0.799 . . . . 60.41 111.103 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.59 80.77 5.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.269 0.557 . . . . 74.52 110.953 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 3.7 mptp? 58.75 62.44 1.92 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.017 -0.992 . . . . 63.21 111.264 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.09 125.62 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.336 -0.847 . . . . 71.43 110.56 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' HG21 ' A' ' 46' ' ' ILE . 24.2 mp0 -133.31 -68.46 0.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 71.31 109.989 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -141.02 126.62 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 72.24 109.899 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.8 mt -114.44 -56.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 64.11 111.494 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.0 t -141.06 155.43 46.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 74.31 110.383 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 14.3 mp0 -114.8 135.94 53.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.697 -0.683 . . . . 74.33 110.526 -175.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -107.59 174.86 5.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.129 -0.693 . . . . 70.13 109.129 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.0 m -71.12 75.16 0.68 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.745 -0.661 . . . . 71.53 110.563 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.79 -61.25 0.48 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.728 -0.669 . . . . 75.41 111.621 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -126.69 162.67 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.092 0.472 . . . . 63.4 110.276 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 37.9 t -96.77 129.23 44.23 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.968 -0.753 . . . . 70.25 108.968 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -90.73 130.69 36.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.558 -0.292 . . . . 65.32 111.115 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.98 148.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 64.3 110.175 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.01 112.55 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.851 -0.796 . . . . 74.52 108.851 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 14' ' ' VAL . 11.9 t80 -109.8 98.99 8.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.465 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.41 40.52 24.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.36 0.6 . . . . 71.33 110.861 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 -17.57 59.06 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.858 -0.61 . . . . 60.43 114.405 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.84 154.88 24.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.077 0.939 . . . . 73.43 110.994 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.4 m -76.52 119.03 19.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 74.45 110.793 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.727 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -122.31 175.45 16.39 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.032 -0.604 . . . . 62.34 111.914 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' SER . 81.3 m-85 -135.68 151.44 50.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.107 0.48 . . . . 74.44 111.198 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.672 HG12 HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.59 146.41 27.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.458 -0.792 . . . . 71.1 109.988 175.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -85.15 159.84 34.37 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.428 -0.892 . . . . 71.12 112.054 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -42.2 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.116 0.484 . . . . 73.22 110.227 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -76.86 -51.84 10.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.651 -0.704 . . . . 73.1 110.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 12' ' ' LEU . 63.1 m-85 -107.84 119.26 38.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.745 . . . . 75.21 108.99 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 61' ' ' SER . 4.8 tt -154.11 157.52 39.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.797 -1.092 . . . . 64.52 108.154 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 14.0 p -81.83 117.54 22.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.372 0.606 . . . . 62.12 110.667 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 74.33 109.761 176.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.861 0.362 . . . . 63.21 110.598 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.0 pt? -113.98 118.87 35.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.38 0.61 . . . . 73.33 110.944 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.2 t-20 -83.82 -15.89 46.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.784 -0.643 . . . . 64.13 110.326 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 12.3 p -68.91 -12.68 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.376 -0.829 . . . . 71.11 113.144 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -101.79 67.25 1.09 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.801 -0.76 . . . . 74.05 110.193 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p 47.49 47.31 17.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.997 -1.001 . . . . 70.11 111.53 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.31 -91.35 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.018 -0.61 . . . . 43.44 112.833 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.24 111.7 1.71 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.108 0.48 . . . . 73.41 110.847 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.45 26.11 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.564 -1.015 . . . . 52.1 110.564 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 54' ' ' TYR . 5.2 m -70.11 -44.93 67.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.243 0.522 . . . . 72.3 109.873 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.77 90.18 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.13 -0.693 . . . . 70.55 109.13 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -108.96 10.33 26.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.481 -0.781 . . . . 75.52 110.99 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -44.56 -59.05 2.64 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.629 0.581 . . . . 72.42 112.516 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -121.89 -20.86 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 72.41 110.972 -179.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.0 pp -138.16 -164.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.51 -0.314 . . . . 72.53 111.708 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA2' HG21 ' A' ' 55' ' ' ILE . . . 177.35 -79.28 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 72.5 113.041 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.623 ' H ' ' N ' ' A' ' 14' ' ' VAL . . . -74.55 172.08 12.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 72.22 111.719 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.9 89.09 8.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.695 -0.684 . . . . 71.3 109.515 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 43.3 Cg_endo -69.53 -55.76 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.495 2.13 . . . . 52.34 112.667 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -118.88 -39.44 2.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.77 2.63 58.44 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.567 -0.742 . . . . 71.33 112.037 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -78.27 66.95 3.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.954 0.407 . . . . 61.32 110.793 -175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 179.2 -49.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.522 -0.763 . . . . 74.11 109.601 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.729 ' HB ' ' HD1' ' A' ' 48' ' ' TYR . 10.9 p -97.84 -39.51 8.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.625 -0.716 . . . . 73.13 110.733 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 64.45 174.32 0.19 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.174 0.59 . . . . 62.33 111.74 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -86.7 121.58 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.332 0.587 . . . . 71.22 111.223 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.7 mt -107.47 -53.23 6.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 72.35 110.701 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -164.56 149.85 10.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 72.44 110.894 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.93 143.65 46.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.54 -0.755 . . . . 74.15 110.626 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.64 173.46 8.97 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.379 0.609 . . . . 75.34 109.52 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.2 m -84.43 80.36 9.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.024 -0.989 . . . . 55.14 110.059 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.64 -53.62 0.68 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 63.32 112.112 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -120.85 152.87 37.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 75.24 110.662 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.06 119.97 40.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.768 -0.827 . . . . 61.45 108.768 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.9 ttmt -82.89 121.04 26.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.588 -0.733 . . . . 60.2 111.377 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.627 ' HB ' HG21 ' A' ' 34' ' ' VAL . 32.7 pt -142.3 153.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.598 -0.728 . . . . 75.22 111.54 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -116.95 114.06 23.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.501 -0.926 . . . . 73.34 108.501 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.729 ' HD1' ' HB ' ' A' ' 34' ' ' VAL . 28.8 t80 -119.34 114.28 22.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.47 -0.332 . . . . 63.34 110.823 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 t30 58.4 34.53 24.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.476 0.655 . . . . 63.01 110.994 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.24 69.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.603 -0.808 . . . . 71.22 113.69 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.1 pt20 -103.94 148.06 26.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.618 0.709 . . . . 73.2 110.984 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -85.7 117.16 24.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.769 . . . . 62.02 109.777 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.39 150.03 18.02 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.185 -1.007 . . . . 75.33 112.496 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' THR . 49.5 m-85 -127.67 140.07 52.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.079 -0.712 . . . . 72.14 109.079 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 ' HA2' ' A' ' 26' ' ' GLY . 2.7 pp -135.61 160.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.94 -0.393 . . . . 55.42 109.94 177.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.12 124.35 6.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.299 -0.953 . . . . 62.25 112.145 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 m -61.43 -18.75 60.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.505 0.669 . . . . 62.1 110.202 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -69.3 -9.12 51.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.392 -0.822 . . . . 72.34 111.447 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 13' ' ' ASN . 7.4 m-85 -131.58 115.06 15.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.803 0.335 . . . . 71.43 110.122 171.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -157.74 174.15 15.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.803 -0.635 . . . . 72.0 109.742 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 15.4 t -108.28 118.93 38.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.52 -0.918 . . . . 65.41 108.52 172.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 109.47 -0.567 . . . . 52.44 109.47 -177.223 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.657 ' HG2' HG13 ' A' ' 2' ' ' ILE . 52.1 ttm . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.798 -0.445 . . . . 75.13 109.798 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.657 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.5 mt 67.6 16.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.078 0.942 . . . . 71.51 109.606 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 5.91 58.02 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.476 -0.784 . . . . 55.15 111.19 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.73 99.46 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.115 0.483 . . . . 73.24 109.937 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -131.09 30.1 4.6 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.691 -0.855 . . . . 61.0 108.691 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -68.72 149.92 48.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.363 -0.835 . . . . 74.45 110.455 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.71 -46.79 95.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.244 -0.65 . . . . 73.52 109.244 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.499 ' ND2' ' HG3' ' A' ' 62' ' ' LYS . 12.3 t-20 67.47 -74.64 0.07 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.152 -0.931 . . . . 62.33 110.977 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.94 -153.88 0.37 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.209 0.528 . . . . 73.15 111.772 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.6 m -143.19 98.2 3.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.069 -0.514 . . . . 73.01 109.964 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.06 -155.44 0.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.53 . . . . 71.11 109.848 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 87.2 mt -71.05 90.67 0.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.571 -0.529 . . . . 71.32 109.571 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 72.5 m-20 -97.96 -29.94 13.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 75.13 112.131 -169.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 55' ' ' ILE . 63.6 t -64.86 -51.39 67.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.718 -0.475 . . . . 72.32 109.718 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.898 ' HG3' HD12 ' A' ' 25' ' ' ILE . 6.5 mtp180 -155.31 -177.01 6.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.151 -0.931 . . . . 70.03 108.528 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.893 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 22.9 t 75.16 3.96 4.14 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.977 0.798 . . . . 71.21 110.246 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.57 16.91 31.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.002 -0.618 . . . . 63.35 111.968 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CG ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -99.69 -46.71 5.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.002 -0.74 . . . . 75.41 109.002 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.52 4.87 49.29 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.72 -1.127 . . . . 72.32 110.57 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.6 m -101.34 -51.39 3.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.275 -0.462 . . . . 73.44 110.717 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.5 88.6 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.379 -0.6 . . . . 74.21 109.379 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 19.6 p90 -95.82 4.7 52.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.879 0.696 . . . . 64.44 112.879 -169.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -106.37 -0.06 24.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.252 -0.579 . . . . 71.31 111.513 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.794 HG22 HG13 ' A' ' 25' ' ' ILE . 54.2 mt -77.41 -55.82 9.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.338 -0.392 . . . . 44.44 111.854 -174.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.898 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.0 mt -140.54 178.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 109.554 -0.535 . . . . 72.51 109.554 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -125.83 -118.1 2.22 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.954 -0.641 . . . . 71.05 112.534 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.912 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -139.81 105.68 5.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.022 0.439 . . . . 62.14 111.933 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -152.32 57.68 2.26 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.842 -0.617 . . . . 64.45 111.054 173.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 28' ' ' LEU . 19.7 Cg_endo -95.66 166.29 1.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.19 2.594 . . . . 64.22 112.172 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 63.44 104.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.4 0.619 . . . . 73.12 111.373 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.94 -32.58 7.36 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.394 -0.682 . . . . 72.43 111.394 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.33 -172.71 2.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.021 -0.363 . . . . 64.52 110.021 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 38.7 ttpt -85.98 157.66 20.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.299 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 94.2 t 76.23 126.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.695 0.759 . . . . 72.44 112.056 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -137.83 175.45 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.304 -0.862 . . . . 64.35 109.839 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.654 ' HA ' HG22 ' A' ' 46' ' ' ILE . 17.3 m -76.06 125.67 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.961 -0.385 . . . . 55.21 109.961 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -81.63 -55.97 7.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.46 -0.337 . . . . 51.21 110.515 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -171.07 150.82 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 31.15 110.9 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -80.02 131.43 35.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.577 -0.738 . . . . 73.05 110.193 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -134.96 114.49 12.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.615 0.245 . . . . 74.34 110.956 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t 71.84 5.52 5.38 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.453 -0.794 . . . . 73.44 111.779 174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.4 -48.76 0.95 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 64.22 111.854 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -84.67 160.53 20.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 73.52 110.315 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 68.5 m -96.28 140.25 31.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.766 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -82.86 118.69 23.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.682 -0.69 . . . . 64.03 111.07 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -133.81 144.55 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 64.22 110.232 173.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -122.03 113.55 19.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.975 -1.12 . . . . 64.43 107.975 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 69.3 t80 -105.56 86.1 2.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.138 -0.483 . . . . 74.45 110.908 -170.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 62.32 46.33 6.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.229 0.538 . . . . 74.41 110.826 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.46 -17.57 58.75 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 73.32 113.512 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.3 pt20 -103.48 128.1 50.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.38 0.609 . . . . 74.1 110.225 176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.33 151.82 21.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 40.32 111.067 -172.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.96 173.7 38.33 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.403 -0.903 . . . . 54.01 113.353 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 72.1 m-85 -132.97 144.74 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 74.21 109.269 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 15' ' ' ARG . 2.8 pp -136.03 161.69 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.618 0.247 . . . . 74.44 110.946 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.36 123.31 6.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.601 -0.809 . . . . 44.24 111.814 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.3 m -64.76 -7.07 9.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.009 0.433 . . . . 71.42 111.7 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -65.76 -37.57 86.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.454 -0.339 . . . . 75.21 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -124.32 120.64 32.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.523 0.678 . . . . 75.4 111.744 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 66.6 mt -155.89 175.64 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.112 -1.44 . . . . 73.33 107.112 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.451 ' OG ' ' HG2' ' A' ' 29' ' ' PRO . 6.1 p -111.47 118.14 34.95 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.607 -0.837 . . . . 55.23 111.456 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -166.88 -22.12 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.029 -0.987 . . . . 71.35 109.206 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 39.5 tp -83.81 34.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.503 -0.771 . . . . 65.03 109.565 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 66' ' ' HIS . 6.7 pt-20 -71.31 177.92 3.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.746 -0.661 . . . . 71.03 109.8 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER 69.93 23.77 5.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.282 0.563 . . . . 75.53 109.734 -168.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 26.7 p80 -91.15 134.42 34.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.345 -0.843 . . . . 64.34 110.175 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -86.2 146.13 26.68 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 75.05 110.962 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -95.25 36.95 1.19 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.803 -0.635 . . . . 75.43 109.545 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 66.53 87.87 0.12 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.854 -0.795 . . . . 71.11 108.854 -169.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 C--O 1.25 1.087 0 CA-C-N 114.875 -1.057 . . . . 72.32 110.494 -175.054 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HB2' ' OD1' ' A' ' 4' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.781 -0.451 . . . . 75.52 109.781 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.622 HG13 ' H ' ' A' ' 3' ' ' GLY . 19.3 pt -98.8 -56.28 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.97 0.414 . . . . 73.43 110.373 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.622 ' H ' HG13 ' A' ' 2' ' ' ILE . . . -161.6 24.61 0.24 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.739 -0.944 . . . . 33.34 110.739 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 2.3 m-20 -60.25 109.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.534 -0.833 . . . . 64.34 110.492 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -100.83 95.2 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.022 -0.536 . . . . 71.1 111.027 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -120.24 -58.2 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.692 -0.685 . . . . 70.21 109.407 174.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt 56.72 82.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 114.655 -1.157 . . . . 61.32 110.465 -173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 67.05 -179.45 0.21 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.187 -0.915 . . . . 73.51 110.8 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.88 33.19 10.22 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.133 0.492 . . . . 44.53 111.096 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 14.2 t -154.75 -176.57 5.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.208 -0.664 . . . . 63.3 109.208 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.9 -40.38 97.4 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.054 0.454 . . . . 70.44 110.389 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.886 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -79.95 69.6 6.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.82 0.819 . . . . 73.01 109.499 174.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.7 t30 -117.61 -44.73 2.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.787 -1.097 . . . . 71.51 110.578 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.413 HG12 ' NE ' ' A' ' 15' ' ' ARG . 18.9 t -124.68 -67.11 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.32 -0.4 . . . . 71.11 111.04 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.581 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -130.59 142.47 50.46 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.553 -0.294 . . . . 74.12 110.894 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 53.9 p 45.92 74.18 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 O-C-N 124.087 0.867 . . . . 65.42 112.654 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . -127.49 -14.69 2.58 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.421 -0.895 . . . . 43.53 111.992 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -163.5 115.62 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.076 -0.713 . . . . 60.13 109.076 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.51 -152.95 24.96 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.5 -0.857 . . . . 73.45 112.402 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 m -68.91 -31.92 71.18 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 75.03 111.571 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -133.04 123.57 26.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 14.6 p90 -130.12 8.59 5.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.731 0.641 . . . . 75.34 112.731 -171.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -116.79 -11.16 10.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.329 0.862 . . . . 72.51 113.329 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 25' ' ' ILE . 5.0 pt -67.15 -56.45 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 114.365 1.246 . . . . 74.03 114.365 -167.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 15' ' ' ARG . 3.3 mp -111.73 -63.58 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.428 1.013 . . . . 54.23 111.664 -176.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.8 -151.61 16.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.212 -0.994 . . . . 52.45 112.944 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.3 97.71 6.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 55.14 111.28 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.2 tp -160.75 87.68 1.75 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.95 -0.568 . . . . 71.53 110.086 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -82.56 81.67 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.874 2.383 . . . . 63.42 111.549 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -104.3 -48.36 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 74.13 110.39 -176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.12 104.66 0.39 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 72.31 112.031 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.91 98.65 11.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.46 . . . . 62.01 110.246 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -149.43 42.7 0.92 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.964 -0.754 . . . . 42.43 108.964 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG11 ' CE1' ' A' ' 48' ' ' TYR . 6.2 p -123.14 -46.78 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.743 -0.662 . . . . 75.42 111.677 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.482 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -83.54 76.71 9.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.497 0.665 . . . . 45.14 110.629 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -128.66 3.32 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.771 -1.104 . . . . 64.41 109.15 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -77.06 -57.76 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.81 -0.632 . . . . 72.02 110.631 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 p -178.62 149.98 0.51 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.475 0.655 . . . . 42.23 111.661 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -112.67 127.23 56.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.987 -1.006 . . . . 71.53 108.55 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -101.94 171.43 7.52 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.541 -0.464 . . . . 75.25 110.776 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.3 t -64.57 -22.27 66.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 34.34 110.826 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.87 -73.78 0.99 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.971 -0.633 . . . . 41.44 111.972 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -117.23 161.91 18.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.151 0.501 . . . . 73.02 110.877 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 57' ' ' THR . 35.4 t -87.97 126.72 35.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.012 -0.736 . . . . 64.24 109.012 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.9 ttmt -83.97 123.05 29.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.133 0.492 . . . . 64.21 111.326 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 35' ' ' GLN . 20.0 pt -139.91 156.8 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.702 -0.681 . . . . 61.2 110.648 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -126.3 113.75 17.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 73.3 109.074 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CE1' ' HD3' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -101.26 84.11 2.58 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.619 -0.432 . . . . 74.32 110.832 -178.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.29 56.15 2.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.069 -0.969 . . . . 74.13 112.098 175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.74 56.57 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 121.09 -0.576 . . . . 42.22 114.16 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.22 128.72 54.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.653 0.726 . . . . 62.21 110.501 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -73.18 133.55 44.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.169 -0.923 . . . . 74.44 110.577 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.8 159.02 23.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.812 -0.708 . . . . 52.41 111.671 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -138.48 139.8 38.94 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.61 -0.515 . . . . 74.53 109.61 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.561 HD13 HD21 ' A' ' 60' ' ' LEU . 2.6 pp -137.52 149.12 25.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.517 -0.311 . . . . 71.23 110.453 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 123.1 8.21 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.638 -0.791 . . . . 74.2 111.943 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -62.3 -18.15 60.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.058 0.392 . . . . 73.53 112.058 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -63.51 -32.98 74.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.026 -0.533 . . . . 75.24 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.87 114.37 26.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.615 0.245 . . . . 73.22 110.354 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 55' ' ' ILE . 32.3 mt -159.22 151.51 21.22 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.884 -0.598 . . . . 73.41 111.206 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.6 m -97.25 118.82 34.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 164.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -98.52 163.3 12.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.797 0.332 . . . . 65.02 111.108 -173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.9 tp -88.62 17.2 5.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 75.32 110.462 -175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.19 66.78 9.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.527 0.679 . . . . 75.43 110.656 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -128.39 70.44 1.37 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.232 -1.025 . . . . 55.44 108.232 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.05 -20.56 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.516 -1.22 . . . . 74.45 109.41 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.2 m80 60.86 83.34 0.15 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.028 -0.987 . . . . 71.43 110.28 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -60.0 124.23 19.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 63.53 110.301 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -76.92 118.11 19.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.092 -0.504 . . . . 73.12 109.917 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.441 -0.79 . . . . 65.43 109.679 -177.243 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' HG2' HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.189 -0.3 . . . . 41.34 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.577 HG12 ' HG2' ' A' ' 1' ' ' MET . 35.5 mm 69.07 52.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 122.374 1.083 . . . . 64.15 109.376 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.74 37.82 0.32 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 108.82 -1.712 . . . . 61.41 108.82 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.33 50.26 0.81 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.095 -1.053 . . . . 73.21 111.182 -167.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -74.42 109.24 7.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.511 0.672 . . . . 73.0 109.496 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 33.5 m-85 -106.44 93.36 4.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.209 0.528 . . . . 75.32 111.319 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 11.6 tt -75.02 -19.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.894 0.854 . . . . 73.33 109.186 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -89.93 24.26 2.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.781 -1.1 . . . . 71.35 110.477 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . . . -107.6 -162.04 0.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.744 -0.662 . . . . 71.42 110.06 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.6 m -109.76 27.19 9.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.295 . . . . 75.34 111.011 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.34 -67.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.999 0.37 . . . . 60.12 111.999 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 6.4 mp -80.69 44.94 0.76 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.75 0.31 . . . . 71.04 111.459 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . 22.4 m120 -74.98 -31.01 61.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 64.03 111.569 -175.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.488 ' HB ' ' CG2' ' A' ' 25' ' ' ILE . 1.0 OUTLIER -95.11 30.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 74.4 111.603 -178.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.841 HH11 ' HA2' ' A' ' 26' ' ' GLY . 17.8 tpt180 -80.48 47.88 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.709 0.29 . . . . 74.1 111.463 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.6 t 64.51 4.87 2.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.494 0.717 . . . . 62.01 112.616 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.32 80.73 0.7 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.393 -0.908 . . . . 63.41 111.484 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 19' ' ' GLY . 35.6 tt0 70.93 175.9 0.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.946 0.498 . . . . 62.22 109.74 -176.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -79.01 59.1 4.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.818 -0.706 . . . . 63.44 112.879 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 t -93.79 -33.33 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.104 0.478 . . . . 65.34 110.148 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.42 ' OD1' HG13 ' A' ' 24' ' ' ILE . 22.2 t-20 -153.3 145.2 23.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.257 -1.016 . . . . 75.13 108.257 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 7.11 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.959 -0.697 . . . . 74.44 111.755 -173.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttt-85 -116.68 -32.78 5.06 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.832 -0.747 . . . . 74.43 112.738 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.501 HG22 HG13 ' A' ' 25' ' ' ILE . 70.4 mt -61.4 -55.96 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 72.54 111.19 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.596 HG23 ' CZ ' ' A' ' 48' ' ' TYR . 12.9 mt -129.7 158.75 42.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.841 ' HA2' HH11 ' A' ' 15' ' ' ARG . . . -131.42 -105.02 1.01 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 119.968 -1.111 . . . . 43.44 113.924 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -147.22 93.58 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.617 -0.512 . . . . 63.13 109.617 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 28' ' ' LEU . 1.3 tm? -154.09 80.54 4.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.488 -0.56 . . . . 63.52 109.488 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 10.3 Cg_exo -75.23 89.09 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.107 2.538 . . . . 73.1 112.115 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.81 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tt0 -117.51 -49.33 2.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.675 -0.693 . . . . 72.31 109.391 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.85 17.08 79.21 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.781 -0.645 . . . . 54.41 114.291 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.81 ' HG3' ' HG2' ' A' ' 30' ' ' GLN . 31.5 mt-30 -80.94 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.618 0.709 . . . . 71.13 110.152 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 4.3 mptp? -101.14 0.1 37.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.381 0.61 . . . . 54.33 109.935 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 41.3 t -93.26 92.18 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 72.14 109.093 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -112.69 141.22 46.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.853 -0.612 . . . . 74.52 110.965 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 46' ' ' ILE . 16.9 m -84.53 126.24 40.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.801 -0.636 . . . . 72.33 109.824 175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.12 -49.63 12.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.125 0.488 . . . . 65.34 110.181 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -163.52 168.39 20.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.533 -0.758 . . . . 71.41 108.97 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 pp20? -139.91 152.36 46.34 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.831 0.348 . . . . 74.53 110.815 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -156.15 129.33 8.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 75.24 109.649 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.7 t 71.8 -0.55 3.15 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.09 -0.505 . . . . 65.13 112.004 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.98 -21.62 10.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.809 -0.71 . . . . 74.44 111.838 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -95.74 150.5 20.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.666 -0.494 . . . . 74.11 109.666 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.4 t -117.34 140.17 49.91 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.157 0.503 . . . . 60.42 110.99 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -82.98 108.74 16.51 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.228 -0.896 . . . . 74.02 108.77 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.64 HD12 HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -130.06 163.21 36.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.028 0.442 . . . . 72.23 111.351 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.665 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 9.1 t30 -101.57 113.13 25.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.375 -0.829 . . . . 71.22 108.859 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.596 ' CZ ' HG23 ' A' ' 25' ' ' ILE . 90.0 t80 -105.6 98.2 7.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.504 -0.317 . . . . 63.13 110.241 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t30 56.21 34.68 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.206 0.526 . . . . 74.52 111.007 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.49 62.42 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.77 -0.729 . . . . 44.2 113.908 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 12.1 pt20 -124.2 155.73 38.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.453 0.627 . . . . 55.32 110.24 174.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -90.5 142.12 28.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.442 -0.345 . . . . 55.04 110.649 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.99 25.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.635 -0.793 . . . . 74.12 112.218 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -129.8 146.76 51.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.764 -0.458 . . . . 63.33 109.764 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 46' ' ' ILE . 2.7 pp -144.38 171.76 6.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 123.146 0.279 . . . . 72.15 110.365 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.64 109.92 3.53 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.718 -0.753 . . . . 62.11 111.839 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 1.4 m -63.78 -24.0 67.58 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.993 0.368 . . . . 74.35 111.993 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -67.79 -43.84 78.76 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.297 -0.41 . . . . 74.13 111.885 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -122.79 117.66 26.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.985 0.421 . . . . 51.43 110.656 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . 85.7 mt -155.05 153.82 31.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.09 -0.959 . . . . 71.12 110.124 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.761 ' HB2' ' HB3' ' A' ' 29' ' ' PRO . 34.8 m -109.24 120.8 43.63 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.482 -0.933 . . . . 63.45 108.482 171.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.748 ' HG2' HD23 ' A' ' 63' ' ' LEU . 28.8 ttpt -100.45 179.82 4.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.428 -169.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.5 pt? -90.63 14.72 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.463 . . . . 74.51 111.754 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -82.09 -5.79 58.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.129 0.49 . . . . 74.14 110.521 178.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -114.28 163.18 15.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.619 -0.719 . . . . 64.34 109.749 172.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -61.12 136.21 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.089 0.471 . . . . 72.44 110.658 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.4 ' CE1' ' HB2' ' A' ' 63' ' ' LEU . 2.5 m-70 -79.18 98.19 6.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.508 -0.769 . . . . 73.11 111.112 -170.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -80.28 102.96 9.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.922 -0.581 . . . . 73.4 110.58 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -92.25 154.21 18.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.563 -0.532 . . . . 63.33 109.563 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.768 -0.634 . . . . 75.25 110.237 -177.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.765 0.317 . . . . 53.1 110.335 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 pt -65.19 139.43 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 73.41 111.37 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.1 -19.41 51.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.996 -0.621 . . . . 73.23 111.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 66.08 176.97 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.178 0.591 . . . . 75.1 111.483 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -99.67 -32.78 10.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.122 -0.49 . . . . 70.41 110.919 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -109.72 103.03 11.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.376 0.608 . . . . 75.12 111.417 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -120.54 -170.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.964 -1.016 . . . . 61.55 109.218 174.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 60' ' ' LEU . 37.2 t-20 60.08 49.23 7.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.741 0.781 . . . . 53.05 109.615 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.35 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.067 -0.969 . . . . 41.22 110.158 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.1 t -114.24 122.44 46.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 70.2 110.56 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.9 146.58 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.1 0.875 . . . . 62.23 112.684 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt 61.05 21.21 11.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.551 -0.75 . . . . 71.0 111.945 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 61' ' ' SER . 16.7 m120 -53.54 -43.6 68.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.071 -0.513 . . . . 71.51 112.064 -175.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.89 48.42 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.172 0.511 . . . . 74.02 110.822 177.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HG3' ' HA2' ' A' ' 19' ' ' GLY . 10.9 tpt180 -80.19 27.38 0.33 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.035 -0.529 . . . . 74.42 111.074 -177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.492 ' HA ' HG22 ' A' ' 55' ' ' ILE . 11.8 t 56.86 32.61 21.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 74.2 111.292 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 110.16 -124.25 7.03 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.487 -0.863 . . . . 53.51 112.057 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 21.6 mm-40 -86.29 11.68 11.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 73.33 110.449 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 15' ' ' ARG . . . 86.89 16.58 61.09 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.374 -1.091 . . . . 64.4 110.374 -170.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.1 m -62.57 -54.26 42.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.028 -0.586 . . . . 72.13 110.711 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -102.4 100.47 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.139 -0.689 . . . . 73.33 109.139 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -93.48 5.32 51.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.732 -0.667 . . . . 73.12 111.45 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -100.98 -38.41 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.466 0.543 . . . . 73.51 112.466 -175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 25' ' ' ILE . 12.7 tt -82.86 -55.33 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.943 0.72 . . . . 64.34 112.943 -169.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 48' ' ' TYR . 16.6 mt -126.82 148.76 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.976 -0.379 . . . . 74.02 109.976 -174.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -150.25 159.0 27.93 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.007 -0.837 . . . . 62.14 111.007 -177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -75.98 96.97 3.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.492 . . . . 73.25 111.78 -174.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -149.84 72.11 9.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.651 -0.704 . . . . 63.32 109.768 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.5 90.48 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.727 2.284 . . . . 72.04 112.055 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' H ' ' HG2' ' A' ' 30' ' ' GLN . 6.4 pt20 -97.33 59.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.51 -0.768 . . . . 74.25 110.141 -177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.39 -78.05 1.78 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.493 -1.043 . . . . 63.13 110.493 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -73.16 137.03 44.87 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.032 -0.729 . . . . 61.04 109.032 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HD3' ' HB3' ' A' ' 61' ' ' SER . 46.6 mttp -116.05 -75.94 0.58 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.022 0.439 . . . . 74.21 110.108 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 ' HD1' ' A' ' 48' ' ' TYR . 8.3 p 174.3 -29.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.179 -0.919 . . . . 75.21 108.619 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 72.58 127.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.414 -1.266 . . . . 72.35 111.491 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 44' ' ' SER . 58.1 t -82.96 108.26 15.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.652 -0.704 . . . . 75.22 110.179 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 46' ' ' ILE . 4.7 mt -75.28 -49.53 27.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.836 -0.62 . . . . 75.11 111.346 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 m -153.24 150.95 29.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.054 0.454 . . . . 72.03 110.937 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.63 123.88 47.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.464 -0.789 . . . . 64.44 109.245 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.34 140.73 26.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.516 -0.179 . . . . 73.34 110.516 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.2 t 75.24 -54.33 0.65 Allowed 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.857 0.723 . . . . 74.31 111.662 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.11 -51.84 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.514 -0.634 . . . . 62.42 111.514 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.622 ' HZ2' ' HG2' ' A' ' 18' ' ' GLU . 25.5 m0 -87.61 160.14 18.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.089 0.471 . . . . 74.45 110.691 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.57 ' HB3' HG13 ' A' ' 36' ' ' VAL . 44.4 m -91.34 140.79 29.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.63 -0.714 . . . . 74.23 109.352 176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 0.3 OUTLIER -105.45 129.88 53.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 120.935 0.398 . . . . 73.32 109.939 -177.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -142.91 170.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.652 -0.704 . . . . 74.33 110.315 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -108.79 115.11 29.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.253 -0.647 . . . . 74.41 109.253 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 25' ' ' ILE . 5.8 t80 -113.47 101.23 9.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 72.24 110.156 -175.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t30 63.02 41.79 7.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.507 0.67 . . . . 53.54 110.35 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.21 56.86 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.555 -0.748 . . . . 53.31 113.65 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 8.1 pt20 -111.79 145.86 38.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.388 0.594 . . . . 74.35 111.689 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 m -72.52 123.21 22.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 74.22 111.002 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.5 168.58 18.6 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.779 -0.724 . . . . 72.33 111.75 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -129.39 144.4 51.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.817 0.341 . . . . 73.33 110.434 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.92 156.26 31.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.74 -0.664 . . . . 54.21 109.668 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -72.36 129.1 14.13 Favored Glycine 0 C--O 1.219 -0.815 0 C-N-CA 120.631 -0.795 . . . . 73.43 112.137 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -77.24 -13.57 59.91 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.322 0.582 . . . . 71.21 110.428 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.575 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 17.3 ptt85 -85.65 -16.84 37.86 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.382 -0.372 . . . . 75.43 111.271 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HD1' ' HG3' ' A' ' 58' ' ' ARG . 30.9 m-85 -127.12 116.33 20.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.204 -0.665 . . . . 74.0 109.204 171.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 97.1 mt -140.96 173.83 11.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.279 0.561 . . . . 75.02 110.876 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 13' ' ' ASN . 10.1 t -109.26 127.44 54.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.696 -0.684 . . . . 73.34 109.174 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 8' ' ' ASN . 75.3 mmtt -79.89 158.22 26.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.718 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.892 HD13 ' H ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -95.6 -5.83 41.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.669 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 74.34 142.23 0.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.368 -0.833 . . . . 70.32 111.273 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -109.83 -3.49 16.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.128 0.418 . . . . 70.22 112.128 -171.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -71.94 148.03 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.991 -0.683 . . . . 74.34 110.54 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -136.01 152.5 50.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.282 -0.636 . . . . 73.04 109.282 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -93.96 110.13 21.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.205 0.526 . . . . 75.14 112.173 -176.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -82.61 -28.25 30.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.114 -1.069 . . . . 72.11 108.114 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 p80 . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.732 -1.122 . . . . 75.14 109.527 173.91 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.882 -0.414 . . . . 55.21 109.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.8 pt 47.94 -169.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.443 1.097 . . . . 62.25 112.625 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.31 87.38 0.11 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.525 -0.845 . . . . 61.2 112.473 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -165.3 -35.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 52.31 110.706 176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -114.92 131.39 56.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.486 -0.324 . . . . 71.41 111.637 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 62.48 19.22 11.04 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.402 -0.817 . . . . 74.21 112.657 171.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 16.5 tt -146.07 147.18 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.019 -0.734 . . . . 73.51 109.019 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 18.7 m120 73.02 -59.45 0.57 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.701 0.626 . . . . 74.42 110.44 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 60.47 -158.72 0.32 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.691 0.619 . . . . 43.31 111.321 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.1 m -132.12 27.49 4.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.465 0.65 . . . . 63.22 109.864 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 12' ' ' LEU . . . -139.66 145.31 38.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.206 -0.906 . . . . 65.0 109.234 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 15' ' ' ARG . 4.3 mm? 67.19 28.69 8.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.471 0.482 . . . . 73.22 110.079 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.639 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 88.0 m-20 -63.19 -50.08 71.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.439 -0.801 . . . . 71.34 111.727 -174.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.02 6.22 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.482 -0.562 . . . . 72.24 109.482 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.458 ' HG3' ' HA ' ' A' ' 12' ' ' LEU . 37.6 mtp180 -69.41 176.89 3.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.793 -0.64 . . . . 65.13 110.911 -172.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.969 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 3.9 m 69.97 44.63 0.79 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.683 -0.689 . . . . 62.0 111.044 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.877 ' HA3' HD12 ' A' ' 25' ' ' ILE . . . -56.49 -35.84 68.05 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 114.246 0.458 . . . . 71.4 114.246 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 21' ' ' ASN . 42.2 mt-10 -90.3 9.93 26.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.213 0.507 . . . . 71.24 110.532 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.485 ' HA3' ' CH2' ' A' ' 43' ' ' TRP . . . 76.73 -65.69 2.83 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 116.097 -0.501 . . . . 63.51 112.229 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.9 p -82.41 -28.31 31.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.854 0.359 . . . . 75.31 110.763 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 27.5 t30 -100.17 118.11 35.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.359 -0.608 . . . . 74.32 109.359 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.969 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 24.2 m-85 -93.8 -36.88 12.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.869 -0.605 . . . . 63.44 111.807 -170.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -73.88 -6.61 48.23 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.068 0.766 . . . . 74.04 113.068 -169.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.44 -35.88 64.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 73.02 111.935 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.877 HD12 ' HA3' ' A' ' 17' ' ' GLY . 33.2 mt -124.13 156.32 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.3 -0.259 . . . . 74.21 110.3 -173.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.45 -135.91 6.1 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.191 -0.528 . . . . 74.31 112.2 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 13' ' ' ASN . . . -148.88 99.18 2.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.066 0.433 . . . . 75.45 112.098 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.9 tp -157.1 69.5 4.44 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 120.976 0.417 . . . . 75.35 110.776 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -97.94 63.73 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.106 2.537 . . . . 34.21 112.506 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.7 -77.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 73.22 110.024 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.9 3.49 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.508 -0.637 . . . . 73.33 111.508 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.79 153.26 14.47 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.904 -1.147 . . . . 75.23 107.904 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -80.07 15.09 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.111 0.481 . . . . 72.43 111.213 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 89.0 t -76.61 97.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 54.4 110.034 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -138.98 169.7 17.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.837 -0.619 . . . . 62.13 110.69 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -98.63 125.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.685 -0.689 . . . . 74.44 109.547 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.523 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -78.29 -55.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.511 0.672 . . . . 72.22 109.618 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.2 t -147.06 155.74 42.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.925 -1.034 . . . . 62.12 109.18 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.74 159.21 35.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.255 0.55 . . . . 74.45 111.412 -176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -132.53 174.24 10.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.574 -0.739 . . . . 64.44 109.337 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 t -74.66 78.89 2.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.708 0.766 . . . . 64.02 110.538 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.03 -70.99 0.31 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.12 -0.946 . . . . 73.41 111.465 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 40.3 m0 -115.42 146.07 41.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.996 0.427 . . . . 72.44 110.425 176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.1 m -115.32 135.8 53.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.795 -0.639 . . . . 73.44 110.094 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 35.7 ttmt -82.57 125.29 30.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.356 0.598 . . . . 73.24 111.355 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 pt -128.08 171.04 16.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.484 -0.78 . . . . 74.42 110.858 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 t-20 -126.58 113.92 17.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.036 -0.727 . . . . 71.34 109.036 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.764 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 31.2 t80 -103.72 77.79 1.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.992 0.425 . . . . 74.23 109.885 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 58.47 48.02 12.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.14 111.863 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.76 -17.21 59.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.584 -0.817 . . . . 71.42 113.66 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.764 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.8 pt20 -100.37 148.39 24.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.659 0.73 . . . . 71.44 110.344 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.3 m -86.74 140.7 29.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.595 -0.729 . . . . 75.2 111.306 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.17 161.39 31.99 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.915 -0.659 . . . . 62.24 112.133 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -132.39 139.03 47.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 2.9 pp -121.53 167.52 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 121.019 -0.273 . . . . 75.41 111.713 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.33 118.86 5.02 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.87 -0.681 . . . . 64.02 111.773 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -58.56 -17.39 21.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.648 0.61 . . . . 55.41 112.648 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -72.06 -25.85 61.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.914 0.338 . . . . 72.12 111.914 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -121.04 119.31 32.12 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.049 0.452 . . . . 54.14 110.767 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.6 mt -156.87 160.87 39.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.48 -0.782 . . . . 73.44 110.192 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -100.29 120.26 39.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.993 0.425 . . . . 53.11 110.549 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -112.24 142.91 44.15 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.35 -48.72 66.67 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.126 0.266 . . . . 71.31 111.056 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HG2' ' N ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER 43.59 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.065 1.346 . . . . 70.23 111.331 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.582 ' N ' ' HG2' ' A' ' 64' ' ' GLU . 7.1 p80 -136.35 67.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.843 0.83 . . . . 73.44 110.554 170.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 67' ' ' HIS . 64.4 m-70 -129.85 -39.06 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.905 -1.043 . . . . 74.02 110.245 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 66' ' ' HIS . 25.4 m-70 67.23 96.87 0.06 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.562 -0.745 . . . . 72.13 109.192 -169.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -46.58 134.16 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.993 -1.003 . . . . 62.45 112.064 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 95.2 m-70 -60.69 -40.09 90.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.721 -1.127 . . . . 75.51 112.677 -167.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 84.2 t60 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.154 -0.926 . . . . 74.44 109.856 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.863 0.363 . . . . 65.55 110.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 pt -125.75 158.03 34.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.984 -0.553 . . . . 65.54 110.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.72 -15.64 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.024 -0.608 . . . . 74.15 112.083 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' HB3' ' HD1' ' A' ' 6' ' ' TYR . 4.2 m-20 -90.81 89.78 7.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.818 0.342 . . . . 73.5 110.506 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -94.4 60.65 2.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.201 0.524 . . . . 71.04 110.028 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 46.0 p90 -82.45 36.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.594 -0.73 . . . . 72.34 111.473 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 6' ' ' TYR . 47.1 mm 74.53 147.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 123.497 0.498 . . . . 73.34 110.196 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 75.24 -38.28 0.36 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.72 0.808 . . . . 54.24 111.663 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 1.72 3.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.732 0.642 . . . . 74.42 112.732 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -72.81 -31.87 65.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.488 -0.19 . . . . 54.35 110.488 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.609 ' HA ' ' OG ' ' A' ' 61' ' ' SER . . . 70.4 -39.05 0.43 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.738 0.815 . . . . 73.25 113.11 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 27' ' ' ALA . 54.4 mt -84.17 22.91 1.13 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.008 0.373 . . . . 74.54 112.008 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 18' ' ' GLU . 2.5 t30 -117.94 6.78 12.21 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.913 0.338 . . . . 72.52 111.913 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' ILE . 6.0 t -82.87 49.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 121.885 -0.509 . . . . 63.44 110.395 -174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.852 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 9.1 ptt180 -120.2 83.16 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.347 0.594 . . . . 72.31 111.965 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 21' ' ' ASN . 13.4 m 59.29 25.78 14.48 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.189 -0.914 . . . . 72.13 111.621 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 56' ' ' GLY . . . 113.85 -143.06 17.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.836 -0.697 . . . . 72.14 111.46 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 13' ' ' ASN . 8.3 mm-40 -61.22 -27.29 68.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.05 0.452 . . . . 53.33 110.887 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.92 63.62 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.348 -0.701 . . . . 72.14 111.348 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 m -87.69 -61.55 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.871 0.367 . . . . 64.22 111.033 -175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.428 ' H ' ' HB2' ' A' ' 16' ' ' SER . 6.6 m120 -123.93 127.23 47.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.168 -0.679 . . . . 53.35 109.168 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -97.56 6.6 47.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.849 -0.614 . . . . 74.43 111.265 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -107.72 -54.66 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.338 -0.392 . . . . 71.51 111.643 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.536 HG12 HG13 ' A' ' 25' ' ' ILE . 8.1 tt -59.94 -41.88 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 74.43 111.627 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.673 HG23 ' CE1' ' A' ' 48' ' ' TYR . 28.3 mt -136.53 165.07 29.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.32 -0.992 . . . . 73.13 108.32 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.852 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 179.9 -166.33 35.37 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.362 -0.923 . . . . 72.33 112.176 -171.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.566 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -81.07 91.78 6.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.05 0.452 . . . . 72.24 111.851 -174.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' HE2' ' A' ' 33' ' ' LYS . 1.8 pt? -173.71 77.42 0.38 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.4 -0.818 . . . . 65.04 109.613 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -88.09 85.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.161 2.574 . . . . 75.15 112.401 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -165.35 155.22 12.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.915 -0.584 . . . . 75.1 109.823 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.8 174.75 50.48 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.934 -0.65 . . . . 72.33 113.317 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -92.45 7.32 43.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 62.3 110.802 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HE2' HD12 ' A' ' 28' ' ' LEU . 22.9 pttp -66.96 -15.71 63.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.922 -0.581 . . . . 73.32 110.995 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 4.4 p -146.63 123.2 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.336 0.589 . . . . 72.11 110.532 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -130.69 132.19 45.26 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.424 -0.584 . . . . 65.21 109.424 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.6 p -75.95 126.66 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.099 0.476 . . . . 60.33 110.553 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.43 -56.61 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.664 -0.495 . . . . 74.41 109.664 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.8 t -179.17 159.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.629 -0.714 . . . . 64.45 109.7 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -85.24 144.96 27.8 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.573 -0.739 . . . . 74.42 109.813 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -146.65 113.36 6.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.9 0.381 . . . . 72.31 110.698 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.0 t 57.9 62.92 1.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 72.21 111.314 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 -59.3 3.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.961 -0.638 . . . . 73.14 112.921 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.507 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 14.4 m0 -91.09 159.61 16.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.786 0.326 . . . . 60.03 110.629 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.804 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 9.6 t -105.22 142.42 35.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.277 -0.42 . . . . 64.31 110.035 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 54' ' ' TYR . 2.9 mtpt -87.88 127.34 35.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 116.178 -0.465 . . . . 62.34 110.829 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 36' ' ' VAL . 46.0 pt -143.23 164.17 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.723 -0.672 . . . . 64.22 110.954 -177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 26.6 t-20 -112.97 117.34 31.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.454 -0.943 . . . . 71.23 108.454 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.673 ' CE1' HG23 ' A' ' 25' ' ' ILE . 5.8 t80 -110.23 105.04 13.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.703 0.287 . . . . 74.04 110.515 -175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.9 t30 62.21 35.29 15.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.675 -0.693 . . . . 65.33 110.919 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.97 -17.48 59.22 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.887 -0.673 . . . . 54.31 113.234 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -107.92 133.78 51.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.35 0.575 . . . . 71.34 110.601 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -73.93 130.83 40.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.896 -0.593 . . . . 65.22 110.808 -175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.02 -172.19 12.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.833 -0.699 . . . . 74.43 112.405 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.506 ' CE2' ' HG2' ' A' ' 45' ' ' LYS . 97.0 m-85 -136.06 144.93 45.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.224 -0.287 . . . . 72.31 110.224 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 44' ' ' SER . 2.6 pp -135.29 162.43 37.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.348 -0.387 . . . . 71.44 110.239 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.626 ' H ' ' HA2' ' A' ' 17' ' ' GLY . . . -79.71 143.55 25.71 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 45.33 112.055 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.793 ' HA ' HD11 ' A' ' 60' ' ' LEU . 8.7 m -85.07 -5.4 59.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.757 0.789 . . . . 74.21 109.332 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -34.37 57.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.361 -0.836 . . . . 74.34 110.809 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -135.87 118.62 16.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.038 0.447 . . . . 73.3 111.457 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 ' HA ' ' A' ' 57' ' ' THR . 5.2 mp -140.38 173.86 11.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.316 -0.856 . . . . 72.41 109.062 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.609 ' OG ' ' HA ' ' A' ' 11' ' ' ALA . 45.9 m -142.39 124.33 15.25 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.658 -0.497 . . . . 71.24 109.658 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -72.96 137.1 45.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 75.4 109.737 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 1.7 pp -66.29 -11.28 49.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.19 0.441 . . . . 64.4 112.19 -174.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.91 98.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.083 0.772 . . . . 62.15 113.083 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -90.5 73.43 6.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.627 -0.879 . . . . 73.03 108.627 171.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.12 141.28 50.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 74.3 111.185 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -90.09 79.83 6.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.584 -0.734 . . . . 71.1 111.097 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 58.45 88.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.431 -0.804 . . . . 74.32 110.813 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -155.91 146.38 21.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.983 -0.747 . . . . 74.31 108.983 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.158 -0.925 . . . . 73.42 110.426 177.206 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.61 ' HG2' HG22 ' A' ' 2' ' ' ILE . 52.6 ttm . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 110.537 -0.171 . . . . 65.34 110.537 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.61 HG22 ' HG2' ' A' ' 1' ' ' MET . 8.4 tp 43.27 86.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.22 1.008 . . . . 74.41 112.455 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.58 41.11 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.484 -0.78 . . . . 71.24 111.646 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -116.18 121.61 42.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.196 0.522 . . . . 72.12 110.77 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -148.92 10.54 0.81 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.527 -0.761 . . . . 72.42 109.235 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.514 -0.767 . . . . 65.11 110.019 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 tt 177.32 137.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.922 -1.035 . . . . 61.54 109.189 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 m120 62.14 -85.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.964 0.412 . . . . 73.5 111.928 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.35 84.7 3.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.219 0.533 . . . . 63.42 111.007 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.1 m -125.21 -54.43 1.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.714 -0.676 . . . . 73.12 110.162 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.6 -85.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.015 0.436 . . . . 73.32 110.782 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.709 HD13 ' HE1' ' A' ' 22' ' ' TYR . 59.2 mt -88.48 133.25 34.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.165 -0.47 . . . . 64.32 110.422 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -117.94 -60.35 1.81 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.978 0.362 . . . . 61.33 111.978 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 55' ' ' ILE . 4.7 t -74.55 -65.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 73.51 111.385 -172.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 58.33 17.96 5.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.934 0.716 . . . . 42.43 112.934 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 21' ' ' ASN . 37.9 t 62.33 25.21 15.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.212 0.53 . . . . 63.42 110.189 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.36 -108.48 0.67 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.112 -0.795 . . . . 74.52 111.112 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' OE1' ' HD3' ' A' ' 58' ' ' ARG . 40.4 mt-10 -118.14 14.59 14.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 71.23 110.201 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.17 48.69 0.18 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.588 -0.733 . . . . 73.2 111.467 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.4 m -94.2 -34.97 12.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 74.03 109.913 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' H ' ' HB3' ' A' ' 16' ' ' SER . 18.5 m-80 -140.24 142.06 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.195 -0.912 . . . . 73.24 109.591 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.709 ' HE1' HD13 ' A' ' 12' ' ' LEU . 55.7 m-85 -129.53 -13.95 4.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.543 0.687 . . . . 75.14 110.274 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -71.73 -49.9 35.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.913 -1.039 . . . . 73.21 111.109 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 tt -97.09 -55.31 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 72.41 111.526 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' A' ' 48' ' ' TYR . 60.6 mt -101.23 127.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.715 -0.476 . . . . 42.15 109.715 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -134.47 -108.54 1.01 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.552 -0.832 . . . . 31.31 111.762 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -132.63 92.25 3.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.443 . . . . 55.0 110.164 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 1.5 pt? -173.39 86.43 0.39 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.352 -0.84 . . . . 72.12 109.834 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.82 71.37 4.12 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.699 2.266 . . . . 62.11 110.835 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.75 140.97 29.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.163 -0.926 . . . . 64.24 111.088 -174.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.83 177.35 28.17 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.678 -0.773 . . . . 75.44 112.129 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -90.92 51.01 1.88 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 72.12 110.045 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG3' HG23 ' A' ' 34' ' ' VAL . 47.1 pttt -175.36 -156.45 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.263 -0.881 . . . . 42.14 109.341 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.511 HG23 ' HG3' ' A' ' 33' ' ' LYS . 82.2 t 75.89 -28.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.24 0.616 . . . . 65.14 112.091 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -59.67 -66.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 75.4 110.9 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -174.38 125.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.11 0.481 . . . . 72.5 110.65 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.2 mt -113.77 -54.06 4.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.227 0.537 . . . . 73.55 110.061 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.9 t -143.06 171.81 13.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.125 -0.694 . . . . 73.35 109.125 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 39.9 mt-10 -137.95 149.71 46.4 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.052 -0.351 . . . . 62.5 110.052 -176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -162.86 117.58 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 65.43 111.628 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 t 63.43 33.05 14.03 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.585 -0.734 . . . . 75.43 112.457 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.55 -32.85 6.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.666 -0.778 . . . . 73.23 112.956 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -102.17 155.13 18.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.992 0.425 . . . . 74.43 110.302 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.689 ' HB2' HG13 ' A' ' 55' ' ' ILE . 25.0 m -106.02 143.46 34.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.135 -0.484 . . . . 64.45 110.689 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HD2' ' CE1' ' A' ' 54' ' ' TYR . 19.1 mmmt -82.8 117.53 22.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.508 -0.769 . . . . 73.01 110.363 -177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.723 ' HA ' HD12 ' A' ' 37' ' ' ILE . 31.4 pt -137.65 171.65 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.966 0.413 . . . . 73.34 110.94 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -115.04 114.68 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.068 -0.716 . . . . 72.34 109.068 171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.656 ' CE2' HG23 ' A' ' 25' ' ' ILE . 6.0 t80 -111.05 113.1 25.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.456 -0.338 . . . . 64.45 110.351 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.85 35.06 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.264 0.554 . . . . 74.3 111.109 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.23 64.52 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 63.43 114.033 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -131.12 167.6 18.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.572 0.686 . . . . 61.12 110.782 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.8 m -70.17 119.98 15.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 64.13 110.85 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.63 169.27 15.79 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.814 -0.707 . . . . 70.52 111.689 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 45' ' ' LYS . 97.5 m-85 -139.02 150.62 46.02 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.637 -0.505 . . . . 73.35 109.637 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.784 HG22 HG13 ' A' ' 14' ' ' VAL . 2.5 pp -130.33 154.01 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 123.088 0.243 . . . . 72.2 110.681 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.34 108.76 3.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.705 -0.958 . . . . 74.12 110.705 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -59.56 -15.04 15.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.661 0.615 . . . . 60.34 112.661 -171.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HD3' ' OE1' ' A' ' 18' ' ' GLU . 11.6 ptm180 -73.4 -16.49 61.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.691 0.282 . . . . 75.42 111.499 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.77 118.62 15.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.321 -0.251 . . . . 73.33 110.321 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 HD13 ' A' ' 55' ' ' ILE . 36.4 mt -153.37 156.1 37.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.568 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.0 t -155.27 121.84 5.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HB2' ' HG3' ' A' ' 64' ' ' GLU . 49.3 mttp -89.07 -163.05 0.93 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.078 -0.51 . . . . 72.12 109.935 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' HIS . 7.4 mp -85.13 32.06 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.225 0.536 . . . . 71.34 109.914 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 62' ' ' LYS . 39.3 mt-10 -80.89 158.33 25.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.485 -0.78 . . . . 74.43 109.42 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 61.4 24.46 14.56 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.052 0.93 . . . . 73.12 108.76 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 3.6 t-160 -151.05 131.82 14.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 72.22 108.725 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -67.23 139.95 57.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.587 -0.445 . . . . 71.12 109.942 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -92.75 150.78 20.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.77 -0.455 . . . . 74.21 109.77 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -96.57 94.03 7.11 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.895 -1.15 . . . . 74.12 107.895 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 . . . . . 0 C--O 1.249 1.068 0 O-C-N 123.959 0.787 . . . . 65.33 109.549 -168.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.913 -0.403 . . . . 62.41 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.6 pt -121.99 109.6 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 74.13 111.2 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.29 13.16 7.48 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.404 -1.078 . . . . 44.22 110.404 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.94 111.13 23.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.918 -0.641 . . . . 64.21 110.193 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -131.09 82.41 2.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.775 -0.454 . . . . 73.42 109.775 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.57 ' HD2' HG13 ' A' ' 7' ' ' ILE . 17.7 t80 -157.18 152.87 26.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.947 -0.57 . . . . 74.21 109.777 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.57 HG13 ' HD2' ' A' ' 6' ' ' TYR . 57.3 mt 68.19 -78.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.095 0.558 . . . . 61.2 111.032 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 59' ' ' TYR . 3.3 m-20 -85.97 -41.99 14.41 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.422 -0.214 . . . . 62.44 110.422 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.42 -159.88 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.911 -0.586 . . . . 52.54 110.582 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.5 t -74.77 -12.92 60.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.901 0.334 . . . . 72.04 111.901 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.98 160.53 22.58 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.295 -0.162 . . . . 54.11 110.764 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt 56.42 42.18 27.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.093 0.473 . . . . 65.24 111.312 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -68.21 -52.88 29.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.761 -0.654 . . . . 44.23 111.362 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG13 HG21 ' A' ' 55' ' ' ILE . 4.8 t -87.85 48.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 74.43 110.589 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.851 ' HD2' ' HB2' ' A' ' 22' ' ' TYR . 3.0 mmt180 -74.79 37.62 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.647 0.61 . . . . 72.23 112.647 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 55' ' ' ILE . 4.5 m 49.64 73.82 0.23 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.484 0.659 . . . . 64.52 112.525 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.719 ' H ' ' HA ' ' A' ' 55' ' ' ILE . . . 101.97 -139.34 14.37 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.572 -0.74 . . . . 25.22 111.472 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -110.59 39.37 2.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.605 -0.887 . . . . 64.24 108.605 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.01 21.25 33.71 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -1.0 . . . . 74.51 111.055 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 m -87.08 -61.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 61.42 111.508 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.401 ' C ' ' HB2' ' A' ' 16' ' ' SER . 15.7 m120 -108.95 34.92 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.582 -0.525 . . . . 64.55 109.582 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.851 ' HB2' ' HD2' ' A' ' 15' ' ' ARG . 28.7 p90 -50.71 -21.99 1.87 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.926 -1.034 . . . . 74.2 113.646 -168.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 23' ' ' ARG . 24.6 ttt-85 -58.5 -35.46 72.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.321 0.489 . . . . 75.22 112.321 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.72 -56.94 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 61.22 111.895 -170.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.593 HG12 ' CD2' ' A' ' 48' ' ' TYR . 1.7 mt -128.27 157.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.338 -0.616 . . . . 61.32 109.338 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -144.79 -77.94 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.703 -1.237 . . . . 45.11 114.34 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.745 ' O ' ' HD3' ' A' ' 29' ' ' PRO . . . -81.35 -153.32 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.677 0.621 . . . . 64.04 112.677 -168.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 61' ' ' SER . 56.9 tp -91.16 90.03 0.33 Allowed Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.355 -0.839 . . . . 75.45 110.762 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 68.2 Cg_endo -85.59 -7.16 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.574 2.182 . . . . 72.31 112.56 -173.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 67.43 166.0 0.23 Allowed 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.638 0.586 . . . . 71.31 110.633 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.2 67.53 2.12 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.074 -0.584 . . . . 72.32 112.637 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -58.63 -67.69 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.358 0.599 . . . . 70.15 110.022 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -139.97 -36.7 0.49 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.848 -1.069 . . . . 72.02 108.785 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -78.46 115.88 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.336 -0.847 . . . . 75.2 110.521 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.453 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 3.9 pm0 -122.79 13.83 9.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.371 -0.377 . . . . 55.01 110.57 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.92 ' HA ' HG22 ' A' ' 46' ' ' ILE . 95.2 t 73.67 118.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.651 -0.704 . . . . 73.23 109.891 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.25 -51.07 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.129 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -168.65 150.72 4.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.606 -0.724 . . . . 71.53 110.394 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.4 mp0 -90.72 125.84 35.81 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.499 -0.773 . . . . 65.35 110.195 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -97.62 177.72 5.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.884 -0.598 . . . . 53.21 109.857 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 p -62.36 76.54 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.011 -0.995 . . . . 71.24 111.411 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.08 -68.41 0.55 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.363 -0.835 . . . . 74.12 112.001 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 42.0 m0 -112.61 160.21 18.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 74.35 110.731 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.2 m -103.55 129.32 50.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.891 -0.595 . . . . 75.3 109.7 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 38.0 ttmt -83.08 132.28 35.12 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.168 0.509 . . . . 74.34 111.738 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.92 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -140.02 153.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.592 -0.731 . . . . 75.14 109.954 176.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -111.98 113.77 26.27 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.428 -0.953 . . . . 74.1 108.428 173.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.685 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 11.8 t80 -115.53 110.96 20.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.253 -0.431 . . . . 62.41 110.137 -172.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.25 33.75 16.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 72.23 110.711 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.52 -10.2 75.26 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 75.51 113.808 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 14.0 pt20 -106.86 147.01 30.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.751 0.775 . . . . 74.14 110.982 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -84.88 131.29 34.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.64 -0.709 . . . . 62.33 111.418 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.84 174.17 26.77 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.786 -0.721 . . . . 62.5 111.849 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 66.6 m-85 -134.02 147.45 50.96 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.27 -0.641 . . . . 75.32 109.27 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.719 ' HA ' ' H ' ' A' ' 17' ' ' GLY . 2.8 pp -126.86 154.65 37.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.529 0.204 . . . . 73.1 110.709 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.35 130.57 11.37 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.556 -0.831 . . . . 72.11 111.817 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 m -69.16 -9.12 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.14 0.495 . . . . 55.2 111.331 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.02 -47.22 86.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.109 0.481 . . . . 71.41 110.189 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CG ' ' HB2' ' A' ' 8' ' ' ASN . 7.7 m-85 -130.2 118.99 22.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.765 -0.652 . . . . 74.53 110.489 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 36' ' ' VAL . 5.0 tt -138.07 134.98 35.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.314 -0.857 . . . . 75.3 108.817 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.513 ' HB3' HD12 ' A' ' 28' ' ' LEU . 71.1 m -83.86 119.59 25.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 75.41 111.237 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.471 ' HG3' ' H ' ' A' ' 63' ' ' LEU . 15.0 tppt? -110.8 175.34 5.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.952 -1.129 . . . . 70.15 107.952 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' H ' ' HG3' ' A' ' 62' ' ' LYS . 4.4 mm? -67.42 -65.12 0.73 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 121.149 -0.22 . . . . 73.04 111.441 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 65' ' ' HIS . 0.1 OUTLIER 61.83 -178.08 0.12 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.184 -0.673 . . . . 71.34 109.184 -176.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.444 ' H ' ' CD ' ' A' ' 64' ' ' GLU . 1.5 t-80 -120.48 77.29 1.26 Allowed 'General case' 0 C--N 1.312 -1.045 0 O-C-N 121.901 -0.499 . . . . 71.42 110.298 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -100.79 96.81 7.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.716 -0.675 . . . . 74.34 110.401 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 14.7 t60 -77.54 133.62 38.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.601 -0.889 . . . . 73.52 108.601 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 43.9 t-80 70.88 12.66 7.11 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.861 0.362 . . . . 63.52 110.666 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 51.1 m-70 70.06 -65.93 0.3 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.251 0.62 . . . . 74.1 110.27 -173.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.0 p80 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.924 -1.036 . . . . 70.11 109.791 176.197 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.365 0.603 . . . . 72.21 110.622 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.3 mt -132.63 120.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 73.43 111.215 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.45 -75.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.121 -1.192 . . . . 70.41 110.121 170.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 44.07 60.13 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.745 0.818 . . . . 72.31 113.177 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 p90 49.84 15.87 0.19 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.262 1.208 . . . . 72.32 114.262 174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -105.33 -42.53 5.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.03 109.734 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 49.6 mm -71.5 128.74 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.468 -0.787 . . . . 73.55 110.025 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 8.4 t30 71.42 104.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.939 0.775 . . . . 63.04 111.043 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.64 -80.2 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.172 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -141.5 -70.19 0.36 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 74.12 110.427 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.47 11.29 18.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.305 0.574 . . . . 72.24 110.551 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.603 ' HA ' ' HD3' ' A' ' 15' ' ' ARG . 85.9 mt -89.63 69.58 7.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 65.12 110.631 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -119.18 -59.14 1.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.064 0.459 . . . . 75.54 111.455 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.35 49.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 72.25 110.352 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.603 ' HD3' ' HA ' ' A' ' 12' ' ' LEU . 22.0 mmm180 -81.23 42.55 0.67 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.926 -0.579 . . . . 75.13 112.363 -171.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.8 p 54.22 22.62 3.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.748 0.819 . . . . 75.54 112.777 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 109.3 -116.05 4.46 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.742 -0.742 . . . . 72.21 111.721 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.677 ' HG2' ' HZ2' ' A' ' 43' ' ' TRP . 2.4 mm-40 -79.03 -72.41 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.633 -0.877 . . . . 73.22 108.633 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.32 30.39 0.37 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.324 -1.51 . . . . 64.03 109.324 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -50.49 64.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.162 -1.019 . . . . 72.5 111.994 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.4 t30 -166.86 60.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.032 -0.729 . . . . 72.31 109.032 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -74.63 7.18 3.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.89 -0.595 . . . . 75.0 111.762 -173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.56 -24.1 56.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.582 . . . . 74.4 110.127 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 25' ' ' ILE . 29.5 pt -79.19 -45.26 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.402 -0.363 . . . . 74.02 111.698 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 24' ' ' ILE . 10.2 mt -132.66 138.05 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.908 -0.405 . . . . 74.43 109.908 -176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.46 -75.42 0.69 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.008 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.09 101.31 3.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.794 0.331 . . . . 44.41 110.722 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -140.05 75.75 28.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.458 -0.571 . . . . 50.3 109.458 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 6.1 Cg_exo -79.85 117.68 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.238 2.625 . . . . 63.35 111.305 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER 75.37 113.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 124.2 0.938 . . . . 74.15 109.953 -174.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.11 -51.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.509 -0.769 . . . . 42.11 111.32 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -134.83 -86.03 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.745 -0.465 . . . . 60.1 109.745 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.93 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 64.1 mttm -127.43 10.53 6.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.609 0.719 . . . . 74.5 109.529 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.74 82.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 122.072 0.939 . . . . 75.51 110.373 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -161.85 44.5 0.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.864 -1.062 . . . . 65.43 109.465 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m 43.82 86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.1 0.96 . . . . 70.3 113.164 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -74.74 -55.93 10.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.925 -0.58 . . . . 70.23 110.389 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -141.61 172.2 13.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 73.5 109.169 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.14 137.57 47.73 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.593 0.235 . . . . 65.23 110.485 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -155.56 132.99 11.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.707 -0.479 . . . . 64.43 109.707 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t 71.87 8.42 6.03 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.557 0.536 . . . . 62.14 111.297 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.98 -32.42 6.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.897 -0.668 . . . . 44.25 112.368 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 18.1 m0 -92.58 158.29 16.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.98 0.419 . . . . 72.02 110.723 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 54' ' ' TYR . 15.2 m -99.56 143.31 29.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.93 -0.577 . . . . 64.54 111.14 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 19.3 mmmt -82.46 121.75 27.15 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.559 -0.746 . . . . 74.33 110.968 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.0 pt -139.57 156.53 26.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.195 -0.457 . . . . 55.42 110.157 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 22.8 t-20 -123.41 118.24 27.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.852 -0.425 . . . . 62.32 109.852 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.712 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 40.3 t80 -121.89 112.07 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.785 -0.643 . . . . 72.43 109.806 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.66 32.53 21.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.386 0.612 . . . . 73.42 111.153 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.16 56.96 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.827 -0.624 . . . . 33.22 113.637 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 5.1 pt20 -92.77 140.1 29.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.714 0.757 . . . . 72.13 110.902 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.2 m -78.79 123.71 27.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.997 -1.001 . . . . 52.53 110.12 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.98 171.81 22.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.72 -0.752 . . . . 54.52 112.331 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.765 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 95.9 m-85 -130.96 147.25 52.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.564 -0.532 . . . . 72.44 109.564 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 2.6 pp -134.84 160.96 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.407 -0.22 . . . . 71.33 110.407 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.516 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -83.78 132.48 11.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.669 -0.777 . . . . 74.41 112.153 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.1 m -63.39 -17.05 62.22 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 74.13 112.025 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 58' ' ' ARG . 58.4 mtt85 -59.12 -48.82 80.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.413 -0.358 . . . . 72.4 111.616 -177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' O ' HD22 ' A' ' 60' ' ' LEU . 7.4 m-85 -117.11 116.77 27.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.312 0.577 . . . . 74.21 111.513 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD22 ' O ' ' A' ' 59' ' ' TYR . 1.2 mm? -142.12 175.28 9.87 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 60.34 108.187 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 m -83.1 119.53 24.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.626 -0.509 . . . . 74.25 109.626 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -97.98 141.08 31.38 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.701 -0.851 . . . . 74.52 108.701 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.59 -21.3 64.52 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.007 -0.277 . . . . 65.13 111.243 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.49 92.57 3.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.052 0.453 . . . . 63.43 110.056 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -111.2 -72.91 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.176 -0.465 . . . . 73.31 110.603 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.6 m170 64.8 172.23 0.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.382 -0.826 . . . . 74.42 111.15 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -117.74 92.91 3.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.764 0.792 . . . . 74.22 109.01 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -92.45 2.75 56.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 74.41 109.215 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 56.47 131.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.383 1.473 . . . . 74.3 112.587 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.492 -0.766 . . . . 73.02 109.864 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.066 -0.346 . . . . 64.13 110.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.736 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -117.45 179.72 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.236 0.541 . . . . 61.43 111.961 -172.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.95 61.27 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.336 -1.106 . . . . 75.2 110.336 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 6' ' ' TYR . 3.5 m-20 66.77 116.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.335 0.654 . . . . 71.35 110.79 -172.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.44 72.08 4.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.524 0.678 . . . . 62.44 111.6 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.451 ' HD2' ' HB3' ' A' ' 4' ' ' ASP . 89.5 m-85 -140.56 -179.9 6.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.028 -1.101 . . . . 74.15 108.028 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.26 89.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.829 -1.175 . . . . 54.34 107.829 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -139.38 136.12 34.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.805 . . . . 74.13 110.613 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.97 93.8 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.767 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 10.5 t -165.18 -44.04 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 54.34 109.486 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -179.47 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.647 -0.706 . . . . 74.3 110.786 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 12' ' ' LEU . 2.2 mm? -73.06 10.14 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.59 -0.732 . . . . 72.13 112.473 -170.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -95.01 1.2 55.14 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.277 0.473 . . . . 75.25 112.277 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 5.7 t -91.5 32.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.045 0.926 . . . . 64.23 108.706 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 22' ' ' TYR . 13.2 tpt180 -78.12 3.67 14.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.856 -1.065 . . . . 63.53 110.829 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.701 ' HB2' HD12 ' A' ' 25' ' ' ILE . 22.4 t 71.59 16.44 5.84 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.659 -0.701 . . . . 72.21 111.449 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.74 -122.23 1.4 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.424 -0.893 . . . . 62.0 112.719 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -160.99 -69.38 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.5 -0.555 . . . . 62.52 109.5 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.18 -32.77 0.48 Allowed Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.142 -0.783 . . . . 45.53 111.142 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.737 HG21 ' CZ2' ' A' ' 43' ' ' TRP . 4.7 t -55.76 -31.75 62.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.204 0.526 . . . . 74.45 111.09 173.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.404 ' OD1' ' HG2' ' A' ' 23' ' ' ARG . 24.8 t30 -171.83 114.05 0.34 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.088 -0.708 . . . . 73.31 109.088 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ARG . 42.5 p90 -132.15 7.74 4.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.054 0.454 . . . . 75.55 110.804 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 23' ' ' ARG . 12.5 ptt180 -88.16 -24.57 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.015 0.746 . . . . 73.31 113.015 -169.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mm -69.92 -55.69 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.734 -0.387 . . . . 73.14 111.872 -171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.1 mp -132.26 -169.43 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.651 -0.5 . . . . 74.44 109.651 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 25' ' ' ILE . . . -145.99 -65.79 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 72.32 112.516 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -151.75 94.14 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.729 -0.277 . . . . 52.41 111.01 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 28' ' ' LEU . 1.2 tm? -166.32 86.29 0.9 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.26 -0.644 . . . . 61.42 109.26 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.86 76.73 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.065 2.51 . . . . 71.31 113.314 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.874 ' HG2' ' H ' ' A' ' 31' ' ' GLY . 49.4 tt0 59.64 -154.43 0.37 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 75.01 110.587 173.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.874 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 90.59 -83.05 1.32 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.26 -0.495 . . . . 75.21 112.292 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.74 -47.35 75.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.155 0.502 . . . . 72.32 111.216 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 26.5 tptp -154.17 168.71 25.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.006 -1.109 . . . . 73.11 108.006 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 48' ' ' TYR . 72.7 t 75.8 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.305 0.574 . . . . 73.35 111.462 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -136.32 148.06 47.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.993 -0.549 . . . . 75.13 110.468 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.3 p -92.04 143.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 73.45 110.065 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -93.84 -56.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.791 0.329 . . . . 72.53 110.369 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 p -173.6 151.18 1.86 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.021 -0.536 . . . . 72.34 110.007 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.7 OUTLIER -110.59 137.85 47.74 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.603 -0.726 . . . . 71.11 111.623 -176.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -95.73 174.14 7.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.092 -1.077 . . . . 64.11 108.092 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.5 t -70.66 -11.25 60.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.011 0.434 . . . . 64.15 110.536 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.94 -74.68 0.97 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.983 -0.627 . . . . 63.13 111.567 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.737 ' CZ2' HG21 ' A' ' 20' ' ' THR . 52.0 m0 -117.61 159.48 22.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.339 . . . . 74.41 110.745 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.0 t -109.9 142.91 40.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.29 -0.414 . . . . 60.05 110.053 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -89.49 116.26 27.52 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.904 0.383 . . . . 65.51 111.697 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 36' ' ' VAL . 40.8 pt -131.61 156.72 42.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 71.11 110.106 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.543 ' O ' HG13 ' A' ' 34' ' ' VAL . 5.4 p30 -115.15 113.83 24.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.3 109.594 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.651 ' CD1' HG21 ' A' ' 34' ' ' VAL . 16.0 t80 -98.91 84.72 3.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.785 -0.45 . . . . 74.24 109.785 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.95 55.11 8.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.097 -0.956 . . . . 75.23 111.663 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.08 -17.17 59.35 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.847 -0.692 . . . . 55.33 113.139 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.31 152.27 21.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.951 0.405 . . . . 60.31 110.407 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.1 m -93.57 114.44 26.78 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.563 -0.744 . . . . 75.34 109.389 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.37 148.35 18.49 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.278 -0.963 . . . . 75.51 112.983 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' SER . 95.8 m-85 -128.79 144.96 51.3 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.234 -1.024 . . . . 71.25 108.234 172.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.766 HD13 HD21 ' A' ' 60' ' ' LEU . 2.7 pp -133.19 158.73 43.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 110.024 -0.362 . . . . 65.3 110.024 175.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.46 127.19 8.19 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.511 -0.852 . . . . 52.41 112.317 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -75.29 -6.73 51.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.622 0.725 . . . . 74.51 110.496 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -74.02 -49.69 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.589 -0.732 . . . . 62.35 110.546 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.12 120.18 34.56 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.984 -0.553 . . . . 75.44 110.305 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 55' ' ' ILE . 6.1 mt -134.59 174.15 10.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.872 -0.603 . . . . 74.41 111.067 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.5 m -148.98 145.83 27.52 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.58 -0.896 . . . . 34.24 108.58 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -117.19 -67.76 0.97 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.842 -0.429 . . . . 74.05 109.842 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -137.03 -58.11 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.352 -0.61 . . . . 75.21 109.352 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 10' ' ' SER . 0.4 OUTLIER 60.97 -179.64 0.11 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.344 -0.844 . . . . 74.51 112.542 174.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 59.09 35.88 23.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.455 -0.793 . . . . 72.24 110.829 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -95.31 130.04 42.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.173 -0.921 . . . . 71.53 110.043 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 61.08 93.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.632 0.583 . . . . 74.23 111.356 -176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -74.82 -27.47 60.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.68 -0.859 . . . . 73.42 108.68 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -178.71 -34.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.092 -1.413 . . . . 64.33 107.782 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 C--O 1.242 0.685 0 CA-C-N 114.725 -1.125 . . . . 62.24 108.68 172.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.606 0.241 . . . . 73.31 110.368 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 4' ' ' ASP . 43.5 mm -122.91 -63.9 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.271 -0.422 . . . . 71.51 109.957 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.5 61.16 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 62.3 112.604 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.618 ' H ' HG22 ' A' ' 2' ' ' ILE . 5.4 m-20 -81.14 0.68 35.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.06 0.457 . . . . 54.23 111.312 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -110.37 23.39 14.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.133 0.492 . . . . 74.11 110.96 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.495 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 81.9 m-85 -111.02 110.71 21.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.679 -0.691 . . . . 74.13 109.747 174.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.2 mp -72.38 -52.97 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.673 -0.694 . . . . 72.32 110.714 -175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m120 61.97 36.3 15.72 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.487 -0.778 . . . . 62.53 111.241 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.55 164.64 22.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.371 -0.377 . . . . 54.24 110.518 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 m 66.85 13.99 9.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.959 -0.564 . . . . 74.31 111.007 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.36 25.42 14.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.636 -0.711 . . . . 70.53 111.971 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 15' ' ' ARG . 3.7 pp -112.3 139.82 47.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 42.23 111.021 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' H ' ' HB2' ' A' ' 27' ' ' ALA . 37.1 m-80 -117.63 -59.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.764 -0.653 . . . . 65.25 110.652 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 55' ' ' ILE . 7.1 t -119.5 13.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.107 -1.072 . . . . 75.3 108.107 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.669 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 3.2 tmt_? -63.66 110.83 2.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.772 -1.104 . . . . 65.34 109.55 -175.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.792 ' CB ' ' HA ' ' A' ' 23' ' ' ARG . 45.9 p 55.71 15.27 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.17 -0.923 . . . . 74.32 112.548 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 55' ' ' ILE . . . 53.92 -109.36 1.09 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.468 -0.653 . . . . 73.42 111.468 -175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -117.77 161.16 20.16 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.729 -0.841 . . . . 73.31 108.729 169.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.03 58.93 2.26 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.178 -0.534 . . . . 60.4 114.2 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 21' ' ' ASN . 6.3 t -103.1 -60.03 1.62 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 117.086 0.443 . . . . 75.13 110.839 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.493 ' H ' HG23 ' A' ' 20' ' ' THR . 7.9 t30 -161.27 -4.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.673 0.749 . . . . 71.52 110.487 177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.5 m-85 -83.47 15.33 3.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.621 -0.718 . . . . 71.43 112.524 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 16' ' ' SER . 98.7 mtt180 -44.64 -23.54 0.13 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.659 0.985 . . . . 74.2 113.659 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 pt -77.4 -5.41 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.732 0.641 . . . . 61.23 112.732 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.585 HG23 ' CE1' ' A' ' 48' ' ' TYR . 53.7 mt -90.09 167.63 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 109.425 -0.583 . . . . 74.41 109.425 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 15' ' ' ARG . . . -150.83 176.62 29.3 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 73.14 111.439 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 13' ' ' ASN . . . -95.32 93.39 7.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.92 0.36 . . . . 74.23 110.941 -176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 tp -171.3 62.61 0.36 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.874 -0.603 . . . . 64.41 110.874 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.02 -40.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.799 1.666 . . . . 70.25 111.631 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.638 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 4.4 pt20 44.71 25.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.866 1.266 . . . . 64.34 113.21 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.46 19.57 57.9 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.371 -0.442 . . . . 73.14 112.624 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.638 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -82.41 -57.64 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.206 -0.294 . . . . 72.13 110.206 -175.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 24.0 ttmm -143.63 -70.57 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.621 -0.432 . . . . 64.52 111.769 -177.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 p -65.49 100.89 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.708 0.766 . . . . 62.41 111.582 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -140.01 -179.45 5.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 72.31 109.629 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG11 HD11 ' A' ' 60' ' ' LEU . 31.8 m -76.11 138.83 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.21 0.529 . . . . 74.15 111.872 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.52 -55.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.67 -0.695 . . . . 64.05 109.955 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.5 t -160.05 155.19 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.949 -0.569 . . . . 74.31 109.98 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.5 mp0 -106.9 153.15 22.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.946 -0.57 . . . . 74.14 110.918 -174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -170.19 131.05 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 45.32 110.364 176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.0 t 69.35 17.35 8.2 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.033 -0.53 . . . . 71.14 111.415 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.98 -18.66 55.46 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.676 -0.773 . . . . 74.22 112.049 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.462 ' HD1' ' HA2' ' A' ' 56' ' ' GLY . 22.1 m0 -105.65 157.48 17.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.86 0.362 . . . . 74.35 110.499 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 20.1 t -121.81 146.55 46.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.947 -0.57 . . . . 63.33 110.092 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CD ' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -80.61 123.12 27.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.63 -0.713 . . . . 72.31 110.88 -176.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 pt -134.1 156.73 41.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.724 -0.671 . . . . 75.1 110.115 175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -115.0 114.68 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.59 -0.522 . . . . 72.43 109.59 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.585 ' CE1' HG23 ' A' ' 25' ' ' ILE . 59.8 t80 -112.46 106.18 14.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.425 -0.352 . . . . 72.23 110.192 -176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 60.32 34.68 20.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.985 -0.552 . . . . 73.41 111.502 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.31 84.03 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.649 -0.786 . . . . 23.1 112.918 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -106.48 156.52 18.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.924 0.392 . . . . 55.31 110.586 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.4 m -76.8 128.4 34.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.674 -0.694 . . . . 64.11 109.886 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' HA2' ' CE1' ' A' ' 22' ' ' TYR . . . -131.14 156.75 21.94 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.31 -0.948 . . . . 42.2 112.436 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' HE1' ' CD ' ' A' ' 45' ' ' LYS . 73.9 m-85 -128.26 140.55 51.83 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.038 -0.356 . . . . 64.51 110.038 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 17' ' ' GLY . 2.7 pp -135.52 151.99 30.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.032 -0.531 . . . . 55.4 109.621 173.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.462 ' HA2' ' HD1' ' A' ' 43' ' ' TRP . . . -76.5 140.0 24.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.27 -0.967 . . . . 65.34 111.743 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 m -65.74 -10.8 40.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.32 0.581 . . . . 74.23 110.55 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -81.17 -11.67 59.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.607 -0.724 . . . . 73.11 111.222 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -135.16 118.44 16.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.222 0.534 . . . . 72.42 112.031 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.497 HD11 HG11 ' A' ' 36' ' ' VAL . 18.7 mt -157.51 173.27 17.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 73.12 108.969 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.4 m -82.99 119.09 24.01 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.402 -0.592 . . . . 71.02 109.402 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' C ' ' HD3' ' A' ' 62' ' ' LYS . 12.4 tmtt? -97.26 -51.54 4.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.646 -0.706 . . . . 75.01 110.441 -173.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 63' ' ' LEU . 2.5 tm? -79.17 -22.65 44.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 64.23 110.294 -176.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 30' ' ' GLN . 11.8 tt0 -79.75 54.58 1.85 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.717 -0.674 . . . . 72.0 111.756 -172.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -149.82 -171.69 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.826 -0.805 . . . . 74.25 108.826 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.9 t60 69.8 163.45 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.422 0.451 . . . . 73.44 111.291 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 74.39 6.84 4.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.614 . . . . 74.44 111.71 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.22 142.68 43.11 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.072 -0.392 . . . . 74.14 110.126 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -119.84 152.82 36.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.269 -0.423 . . . . 65.13 111.079 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.9 m170 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.532 -0.747 . . . . 73.34 109.238 172.374 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.41 -0.589 . . . . 71.34 109.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt 63.19 102.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.5 0.667 . . . . 75.21 111.387 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.97 -9.9 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 65.14 112.189 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.43 124.12 31.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.236 0.541 . . . . 65.3 110.178 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 22' ' ' TYR . 81.0 m-85 -130.85 35.48 3.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.618 -0.719 . . . . 75.15 109.571 -176.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 5' ' ' TYR . 75.8 t80 75.43 143.58 0.08 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.26 0.975 . . . . 74.14 109.854 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -86.0 123.3 39.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.033 0.444 . . . . 61.21 111.003 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.3 t30 70.38 175.77 0.29 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.174 -0.921 . . . . 72.54 110.163 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 59.8 75.67 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.748 0.419 . . . . 65.43 110.673 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.9 m 63.43 49.3 3.21 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.331 -0.849 . . . . 54.1 110.634 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' ALA . . . -77.58 -152.17 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.207 -0.906 . . . . 72.32 110.781 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.877 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.4 pt? -75.02 39.88 0.14 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.871 0.367 . . . . 72.23 111.654 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -68.41 -54.68 15.52 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.349 0.5 . . . . 73.02 112.349 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.08 21.31 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.641 0.734 . . . . 64.35 109.203 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.725 ' CG ' ' HA ' ' A' ' 12' ' ' LEU . 19.0 mmt180 -54.62 -38.52 66.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 73.1 112.797 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.6 ' HB2' HD12 ' A' ' 25' ' ' ILE . 23.2 m 65.23 28.61 12.0 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.531 0.519 . . . . 62.23 111.677 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.87 133.77 27.22 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.667 -0.778 . . . . 51.34 111.914 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.14 -31.34 69.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.125 0.488 . . . . 71.13 110.281 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.06 -109.44 1.27 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.722 -0.951 . . . . 50.14 110.722 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.8 p -99.7 -4.81 29.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.353 0.597 . . . . 74.34 109.5 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -77.68 86.64 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.322 -0.854 . . . . 74.25 110.496 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.586 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 38.3 m-85 -93.9 5.78 50.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 71.11 111.548 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -90.26 -0.54 57.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.51 109.551 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.487 HG23 HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -52.4 -42.38 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.179 -0.919 . . . . 72.44 110.208 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' SER . 68.1 mt -132.58 -79.66 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 110.441 -0.207 . . . . 72.4 110.441 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . 140.08 169.76 11.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.21 -0.995 . . . . 70.14 112.643 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -92.91 94.46 8.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.102 -0.333 . . . . 71.4 110.102 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.605 ' HG ' HE22 ' A' ' 30' ' ' GLN . 19.4 tp -122.51 85.18 48.24 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.315 -0.624 . . . . 74.44 109.315 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.77 93.81 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.292 2.661 . . . . 72.32 113.378 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.605 HE22 ' HG ' ' A' ' 28' ' ' LEU . 2.5 mp0 -85.79 160.05 19.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 74.5 109.777 171.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.03 83.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.362 -0.446 . . . . 74.2 112.47 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -76.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.713 -0.477 . . . . 74.41 109.713 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HG2' ' H ' ' A' ' 35' ' ' GLN . 4.1 ttmp? 71.94 143.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.614 -0.721 . . . . 55.22 111.895 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 m -77.13 -19.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.918 -0.583 . . . . 75.32 111.388 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.709 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 23.3 tt0 70.79 174.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.668 -0.696 . . . . 73.24 110.946 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.709 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 7.5 p -102.58 143.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.142 -0.481 . . . . 42.5 110.547 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.715 HD11 ' HB2' ' A' ' 47' ' ' ASN . 5.3 mt -76.65 -56.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 109.828 -0.434 . . . . 72.44 109.828 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -172.18 161.67 5.49 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.585 -0.734 . . . . 71.14 109.599 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.6 OUTLIER -117.15 139.8 50.31 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.74 -0.664 . . . . 54.01 110.289 -177.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -173.62 156.85 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.185 -0.461 . . . . 60.14 109.922 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m 64.84 19.3 11.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.115 -0.493 . . . . 73.21 111.691 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.78 27.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.96 -0.638 . . . . 71.23 113.181 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -125.49 162.33 25.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.446 0.641 . . . . 74.41 111.479 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 36.6 m -101.17 122.57 43.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.254 -0.884 . . . . 70.41 109.609 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.0 ttmt -82.53 124.19 29.89 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.095 -0.502 . . . . 61.43 110.716 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 36' ' ' VAL . 9.7 pt -126.19 148.55 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.571 -0.74 . . . . 73.31 110.922 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.715 ' HB2' HD11 ' A' ' 37' ' ' ILE . 26.2 t-20 -109.54 113.39 26.14 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.294 -0.632 . . . . 70.41 109.294 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 32.7 t80 -104.03 85.69 2.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.124 0.488 . . . . 53.51 109.705 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.4 t30 60.88 50.03 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 73.2 111.107 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.67 -17.66 58.87 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.059 -0.591 . . . . 64.53 114.213 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -103.41 147.39 27.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.075 0.937 . . . . 75.44 110.753 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.5 m -93.65 129.46 39.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.893 -0.594 . . . . 63.41 111.45 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.17 170.69 22.47 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.585 -0.606 . . . . 53.43 111.585 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -131.79 151.38 51.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 72.34 110.538 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 44' ' ' SER . 2.5 pp -143.69 153.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.801 -0.636 . . . . 73.52 109.919 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.622 ' H ' HD12 ' A' ' 12' ' ' LEU . . . -74.62 128.4 10.32 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.502 -0.856 . . . . 70.12 111.392 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.2 m -64.23 -4.5 3.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.406 0.521 . . . . 74.4 112.406 -174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -68.65 -34.37 75.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.169 -0.308 . . . . 64.31 110.169 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -130.05 119.43 23.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.011 0.434 . . . . 71.33 110.378 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 61' ' ' SER . 3.6 tt -155.53 129.81 8.89 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.715 -0.846 . . . . 73.13 108.715 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.41 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.7 t -87.51 120.67 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.461 -0.57 . . . . 53.02 109.461 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HG2' ' H ' ' A' ' 63' ' ' LEU . 12.5 ttmm -75.96 -163.65 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.938 -0.574 . . . . 64.3 110.534 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 2.8 pp -67.47 -31.48 71.66 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.335 -0.228 . . . . 71.14 110.752 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' N ' HD12 ' A' ' 63' ' ' LEU . 13.7 mm-40 46.78 65.5 1.21 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.7 1.0 . . . . 71.12 113.7 171.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 52.86 92.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.439 -0.8 . . . . 70.42 112.579 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -116.59 164.78 14.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.918 -0.583 . . . . 73.42 110.109 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.99 135.59 37.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.083 0.468 . . . . 64.32 110.318 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -97.05 106.32 18.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.034 -0.53 . . . . 72.42 109.756 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -85.9 113.9 22.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.961 0.41 . . . . 63.5 110.54 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.681 -0.676 . . . . 73.23 109.598 178.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.343 -0.243 . . . . 74.42 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -89.07 84.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.49 -0.93 . . . . 71.34 108.49 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 4' ' ' ASP . . . -109.96 0.77 30.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.207 -0.997 . . . . 60.21 113.357 -172.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 m-20 71.89 -51.05 0.7 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.934 0.494 . . . . 65.21 112.036 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -79.1 -37.04 39.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 75.33 110.544 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -94.33 74.6 3.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.837 -0.62 . . . . 73.42 110.687 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.8 tt -174.53 154.5 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.299 -0.864 . . . . 74.4 108.997 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.577 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 60.7 t30 -93.49 91.0 6.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.595 0.236 . . . . 72.45 110.539 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.28 98.74 5.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.914 0.388 . . . . 72.34 111.128 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 m -151.69 -71.78 0.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.109 -0.496 . . . . 72.22 110.123 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.64 -57.49 0.1 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.789 -0.641 . . . . 75.12 109.644 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.786 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 mm? -82.33 75.26 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.338 -0.986 . . . . 65.32 108.338 172.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.16 -38.24 19.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.599 0.592 . . . . 72.04 112.599 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 16' ' ' SER . 47.8 t -77.26 -66.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.454 -0.498 . . . . 74.23 111.463 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.425 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 31.4 mmt180 53.86 20.86 2.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.599 0.592 . . . . 44.41 112.599 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.686 ' H ' HG12 ' A' ' 14' ' ' VAL . 14.9 m 61.47 25.94 15.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.853 0.461 . . . . 55.23 111.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.38 -113.31 3.5 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.645 -0.788 . . . . 73.14 112.573 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HG2' ' HE1' ' A' ' 43' ' ' TRP . 15.3 mm-40 -73.69 -5.83 43.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.641 0.258 . . . . 72.33 111.192 -175.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . 94.58 29.11 9.61 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.052 -0.594 . . . . 62.44 112.2 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 p -75.42 -62.01 1.71 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 72.55 110.955 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.444 ' HB3' HG22 ' A' ' 24' ' ' ILE . 39.1 m-80 -103.58 93.34 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.841 -0.618 . . . . 70.24 110.354 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -93.03 -1.13 56.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.055 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -82.89 -24.08 33.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 70.34 111.267 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 25' ' ' ILE . 4.8 tt -93.16 -55.36 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.686 -0.233 . . . . 75.32 111.317 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.671 HG13 HG12 ' A' ' 24' ' ' ILE . 7.2 mt -129.54 138.65 53.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.313 -0.625 . . . . 64.31 109.313 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -143.21 -71.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.103 -1.046 . . . . 35.24 113.622 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.786 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . . . -74.69 -162.03 0.15 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.386 0.513 . . . . 74.33 112.386 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.466 HD22 HE21 ' A' ' 30' ' ' GLN . 1.4 tt -91.91 90.16 0.37 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.166 -0.924 . . . . 75.52 109.352 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 27' ' ' ALA . 52.3 Cg_endo -82.26 6.74 5.53 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.906 2.404 . . . . 73.02 113.105 -169.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.466 HE21 HD22 ' A' ' 28' ' ' LEU . 33.2 mm-40 70.59 -67.1 0.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.481 0.712 . . . . 73.11 111.251 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.77 77.73 0.21 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.724 -0.751 . . . . 63.54 112.713 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.76 -50.94 67.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.001 0.429 . . . . 72.24 110.664 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -139.98 19.19 2.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.414 -0.958 . . . . 63.34 108.414 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 47' ' ' ASN . 15.2 t -129.97 116.39 37.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.785 -1.098 . . . . 70.43 111.217 -169.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.938 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 4.3 pm0 -145.22 -86.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.774 -0.37 . . . . 72.42 110.519 169.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.938 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 75.4 t -144.43 114.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.827 -0.434 . . . . 71.1 109.827 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.4 mt -99.85 -56.69 5.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.857 -0.337 . . . . 73.32 110.39 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -167.56 153.27 7.44 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.905 0.383 . . . . 53.32 110.213 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 5.5 pt-20 -117.38 149.47 40.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.384 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -160.24 130.59 5.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.524 . . . . 70.24 109.798 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t 71.84 24.55 3.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.348 0.594 . . . . 74.23 111.106 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.89 44.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 64.12 112.853 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.473 ' HE1' ' HG2' ' A' ' 18' ' ' GLU . 9.6 m0 -119.09 152.7 36.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.921 0.391 . . . . 74.13 110.912 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 38.2 m -97.05 137.1 36.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.896 -0.593 . . . . 72.24 109.547 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.79 131.0 45.25 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.881 -0.414 . . . . 73.02 109.881 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 37' ' ' ILE . 25.2 pt -145.0 171.24 5.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 65.12 110.949 -174.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 34' ' ' VAL . 23.7 t-20 -113.01 113.65 25.78 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.942 -0.762 . . . . 64.23 108.942 172.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.638 ' CD2' HG12 ' A' ' 25' ' ' ILE . 50.7 t80 -110.1 106.9 16.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.597 -0.274 . . . . 71.31 110.336 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.05 34.43 13.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.68 0.753 . . . . 75.12 110.654 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.92 73.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.936 -0.649 . . . . 74.21 113.571 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 10.6 pt20 -120.45 157.57 29.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.382 0.591 . . . . 75.24 110.882 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 m -73.02 125.26 27.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 74.44 110.752 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.7 166.03 24.37 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.575 -0.821 . . . . 50.24 112.313 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -132.81 148.19 52.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.805 -0.443 . . . . 62.55 109.805 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -137.18 168.23 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.205 -0.452 . . . . 65.44 110.098 177.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.38 155.03 19.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.347 -0.93 . . . . 73.43 111.981 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.2 m -85.87 -21.76 27.87 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.322 0.582 . . . . 32.53 109.682 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.0 -41.93 13.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.69 -0.687 . . . . 62.12 110.448 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 8' ' ' ASN . 20.5 m-85 -95.14 113.07 24.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.4 -0.963 . . . . 75.23 108.4 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -158.68 174.1 15.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.648 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -121.17 117.64 27.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.454 -0.943 . . . . 65.33 108.454 169.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.759 ' HG3' ' H ' ' A' ' 63' ' ' LEU . 41.6 tptt -114.12 -154.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.733 -1.21 . . . . 71.41 107.733 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.759 ' H ' ' HG3' ' A' ' 62' ' ' LYS . 57.0 tp -77.41 -62.97 1.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.566 -0.531 . . . . 71.11 109.566 176.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' OE1' ' HB3' ' A' ' 62' ' ' LYS . 2.3 mp0 56.15 -175.08 0.05 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.554 -0.748 . . . . 72.54 111.864 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -129.75 93.22 3.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.75 -0.833 . . . . 72.52 108.75 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.27 128.56 22.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.63 -0.714 . . . . 64.41 110.73 -173.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -89.46 123.16 33.34 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.493 -0.776 . . . . 74.34 111.117 -175.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -62.47 134.78 56.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.486 -0.325 . . . . 75.24 110.422 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -88.78 142.45 27.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.055 -0.35 . . . . 74.32 110.055 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--O 1.248 0.993 0 O-C-N 123.969 0.793 . . . . 72.42 110.278 -176.277 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.715 0.293 . . . . 74.11 110.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.719 HD12 ' HA3' ' A' ' 19' ' ' GLY . 1.7 pp -143.6 14.91 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.255 -0.43 . . . . 72.42 111.434 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.59 6.05 66.7 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.999 -0.619 . . . . 51.31 112.723 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.44 -4.73 57.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.22 0.533 . . . . 72.14 111.085 -177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.416 ' O ' HG13 ' A' ' 7' ' ' ILE . 93.7 m-85 -87.27 -39.15 15.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.36 . . . . 72.23 111.234 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 59.23 27.16 16.11 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.15 0.426 . . . . 72.42 112.15 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 5' ' ' TYR . 71.2 mt -102.49 114.91 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.273 0.559 . . . . 44.23 112.219 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 59' ' ' TYR . 4.9 m-20 -93.73 92.01 7.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.591 -0.731 . . . . 74.24 109.593 171.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.33 84.1 0.78 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.0 0.429 . . . . 64.31 110.893 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -157.01 24.71 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.785 -0.643 . . . . 64.14 109.78 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.98 -6.36 1.1 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.666 -0.697 . . . . 75.15 111.515 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 53.7 mt -97.54 128.06 43.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.249 -0.649 . . . . 75.1 109.249 177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.69 -42.23 5.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.922 0.392 . . . . 55.13 111.072 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.65 49.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.481 0.658 . . . . 71.44 109.813 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.546 ' HD2' ' OD1' ' A' ' 21' ' ' ASN . 5.7 mmm180 -43.99 -72.62 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.731 -1.122 . . . . 63.13 112.938 -173.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.985 ' HB2' HD12 ' A' ' 25' ' ' ILE . 2.2 m 57.64 37.66 27.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.239 0.543 . . . . 73.41 110.257 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -83.91 168.87 45.76 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.801 -0.714 . . . . 71.34 113.429 -172.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -70.88 -42.36 70.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.489 0.661 . . . . 64.25 109.512 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 2' ' ' ILE . . . -126.4 -65.25 0.16 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.186 -0.916 . . . . 73.34 111.583 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 4.5 p -123.82 -6.53 7.94 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.638 -0.331 . . . . 72.21 111.811 177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.546 ' OD1' ' HD2' ' A' ' 15' ' ' ARG . 10.8 t-20 75.13 122.82 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.992 0.808 . . . . 73.21 111.807 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.418 ' HE1' ' HG1' ' A' ' 20' ' ' THR . 31.3 m-85 -129.62 -60.81 1.03 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.556 -0.747 . . . . 71.11 111.008 175.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -119.06 -13.51 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.317 0.858 . . . . 75.01 113.317 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG12 HG13 ' A' ' 25' ' ' ILE . 11.6 tt -61.79 -55.89 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.72 -0.392 . . . . 53.32 112.022 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.985 HD12 ' HB2' ' A' ' 16' ' ' SER . 59.4 mt -138.44 155.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.079 -0.712 . . . . 71.2 109.079 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.9 -113.05 2.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.492 -0.861 . . . . 73.41 112.37 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.81 94.55 4.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.197 0.522 . . . . 51.44 110.975 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 tp -147.43 84.98 6.93 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.67 -0.696 . . . . 61.31 109.41 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -92.6 -10.85 2.0 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.005 2.47 . . . . 73.23 113.398 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -94.67 97.37 10.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.629 0.728 . . . . 72.34 110.694 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.0 150.06 21.26 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.413 -0.812 . . . . 64.3 111.435 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -68.91 -24.14 64.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.12 0.486 . . . . 73.13 110.381 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -122.13 22.14 10.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.363 0.601 . . . . 73.31 109.521 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.72 108.0 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.712 -0.677 . . . . 55.01 110.793 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -166.23 156.81 12.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.15 109.888 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 46' ' ' ILE . 61.9 t -73.8 125.14 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.031 -0.359 . . . . 71.3 110.031 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.63 -56.34 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.774 0.321 . . . . 75.53 110.586 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -144.45 159.31 42.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.406 -0.361 . . . . 72.23 110.179 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 9.7 pt-20 -129.01 142.61 50.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.161 -0.472 . . . . 71.04 110.799 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -112.03 173.36 6.4 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.499 -0.926 . . . . 75.02 108.499 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -74.51 69.18 1.67 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.345 0.593 . . . . 54.24 109.749 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.77 -75.65 0.21 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.243 -0.743 . . . . 62.54 111.243 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -118.46 144.88 45.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.087 0.47 . . . . 73.34 110.782 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 27.4 m -101.39 139.38 37.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.724 -0.671 . . . . 74.32 110.678 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD2' ' HE1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -82.03 114.69 20.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.401 0.68 . . . . 63.11 110.16 178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 36' ' ' VAL . 20.1 pt -132.19 167.98 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.184 0.516 . . . . 73.54 111.551 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.84 114.63 14.92 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.574 -0.899 . . . . 74.31 108.574 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.673 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 43.3 t80 -99.7 88.37 3.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.864 0.364 . . . . 74.52 110.247 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 58.6 47.1 13.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.537 0.684 . . . . 52.22 110.88 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.35 -6.07 74.94 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.678 -0.772 . . . . 71.14 113.856 173.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.5 pt20 -113.24 162.41 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.678 0.739 . . . . 73.31 111.237 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -73.82 143.32 45.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.484 -0.78 . . . . 73.15 111.887 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 16' ' ' SER . . . -161.92 155.58 26.88 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.541 -0.838 . . . . 51.32 112.508 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' HE1' ' HD2' ' A' ' 45' ' ' LYS . 78.8 m-85 -141.71 145.28 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.301 -0.629 . . . . 72.42 109.301 172.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 15' ' ' ARG . 2.5 pp -131.12 145.35 35.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 121.243 -0.183 . . . . 75.23 110.589 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.28 126.55 22.8 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.408 -0.901 . . . . 74.32 111.148 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -57.07 -22.06 36.38 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.507 0.323 . . . . 54.24 111.823 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -55.91 -34.63 65.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.463 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.726 ' HB2' ' HB3' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -127.68 119.15 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.011 0.434 . . . . 72.42 111.216 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -144.6 156.16 43.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.82 -0.807 . . . . 73.34 108.82 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.632 ' H ' HD23 ' A' ' 60' ' ' LEU . 34.5 t -98.84 141.78 31.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.931 0.395 . . . . 61.34 110.26 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -68.53 138.4 55.14 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.363 -0.835 . . . . 74.12 110.404 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.0 mt -102.8 -49.18 3.87 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.964 -0.754 . . . . 74.34 108.964 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 44.84 83.16 0.03 OUTLIER 'General case' 0 C--O 1.237 0.409 0 O-C-N 124.382 1.051 . . . . 74.55 111.989 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -63.56 126.61 28.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.406 -0.59 . . . . 65.34 109.406 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.9 146.73 37.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.095 -0.502 . . . . 64.3 110.444 -171.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -107.73 127.72 53.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.764 0.316 . . . . 70.32 110.556 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -108.14 136.14 48.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.189 -0.671 . . . . 72.21 109.189 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -66.31 153.74 41.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 74.04 110.855 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.742 -0.647 . . . . 54.52 110.007 176.366 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.889 0.376 . . . . 74.42 110.183 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tt -147.3 112.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.561 0.696 . . . . 74.12 110.787 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.63 18.33 6.37 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.786 -0.926 . . . . 72.14 110.786 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 41.22 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.997 -0.602 . . . . 75.42 111.011 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -82.12 -52.67 6.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.27 -0.423 . . . . 74.44 111.376 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 60.85 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.692 0.758 . . . . 75.32 110.314 -172.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -106.49 -166.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.235 -0.893 . . . . 73.11 112.004 -169.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . 9.0 p30 59.41 131.13 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.262 1.425 . . . . 75.21 113.27 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.59 -85.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.88 -1.055 . . . . 62.33 109.275 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.5 t -174.96 160.31 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 75.12 109.185 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.609 ' H ' ' HB3' ' A' ' 61' ' ' SER . . . 65.0 168.6 0.19 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.909 0.756 . . . . 64.02 112.691 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.7 mt 56.42 30.41 16.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.372 -0.831 . . . . 73.25 112.763 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' OD1' ' HB ' ' A' ' 55' ' ' ILE . 38.3 t30 -110.58 -59.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.162 0.506 . . . . 55.31 111.478 -176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.724 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 4.3 t -86.04 48.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 71.21 110.823 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.785 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 14.6 mmt180 -77.92 -1.11 30.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.08 -0.509 . . . . 73.4 112.235 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.3 t 66.47 28.18 9.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.615 -1.254 . . . . 71.23 107.615 -167.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 15' ' ' ARG . . . 160.14 -170.36 36.21 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.421 -1.872 . . . . 71.22 108.421 -174.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -110.56 -73.93 0.66 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.359 1.08 . . . . 75.24 109.619 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.79 -7.61 17.35 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 44.45 111.233 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 -39.34 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.445 . . . . 72.01 111.271 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -141.78 130.96 23.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.909 -0.774 . . . . 61.53 108.909 177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 49.8 p90 -130.02 8.2 5.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.085 -0.507 . . . . 72.31 110.675 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -79.18 -48.84 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.239 0.829 . . . . 71.32 113.239 -166.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 24' ' ' ILE . 3.4 mp -77.47 -56.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.56 -0.456 . . . . 61.41 112.224 -167.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.724 ' HB ' ' O ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -130.3 163.71 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.79 -0.448 . . . . 72.34 109.79 -176.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.785 ' HA2' ' HD3' ' A' ' 15' ' ' ARG . . . -121.17 -67.13 0.26 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.059 -0.591 . . . . 20.01 112.019 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . . . -151.17 94.15 2.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.777 0.322 . . . . 73.44 110.401 176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -157.59 86.04 2.68 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 72.13 109.926 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.732 ' HB2' ' HB3' ' A' ' 35' ' ' GLN . 51.3 Cg_endo -106.26 -164.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.81 3.006 . . . . 74.12 113.194 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.739 ' HG3' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER 75.39 109.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.311 -0.859 . . . . 75.42 112.567 170.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.89 -102.63 2.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.352 -0.84 . . . . 63.31 113.649 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.59 -13.17 60.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.269 0.557 . . . . 74.21 110.643 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HD2' ' HE2' ' A' ' 48' ' ' TYR . 45.7 mmtm -126.46 136.57 52.8 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.502 -0.772 . . . . 73.51 109.405 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.67 148.46 5.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.974 0.416 . . . . 61.04 110.59 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.795 ' HG3' HG12 ' A' ' 36' ' ' VAL . 12.5 pt20 -124.2 -34.17 2.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 72.13 111.643 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.795 HG12 ' HG3' ' A' ' 35' ' ' GLN . 5.5 p -165.76 125.81 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.35 . . . . 75.21 111.079 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.6 mt -113.68 -56.24 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.45 -0.341 . . . . 72.24 110.601 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.3 t -155.22 149.25 25.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.033 0.444 . . . . 54.23 110.311 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 2.6 mp0 -104.95 146.35 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.603 -0.726 . . . . 73.21 110.399 -173.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.49 119.51 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.461 -0.336 . . . . 74.31 110.784 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t 65.99 24.86 11.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.672 -0.695 . . . . 75.44 111.756 172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.29 -46.63 1.13 Allowed Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.664 -0.779 . . . . 73.3 112.676 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 56' ' ' GLY . 47.9 m0 -90.08 161.4 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.048 0.451 . . . . 73.21 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 22.8 t -111.22 134.24 52.96 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.239 -1.022 . . . . 55.13 108.239 171.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 32.4 ttmt -82.09 130.93 35.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.983 -0.553 . . . . 74.24 111.889 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.747 ' HA ' HD12 ' A' ' 37' ' ' ILE . 23.2 pt -134.99 171.91 16.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.494 -0.776 . . . . 73.32 109.121 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -134.91 117.79 16.22 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.662 -0.415 . . . . 74.32 110.507 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.647 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 7.0 m-85 -122.48 114.18 20.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.003 0.43 . . . . 75.5 111.067 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.29 34.37 13.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.871 -1.059 . . . . 74.35 110.955 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.4 -17.76 46.24 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.833 -0.621 . . . . 51.22 113.693 173.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 20.8 pt20 -93.53 153.53 18.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.303 0.552 . . . . 71.42 110.197 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 m -75.0 118.06 17.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.172 -0.467 . . . . 33.44 110.856 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.92 168.57 13.07 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.748 -0.739 . . . . 73.43 111.883 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 84.7 m-85 -144.0 166.47 24.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.56 -0.533 . . . . 71.13 109.56 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 2.7 pp -123.79 143.42 37.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 108.702 -0.851 . . . . 72.24 108.702 166.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' A' ' 43' ' ' TRP . . . -96.55 100.31 2.46 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.15 -1.024 . . . . 71.13 111.251 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 m -50.52 -20.84 1.27 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.283 0.846 . . . . 63.45 113.283 -172.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.477 ' HA ' HG22 ' A' ' 7' ' ' ILE . 13.9 mtm180 -53.11 -37.19 61.53 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.766 0.317 . . . . 74.32 110.593 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.78 147.95 45.92 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.072 0.463 . . . . 72.44 109.846 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 8' ' ' ASN . 73.0 mt -152.59 135.79 15.75 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.479 -175.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.609 ' HB3' ' H ' ' A' ' 11' ' ' ALA . 3.4 p -129.08 135.87 49.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.759 -0.655 . . . . 73.52 109.686 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -140.28 114.83 9.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.892 -0.41 . . . . 75.24 109.892 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.39 -42.86 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.509 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.739 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 11.6 pt-20 46.5 -163.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.108 0.88 . . . . 74.22 111.777 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -70.08 145.5 51.59 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.884 -0.413 . . . . 64.42 109.884 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -76.38 126.89 31.8 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.775 -0.454 . . . . 74.15 109.775 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.56 145.69 38.85 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.711 -0.396 . . . . 73.15 110.757 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 134.83 38.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 72.13 110.355 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -96.84 -34.66 11.2 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.418 -0.586 . . . . 71.44 109.418 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.202 -0.904 . . . . 37.85 109.674 174.101 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.575 0.226 . . . . 73.03 110.768 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.3 mp 50.12 87.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.515 -0.766 . . . . 62.15 111.942 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.49 -20.01 75.29 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.361 -0.923 . . . . 61.13 111.415 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.6 t0 63.63 41.39 7.2 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.764 0.792 . . . . 62.41 110.204 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -80.98 95.58 6.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 74.44 110.657 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -68.47 124.29 23.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.827 -0.624 . . . . 73.14 109.962 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 16' ' ' SER . 4.0 mp -77.64 -72.41 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.842 -0.429 . . . . 61.11 109.842 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.1 t30 69.69 -60.56 0.47 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.673 -0.694 . . . . 70.41 111.232 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.43 27.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.665 0.603 . . . . 72.22 111.301 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.4 t 72.4 -40.38 0.47 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.328 -0.851 . . . . 55.21 111.504 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.68 -61.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.859 0.361 . . . . 70.33 111.18 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -81.89 129.39 34.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 73.24 111.639 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.13 6.93 20.53 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.657 0.741 . . . . 65.34 110.175 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.0 m -62.61 -3.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.775 1.028 . . . . 74.53 113.775 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HA ' HG22 ' A' ' 25' ' ' ILE . 17.9 mtm180 -121.41 -46.04 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.039 0.381 . . . . 74.05 111.113 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.621 ' HA ' HG21 ' A' ' 7' ' ' ILE . 66.4 m 64.91 4.25 2.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.481 0.919 . . . . 65.15 113.481 172.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.84 -109.58 1.71 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.964 -0.636 . . . . 74.11 112.272 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -157.63 154.61 28.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.474 -0.565 . . . . 65.34 109.474 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.94 -135.83 2.02 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.622 -0.799 . . . . 71.43 112.308 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -72.68 -8.11 53.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.919 0.39 . . . . 75.42 111.515 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -136.11 138.93 42.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.943 -0.762 . . . . 62.11 108.943 172.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.2 -16.39 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.776 0.798 . . . . 74.4 110.086 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 23' ' ' ARG . 61.3 mtt85 -89.16 6.54 39.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.732 -1.122 . . . . 74.53 109.871 172.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 55' ' ' ILE . 10.4 tp -55.83 -9.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 114.903 -1.044 . . . . 73.14 113.679 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.626 HG22 ' HA ' ' A' ' 15' ' ' ARG . 1.3 pp -59.74 135.1 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.227 0.537 . . . . 63.11 112.123 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.25 148.8 5.31 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.585 -0.816 . . . . 40.52 113.904 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.698 ' HA ' HD22 ' A' ' 60' ' ' LEU . . . -146.98 -178.51 6.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.655 -0.498 . . . . 62.45 109.655 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 36' ' ' VAL . 41.2 mt -128.67 65.84 73.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 111.861 0.319 . . . . 71.54 111.861 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 27' ' ' ALA . 3.6 Cg_endo -86.0 -55.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.29 1.993 . . . . 75.43 111.044 175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 179.37 131.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.281 -0.872 . . . . 74.23 109.486 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.14 168.73 11.35 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.192 -1.004 . . . . 74.51 113.225 175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.38 15.0 11.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.139 0.495 . . . . 73.2 110.532 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -25.44 62.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.77 -0.65 . . . . 75.31 110.264 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.869 HG13 ' H ' ' A' ' 35' ' ' GLN . 2.4 p -135.85 -80.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.029 -0.532 . . . . 64.03 110.092 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.869 ' H ' HG13 ' A' ' 34' ' ' VAL . 26.5 tt0 65.89 152.93 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.711 0.767 . . . . 73.23 112.123 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 28' ' ' LEU . 71.2 t -91.12 137.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.668 -0.697 . . . . 51.14 110.462 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.78 -55.69 6.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.245 -0.65 . . . . 74.43 109.245 175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.9 m -159.45 155.32 26.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.243 -0.89 . . . . 75.12 109.097 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 7.7 pt-20 -124.91 141.97 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.962 0.41 . . . . 24.45 111.01 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.27 159.52 7.29 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 115.791 -0.641 . . . . 72.23 109.859 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 27.51 16.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.013 0.745 . . . . 72.04 113.013 158.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.83 -50.6 0.83 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.518 -0.849 . . . . 53.24 113.271 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 31.5 m0 -123.0 162.33 22.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.466 0.65 . . . . 65.23 111.251 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 55' ' ' ILE . 20.8 t -103.45 120.47 40.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.194 -0.912 . . . . 64.03 108.687 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HD3' ' CE2' ' A' ' 54' ' ' TYR . 31.2 ttpt -82.45 137.01 34.8 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 112.529 0.566 . . . . 70.24 112.529 -171.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.7 170.94 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.192 -0.913 . . . . 63.53 110.547 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 24.4 t-20 -127.8 113.89 16.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.336 -0.616 . . . . 53.24 109.336 174.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.687 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 34.1 t80 -125.87 112.85 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.478 -0.328 . . . . 73.21 110.554 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.98 37.31 18.22 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.702 0.763 . . . . 73.31 110.509 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.63 -17.45 58.52 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.634 -0.712 . . . . 73.03 114.022 175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.687 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 29.7 pt20 -98.9 155.71 17.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.416 0.608 . . . . 74.12 110.789 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.8 m -97.57 114.06 25.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.759 -0.655 . . . . 71.54 109.773 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.06 -176.69 15.93 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.82 -0.705 . . . . 72.13 112.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 73.3 m-85 -136.89 139.31 41.52 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.18 -0.674 . . . . 71.05 109.18 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -120.18 155.58 23.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.881 -0.414 . . . . 60.05 109.881 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.66 116.37 4.35 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.03 -1.081 . . . . 35.24 111.553 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -12.36 25.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.692 0.397 . . . . 64.3 111.869 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -69.57 -34.77 74.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.387 -0.369 . . . . 74.12 111.508 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.76 120.01 26.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.086 0.47 . . . . 75.52 111.918 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 27' ' ' ALA . 56.4 mt -155.66 152.1 28.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.981 -1.009 . . . . 74.21 108.907 174.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.5 t -92.92 120.3 33.1 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.211 -0.663 . . . . 63.42 109.211 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.34 159.06 18.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.357 -0.383 . . . . 74.31 110.56 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.1 pp -82.57 -4.26 57.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.325 0.583 . . . . 54.22 110.57 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.7 tm-20 -88.99 152.54 21.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.441 -0.8 . . . . 75.21 108.953 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 14.5 m80 71.06 29.3 2.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.365 0.602 . . . . 74.11 109.76 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -77.62 140.29 39.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.157 -0.928 . . . . 73.33 110.496 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -114.17 138.92 49.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.517 -0.31 . . . . 74.54 110.645 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -117.1 -38.76 3.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.551 -0.537 . . . . 73.53 109.551 175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -72.75 130.87 41.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.742 -0.663 . . . . 72.13 109.755 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.2 m170 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.102 -0.951 . . . . 73.04 109.721 179.913 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.114 -0.698 . . . . 75.21 109.114 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.86 HD13 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -92.26 118.65 38.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.193 0.521 . . . . 73.33 112.007 -174.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.36 -63.3 1.87 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.928 -0.869 . . . . 52.05 110.928 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 70.58 -56.07 0.61 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.879 0.872 . . . . 73.21 112.803 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.763 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 87.5 t80 -78.84 123.48 27.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.015 0.436 . . . . 70.22 111.637 -174.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -110.65 164.95 12.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 62.51 109.882 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.4 tt -131.18 122.31 51.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.195 0.521 . . . . 73.34 110.538 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.812 HD22 ' HA ' ' A' ' 13' ' ' ASN . 1.6 m-20 -84.49 163.02 19.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.718 -0.673 . . . . 74.43 111.615 -176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.48 166.13 32.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.881 -1.054 . . . . 74.44 108.615 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.4 m 65.45 33.08 9.09 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.783 0.677 . . . . 75.53 110.373 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.51 -155.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.791 -0.64 . . . . 53.33 110.323 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HB2' ' HA3' ' A' ' 17' ' ' GLY . 27.1 tp 58.93 27.72 16.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.209 0.528 . . . . 72.13 110.71 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.812 ' HA ' HD22 ' A' ' 8' ' ' ASN . 27.1 t-20 -58.41 -42.27 86.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.719 -0.673 . . . . 54.52 110.87 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.18 -65.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 107.697 -1.223 . . . . 72.14 107.697 170.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.678 ' HG2' HG22 ' A' ' 55' ' ' ILE . 4.3 mmp_? -138.57 -164.42 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.847 -1.069 . . . . 74.44 108.482 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 34.5 t 65.63 74.65 0.37 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.419 0.628 . . . . 64.21 110.699 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 12' ' ' LEU . . . -176.2 -173.71 42.09 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.49 -0.777 . . . . 72.13 111.2 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.13 84.14 1.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.391 0.615 . . . . 53.13 110.807 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.15 -86.8 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 115.345 -0.843 . . . . 43.45 111.311 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -123.52 -65.23 1.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.915 0.388 . . . . 73.2 110.661 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -130.86 133.06 45.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.602 -0.888 . . . . 71.41 108.602 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 2.7 p90 -108.91 8.4 26.44 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.124 0.416 . . . . 73.15 112.124 -171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 38.0 ttt180 -115.25 -2.44 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.787 -0.365 . . . . 74.35 111.633 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -58.41 -56.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.093 0.405 . . . . 75.33 112.093 -172.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG3' ' A' ' 15' ' ' ARG . 2.7 mp -129.13 -78.0 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 63.32 110.23 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' A' ' 16' ' ' SER . . . 148.69 -171.23 29.06 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.217 -0.753 . . . . 72.23 111.217 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.28 94.41 4.33 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 65.14 110.543 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 28' ' ' LEU . 1.5 pt? -120.52 85.37 37.75 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.375 0.607 . . . . 75.02 110.122 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.56 5.14 6.56 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.557 2.838 . . . . 64.52 113.029 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.36 59.52 4.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.719 . . . . 74.43 111.615 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.43 -33.88 5.04 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.808 -0.633 . . . . 72.13 113.432 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -113.47 -164.91 0.95 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.045 0.422 . . . . 74.54 110.35 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.758 ' HG3' ' H ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -175.55 -85.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.52 0.512 . . . . 75.21 110.373 175.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.758 ' H ' ' HG3' ' A' ' 33' ' ' LYS . 36.9 t -142.12 -85.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.425 ' H ' ' HB ' ' A' ' 34' ' ' VAL . 12.4 mm100 -157.89 -39.31 0.07 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 72.15 110.111 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.4 p 44.35 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.417 1.087 . . . . 70.34 112.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.57 -57.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 73.43 111.278 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 t -167.29 169.16 12.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.43 109.762 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.0 pt-20 -123.52 161.89 24.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.194 0.521 . . . . 75.54 111.418 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -153.21 115.3 4.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.25 -0.886 . . . . 65.03 109.528 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.4 t 68.67 26.3 6.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.548 -0.751 . . . . 43.45 111.419 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.28 -22.1 25.45 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.283 -0.961 . . . . 73.25 113.564 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -109.73 145.16 37.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.874 0.337 . . . . 73.23 110.942 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.739 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 13.6 m -109.59 132.11 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.073 -0.512 . . . . 71.11 109.742 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -84.45 132.5 34.55 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.849 0.356 . . . . 75.23 111.17 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -139.26 144.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.126 -0.488 . . . . 64.22 109.921 173.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.85 114.12 26.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.414 -0.587 . . . . 71.12 109.414 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 60.5 t80 -110.79 107.71 17.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.574 -0.528 . . . . 74.21 109.574 -177.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.4 m120 61.87 34.71 16.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.557 -0.747 . . . . 63.05 110.66 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 -17.89 58.24 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.67 -0.696 . . . . 52.24 113.995 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 3.5 pt20 -95.99 154.96 16.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.026 0.913 . . . . 74.4 110.788 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 m -87.42 123.92 32.86 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.916 -0.584 . . . . 74.45 110.791 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.97 169.66 21.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.65 -0.58 . . . . 63.12 111.65 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 15' ' ' ARG . 99.3 m-85 -136.39 143.11 43.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.897 0.348 . . . . 75.24 110.818 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 60' ' ' LEU . 2.8 pp -119.52 166.36 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 72.05 109.581 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.79 132.97 11.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.374 -0.917 . . . . 70.52 112.458 -176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 m -67.61 -17.64 64.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.788 0.328 . . . . 65.31 111.151 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 58' ' ' ARG . 5.3 mmt85 -53.98 -50.23 67.03 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.238 -0.437 . . . . 65.12 111.196 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.663 ' HB3' ' ND2' ' A' ' 8' ' ' ASN . 22.5 m-85 -121.38 118.86 30.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.975 -0.379 . . . . 75.22 109.975 177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 55' ' ' ILE . 26.3 mt -155.66 148.29 24.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.843 0.354 . . . . 45.5 110.663 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB3' HD21 ' A' ' 13' ' ' ASN . 31.7 p -108.25 121.74 45.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.215 -0.448 . . . . 52.04 110.675 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.763 ' HB2' ' HD1' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -66.86 147.51 53.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.012 -0.736 . . . . 74.32 109.012 171.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HG ' ' HE2' ' A' ' 33' ' ' LYS . 5.8 mp -77.5 5.5 8.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.143 0.794 . . . . 65.13 113.143 -166.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -79.22 78.81 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.327 0.584 . . . . 61.04 109.941 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.49 170.72 15.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.807 -0.633 . . . . 73.33 110.133 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -76.39 153.52 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 73.43 110.913 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 81.8 m-70 -119.64 169.29 10.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.702 -0.681 . . . . 73.02 110.012 174.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 8.5 m-70 69.76 87.22 0.12 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.892 0.745 . . . . 72.12 111.274 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -119.81 129.68 54.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.317 -0.856 . . . . 73.13 109.359 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 74.14 110.173 176.626 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 25.8 ttt . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 111.087 0.032 . . . . 72.02 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 1' ' ' MET . 44.1 mm 70.13 133.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 123.484 0.49 . . . . 52.34 110.588 -175.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.49 63.42 0.9 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.271 -1.132 . . . . 73.13 110.271 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.152 -0.524 . . . . 74.23 112.371 -173.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -170.37 -68.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.938 0.399 . . . . 72.31 110.532 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.566 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 11.2 t80 -158.29 -69.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.873 -0.603 . . . . 72.01 109.511 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 11' ' ' ALA . 54.8 mt 72.22 142.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.261 0.553 . . . . 74.45 112.223 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -113.97 85.79 2.28 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.957 -0.565 . . . . 54.25 110.501 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.21 -82.03 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.312 -0.858 . . . . 44.44 113.289 173.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 m -81.12 -62.8 1.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.143 0.423 . . . . 54.14 112.143 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 7' ' ' ILE . . . 63.92 -179.45 0.16 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.123 -0.49 . . . . 63.23 112.08 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.539 HD22 HD21 ' A' ' 28' ' ' LEU . 87.2 mt 65.13 1.23 1.47 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.264 0.839 . . . . 63.22 113.264 173.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -118.94 9.81 12.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.337 0.495 . . . . 73.35 112.337 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG12 ' H ' ' A' ' 17' ' ' GLY . 46.8 t -65.92 -59.96 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.937 0.347 . . . . 62.41 111.937 -170.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.579 ' NH1' ' HA ' ' A' ' 65' ' ' HIS . 20.0 ttm105 65.84 74.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.711 -0.677 . . . . 73.53 111.11 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 24' ' ' ILE . 37.8 p 49.38 31.65 4.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.417 -0.811 . . . . 71.44 113.176 173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.636 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -80.51 -7.03 88.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.742 . . . . 70.22 112.104 178.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.76 107.49 3.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 61.32 109.78 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.72 -173.27 43.91 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.538 -0.625 . . . . 73.32 111.538 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -83.56 -24.17 31.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.093 0.473 . . . . 74.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -124.99 133.32 53.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.69 -0.856 . . . . 53.53 108.69 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.96 8.03 43.26 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.997 0.427 . . . . 73.24 110.973 -173.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -115.96 -0.79 12.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 61.41 111.18 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.457 ' HB ' ' HA2' ' A' ' 53' ' ' GLY . 2.3 pp -88.54 0.12 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.682 0.623 . . . . 72.2 112.682 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 26' ' ' GLY . 1.6 mt 68.54 172.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.109 0.48 . . . . 72.21 111.345 174.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' H ' HG22 ' A' ' 25' ' ' ILE . . . 177.46 49.36 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.037 -1.225 . . . . 72.54 110.037 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.53 9.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.883 0.373 . . . . 75.24 111.443 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD21 HD22 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.58 69.12 79.08 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.586 -0.894 . . . . 53.23 108.586 172.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -84.66 67.39 6.42 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.342 2.695 . . . . 64.33 112.503 -168.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 69.18 119.36 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.937 -1.028 . . . . 60.32 112.002 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.1 -6.95 37.32 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.091 -0.804 . . . . 64.15 111.091 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.719 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -147.77 134.72 20.22 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.756 . . . . 72.31 108.96 179.102 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -128.03 92.77 3.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.03 0.443 . . . . 71.41 111.118 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 28' ' ' LEU . 27.5 m -100.72 176.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.196 -0.668 . . . . 75.01 109.196 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -137.76 146.26 43.41 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.681 -0.408 . . . . 74.03 110.547 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -78.2 113.04 16.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.341 -0.39 . . . . 74.23 110.138 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 37' ' ' ILE . 4.0 mp -71.42 -56.74 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 64.51 110.481 -177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -170.36 165.76 8.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.585 -0.734 . . . . 61.31 110.693 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -118.02 169.32 9.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.111 -0.949 . . . . 63.14 110.094 178.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -173.48 123.38 0.37 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.106 0.254 . . . . 71.24 110.789 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t 70.65 32.44 2.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.612 -0.722 . . . . 54.22 110.874 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.37 -36.29 4.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.749 -0.739 . . . . 45.03 112.617 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -100.32 155.7 17.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.913 0.387 . . . . 73.41 110.779 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 25.6 t -110.11 139.94 44.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.939 -0.573 . . . . 72.02 109.904 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.693 ' HE2' ' HE1' ' A' ' 54' ' ' TYR . 14.6 ttmt -89.67 129.21 36.13 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 116.096 -0.502 . . . . 73.24 111.207 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.85 143.2 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.598 -0.728 . . . . 71.05 110.598 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -109.73 114.59 28.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.623 -0.88 . . . . 75.21 108.623 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.583 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 1.8 t80 -122.84 110.22 15.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.304 -0.407 . . . . 73.44 110.457 -174.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t30 59.71 34.28 22.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.561 0.696 . . . . 73.33 110.676 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.08 -3.87 73.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 72.21 113.671 174.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 2.8 pt20 -118.8 156.08 30.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.437 0.619 . . . . 64.24 110.257 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m -98.6 128.11 44.78 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 72.12 111.302 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' A' ' 24' ' ' ILE . . . -116.12 162.47 12.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.091 -0.576 . . . . 20.35 111.803 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.693 ' HE1' ' HE2' ' A' ' 45' ' ' LYS . 91.1 m-85 -138.3 139.09 38.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.848 -0.427 . . . . 72.42 109.848 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.587 HD13 HD21 ' A' ' 60' ' ' LEU . 2.4 pp -137.75 154.95 29.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 74.14 110.907 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 110.45 3.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.362 -0.695 . . . . 60.53 111.362 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -4.39 53.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.575 0.226 . . . . 70.45 111.479 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.566 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 70.4 mtt180 -61.72 -53.57 54.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.17 0.509 . . . . 64.14 109.989 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -130.51 118.97 21.9 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.038 -0.528 . . . . 74.43 110.291 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 55' ' ' ILE . 95.8 mt -114.36 127.49 55.87 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.578 -0.737 . . . . 71.4 109.052 176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 14' ' ' VAL . 25.4 t -148.61 159.82 43.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.034 -0.53 . . . . 61.32 110.091 -171.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.2 tttt -75.6 113.17 12.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.763 -0.199 . . . . 72.21 110.819 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD22 ' HA3' ' A' ' 17' ' ' GLY . 10.1 mp -96.77 -65.56 0.96 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.833 -0.347 . . . . 62.34 110.809 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -159.16 167.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.809 0.338 . . . . 74.1 111.196 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.579 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 51.8 p-80 -125.47 11.52 8.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.786 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.27 136.82 7.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.41 109.747 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.44 ' O ' ' HB3' ' A' ' 68' ' ' HIS . 15.0 t60 -133.19 -72.26 0.51 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.951 -0.299 . . . . 73.23 111.293 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 67' ' ' HIS . 78.8 t60 70.72 121.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.905 0.753 . . . . 73.45 110.461 -171.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -74.54 121.31 21.34 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.153 -0.476 . . . . 74.52 109.956 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.366 -0.826 . . . . 70.55 110.252 179.147 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.652 0.263 . . . . 62.33 110.539 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.41 16.3 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.891 0.33 . . . . 73.33 111.891 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.33 -14.48 28.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.516 -0.849 . . . . 63.2 112.751 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.586 ' HB3' HD11 ' A' ' 7' ' ' ILE . 22.5 m-20 -80.97 104.74 11.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.658 0.266 . . . . 63.54 110.512 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.59 133.58 55.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.418 -0.355 . . . . 72.44 110.774 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 56.83 86.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.669 0.606 . . . . 75.33 110.993 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 4' ' ' ASP . 43.6 mm -82.28 89.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 71.3 111.791 -172.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t30 73.77 -64.55 0.39 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.339 -0.846 . . . . 74.21 113.28 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.18 -163.98 0.25 Allowed 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.413 0.446 . . . . 71.34 110.094 -171.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.8 p -97.66 18.48 15.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.981 0.42 . . . . 72.4 110.735 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.42 -82.81 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.41 -0.359 . . . . 65.23 111.656 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 5.3 mp -76.35 92.9 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 74.44 110.792 -174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 61' ' ' SER . 29.6 m-80 -117.56 -58.31 2.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.931 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 48' ' ' TYR . 2.6 t -121.14 37.31 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.441 0.639 . . . . 72.43 110.314 -174.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 20.0 mmm180 -75.41 32.73 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.874 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' TYR . 33.0 t 60.69 37.42 19.09 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.675 0.75 . . . . 60.32 109.822 -177.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' N ' ' A' ' 56' ' ' GLY . . . 90.34 -57.89 3.5 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.179 -0.919 . . . . 71.41 111.372 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.64 168.76 22.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.47 -0.937 . . . . 74.34 108.47 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.44 36.91 0.82 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.371 -0.442 . . . . 75.22 113.437 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.1 m -90.34 -34.08 15.83 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.338 -0.615 . . . . 74.43 109.338 174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.514 HD22 HG12 ' A' ' 24' ' ' ILE . 4.2 t30 -142.74 52.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.541 -0.911 . . . . 72.22 108.541 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -62.5 -6.36 3.33 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.477 -1.238 . . . . 73.1 113.422 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -72.19 -11.99 60.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.198 0.444 . . . . 74.44 112.198 -174.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.887 HG22 HG13 ' A' ' 25' ' ' ILE . 47.5 mm -70.62 -55.79 13.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.301 0.482 . . . . 72.15 112.301 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.887 HG13 HG22 ' A' ' 24' ' ' ILE . 18.7 mt -135.98 -83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 121.035 -0.266 . . . . 75.54 111.239 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' HD2' ' A' ' 15' ' ' ARG . . . 124.96 -169.24 16.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.578 -0.82 . . . . 30.45 112.465 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.51 92.67 8.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.456 -0.438 . . . . 31.04 110.693 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.76 87.8 2.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.649 -0.705 . . . . 73.22 109.743 176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.67 72.81 3.66 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.991 2.46 . . . . 73.0 112.459 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -168.5 98.44 0.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.563 . . . . 74.35 110.453 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.37 167.44 12.37 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 111.103 -0.799 . . . . 60.41 111.103 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.59 80.77 5.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.269 0.557 . . . . 74.52 110.953 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 3.7 mptp? 58.75 62.44 1.92 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.017 -0.992 . . . . 63.21 111.264 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.09 125.62 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.336 -0.847 . . . . 71.43 110.56 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.407 ' O ' HG21 ' A' ' 46' ' ' ILE . 24.2 mp0 -133.31 -68.46 0.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 71.31 109.989 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -141.02 126.62 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 72.24 109.899 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.8 mt -114.44 -56.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 64.11 111.494 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.0 t -141.06 155.43 46.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 74.31 110.383 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 14.3 mp0 -114.8 135.94 53.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.697 -0.683 . . . . 74.33 110.526 -175.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -107.59 174.86 5.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.129 -0.693 . . . . 70.13 109.129 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.0 m -71.12 75.16 0.68 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.745 -0.661 . . . . 71.53 110.563 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.79 -61.25 0.48 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.728 -0.669 . . . . 75.41 111.621 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -126.69 162.67 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.092 0.472 . . . . 63.4 110.276 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 37.9 t -96.77 129.23 44.23 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.968 -0.753 . . . . 70.25 108.968 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -90.73 130.69 36.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.558 -0.292 . . . . 65.32 111.115 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.98 148.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 64.3 110.175 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.01 112.55 19.19 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.851 -0.796 . . . . 74.52 108.851 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 14' ' ' VAL . 11.9 t80 -109.8 98.99 8.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.465 -172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 t30 58.41 40.52 24.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.36 0.6 . . . . 71.33 110.861 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 -17.57 59.06 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.858 -0.61 . . . . 60.43 114.405 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.84 154.88 24.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.077 0.939 . . . . 73.43 110.994 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.4 m -76.52 119.03 19.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 74.45 110.793 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.727 ' HA2' HG21 ' A' ' 24' ' ' ILE . . . -122.31 175.45 16.39 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.032 -0.604 . . . . 62.34 111.914 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' SER . 81.3 m-85 -135.68 151.44 50.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.107 0.48 . . . . 74.44 111.198 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.672 HG12 HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -137.59 146.41 27.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.458 -0.792 . . . . 71.1 109.988 175.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' N ' ' HA2' ' A' ' 17' ' ' GLY . . . -85.15 159.84 34.37 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.428 -0.892 . . . . 71.12 112.054 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -42.2 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.116 0.484 . . . . 73.22 110.227 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -76.86 -51.84 10.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.651 -0.704 . . . . 73.1 110.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 12' ' ' LEU . 63.1 m-85 -107.84 119.26 38.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.745 . . . . 75.21 108.99 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 61' ' ' SER . 4.8 tt -154.11 157.52 39.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.797 -1.092 . . . . 64.52 108.154 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 14.0 p -81.83 117.54 22.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.372 0.606 . . . . 62.12 110.667 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HZ2' ' HB3' ' A' ' 60' ' ' LEU . 4.2 mppt? -127.66 114.15 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 74.33 109.761 176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.65 -36.58 82.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.597 -0.729 . . . . 72.45 110.998 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 72.4 0.8 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.399 0.619 . . . . 73.4 110.269 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -128.11 4.66 5.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.909 -1.145 . . . . 71.43 107.909 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -143.93 102.66 3.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.597 -1.183 . . . . 74.21 109.885 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -65.22 158.48 26.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.138 -0.483 . . . . 64.3 109.994 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -120.08 102.84 8.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.544 0.688 . . . . 64.11 111.285 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 12.7 t-160 -80.52 148.61 30.33 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.812 -1.181 . . . . 74.22 107.812 172.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 57.2 m-70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.828 -0.606 . . . . 74.53 109.725 -172.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' OD1' ' A' ' 4' ' ' ASP . 26.2 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 110.068 -0.345 . . . . 72.32 110.068 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 tp -134.61 -19.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.493 0.664 . . . . 54.03 110.191 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.91 49.27 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 109.316 -1.514 . . . . 63.43 109.316 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -82.66 156.67 23.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.328 -0.936 . . . . 75.01 111.374 -167.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 62.21 74.16 0.45 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.339 -0.846 . . . . 73.53 111.405 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -96.41 98.13 10.01 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.559 0.695 . . . . 74.12 109.251 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.4 tp -147.2 100.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 75.34 111.258 -172.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.07 -86.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.308 -0.86 . . . . 71.35 112.093 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 55.09 -154.01 0.3 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.401 0.438 . . . . 63.02 110.106 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 p -124.65 80.91 1.9 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.313 0.578 . . . . 70.12 109.672 172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.35 167.83 21.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.63 -0.714 . . . . 63.21 110.598 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.815 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.0 pt? -113.98 118.87 35.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.38 0.61 . . . . 73.33 110.944 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.2 t-20 -83.82 -15.89 46.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.784 -0.643 . . . . 64.13 110.326 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 12.3 p -68.91 -12.68 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.376 -0.829 . . . . 71.11 113.144 -170.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -101.79 67.25 1.09 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.801 -0.76 . . . . 74.05 110.193 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p 47.49 47.31 17.37 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.997 -1.001 . . . . 70.11 111.53 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.31 -91.35 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.018 -0.61 . . . . 43.44 112.833 -175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.24 111.7 1.71 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.108 0.48 . . . . 73.41 110.847 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.0 -166.45 26.11 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.564 -1.015 . . . . 52.1 110.564 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 54' ' ' TYR . 5.2 m -70.11 -44.93 67.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.243 0.522 . . . . 72.3 109.873 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.77 90.18 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.13 -0.693 . . . . 70.55 109.13 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -108.96 10.33 26.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.481 -0.781 . . . . 75.52 110.99 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -44.56 -59.05 2.64 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.629 0.581 . . . . 72.42 112.516 -173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -121.89 -20.86 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 72.41 110.972 -179.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.0 pp -138.16 -164.96 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.51 -0.314 . . . . 72.53 111.708 -170.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA2' HG21 ' A' ' 55' ' ' ILE . . . 177.35 -79.28 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 72.5 113.041 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.623 ' H ' ' N ' ' A' ' 14' ' ' VAL . . . -74.55 172.08 12.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.19 0.519 . . . . 72.22 111.719 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.9 89.09 8.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.695 -0.684 . . . . 71.3 109.515 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 61' ' ' SER . 43.3 Cg_endo -69.53 -55.76 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.495 2.13 . . . . 52.34 112.667 -178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -118.88 -39.44 2.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.77 2.63 58.44 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.567 -0.742 . . . . 71.33 112.037 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -78.27 66.95 3.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.954 0.407 . . . . 61.32 110.793 -175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 179.2 -49.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.522 -0.763 . . . . 74.11 109.601 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.729 ' HB ' ' HD1' ' A' ' 48' ' ' TYR . 10.9 p -97.84 -39.51 8.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.625 -0.716 . . . . 73.13 110.733 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 64.45 174.32 0.19 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.174 0.59 . . . . 62.33 111.74 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -86.7 121.58 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.332 0.587 . . . . 71.22 111.223 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 46' ' ' ILE . 5.7 mt -107.47 -53.23 6.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 72.35 110.701 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -164.56 149.85 10.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.393 . . . . 72.44 110.894 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.93 143.65 46.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.54 -0.755 . . . . 74.15 110.626 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.64 173.46 8.97 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.379 0.609 . . . . 75.34 109.52 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.2 m -84.43 80.36 9.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.024 -0.989 . . . . 55.14 110.059 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.64 -53.62 0.68 Allowed Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 63.32 112.112 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -120.85 152.87 37.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.424 . . . . 75.24 110.662 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.06 119.97 40.8 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.768 -0.827 . . . . 61.45 108.768 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 45' ' ' LYS . 36.9 ttmt -82.89 121.04 26.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.588 -0.733 . . . . 60.2 111.377 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.627 ' HB ' HG21 ' A' ' 34' ' ' VAL . 32.7 pt -142.3 153.0 18.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.598 -0.728 . . . . 75.22 111.54 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -116.95 114.06 23.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.501 -0.926 . . . . 73.34 108.501 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.729 ' HD1' ' HB ' ' A' ' 34' ' ' VAL . 28.8 t80 -119.34 114.28 22.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.47 -0.332 . . . . 63.34 110.823 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 t30 58.4 34.53 24.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.476 0.655 . . . . 63.01 110.994 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.24 69.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.603 -0.808 . . . . 71.22 113.69 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 48' ' ' TYR . 11.1 pt20 -103.94 148.06 26.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.618 0.709 . . . . 73.2 110.984 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.4 m -85.7 117.16 24.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.507 -0.769 . . . . 62.02 109.777 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.39 150.03 18.02 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.185 -1.007 . . . . 75.33 112.496 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' HB ' ' A' ' 20' ' ' THR . 49.5 m-85 -127.67 140.07 52.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.079 -0.712 . . . . 72.14 109.079 174.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.512 HG21 ' HA2' ' A' ' 26' ' ' GLY . 2.7 pp -135.61 160.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.94 -0.393 . . . . 55.42 109.94 177.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.12 124.35 6.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.299 -0.953 . . . . 62.25 112.145 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 m -61.43 -18.75 60.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.505 0.669 . . . . 62.1 110.202 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -69.3 -9.12 51.78 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.392 -0.822 . . . . 72.34 111.447 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 13' ' ' ASN . 7.4 m-85 -131.58 115.06 15.6 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.803 0.335 . . . . 71.43 110.122 171.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -157.74 174.15 15.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.803 -0.635 . . . . 72.0 109.742 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 15.4 t -108.28 118.93 38.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.52 -0.918 . . . . 65.41 108.52 172.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -119.05 79.97 1.48 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.47 -0.567 . . . . 52.44 109.47 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 65' ' ' HIS . 0.6 OUTLIER -138.02 -48.64 0.55 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.464 -0.789 . . . . 65.11 110.649 -174.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 54.25 77.87 0.18 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.811 0.694 . . . . 72.13 109.18 -166.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.438 ' HB3' HD12 ' A' ' 63' ' ' LEU . 8.6 p80 -89.92 151.06 21.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.654 -0.703 . . . . 74.12 110.841 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 67.65 98.58 0.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.186 0.929 . . . . 75.35 111.575 -173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -82.81 -37.66 24.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.413 -0.958 . . . . 72.04 108.413 172.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -90.2 142.71 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.32 -0.854 . . . . 71.43 109.668 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 30.7 p-80 -117.99 73.94 0.92 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.146 -0.687 . . . . 72.3 109.146 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 69' ' ' HIS . 34.1 m80 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 114.777 -1.101 . . . . 65.15 110.281 -170.128 . . . . . . . . 1 1 . 1 stop_ save_